data_2mq1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mq1 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.965 0.412 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 4.4 m -46.0 145.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -82.36 -26.61 32.75 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 -33.31 12.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 110.567 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -104.33 -25.4 12.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -0.898 . . . . 0.0 110.83 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.26 -9.24 49.03 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 5.7 mp -73.28 158.45 86.75 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.993 -1.298 . . . . 0.0 108.819 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -68.15 104.34 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.8 1.667 . . . . 0.0 112.883 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.4 mt -50.99 120.15 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.43 0.633 . . . . 0.0 110.236 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -88.31 -27.07 21.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.69 144.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -80.78 100.11 8.6 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.802 -1.186 . . . . 0.0 110.453 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 95.1 1.64 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -80.89 137.28 36.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.037 -0.684 . . . . 0.0 110.168 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 9.7 mtp -121.74 134.18 54.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.122 0.486 . . . . 0.0 110.238 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.37 155.9 45.17 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.69 2.97 52.47 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.145 -1.19 . . . . 0.0 111.364 -0.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.3 t -56.74 -33.48 66.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.537 -0.727 . . . . 0.0 109.389 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 66.93 26.69 9.12 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 33.8 m170 -97.49 162.49 13.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.902 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -118.07 160.79 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.157 0.98 . . . . 0.0 111.019 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 93.5 m-85 -164.53 -165.23 0.91 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.59 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -85.06 113.12 21.24 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -47.67 -16.38 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.973 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 25' ' ' CYS . 7.4 t70 -82.73 -50.68 8.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.027 -1.046 . . . . 0.0 109.488 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 3.0 m -78.86 -20.85 48.56 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.81 -1.182 . . . . 0.0 108.096 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.93 71.33 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.7 pt -80.32 -33.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 121.001 -1.062 . . . . 0.0 108.793 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.0 -34.37 77.86 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.876 -1.13 . . . . 0.0 107.988 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.17 -42.52 72.36 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.94 95.82 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 mttp . . . . . 0 C--N 1.303 -1.431 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.218 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 39' ' ' MET . 10.8 ptm . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.556 0.693 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 t -62.12 139.8 96.03 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.77 . . . . 0.0 108.981 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.69 -36.97 20.08 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.875 1.716 . . . . 0.0 112.416 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.89 -36.94 0.79 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.601 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -83.6 -14.16 52.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.281 . . . . 0.0 110.277 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 t 47.65 36.02 5.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.077 -1.015 . . . . 0.0 109.464 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.33 161.11 38.15 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 108.786 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.73 73.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.153 1.902 . . . . 0.0 111.884 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 45' ' ' ASP . 59.0 t -47.16 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 0.0 109.501 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -66.72 -62.79 1.27 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.161 -0.962 . . . . 0.0 108.517 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.03 134.31 17.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.799 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -94.34 145.97 7.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.616 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.09 150.79 44.75 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.438 0.637 . . . . 0.0 109.781 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -94.91 150.12 20.51 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.566 -0.709 . . . . 0.0 109.75 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.87 168.26 25.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.267 -0.895 . . . . 0.0 109.69 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.524 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -80.64 157.43 25.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.308 -0.87 . . . . 0.0 108.828 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -75.5 26.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.052 . . . . 0.0 109.864 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -144.29 13.91 2.08 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.434 ' OG ' ' OG1' ' A' ' 54' ' ' THR . 0.7 OUTLIER -97.11 -19.05 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.777 -0.837 . . . . 0.0 110.365 -179.042 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 mt -110.81 165.4 11.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.539 -0.726 . . . . 0.0 109.784 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 24.4 m-85 -119.19 113.88 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.0 mtp -80.61 144.41 32.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.726 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.592 ' HE ' ' HE2' ' A' ' 22' ' ' HIS . 13.3 mmt85 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -74.15 176.35 6.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.72 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 70' ' ' THR . 78.4 m-85 -159.05 -170.87 3.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.86 -11.43 14.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 110.278 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 74' ' ' GLN . 3.5 m -150.91 133.5 15.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.975 -1.078 . . . . 0.0 109.343 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 73' ' ' SER . 2.1 tp60 -44.12 -31.93 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -61.66 -31.98 72.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 110.496 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.02 -35.62 23.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 108.639 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.83 -34.35 62.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.682 HE22 HD21 ' A' ' 82' ' ' ASN . 0.9 OUTLIER -68.17 -39.01 82.67 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.108 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.543 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -66.02 -21.55 66.4 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 25.8 t60 -76.05 -36.91 58.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.919 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.414 ' H ' HG12 ' A' ' 81' ' ' ILE . 6.6 mm -62.05 -53.28 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 110.038 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.682 HD21 HE22 ' A' ' 78' ' ' GLN . 3.8 p30 -72.18 -19.02 61.82 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.68 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 34.6 m170 -85.71 -25.9 26.21 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.525 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -129.97 -20.11 3.16 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.278 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 8.5 m-70 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.398 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 4.3 t -46.37 146.37 1.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 110.073 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -18.56 39.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.458 -0.776 . . . . 0.0 109.303 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.03 -51.23 3.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 10.3 m -84.14 -14.65 49.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.406 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.24 9.13 14.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.23 158.62 33.68 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.343 -1.092 . . . . 0.0 108.693 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.73 101.53 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.989 1.793 . . . . 0.0 112.267 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.2 mt -50.27 120.74 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.514 0.673 . . . . 0.0 110.578 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.32 -31.66 20.06 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.06 141.89 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -81.74 102.03 10.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.544 -1.347 . . . . 0.0 110.688 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -75.54 85.74 0.84 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.588 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.5 ttt-85 -69.33 134.87 49.62 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 122.09 -0.653 . . . . 0.0 110.454 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 21' ' ' LYS . 9.4 mmm -118.4 132.42 56.26 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -116.24 156.46 47.07 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.72 -1.74 47.83 Favored 'Cis proline' 0 N--CA 1.49 1.285 0 C-N-CA 124.137 -1.193 . . . . 0.0 111.533 -0.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.581 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -51.04 -34.16 28.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.588 ' CG ' HH21 ' A' ' 16' ' ' ARG . 3.4 ttmt 67.68 25.86 8.04 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.581 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 21.3 m170 -94.16 179.77 5.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.2 m -144.54 153.27 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 110.788 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 73.9 m-85 -158.42 170.34 22.44 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -55.61 113.63 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.039 -1.465 . . . . 0.0 108.171 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.463 ' CE2' ' CD ' ' A' ' 52' ' ' GLN . 35.5 t80 -49.43 -11.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.855 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -74.56 -44.5 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.021 -1.049 . . . . 0.0 108.831 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -80.49 -25.48 38.77 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.886 -1.133 . . . . 0.0 108.119 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.69 83.58 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.486 -0.885 . . . . 0.0 108.702 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.5 pt -78.86 -34.95 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.024 -1.047 . . . . 0.0 108.918 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.62 -21.9 66.62 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.267 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -80.09 -40.68 27.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.9 -29.82 62.27 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.465 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 C--N 1.305 -1.365 0 O-C-N 121.102 -0.999 . . . . 0.0 108.424 179.698 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.445 ' O ' ' CG ' ' A' ' 39' ' ' MET . 15.4 ptm . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.261 0.553 . . . . 0.0 109.853 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -64.03 124.36 85.0 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.076 -1.015 . . . . 0.0 109.758 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -44.31 -22.86 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.127 1.885 . . . . 0.0 113.068 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.22 -64.65 0.87 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 62.9 m -69.69 -43.65 72.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.232 -1.158 . . . . 0.0 108.564 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.6 p 76.9 57.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.832 -0.543 . . . . 0.0 111.622 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.443 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 174.82 -48.19 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.386 -1.446 . . . . 0.0 112.117 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 45' ' ' ASP . 64.9 Cg_endo -86.47 51.44 2.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.57 2.18 . . . . 0.0 115.706 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -95.35 117.28 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.263 -1.523 . . . . 0.0 109.211 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -98.27 -65.55 0.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.426 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -141.75 137.94 31.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mt -92.45 145.9 7.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.737 -1.227 . . . . 0.0 109.696 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -137.28 149.0 46.79 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.755 0.788 . . . . 0.0 109.844 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 32.0 mt-30 -94.74 136.15 35.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.831 -0.543 . . . . 0.0 110.03 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.96 155.62 48.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.619 -0.675 . . . . 0.0 110.027 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.75 158.2 22.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.35 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.527 ' C ' ' H ' ' A' ' 57' ' ' SER . 7.8 ttp180 -49.33 -69.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -0.98 . . . . 0.0 109.988 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.32 27.52 0.57 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 55' ' ' ARG . 17.0 t -85.05 -27.94 26.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.909 -1.347 . . . . 0.0 108.858 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -112.43 173.73 6.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 17.6 m-85 -113.27 120.54 41.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.852 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 mtp -81.65 144.66 31.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 109.916 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' NE2' ' A' ' 80' ' ' HIS . 50.3 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.362 -0.836 . . . . 0.0 109.479 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 70' ' ' THR . 12.0 mmt-85 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.513 ' H ' ' HG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -48.19 173.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 109.424 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.81 -173.75 4.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -116.65 -5.15 11.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.695 -0.628 . . . . 0.0 109.804 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -145.81 125.62 13.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.942 . . . . 0.0 109.061 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -45.38 -22.69 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.6 tmm_? -69.86 -36.32 75.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 110.129 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -82.57 -33.95 27.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 tp -70.1 -38.29 75.62 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -67.52 -30.43 70.08 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.48 -20.98 62.0 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.591 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -78.09 -41.58 34.82 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.355 -1.338 . . . . 0.0 108.429 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.8 mm -56.3 -54.98 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 109.281 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.497 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 5.8 p30 -69.35 -23.56 63.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.526 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.9 m170 -87.68 -11.73 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.189 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.37 -49.95 2.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.264 -0.897 . . . . 0.0 112.858 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.492 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.214 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 4.9 t -45.95 146.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.818 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.8 -25.43 40.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -48.8 4.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.278 -0.889 . . . . 0.0 110.301 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 10.4 m -78.07 -15.61 58.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.83 13.06 12.03 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.66 158.75 31.2 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.546 -0.973 . . . . 0.0 108.48 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -65.85 103.45 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.088 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -49.47 116.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.336 0.589 . . . . 0.0 110.447 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 -31.72 33.94 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.57 145.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -73.99 102.07 4.04 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.491 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.13 85.72 1.11 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH2' ' OG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -71.28 141.44 50.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.904 -0.762 . . . . 0.0 110.519 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 21' ' ' LYS . 11.4 mtp -129.58 132.84 46.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.756 -0.59 . . . . 0.0 109.887 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -118.03 156.03 50.66 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.83 3.58 41.46 Favored 'Cis proline' 0 N--CA 1.492 1.385 0 C-N-CA 124.112 -1.203 . . . . 0.0 111.799 -0.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.589 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -55.39 -37.04 67.05 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.427 -0.795 . . . . 0.0 109.008 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' O ' ' NH2' ' A' ' 16' ' ' ARG . 3.0 tttm 68.78 29.14 5.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 4.9 m80 -100.41 -174.75 2.73 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.759 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.572 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -141.66 155.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.396 -0.815 . . . . 0.0 110.998 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.8 m-85 -164.17 168.3 19.11 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -55.43 112.61 1.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.193 -1.403 . . . . 0.0 108.008 178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -49.63 -31.3 10.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 0.0 109.883 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -39.99 84.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -81.38 -23.66 37.52 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.21 -35.89 74.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.517 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.1 pt -86.7 -35.13 8.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.163 -0.961 . . . . 0.0 109.419 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.71 -23.82 60.91 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.333 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.566 ' CE1' ' SG ' ' A' ' 28' ' ' CYS . 40.7 m170 -78.44 -55.45 5.21 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.24 -32.31 66.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.388 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 mttm . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.034 -1.041 . . . . 0.0 109.367 179.751 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.421 ' O ' ' C ' ' A' ' 40' ' ' CYS . 7.4 mtm . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -38.72 102.91 0.26 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.049 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.466 ' CG ' ' HD1' ' A' ' 32' ' ' HIS . 51.3 Cg_exo -50.56 -19.48 5.0 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.796 1.664 . . . . 0.0 112.33 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.15 -37.21 2.95 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.71 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.0 m -104.84 -31.63 9.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -1.113 . . . . 0.0 110.319 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 75.59 63.02 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.079 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.8 160.31 67.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.88 90.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.553 2.169 . . . . 0.0 112.38 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.49 94.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 108.687 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ILE . 5.3 tt0 -61.75 -62.85 1.51 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.191 -0.943 . . . . 0.0 108.638 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.413 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.78 139.07 22.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.273 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.54 143.11 13.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.826 -1.171 . . . . 0.0 109.844 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -136.73 141.14 43.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.785 0.802 . . . . 0.0 110.025 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -85.52 149.2 25.54 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.329 0.585 . . . . 0.0 109.669 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.86 165.93 27.45 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.32 169.78 10.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.772 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -90.38 74.86 6.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.398 1.095 . . . . 0.0 108.649 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.82 4.42 0.1 Allowed Glycine 0 C--N 1.288 -2.113 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.6 m -90.23 -34.0 15.96 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.089 -1.242 . . . . 0.0 109.536 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.23 173.88 6.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.701 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -134.66 128.5 33.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.673 -0.642 . . . . 0.0 109.521 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.08 144.73 29.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.537 -0.727 . . . . 0.0 110.577 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' CB ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 109.371 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.71 HH11 HH22 ' A' ' 84' ' ' ARG . 68.5 mtp180 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.254 0.549 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.527 ' OG1' ' NH2' ' A' ' 16' ' ' ARG . 1.2 p -56.18 170.01 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 69' ' ' ARG . 37.2 m-85 -158.0 170.01 23.27 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -108.03 -5.65 16.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.742 -0.598 . . . . 0.0 109.727 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.3 t -158.57 129.49 6.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.2 tp60 -42.27 -26.15 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.331 0.586 . . . . 0.0 109.439 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 tmt_? -64.17 -34.79 78.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -83.17 -36.52 24.65 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 108.41 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.34 -33.15 67.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.437 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 23.3 tp60 -69.99 -33.32 71.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.532 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.34 61.43 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.424 ' CD2' ' CB ' ' A' ' 61' ' ' CYS . 26.3 t60 -74.22 -44.12 54.44 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.471 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.18 -53.53 47.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.549 -0.72 . . . . 0.0 109.196 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 14.8 m-20 -64.65 -22.51 66.99 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.22 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 18.1 m170 -87.41 -12.24 46.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.125 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.71 HH22 HH11 ' A' ' 69' ' ' ARG . 15.3 mmt-85 -120.9 -43.45 2.46 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.25 -0.906 . . . . 0.0 112.866 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.634 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.773 0 O-C-N 120.592 -1.317 . . . . 0.0 110.244 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.318 0.58 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.567 ' SG ' ' N ' ' A' ' 8' ' ' GLY . 10.4 p -51.56 143.89 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.39 -0.819 . . . . 0.0 110.057 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.85 -4.48 57.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -85.46 -33.27 21.91 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -135.68 -15.96 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.621 -0.674 . . . . 0.0 110.488 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.567 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.09 14.31 64.68 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.212 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.52 156.62 37.32 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.088 -1.243 . . . . 0.0 108.432 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.97 136.52 66.18 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.778 1.652 . . . . 0.0 111.788 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.0 mt -88.17 93.79 4.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.61 0.719 . . . . 0.0 110.313 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -69.34 -36.35 76.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.23 142.72 36.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -73.31 106.04 4.96 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.135 -0.978 . . . . 0.0 111.123 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.79 81.27 0.77 Allowed Glycine 0 C--N 1.297 -1.616 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.525 HH12 ' C ' ' A' ' 21' ' ' LYS . 19.8 ttm-85 -65.8 133.01 50.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.942 -0.74 . . . . 0.0 109.164 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.533 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 31.3 mtp -119.12 134.62 55.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 110.566 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.445 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -118.75 156.5 51.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.88 -1.32 43.76 Favored 'Cis proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.962 -1.266 . . . . 0.0 111.32 0.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.604 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -49.87 -41.2 44.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.525 ' C ' HH12 ' A' ' 16' ' ' ARG . 5.4 ttmt 74.08 27.96 1.51 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 23.3 m80 -99.82 -175.99 3.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.486 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 2.9 m -145.3 153.55 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.171 -0.956 . . . . 0.0 111.376 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 66.3 m-85 -154.23 -149.94 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -90.54 107.81 19.4 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.558 ' CD2' ' CG ' ' A' ' 52' ' ' GLN . 51.2 t80 -48.34 -13.48 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 109.832 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -83.05 -48.95 10.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 109.703 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 3.4 m -79.91 -23.15 42.0 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 108.361 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' ' CD1' ' A' ' 50' ' ' ILE . . . -68.31 -35.25 77.54 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.4 pt -81.75 -34.34 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 O-C-N 120.948 -1.095 . . . . 0.0 109.241 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.62 -23.94 63.58 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.854 -1.139 . . . . 0.0 108.406 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.24 -40.4 27.11 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.185 -0.947 . . . . 0.0 108.833 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -31.24 63.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.1 mttt . . . . . 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 -179.427 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 42' ' ' GLY . 10.6 t -102.74 74.49 0.17 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.804 -0.56 . . . . 0.0 111.008 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -35.3 -21.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.517 2.145 . . . . 0.0 114.034 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -75.34 -35.48 47.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.607 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.9 m -125.81 -33.46 2.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 122.019 -0.695 . . . . 0.0 109.424 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' CYS . 2.8 p 83.99 78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.904 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.66 160.03 48.91 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.22 81.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.014 1.809 . . . . 0.0 111.612 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.4 t -48.49 101.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 108.728 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -61.53 1.74 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.3 122.97 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.292 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.472 ' CD1' ' O ' ' A' ' 29' ' ' ALA . 6.8 mt -79.89 147.41 6.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.876 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -139.03 162.54 34.69 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.605 0.717 . . . . 0.0 110.559 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.558 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 45.7 mt-30 -99.12 134.51 41.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.77 -0.581 . . . . 0.0 110.539 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.25 155.28 47.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.51 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.38 155.86 17.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.833 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.562 ' C ' ' H ' ' A' ' 57' ' ' SER . 1.1 ptm180 -51.61 -55.44 19.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.815 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.56 7.69 0.94 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.562 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -103.61 -8.21 20.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.39 -1.065 . . . . 0.0 109.741 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.8 mt -130.99 169.09 16.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 110.098 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 44.8 m-85 -122.59 122.35 38.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.5 mtt -87.64 144.83 26.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 0.0 110.336 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 51.7 t . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.634 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.523 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.19 175.82 10.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 70' ' ' THR . 88.6 m-85 -157.49 -164.63 1.61 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.378 -0.826 . . . . 0.0 108.941 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.519 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -116.31 -9.52 11.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.766 -0.584 . . . . 0.0 110.106 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 75' ' ' ARG . 62.7 m -147.22 128.45 14.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.653 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.24 -18.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.22 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' SER . 7.6 tmm_? -74.25 -33.91 63.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.695 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.94 -35.78 25.73 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.8 -33.95 64.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -71.03 -30.58 66.82 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.547 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.48 -21.15 61.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.38 -39.83 62.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.174 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 81' ' ' ILE . 28.0 mm -57.58 -59.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.871 0.843 . . . . 0.0 110.029 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.463 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.0 p30 -67.44 -20.11 65.46 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.555 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 37.5 m170 -86.94 -13.46 44.63 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -124.79 -41.03 2.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.177 -0.952 . . . . 0.0 112.334 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 . . . . . 0 C--N 1.301 -1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.609 -179.689 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 3.0 t80 . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 48.2 t -45.66 146.18 1.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.881 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -27.62 18.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.443 -0.786 . . . . 0.0 109.452 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.7 -38.78 10.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.9 m -96.09 -28.64 14.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.463 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.51 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.73 4.73 90.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.92 156.29 40.69 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.122 -1.222 . . . . 0.0 108.654 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.11 138.28 85.6 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.914 1.742 . . . . 0.0 112.089 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 13' ' ' VAL . 40.5 mt -84.7 -67.4 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.642 -0.661 . . . . 0.0 111.002 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.0 -32.71 0.24 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.607 ' H ' ' C ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -145.17 120.06 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -67.21 113.26 5.0 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.655 -0.653 . . . . 0.0 110.863 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.75 82.2 1.67 Allowed Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.61 ' NH2' ' HZ2' ' A' ' 21' ' ' LYS . 4.0 ttt-85 -64.9 133.99 53.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 122.141 -0.623 . . . . 0.0 109.946 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.5 mtp -118.09 133.58 55.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.079 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.87 156.78 49.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.43 1.24 56.47 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.017 0.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.59 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 5.7 t -54.68 -38.04 66.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.407 -0.808 . . . . 0.0 109.13 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.61 ' HZ2' ' NH2' ' A' ' 16' ' ' ARG . 5.4 tttm 76.56 29.33 0.68 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.599 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 2.6 m80 -101.58 -179.17 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -145.88 155.31 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.033 -1.042 . . . . 0.0 110.97 -179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 51.2 m-85 -159.71 167.12 29.1 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 20.4 p -51.68 110.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.212 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -49.67 -10.92 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.622 -0.674 . . . . 0.0 110.356 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.1 m-20 -78.65 -44.31 24.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.725 -1.234 . . . . 0.0 109.51 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 p -80.51 -25.35 38.79 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 108.196 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.71 88.46 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.7 pt -82.57 -34.55 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.629 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.15 -19.48 59.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.151 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.18 -54.06 6.98 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.27 -0.894 . . . . 0.0 109.161 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -67.62 -30.97 70.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 mttp . . . . . 0 C--N 1.307 -1.27 0 O-C-N 121.024 -1.047 . . . . 0.0 109.071 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -42.87 106.12 0.46 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.0 109.621 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.47 -21.92 8.17 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.568 1.512 . . . . 0.0 112.124 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.21 -42.12 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.747 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.599 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 4.8 m -100.88 -30.33 11.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -1.159 . . . . 0.0 110.608 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.19 57.04 0.09 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 109.06 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.48 160.96 48.33 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.609 -0.682 . . . . 0.0 109.209 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.08 89.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.538 2.158 . . . . 0.0 112.048 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.45 101.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.187 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.55 -66.22 0.57 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.437 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -151.35 134.8 16.17 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.485 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.26 145.81 7.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.666 -1.271 . . . . 0.0 109.107 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.53 146.82 44.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.75 142.16 27.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.774 -0.579 . . . . 0.0 109.605 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.38 159.07 44.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.355 -0.841 . . . . 0.0 110.204 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.467 ' H ' ' HG1' ' A' ' 54' ' ' THR . 0.0 OUTLIER -76.38 162.82 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.05 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.567 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -66.32 -60.32 2.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 110.064 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.39 25.89 0.58 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.567 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.3 t -91.17 -23.6 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.4 173.45 6.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.734 -0.604 . . . . 0.0 109.71 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -117.08 119.91 36.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.4 mmt -75.9 144.52 41.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 110.341 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.035 179.493 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -82.71 174.79 10.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.954 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' A' ' 70' ' ' THR . 98.2 m-85 -158.31 -177.92 6.9 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.546 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -113.9 -2.7 13.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.587 -0.695 . . . . 0.0 110.549 -178.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.483 ' HG ' ' C ' ' A' ' 72' ' ' LEU . 1.5 m -154.57 131.39 10.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.814 -1.179 . . . . 0.0 109.865 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.3 tp60 -43.39 -30.18 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -63.77 -35.05 79.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.509 -0.745 . . . . 0.0 110.131 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.1 m-20 -81.19 -37.82 28.07 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.995 0.903 . . . . 0.0 108.705 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 tt -74.43 -31.07 62.16 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLN . 22.6 tp60 -71.07 -33.73 70.52 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.31 -19.92 61.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.416 ' ND1' ' OH ' ' A' ' 71' ' ' TYR . 77.7 t60 -72.67 -47.52 46.75 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.601 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mm -56.17 -51.05 67.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.688 -0.633 . . . . 0.0 109.61 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.05 -18.66 62.56 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.867 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.0 m170 -87.67 -27.32 22.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.075 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -23.82 2.96 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.485 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 5.4 m-70 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.163 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.8 t -46.93 146.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.874 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.43 -24.11 39.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.447 -0.783 . . . . 0.0 109.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -60.95 1.44 Allowed 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.375 -0.828 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 7.3 m -68.27 -14.93 63.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 110.291 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.49 11.33 5.12 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 152.49 37.83 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.988 . . . . 0.0 108.572 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.76 100.37 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.729 1.619 . . . . 0.0 112.259 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.8 mt -47.37 117.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.681 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -83.14 -32.08 26.84 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.12 143.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -73.19 100.71 3.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 120.852 -1.155 . . . . 0.0 111.032 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -76.53 86.86 0.93 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.46 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.6 ttt-85 -77.79 141.43 39.22 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.761 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.553 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 11.2 mtp -128.72 132.45 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.968 -0.457 . . . . 0.0 109.949 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.6 156.22 45.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.73 4.08 46.07 Favored 'Cis proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.344 -0.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.2 t -55.81 -35.36 66.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.509 -0.745 . . . . 0.0 109.122 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' MET . 4.5 tttt 66.62 27.77 9.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.609 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 27.0 m170 -93.54 -173.3 3.15 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.478 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.553 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -142.89 156.68 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 110.346 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 85.7 m-85 -165.66 166.26 18.14 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -57.68 114.75 2.41 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -47.65 -21.27 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.016 -1.052 . . . . 0.0 109.808 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.36 -39.87 62.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.061 -1.024 . . . . 0.0 108.248 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.537 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.02 -22.29 33.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.28 72.11 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.4 pt -80.52 -35.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 121.104 -0.998 . . . . 0.0 108.67 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.57 -38.81 91.57 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.693 -1.203 . . . . 0.0 107.876 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.26 -34.88 73.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -35.78 76.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.835 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mttt . . . . . 0 C--N 1.302 -1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 108.704 179.623 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.7 ptp . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.881 0.848 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.539 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 1.5 t -71.0 136.65 84.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -45.81 -46.68 15.07 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.911 1.741 . . . . 0.0 113.074 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.08 4.26 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.214 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.609 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -94.07 -14.97 25.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.257 . . . . 0.0 110.586 -178.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 p 48.48 38.18 10.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -92.22 161.1 33.86 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.357 -0.84 . . . . 0.0 108.999 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLN . 19.6 Cg_endo -59.73 71.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.2 1.933 . . . . 0.0 112.068 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 45' ' ' ASP . 61.2 t -44.99 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.17 -0.956 . . . . 0.0 109.724 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' PRO . 3.7 tt0 -65.61 -61.74 1.92 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.069 -1.019 . . . . 0.0 108.344 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.76 137.53 21.39 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.769 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mt -94.78 147.31 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.641 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -140.53 154.48 46.56 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.29 0.567 . . . . 0.0 109.706 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.22 138.47 45.52 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.25 0.548 . . . . 0.0 109.692 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.69 165.97 25.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -82.88 157.89 22.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.853 . . . . 0.0 109.091 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -72.53 31.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -146.79 14.28 1.54 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 m -97.21 -28.63 14.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.702 -0.881 . . . . 0.0 110.404 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.11 172.42 7.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.607 -0.683 . . . . 0.0 109.783 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 41.7 m-85 -116.89 124.1 48.64 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -86.44 144.55 27.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.91 . . . . 0.0 110.393 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.585 ' N ' ' SD ' ' A' ' 60' ' ' MET . 42.1 t . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.483 -0.761 . . . . 0.0 109.125 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.594 0.712 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.476 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -90.56 -173.84 3.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.6 ' HH ' ' CG ' ' A' ' 80' ' ' HIS . 95.6 m-85 -152.39 178.29 9.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.991 . . . . 0.0 108.903 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.539 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.33 -10.04 14.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.715 -0.615 . . . . 0.0 109.743 -179.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 75' ' ' ARG . 48.2 t -153.18 132.29 12.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.002 . . . . 0.0 109.91 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.54 -22.08 0.43 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.103 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.8 ttt-85 -70.89 -32.51 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -83.52 -34.67 25.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 tt -75.68 -33.88 60.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.438 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 20.6 tp60 -70.3 -33.58 71.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.545 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.84 -19.32 60.77 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.629 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 24.3 t60 -74.81 -44.76 47.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.531 -1.267 . . . . 0.0 108.605 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mm -56.73 -53.3 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.722 0.772 . . . . 0.0 109.443 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 3.7 m-20 -69.38 -19.72 63.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.215 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 18.4 m170 -87.49 -25.92 23.46 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.781 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.64 -34.24 1.79 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.066 -1.021 . . . . 0.0 112.651 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.629 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 7.6 m-70 . . . . . 0 C--N 1.297 -1.679 0 O-C-N 120.917 -1.114 . . . . 0.0 109.001 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 13.2 t -45.76 146.39 1.16 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 109.991 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.64 -25.92 32.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.599 -0.688 . . . . 0.0 109.71 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.66 -42.63 7.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 48.1 m -90.55 -29.7 17.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.061 -1.024 . . . . 0.0 110.666 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 1.36 87.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.88 158.8 49.97 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 108.502 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -68.54 97.73 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.878 1.719 . . . . 0.0 112.5 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -41.68 113.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -82.97 -32.71 26.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -133.14 147.01 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.05 104.49 16.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.822 -1.174 . . . . 0.0 111.114 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.4 91.27 1.15 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.542 ' NH2' ' O ' ' A' ' 21' ' ' LYS . 2.5 tpt85 -74.63 135.84 41.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.082 -0.657 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.539 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 8.3 mtp -126.34 132.2 51.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.921 -0.487 . . . . 0.0 109.766 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.423 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.28 156.33 48.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.63 3.8 40.11 Favored 'Cis proline' 0 N--CA 1.49 1.321 0 C-N-CA 124.07 -1.221 . . . . 0.0 111.112 -0.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.6 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -55.07 -32.01 61.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' NH2' ' A' ' 16' ' ' ARG . 1.8 mttp 59.52 31.09 20.76 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.606 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 9.3 m170 -96.16 -173.15 2.72 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.591 -0.693 . . . . 0.0 109.374 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.488 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -147.36 149.0 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 110.58 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 37.1 m-85 -158.35 170.6 21.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -59.31 113.89 2.38 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 117.887 -1.525 . . . . 0.0 107.222 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -46.31 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 110.367 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.1 m-20 -78.93 -41.14 30.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.001 -1.062 . . . . 0.0 108.724 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -80.35 -22.08 41.76 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.0 -1.062 . . . . 0.0 108.57 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.84 -29.06 65.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 pt -89.14 -28.5 5.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.658 -1.276 . . . . 0.0 108.955 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.4 mt -66.77 -35.89 81.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.09 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -76.27 -44.38 37.46 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.607 ' N ' ' CG ' ' A' ' 32' ' ' HIS . 1.2 pt-20 -52.31 -32.74 39.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 mttm . . . . . 0 C--N 1.304 -1.381 0 O-C-N 121.274 -0.891 . . . . 0.0 109.56 179.659 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 39' ' ' MET . 11.9 ptm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.607 0.717 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.2 143.18 97.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 108.995 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.18 -38.11 95.49 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.125 1.217 . . . . 0.0 112.076 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.33 -45.38 1.35 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.61 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.606 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -89.48 -10.76 45.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.817 -1.402 . . . . 0.0 110.732 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t 48.37 37.48 8.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 108.842 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -89.56 161.1 40.34 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.406 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.2 76.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.488 2.125 . . . . 0.0 111.71 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' ASP . 17.3 t -48.97 109.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.283 -0.885 . . . . 0.0 109.983 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -72.03 -62.25 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 108.56 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.423 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.78 134.5 16.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.692 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mt -92.79 144.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.819 -1.176 . . . . 0.0 109.88 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -140.8 146.47 37.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.448 0.642 . . . . 0.0 109.44 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -91.27 150.88 21.13 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.584 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.87 167.84 26.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.489 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -90.49 165.27 13.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.362 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -59.5 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -0.969 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.66 18.9 22.88 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 54' ' ' THR . 50.9 m -85.16 -21.23 29.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.052 -1.263 . . . . 0.0 108.999 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.06 173.1 11.56 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 6.3 m-85 -117.92 109.41 16.48 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.572 -0.705 . . . . 0.0 110.425 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -71.92 144.77 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 0.0 110.138 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' NE2' ' A' ' 80' ' ' HIS . 44.7 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.824 . . . . 0.0 109.555 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.863 0.363 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.492 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 7.8 p -94.22 158.56 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 110.867 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.641 ' HH ' ' CG ' ' A' ' 80' ' ' HIS . 75.7 m-85 -152.1 173.35 15.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -100.92 -10.78 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.586 -178.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -162.12 138.99 8.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.807 -1.183 . . . . 0.0 110.519 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -42.99 -31.17 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.41 0.624 . . . . 0.0 109.752 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -66.27 -32.28 73.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.443 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.34 -33.56 22.03 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.52 ' O ' ' ND1' ' A' ' 80' ' ' HIS . 0.2 OUTLIER -75.48 -35.18 60.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -72.63 -34.3 67.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.82 -19.64 62.65 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.641 ' CG ' ' HH ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -77.76 -40.99 39.1 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.396 -1.322 . . . . 0.0 108.641 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.438 ' H ' HG12 ' A' ' 81' ' ' ILE . 3.8 mm -55.71 -54.77 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 108.405 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.48 -26.28 66.29 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.772 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -89.97 -11.97 40.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.579 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -112.19 -54.6 2.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.226 -0.921 . . . . 0.0 112.945 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.233 0.539 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 t -45.54 146.74 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.214 -0.928 . . . . 0.0 109.987 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -36.15 66.89 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -54.32 2.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 4.0 m -66.05 -13.87 60.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.094 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 4.72 0.47 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 7' ' ' CYS . 5.4 mp -88.96 157.87 47.97 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.249 . . . . 0.0 108.475 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.04 99.29 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.854 1.703 . . . . 0.0 112.539 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.1 mt -47.06 121.43 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -142.45 145.3 23.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -77.39 105.91 8.81 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.714 -1.241 . . . . 0.0 111.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.18 79.88 1.44 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 51' ' ' GLU . 11.5 ttt-85 -58.15 136.71 57.29 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.835 -0.803 . . . . 0.0 109.483 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.556 ' SD ' ' SG ' ' A' ' 40' ' ' CYS . 25.0 ttm -121.59 137.93 54.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.541 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -127.41 156.85 74.39 Favored Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 -0.34 38.15 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 C-N-CA 124.225 -1.156 . . . . 0.0 112.047 0.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.593 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 1.9 t -55.88 -36.82 68.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.1 OUTLIER 74.04 26.92 1.65 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.593 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 2.1 m170 -95.45 -169.25 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -146.44 153.89 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 109.979 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.2 m-85 -159.09 163.01 36.61 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.56 113.08 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.218 -1.393 . . . . 0.0 107.864 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -53.73 -19.18 3.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.453 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.41 -37.07 26.06 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.772 -1.205 . . . . 0.0 108.292 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -83.2 -25.51 31.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.26 72.12 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 pt -87.99 -33.87 6.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.189 -0.944 . . . . 0.0 109.211 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.39 -26.66 58.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.056 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 28' ' ' CYS . 18.2 m170 -76.74 -50.21 14.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.213 -0.929 . . . . 0.0 108.684 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.33 -27.97 68.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.3 mttt . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.665 -179.845 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 40' ' ' CYS . 2.7 mtt . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.32 0.581 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.556 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -37.1 102.1 0.23 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 122.017 -0.427 . . . . 0.0 111.088 -178.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.65 -14.55 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.667 1.578 . . . . 0.0 111.54 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.1 -38.61 4.02 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.192 -1.004 . . . . 0.0 110.835 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.4 m -120.54 -21.31 6.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.415 -1.05 . . . . 0.0 110.771 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 73.97 55.53 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.142 -179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.95 161.42 30.96 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' GLN . 13.1 Cg_endo -58.7 83.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.389 2.059 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.69 97.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.205 -0.934 . . . . 0.0 109.07 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' PRO . 8.1 mt-30 -64.11 -64.0 1.0 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.274 -0.891 . . . . 0.0 108.984 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.458 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.27 126.66 7.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.554 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.32 145.03 7.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 110.25 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' ARG . 24.5 mt-10 -137.31 151.5 48.71 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.766 0.793 . . . . 0.0 110.185 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -90.49 147.61 23.28 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.692 -0.63 . . . . 0.0 109.714 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -152.15 167.39 28.68 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.427 ' OG1' ' OG ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -81.62 163.79 22.31 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.143 -0.973 . . . . 0.0 109.002 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.538 ' C ' ' H ' ' A' ' 57' ' ' SER . 4.6 mtm180 -66.74 -69.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 110.671 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.99 28.36 0.3 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.637 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 55' ' ' ARG . 32.5 m -93.25 -36.9 12.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.277 . . . . 0.0 109.798 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.14 173.34 6.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.731 . . . . 0.0 109.915 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.06 106.8 14.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 ttt -72.19 144.41 48.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 109.454 179.681 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.184 0.516 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.521 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -62.23 177.99 0.43 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 70' ' ' THR . 26.5 m-85 -162.51 179.44 7.77 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.49 -7.93 15.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 109.834 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' ARG . 40.5 t -157.52 130.03 7.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.022 -1.049 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -42.73 -27.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.648 -0.657 . . . . 0.0 109.308 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.4 tmt_? -64.01 -34.96 79.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 110.535 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' CG ' ' CD1' ' A' ' 71' ' ' TYR . 27.3 t0 -83.11 -35.61 25.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 108.626 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.39 -32.67 64.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 74' ' ' GLN . 22.4 tp60 -69.08 -35.25 76.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.561 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.89 -20.35 62.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -74.52 -44.09 52.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.004 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.0 mm -58.02 -50.61 77.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.484 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.459 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.8 p30 -74.79 -18.56 60.45 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.796 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 35.1 m170 -86.19 -24.37 26.13 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.568 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.28 -26.59 2.55 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.108 -0.995 . . . . 0.0 112.115 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.486 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 6.2 m-70 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 109.064 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.111 0.482 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -44.69 146.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 110.249 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.65 -23.52 36.89 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.486 ' NZ ' ' SG ' ' A' ' 7' ' ' CYS . 2.4 ttpt -98.6 -50.68 4.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 110.518 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.486 ' SG ' ' NZ ' ' A' ' 6' ' ' LYS . 2.0 m -87.32 -17.78 31.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 111.16 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.01 -1.81 9.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.73 158.63 70.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.144 -1.209 . . . . 0.0 108.749 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.01 102.92 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.941 1.761 . . . . 0.0 112.938 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.3 mt -49.73 125.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.513 0.673 . . . . 0.0 110.37 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -91.49 -29.41 17.02 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.83 143.75 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -79.8 103.93 10.03 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -76.05 81.84 1.02 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.839 -2.504 . . . . 0.0 106.839 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -64.76 131.55 47.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.31 0.576 . . . . 0.0 110.286 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 21' ' ' LYS . 16.6 mtp -117.55 132.2 56.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.987 -0.445 . . . . 0.0 110.347 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -117.87 156.6 49.79 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.97 2.58 48.59 Favored 'Cis proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.154 -1.186 . . . . 0.0 111.289 -0.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.597 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -56.27 -36.91 69.12 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.624 -0.673 . . . . 0.0 109.294 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' MET . 5.0 ttmt 73.52 25.77 2.06 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 24.7 m80 -95.09 -179.06 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.195 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.478 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.3 m -146.33 151.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.083 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 31.6 m-85 -158.74 168.28 27.27 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 2.8 m -53.07 115.47 1.89 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.936 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -50.9 -11.83 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -76.72 -46.97 23.32 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.14 -0.975 . . . . 0.0 109.042 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.429 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 m -78.84 -22.96 45.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.998 -1.064 . . . . 0.0 108.412 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.466 ' O ' ' CD1' ' A' ' 50' ' ' ILE . . . -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.3 pt -80.02 -33.7 14.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.039 -1.038 . . . . 0.0 108.986 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.11 -23.94 65.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.123 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -82.75 -34.77 27.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -27.07 44.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.518 -0.738 . . . . 0.0 109.06 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mttp . . . . . 0 N--CA 1.486 1.351 0 O-C-N 121.218 -0.927 . . . . 0.0 109.249 -179.796 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 ptm . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' SER . 51.9 t -71.34 114.57 28.96 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.863 . . . . 0.0 109.32 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -49.41 -15.56 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.426 1.417 . . . . 0.0 111.856 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.95 -63.92 0.84 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.0 m -90.4 -22.13 21.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.3 p 74.27 36.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.18 157.18 34.3 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 85.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.442 2.095 . . . . 0.0 112.016 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 5.2 m -55.08 104.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.1 tt0 -48.07 -54.94 11.45 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.041 -1.037 . . . . 0.0 108.353 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.438 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -159.04 135.51 9.25 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.796 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.466 ' CD1' ' O ' ' A' ' 29' ' ' ALA . 3.0 mt -87.7 145.97 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.887 -1.133 . . . . 0.0 109.599 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -138.77 152.97 48.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.518 0.675 . . . . 0.0 109.731 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -96.38 139.14 32.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.74 -0.6 . . . . 0.0 109.877 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.19 161.05 39.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.498 ' H ' ' HG1' ' A' ' 54' ' ' THR . 0.0 OUTLIER -80.4 157.92 26.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.279 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 57' ' ' SER . 68.1 mtp180 -53.51 -72.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.235 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.58 30.06 0.36 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 55' ' ' ARG . 19.6 t -86.86 -31.17 20.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.947 -1.325 . . . . 0.0 109.289 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -99.29 173.62 6.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 23.0 m-85 -118.59 117.31 28.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.8 mtt -79.55 144.59 33.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.335 -0.853 . . . . 0.0 110.751 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -80.22 176.02 10.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 110.012 -179.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.529 ' CG ' ' O ' ' A' ' 70' ' ' THR . 87.4 m-85 -158.29 -168.39 2.45 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -119.89 -6.75 10.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.643 -179.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -146.2 127.98 15.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 108.847 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -47.06 -26.0 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -66.35 -31.13 71.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.479 -0.763 . . . . 0.0 109.919 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.68 -34.39 24.98 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.1 -35.27 59.39 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.715 HE22 HD21 ' A' ' 82' ' ' ASN . 0.3 OUTLIER -67.09 -39.74 86.83 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.544 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -66.65 -20.75 66.06 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.13 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.552 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 61.7 t60 -74.8 -40.03 61.36 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.837 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mm -60.15 -52.11 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.654 -0.654 . . . . 0.0 110.379 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.715 HD21 HE22 ' A' ' 78' ' ' GLN . 2.6 p30 -74.55 -18.09 60.64 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.036 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 35.1 m170 -85.85 -26.58 25.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.532 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -128.72 -26.11 2.75 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.856 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.552 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 6.7 m-70 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.037 -1.04 . . . . 0.0 109.026 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 8' ' ' GLY . 8.6 p -46.83 128.46 10.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 109.874 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.72 -13.1 60.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.24 -40.29 45.42 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.19 -0.944 . . . . 0.0 109.302 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -124.48 -21.11 4.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.762 -0.586 . . . . 0.0 110.708 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.71 15.93 60.76 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.26 155.47 38.82 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.295 -1.121 . . . . 0.0 108.496 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.5 109.92 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.904 1.736 . . . . 0.0 112.154 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.1 mt -58.12 112.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.559 0.695 . . . . 0.0 110.466 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -82.12 -33.55 29.61 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.85 137.5 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -76.35 104.81 7.05 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.95 -1.094 . . . . 0.0 110.652 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -78.35 86.44 1.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -70.49 133.43 46.8 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 122.146 -0.62 . . . . 0.0 111.023 -178.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' LYS . 2.7 mmm -118.91 135.25 54.68 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.456 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -119.2 153.32 53.21 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.95 -4.78 44.38 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 124.276 -1.135 . . . . 0.0 111.621 0.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t -48.18 -30.21 4.43 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 6.7 mtmm 60.29 28.93 18.57 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.592 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 28.3 m170 -93.86 173.05 7.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.545 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 13.7 m -136.67 151.22 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.707 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 83.4 m-85 -160.9 159.71 30.03 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -47.19 110.27 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -47.06 -16.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.697 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -77.54 -44.82 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.069 . . . . 0.0 108.848 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 36.7 m -79.12 -21.0 47.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.899 -1.126 . . . . 0.0 108.0 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.3 78.2 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 pt -76.11 -33.52 24.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 108.781 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.4 -39.7 92.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.618 -1.233 . . . . 0.0 107.681 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -71.97 -25.35 61.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.363 -0.836 . . . . 0.0 108.771 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.27 -36.89 39.07 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.087 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 C--N 1.303 -1.425 0 O-C-N 120.888 -1.133 . . . . 0.0 108.129 179.248 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.446 ' CG ' ' O ' ' A' ' 39' ' ' MET . 10.2 ptm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.512 0.672 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -69.23 129.53 91.83 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.52 -29.35 2.1 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.22 1.946 . . . . 0.0 113.623 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.54 -63.68 1.02 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 70.8 m -67.55 -45.08 76.71 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.432 -1.04 . . . . 0.0 109.025 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 76.98 53.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.709 -0.62 . . . . 0.0 111.412 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.456 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.2 OUTLIER 176.38 -48.59 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.489 -1.382 . . . . 0.0 112.205 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 45' ' ' ASP . 84.6 Cg_endo -83.48 46.28 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.637 2.225 . . . . 0.0 116.095 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.0 t -92.95 118.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.272 -1.517 . . . . 0.0 109.397 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -101.74 -64.51 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.456 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.51 144.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.7 -1.25 . . . . 0.0 110.289 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -139.22 140.53 37.78 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.894 0.854 . . . . 0.0 109.943 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -85.27 147.06 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.7 162.01 38.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.442 -0.786 . . . . 0.0 109.882 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.84 162.03 19.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.547 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -50.96 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.44 27.32 0.46 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.5 t -81.77 -18.8 42.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.991 -1.3 . . . . 0.0 109.06 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mt -117.69 173.58 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 16.5 m-85 -118.22 117.0 27.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mmt -79.41 144.61 33.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.78 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.476 ' NH1' ' OH ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.25 0.548 . . . . 0.0 109.778 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.545 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -92.76 175.37 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 70' ' ' THR . 98.4 m-85 -157.56 -174.73 5.01 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -115.63 -6.06 12.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.634 -0.666 . . . . 0.0 110.078 -178.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 76' ' ' ASP . 24.3 p -150.19 130.5 13.72 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.021 . . . . 0.0 109.606 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 78' ' ' GLN . 9.8 mm-40 -44.17 -31.01 0.86 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -62.24 -33.25 74.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 0.0 109.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.8 m-20 -82.98 -36.97 24.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 108.726 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 tt -75.13 -30.75 60.9 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 74' ' ' GLN . 23.9 tp60 -71.4 -34.52 70.44 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.18 -19.99 62.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -72.8 -47.51 45.9 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.671 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mm -56.56 -51.08 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -70.46 -18.95 62.99 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.774 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.2 m170 -87.45 -27.87 22.45 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.828 -1.149 . . . . 0.0 112.151 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 -16.67 4.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.977 -1.077 . . . . 0.0 112.157 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.5 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.3 m-70 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.98 0.419 . . . . 0.0 111.012 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.8 t -46.62 146.17 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.57 -27.03 18.44 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 110.513 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.75 -38.96 11.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 110.069 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 11.5 m -93.19 -29.87 15.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.529 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.72 11.56 82.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.93 156.66 36.3 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.464 -1.021 . . . . 0.0 108.541 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.58 142.5 71.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.951 1.767 . . . . 0.0 111.668 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.0 mt -95.39 73.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.521 -0.737 . . . . 0.0 110.77 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.42 -37.46 7.69 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.52 142.32 20.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -70.9 107.98 4.3 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.599 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -73.44 80.79 0.74 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.585 ' NH1' ' SG ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -61.07 141.96 57.01 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.027 -0.69 . . . . 0.0 109.932 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 21' ' ' LYS . 6.9 mtp -130.7 126.31 36.19 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -115.06 158.06 41.87 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.25 -2.06 50.24 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.446 -0.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.594 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 9.7 t -57.4 -35.61 70.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 109.336 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' MET . 7.5 ttmt 75.92 29.57 0.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.594 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -94.04 164.44 13.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 33.2 m -131.44 148.03 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.334 -0.854 . . . . 0.0 110.888 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 42.1 m-85 -154.92 168.78 25.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -51.17 109.15 0.3 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.42 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.471 ' CE2' ' CD ' ' A' ' 52' ' ' GLN . 38.2 t80 -47.13 -20.44 0.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.495 -0.753 . . . . 0.0 109.78 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -74.89 -35.48 62.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 12.3 p -82.46 -27.19 32.02 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' N ' ' SG ' ' A' ' 28' ' ' CYS . . . -67.67 -37.04 81.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.902 . . . . 0.0 108.629 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.5 pt -83.06 -34.61 11.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mt -73.72 -22.81 59.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.755 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -79.78 -42.93 23.44 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.183 -0.948 . . . . 0.0 108.778 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -75.05 -29.12 60.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.7 mttt . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.025 -1.047 . . . . 0.0 108.926 179.77 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 44' ' ' SER . 43.9 t -45.3 107.82 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.66 -17.14 2.76 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.262 1.308 . . . . 0.0 111.71 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.46 -50.77 1.51 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.431 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.577 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 69.8 m -92.48 -28.98 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.245 . . . . 0.0 109.942 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.7 p 75.69 46.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.6 160.05 64.76 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.1 94.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.532 2.154 . . . . 0.0 112.181 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.478 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 10.5 m -59.49 108.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' ILE . 2.5 tt0 -47.97 -56.23 8.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.476 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -160.66 132.41 5.87 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.903 0.859 . . . . 0.0 108.979 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.25 145.23 8.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.815 -1.178 . . . . 0.0 109.508 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -138.59 156.67 47.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.842 0.829 . . . . 0.0 110.321 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.471 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 21.9 mt-30 -95.67 134.71 38.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.89 -0.506 . . . . 0.0 110.027 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.585 ' SG ' ' NH1' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -133.4 153.31 51.71 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.364 0.602 . . . . 0.0 109.987 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.439 ' O ' ' OG ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -83.59 158.64 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.795 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 57' ' ' SER . 15.5 ttp85 -48.62 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.442 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.21 28.65 0.26 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.869 -1.158 . . . . 0.0 110.329 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 55' ' ' ARG . 55.3 p -90.19 -19.11 24.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.337 . . . . 0.0 109.592 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 mt -119.49 173.61 6.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.774 -0.579 . . . . 0.0 109.989 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 26.4 m-85 -116.32 119.8 36.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mtt -85.43 144.49 27.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.494 -0.754 . . . . 0.0 109.358 179.614 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.495 ' O ' ' CE2' ' A' ' 71' ' ' TYR . 11.5 mpt_? . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -60.44 177.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.606 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 70' ' ' THR . 57.6 m-85 -160.92 -167.4 1.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.419 -0.8 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -114.63 -8.21 12.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.68 -0.638 . . . . 0.0 110.13 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' ARG . 72.6 m -147.45 127.97 14.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 109.626 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -45.9 -19.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 109.126 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.1 ttt-85 -71.37 -33.63 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.77 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.5 -37.68 24.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.66 -34.46 64.94 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 10.2 tp60 -70.54 -30.51 67.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.06 -21.19 61.56 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.62 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 16.4 t60 -76.66 -35.86 57.7 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.794 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.8 mm -63.92 -51.29 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.445 -0.784 . . . . 0.0 109.695 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.472 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.2 p30 -74.23 -19.05 60.65 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.718 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 37.9 m170 -86.46 -23.04 26.15 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.781 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 -26.56 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.995 -1.066 . . . . 0.0 111.926 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.62 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 6.3 m-70 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 108.964 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 6.1 t -48.02 146.5 2.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.061 -1.024 . . . . 0.0 109.87 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.54 -24.06 45.86 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -64.88 1.01 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.426 -0.797 . . . . 0.0 109.441 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 12.5 m -61.14 -22.0 64.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.21 9.48 29.68 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -101.2 157.81 32.97 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.37 -1.077 . . . . 0.0 108.773 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.73 105.87 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.879 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 60.9 mt -53.5 122.67 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.473 0.654 . . . . 0.0 110.594 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -31.18 22.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.5 t -138.22 145.29 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.477 ' OH ' ' CE ' ' A' ' 60' ' ' MET . 3.2 m-30 -76.78 98.61 4.86 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.792 -1.193 . . . . 0.0 110.893 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 88.24 0.86 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -76.79 141.42 40.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.976 -0.72 . . . . 0.0 110.322 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.524 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 15.4 mtp -129.38 132.98 47.16 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.167 0.508 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -116.19 156.36 47.11 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.87 2.64 48.0 Favored 'Cis proline' 0 N--CA 1.491 1.324 0 C-N-CA 124.164 -1.182 . . . . 0.0 111.316 -0.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.601 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -53.09 -40.11 63.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 tttp 71.59 31.22 2.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 9.1 m170 -104.63 174.14 6.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.567 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -128.95 159.8 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.619 0.723 . . . . 0.0 110.349 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 74.6 m-85 -166.26 174.06 9.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -62.57 115.41 4.24 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.619 178.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -49.44 -21.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 109.946 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.7 -41.23 60.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.03 -1.044 . . . . 0.0 108.568 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.502 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.13 -22.0 33.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.21 -33.52 71.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 pt -80.22 -37.02 17.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 121.044 -1.035 . . . . 0.0 108.621 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.27 -36.01 78.86 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.004 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -70.02 -39.94 75.52 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mttt . . . . . 0 C--N 1.304 -1.395 0 O-C-N 121.196 -0.94 . . . . 0.0 108.859 179.779 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 39' ' ' MET . 10.2 ptm . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.675 0.75 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -62.22 143.3 95.45 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -52.93 -36.19 74.05 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.55 1.5 . . . . 0.0 112.044 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.56 -45.46 0.78 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.598 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 3.2 m -81.61 -15.91 53.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.993 -1.298 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t 49.37 36.75 10.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -90.61 161.18 37.18 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.016 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.99 75.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.297 1.998 . . . . 0.0 112.012 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ASP . 37.9 t -47.35 99.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.018 -1.051 . . . . 0.0 109.489 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.5 tt0 -67.31 -61.02 2.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 108.583 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -150.1 135.34 18.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.015 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mt -93.83 146.68 6.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.953 -1.092 . . . . 0.0 109.845 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -141.38 141.38 33.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.98 142.82 27.75 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.645 -0.659 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 169.26 19.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.296 -0.877 . . . . 0.0 109.847 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.531 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -87.13 162.12 17.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.873 . . . . 0.0 109.583 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 55' ' ' ARG . 1.1 ttp180 -70.04 38.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.021 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -153.27 17.55 0.69 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.74 -27.33 12.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.875 . . . . 0.0 110.243 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 mt -113.0 172.32 7.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.57 -0.706 . . . . 0.0 110.017 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 19.5 m-85 -129.37 120.39 25.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.477 ' CE ' ' OH ' ' A' ' 14' ' ' TYR . 1.8 mpt? -81.77 144.76 30.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.245 -0.91 . . . . 0.0 110.628 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 54.1 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.456 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.52 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -91.94 179.32 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.497 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 70' ' ' THR . 61.8 m-85 -158.37 -169.74 2.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.391 -0.818 . . . . 0.0 109.069 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -111.92 -9.71 14.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.673 -0.642 . . . . 0.0 110.191 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.6 t -152.9 133.84 14.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.969 -1.082 . . . . 0.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 78' ' ' GLN . 5.1 mm-40 -44.96 -30.11 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.9 -34.9 79.0 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.014 0.911 . . . . 0.0 109.786 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.7 m-20 -83.39 -33.97 25.65 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.15 -0.969 . . . . 0.0 108.556 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.91 -34.17 62.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.455 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 11.7 tp60 -70.25 -32.04 69.7 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.09 -20.84 61.59 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.441 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.3 OUTLIER -76.47 -38.77 54.85 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.013 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.539 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 5.3 mm -62.11 -54.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.46 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 4.8 p30 -69.21 -20.1 63.97 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.651 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 36.8 m170 -86.88 -13.37 45.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.515 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -122.21 -40.51 2.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.099 -1.001 . . . . 0.0 113.468 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 120.856 -1.152 . . . . 0.0 110.143 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 17.2 t -45.97 146.17 1.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.546 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.03 -27.44 24.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -91.64 -44.34 9.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 110.095 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 12.9 m -87.94 -27.03 22.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 110.334 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.71 11.4 83.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.14 158.19 32.24 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -1.044 . . . . 0.0 108.882 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.35 106.39 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.961 1.774 . . . . 0.0 112.128 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.0 mt -54.23 105.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.875 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -71.78 -36.49 70.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.02 141.94 28.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -73.22 112.12 8.97 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.965 -1.084 . . . . 0.0 111.106 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -77.72 78.01 1.55 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.444 HH12 ' C ' ' A' ' 21' ' ' LYS . 4.0 tpt85 -58.23 140.53 52.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 122.155 -0.615 . . . . 0.0 110.235 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.5 mtp -130.04 129.01 43.1 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -120.89 156.22 56.76 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.69 0.53 52.94 Favored 'Cis proline' 0 N--CA 1.49 1.268 0 C-N-CA 124.191 -1.17 . . . . 0.0 112.084 0.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.589 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 35.4 t -54.9 -29.68 56.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 109.12 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' C ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER 68.83 25.98 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.658 ' HE2' ' NH2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -95.37 175.52 6.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.675 -0.641 . . . . 0.0 109.37 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -144.98 153.42 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.817 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 26.5 m-85 -159.58 168.14 26.83 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -48.79 111.78 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.86 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -49.12 -18.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.391 -0.818 . . . . 0.0 109.098 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 25' ' ' CYS . 29.3 t0 -77.23 -36.37 54.72 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -82.86 -25.78 32.24 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.25 -36.97 77.72 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.1 pt -80.57 -35.01 14.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.986 -1.071 . . . . 0.0 109.323 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -67.83 -22.17 65.16 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.516 -1.273 . . . . 0.0 107.965 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -82.3 -35.24 28.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -74.39 -31.8 62.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.662 -0.649 . . . . 0.0 109.603 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 mttt . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.158 -0.964 . . . . 0.0 110.137 -179.312 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.9 mtp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 44' ' ' SER . 42.6 t -43.92 106.89 0.54 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.4 -17.22 4.02 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.305 1.337 . . . . 0.0 111.754 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.85 -47.71 2.63 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.394 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.575 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 62.1 m -99.37 -30.0 12.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 78.35 52.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.706 -0.622 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.41 158.47 75.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 109.068 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.71 100.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.605 2.203 . . . . 0.0 112.586 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.494 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 12.7 m -68.31 106.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -49.24 -54.81 14.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.774 -1.204 . . . . 0.0 108.28 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.451 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -159.6 125.34 4.24 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.475 178.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mt -78.94 144.83 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.917 -1.114 . . . . 0.0 109.096 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -138.93 153.24 48.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.917 0.865 . . . . 0.0 110.0 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -96.36 138.55 33.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.88 -0.512 . . . . 0.0 109.776 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 158.91 43.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.902 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.77 158.3 24.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.55 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.543 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -50.87 -71.0 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 110.142 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.28 27.62 0.44 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 55' ' ' ARG . 9.4 t -86.9 -25.18 24.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.87 -1.37 . . . . 0.0 109.125 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.8 mt -115.35 173.72 6.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.48 116.24 30.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.781 -0.574 . . . . 0.0 109.727 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.7 tpt -79.46 144.48 33.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.823 . . . . 0.0 109.159 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.658 ' NH2' ' HE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.63 171.5 5.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.079 -1.013 . . . . 0.0 109.563 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -154.36 -174.45 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.373 -0.83 . . . . 0.0 108.796 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -118.61 -4.79 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.617 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -147.45 123.41 10.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.229 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 73' ' ' SER . 0.5 OUTLIER -44.39 -21.55 0.05 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.4 ttt180 -68.81 -37.0 78.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.403 -0.81 . . . . 0.0 109.649 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.41 -35.66 34.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.47 -32.96 66.65 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.7 tp60 -69.28 -30.91 69.11 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -74.82 -19.93 59.98 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -71.8 -47.46 53.16 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.749 -1.18 . . . . 0.0 108.207 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 mm -56.85 -55.77 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.644 0.735 . . . . 0.0 109.586 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.64 -18.24 64.76 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 10.9 m170 -85.47 -32.39 22.29 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.924 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -130.61 -25.02 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.175 -0.953 . . . . 0.0 112.685 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.512 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 3.8 m-70 . . . . . 0 C--N 1.302 -1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 109.023 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.0 t -46.36 146.53 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.631 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.28 -28.33 38.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.373 -0.829 . . . . 0.0 109.711 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 -59.4 1.75 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 13.1 m -60.06 -28.62 67.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.14 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.2 73.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.3 158.37 31.89 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.432 -1.04 . . . . 0.0 108.638 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.17 100.04 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.855 1.703 . . . . 0.0 112.233 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.5 mt -45.67 115.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.94 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.7 -32.28 25.62 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.87 140.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -76.76 103.85 6.94 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.819 -1.175 . . . . 0.0 110.835 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 84.29 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.494 HH21 ' CG ' ' A' ' 21' ' ' LYS . 6.2 ttt-85 -66.73 130.98 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 122.223 -0.575 . . . . 0.0 110.166 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' LYS . 16.7 mtp -117.0 132.62 56.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.879 -0.513 . . . . 0.0 110.279 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.453 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -115.81 156.75 46.06 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.55 -1.54 51.83 Favored 'Cis proline' 0 N--CA 1.492 1.405 0 C-N-CA 124.119 -1.201 . . . . 0.0 111.958 -0.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.588 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 3.5 t -54.19 -31.58 53.32 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.2 OUTLIER 68.79 24.85 6.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.588 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 0.5 OUTLIER -89.72 179.96 5.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.2 m -146.32 150.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 34.6 m-85 -159.09 169.71 23.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -52.5 114.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.206 179.341 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.492 ' CD2' ' CG ' ' A' ' 52' ' ' GLN . 34.1 t80 -52.22 -15.3 0.57 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.339 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -41.14 63.55 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.548 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 p -81.23 -27.63 35.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.7 -35.99 81.44 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 108.809 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.3 pt -79.91 -34.48 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.129 -1.029 . . . . 0.0 108.873 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.9 mt -64.0 -24.86 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.204 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -80.63 -40.71 25.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -23.34 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.395 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mttt . . . . . 0 N--CA 1.486 1.37 0 O-C-N 121.261 -0.899 . . . . 0.0 108.584 179.513 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.6 t -64.01 114.3 13.22 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 109.002 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -54.68 -12.3 4.33 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.199 1.266 . . . . 0.0 111.554 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.74 -59.76 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.548 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 3.8 m -92.34 -24.55 18.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.226 -1.161 . . . . 0.0 109.969 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER 74.86 40.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.3 157.11 43.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.69 97.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.5 2.133 . . . . 0.0 112.228 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.469 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 4.5 m -68.99 112.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -55.36 -53.66 53.44 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 108.897 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.453 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -157.68 133.67 9.37 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.791 -1.163 . . . . 0.0 109.787 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.17 145.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 120.981 -1.074 . . . . 0.0 109.353 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -138.34 153.84 48.97 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.706 0.765 . . . . 0.0 109.764 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.492 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 33.0 mt-30 -95.17 139.4 31.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.663 -0.648 . . . . 0.0 110.084 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 m -139.89 157.8 45.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.661 -0.649 . . . . 0.0 109.859 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 158.67 21.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.798 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.548 ' C ' ' H ' ' A' ' 57' ' ' SER . 36.9 ttp85 -49.92 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -0.873 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.82 29.08 0.39 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.548 ' H ' ' C ' ' A' ' 55' ' ' ARG . 10.8 t -85.62 -27.69 25.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.95 -1.324 . . . . 0.0 108.914 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mt -107.59 173.54 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.472 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 24.8 m-85 -118.15 119.61 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -80.51 144.11 32.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.664 -0.648 . . . . 0.0 109.467 179.858 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.666 HH22 ' NH2' ' A' ' 84' ' ' ARG . 49.3 mtt180 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -77.33 175.71 9.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.567 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.535 ' CG ' ' O ' ' A' ' 70' ' ' THR . 92.1 m-85 -157.84 -170.66 3.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -118.46 -5.75 10.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.671 -0.643 . . . . 0.0 109.676 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.3 m -149.41 129.88 13.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.982 . . . . 0.0 109.431 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.472 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 6.6 mm-40 -47.28 -24.46 0.75 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 109.046 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -68.16 -32.77 73.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 109.115 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 m-20 -81.62 -36.38 28.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -75.41 -33.41 60.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 74' ' ' GLN . 24.4 tp60 -68.41 -33.36 74.08 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.22 -21.17 62.17 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.411 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 45.9 t60 -74.85 -38.22 62.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.028 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.42 -52.62 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.146 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.488 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.8 p30 -72.37 -18.84 61.71 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.753 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 38.9 m170 -86.65 -26.7 24.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.464 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.666 ' NH2' HH22 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -130.51 -14.3 3.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.154 -0.966 . . . . 0.0 112.053 -178.077 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 10.2 m-70 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.117 -0.989 . . . . 0.0 109.828 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.516 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 4.0 m -46.45 146.3 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 108.988 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -25.88 21.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.35 -31.27 13.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.417 -0.802 . . . . 0.0 110.369 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -24.43 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.838 . . . . 0.0 110.646 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . 78.93 -0.44 78.49 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.082 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.531 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 4.2 mp -79.55 163.96 56.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.075 -1.25 . . . . 0.0 108.258 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.08 133.32 24.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.146 1.231 . . . . 0.0 112.091 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.05 118.09 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.739 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.407 ' CD ' ' H ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -84.53 -29.71 25.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.734 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.96 144.78 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.31 99.41 9.33 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.634 -1.291 . . . . 0.0 110.231 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.27 87.59 0.59 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 51' ' ' GLU . 2.4 ttt-85 -64.91 143.5 57.91 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 122.115 -0.638 . . . . 0.0 110.169 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.561 ' SD ' ' SG ' ' A' ' 40' ' ' CYS . 6.8 mtp -125.6 134.33 51.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -122.54 154.18 62.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.72 6.63 37.34 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 124.174 -1.177 . . . . 0.0 111.26 -0.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.596 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -55.7 -38.19 69.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.638 -0.663 . . . . 0.0 109.421 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.7 tttp 71.12 24.22 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.596 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 37.6 m170 -100.33 175.55 5.67 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.485 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 1.3 m -143.12 154.03 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.832 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 48.0 m-85 -151.92 -158.36 0.89 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -81.36 108.92 15.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.463 ' CE2' ' CD ' ' A' ' 52' ' ' GLN . 43.2 t80 -49.84 -11.55 0.06 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.051 -1.031 . . . . 0.0 109.722 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.6 t70 -82.35 -49.29 10.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 108.996 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 3.9 m -79.4 -22.15 44.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.826 -1.172 . . . . 0.0 108.051 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.87 78.04 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 pt -78.86 -34.01 16.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 121.119 -0.988 . . . . 0.0 108.767 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.9 mt -65.42 -38.7 90.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.832 -1.147 . . . . 0.0 107.995 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -70.54 -31.32 68.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.83 -36.24 62.4 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mttm . . . . . 0 C--N 1.303 -1.45 0 O-C-N 121.039 -1.038 . . . . 0.0 108.262 179.236 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.5 mtp . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 121.94 0.876 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.561 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 24.9 t -91.47 112.06 52.3 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -45.95 -19.17 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.86 1.706 . . . . 0.0 112.772 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 -62.51 0.82 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.5 m -93.83 2.27 56.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -1.157 . . . . 0.0 110.529 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.6 p 48.45 36.03 6.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 109.566 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.71 161.43 27.6 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.299 -0.876 . . . . 0.0 109.003 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' GLN . 20.2 Cg_endo -62.93 80.67 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.344 2.029 . . . . 0.0 111.976 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.5 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 5.6 m -52.96 98.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -50.6 -51.12 51.43 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.519 -1.363 . . . . 0.0 108.202 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.475 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -158.55 123.19 4.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.668 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.1 mt -81.05 144.91 9.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 120.797 -1.19 . . . . 0.0 109.168 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 16' ' ' ARG . 28.0 mt-10 -138.97 151.17 46.64 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.702 0.763 . . . . 0.0 110.363 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 19.5 mt-30 -85.72 143.29 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.347 0.594 . . . . 0.0 110.071 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.44 159.32 42.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.478 -0.764 . . . . 0.0 109.471 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.429 ' OG1' ' OG ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -80.81 166.41 20.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.333 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 57' ' ' SER . 3.5 tmm_? -68.51 -74.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 110.561 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.15 24.71 0.26 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.365 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 55' ' ' ARG . 3.3 m -92.56 -6.31 49.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.972 -1.31 . . . . 0.0 109.82 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mt -129.03 174.81 9.21 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.621 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -120.67 108.58 14.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.801 -0.562 . . . . 0.0 110.332 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.52 144.74 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.381 -0.825 . . . . 0.0 110.368 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 80' ' ' HIS . 49.6 t . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.405 -0.81 . . . . 0.0 109.673 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.941 0.4 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.47 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 2.1 p -94.12 155.0 17.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.647 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.473 ' OH ' ' CG ' ' A' ' 80' ' ' HIS . 72.6 m-85 -149.97 176.98 10.28 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.543 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -103.11 -11.11 18.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.537 -0.727 . . . . 0.0 110.472 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ASP . 58.7 m -160.63 138.05 9.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.801 -1.187 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.621 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 4.9 mm-40 -43.34 -31.64 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.612 -0.68 . . . . 0.0 109.68 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -65.88 -31.68 72.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.415 -0.803 . . . . 0.0 109.962 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 73.6 m-20 -86.22 -32.73 21.01 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.487 ' O ' ' ND1' ' A' ' 80' ' ' HIS . 0.3 OUTLIER -76.83 -35.03 57.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -72.38 -34.73 68.14 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.08 -20.09 62.4 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.596 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -77.39 -39.12 48.26 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.645 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.5 mm -58.14 -55.35 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.19 -25.2 66.01 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.604 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -88.78 -11.04 46.07 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.808 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -118.37 -48.62 2.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.152 -0.967 . . . . 0.0 113.355 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 110.002 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.362 0.601 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 6.6 t -46.26 145.8 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.037 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -21.44 30.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.057 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -39.68 12.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.038 -1.038 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -106.58 -16.98 14.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 111.384 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.43 4.12 68.42 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.429 -1.367 . . . . 0.0 109.979 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.27 157.65 56.06 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.057 -1.261 . . . . 0.0 109.035 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.7 112.16 2.11 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.129 1.886 . . . . 0.0 112.549 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 67.6 mt -61.82 124.86 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.05 -29.25 18.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 t -133.4 145.31 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -82.75 98.73 9.25 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.658 -1.276 . . . . 0.0 110.814 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.69 95.34 1.35 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.597 HH12 ' CB ' ' A' ' 70' ' ' THR . 3.0 tpt180 -81.52 144.83 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.99 -0.712 . . . . 0.0 111.064 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.541 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 5.4 mtp -131.72 130.18 41.61 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -113.9 157.28 42.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.345 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.48 -1.06 51.67 Favored 'Cis proline' 0 N--CA 1.491 1.344 0 C-N-CA 124.178 -1.176 . . . . 0.0 111.786 -0.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.596 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 14.5 t -52.01 -35.36 46.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.2 OUTLIER 69.3 30.17 4.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.602 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 30.8 m170 -100.22 165.9 11.26 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.876 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -122.64 161.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.942 0.877 . . . . 0.0 110.462 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.541 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 97.3 m-85 -163.55 -164.41 0.92 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -83.9 113.66 21.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -47.53 -14.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.051 -1.03 . . . . 0.0 109.364 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -79.77 -42.96 23.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 54.5 m -83.08 -23.2 33.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.54 -37.41 77.06 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 pt -74.74 -37.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.468 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mt -53.5 -38.52 63.78 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -67.05 -42.03 85.48 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.564 -0.71 . . . . 0.0 109.211 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -61.46 -34.0 74.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 108.782 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mttm . . . . . 0 C--N 1.302 -1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.998 179.619 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.455 ' CG ' ' O ' ' A' ' 39' ' ' MET . 7.5 ptm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.503 0.668 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.478 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 0.4 OUTLIER -57.04 145.89 62.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.86 -38.91 68.85 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.768 1.645 . . . . 0.0 112.61 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.84 -21.8 2.84 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.624 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.602 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -94.49 -15.81 23.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.176 -1.191 . . . . 0.0 110.169 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.9 p 47.63 36.48 5.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -90.93 160.73 37.35 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 108.775 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' GLN . 14.9 Cg_endo -58.27 74.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.131 1.887 . . . . 0.0 112.001 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' ASP . 47.2 t -47.42 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.051 -1.03 . . . . 0.0 109.683 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' PRO . 5.0 tt0 -64.62 -61.06 2.43 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -150.61 137.64 19.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.911 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mt -94.61 147.21 5.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.805 -1.184 . . . . 0.0 109.6 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -140.68 147.02 38.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.443 0.64 . . . . 0.0 109.826 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -97.02 144.8 26.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.633 -0.667 . . . . 0.0 109.221 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 168.08 25.07 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.012 . . . . 0.0 110.323 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 154.36 22.28 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -57.52 -23.78 52.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 110.081 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.82 21.83 44.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.83 -25.99 14.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -1.135 . . . . 0.0 109.924 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -114.15 172.68 6.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.697 -0.627 . . . . 0.0 109.628 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.504 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 53.4 m-85 -122.19 123.18 40.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 mmt -88.88 145.28 25.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.274 -0.891 . . . . 0.0 110.949 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 80' ' ' HIS . 46.9 t . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.011 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.667 HH12 HH21 ' A' ' 84' ' ' ARG . 19.3 mmm-85 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.597 ' CB ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -83.84 174.87 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 70' ' ' THR . 89.8 m-85 -156.18 -166.33 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.366 -0.834 . . . . 0.0 108.819 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.499 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -118.11 -8.81 10.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.678 -0.639 . . . . 0.0 110.046 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 76' ' ' ASP . 17.9 p -145.35 130.0 18.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.514 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.504 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 6.3 mm-40 -47.81 -25.65 1.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 108.699 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -68.4 -32.89 73.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.528 0.68 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 73' ' ' SER . 36.5 m-20 -84.21 -34.52 23.9 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 tt -74.95 -34.05 62.0 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -71.58 -30.22 65.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.06 -20.55 60.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.589 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -75.83 -41.0 53.8 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.724 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.53 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 4.6 mm -61.53 -52.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -64.65 -23.02 67.12 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.482 -0.761 . . . . 0.0 109.023 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 28.7 m170 -88.12 -12.9 42.72 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.531 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.667 HH21 HH12 ' A' ' 69' ' ' ARG . 11.1 mmt180 -118.67 -46.21 2.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 113.067 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.481 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 110.031 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.466 ' O ' ' CD2' ' A' ' 3' ' ' PHE . 13.9 p90 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.3 t -45.95 146.29 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.72 -30.45 26.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 110.624 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.45 -40.16 10.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.018 -1.051 . . . . 0.0 110.293 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 12.6 m -88.55 -25.86 22.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.052 -1.03 . . . . 0.0 110.089 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.42 10.49 70.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 158.29 32.46 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.36 -1.082 . . . . 0.0 108.601 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.02 98.96 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.857 1.704 . . . . 0.0 112.083 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.5 mt -45.58 110.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.986 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -35.07 40.86 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.0 138.75 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -78.78 106.96 11.15 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.98 -1.075 . . . . 0.0 110.78 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.58 85.13 0.85 Allowed Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -65.66 130.84 44.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 122.0 -0.706 . . . . 0.0 109.789 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.519 ' O ' ' N ' ' A' ' 21' ' ' LYS . 14.5 mtp -116.27 124.61 50.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.863 -0.523 . . . . 0.0 110.139 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.66 ' CD1' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -112.76 156.72 42.11 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.95 2.57 48.47 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 124.153 -1.186 . . . . 0.0 111.462 -0.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.59 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 1.0 OUTLIER -56.92 -35.81 69.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.549 -0.719 . . . . 0.0 109.433 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 ttmt 74.51 21.97 2.19 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.59 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 3.3 m80 -90.5 178.72 6.03 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.879 -0.729 . . . . 0.0 109.149 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.456 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.3 m -146.57 149.06 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 21.5 m-85 -158.61 170.0 23.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -50.68 112.7 0.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.77 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -51.16 -15.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.613 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -82.26 -32.7 29.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.546 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -85.68 -26.29 26.05 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 108.651 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.29 -35.09 68.6 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -84.46 -34.92 10.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.252 -0.905 . . . . 0.0 108.811 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mt -68.18 -22.97 64.8 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.004 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.39 -40.57 21.1 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.26 -36.74 85.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.475 -0.765 . . . . 0.0 109.91 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.971 -1.081 . . . . 0.0 109.756 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.0 ptt? . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.8 t -74.52 114.6 35.54 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.306 -0.871 . . . . 0.0 109.016 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.51 -17.11 6.2 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.427 1.418 . . . . 0.0 112.349 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.56 -58.63 1.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.586 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 3.5 m -93.29 -24.85 18.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -1.169 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.5 p 76.35 41.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.39 158.18 42.08 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.06 92.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.578 2.185 . . . . 0.0 112.141 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.476 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 4.0 m -62.1 111.14 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.037 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -47.17 -58.89 3.57 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.13 -0.981 . . . . 0.0 108.932 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -161.93 125.89 3.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.278 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -74.08 144.71 12.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.817 -1.177 . . . . 0.0 109.745 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -138.94 143.22 38.53 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 109.656 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -83.46 144.87 29.28 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.438 0.637 . . . . 0.0 110.079 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.21 158.86 43.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.795 . . . . 0.0 109.532 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.43 162.35 24.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.226 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.536 ' CG ' ' H ' ' A' ' 56' ' ' GLY . 3.9 ptp85 -66.4 -59.79 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.039 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -72.99 21.27 1.01 Allowed Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -90.29 -17.98 26.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.128 -1.219 . . . . 0.0 109.632 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.5 mt -118.86 173.29 6.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 24.6 m-85 -114.21 117.15 30.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 60' ' ' MET . 1.6 mpt? -82.59 144.47 30.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.344 -0.847 . . . . 0.0 110.346 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.662 ' NE ' ' HD1' ' A' ' 80' ' ' HIS . 17.1 mtm180 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.54 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -78.79 176.61 9.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 70' ' ' THR . 93.9 m-85 -158.66 -171.94 3.63 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.517 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -114.68 -7.72 12.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.077 -178.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 76' ' ' ASP . 1.6 m -146.2 126.37 13.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.1 tp60 -43.34 -26.95 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 73' ' ' SER . 5.5 tmm_? -63.95 -35.55 81.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.963 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.2 m-20 -80.85 -38.73 27.68 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.216 -0.928 . . . . 0.0 108.64 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.76 -30.93 64.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.9 tp60 -69.64 -32.66 71.46 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -20.11 61.4 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.662 ' HD1' ' NE ' ' A' ' 69' ' ' ARG . 53.1 t60 -73.04 -44.89 60.18 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.683 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.3 mm -59.36 -50.9 78.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.441 0.639 . . . . 0.0 109.699 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -70.4 -18.79 63.03 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.572 -0.705 . . . . 0.0 109.605 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 15.9 m170 -86.71 -28.45 23.09 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.101 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -128.66 -21.77 3.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.128 -0.983 . . . . 0.0 112.025 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.515 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.5 m-70 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.584 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 1.5 p90 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.984 0.897 . . . . 0.0 109.969 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 37.1 t -46.78 143.03 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 108.463 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 -28.75 19.98 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.013 -1.054 . . . . 0.0 110.464 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -93.86 -38.96 10.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.078 -1.014 . . . . 0.0 110.75 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.556 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -100.03 -23.46 14.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.94 . . . . 0.0 110.822 -179.186 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 6.97 88.75 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.322 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.67 152.13 51.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.967 -1.314 . . . . 0.0 108.367 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.62 137.7 81.91 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.749 1.633 . . . . 0.0 112.696 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -86.95 116.31 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.075 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -81.92 -28.27 32.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.55 146.74 18.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -78.81 98.56 6.36 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.722 -1.236 . . . . 0.0 110.377 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.55 83.71 0.55 Allowed Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 51' ' ' GLU . 5.4 ttt-85 -61.52 145.89 50.46 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.305 0.574 . . . . 0.0 110.003 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.491 ' O ' ' N ' ' A' ' 21' ' ' LYS . 5.3 mtp -128.58 133.55 48.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.921 -0.487 . . . . 0.0 110.4 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -122.35 154.75 62.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.13 4.17 48.25 Favored 'Cis proline' 0 N--CA 1.49 1.315 0 C-N-CA 124.219 -1.159 . . . . 0.0 111.493 0.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.59 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -56.42 -37.83 70.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.606 -0.684 . . . . 0.0 109.459 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.0 ttmm 74.29 27.39 1.48 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.59 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 13.0 m170 -100.58 177.61 4.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.445 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -145.26 153.3 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.433 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 62.8 m-85 -153.51 -166.85 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.6 p -72.6 112.12 8.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -51.55 -11.0 0.11 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.326 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 25' ' ' CYS . 3.2 t70 -77.29 -48.85 16.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.014 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 31.3 m -78.45 -25.24 45.86 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.78 -1.2 . . . . 0.0 108.222 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.7 -35.68 80.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 108.979 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.9 pt -80.77 -33.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.87 -23.69 66.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -77.38 -53.22 7.94 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.564 -0.71 . . . . 0.0 109.237 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.59 -24.67 64.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 mttm . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 108.559 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.9 ptm . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' SER . 46.6 t -77.13 114.55 40.89 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 109.41 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.19 -15.58 1.44 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.691 1.594 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.86 -62.24 0.82 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -92.35 -20.5 21.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -1.122 . . . . 0.0 110.194 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.4 p 72.11 35.45 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.281 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.46 160.77 26.6 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.56 -0.713 . . . . 0.0 109.107 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.08 81.54 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.434 2.089 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 4.6 m -52.66 111.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -59.65 -52.21 66.5 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.875 -1.141 . . . . 0.0 108.75 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.58 124.49 6.69 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.795 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mt -84.93 144.86 8.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.836 -1.165 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 16' ' ' ARG . 29.0 mt-10 -137.77 149.79 46.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.621 0.724 . . . . 0.0 109.658 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -95.09 141.71 28.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.703 -0.623 . . . . 0.0 110.016 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 160.53 40.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.423 -0.798 . . . . 0.0 109.766 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 158.6 31.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 57' ' ' SER . 26.4 ttp85 -56.27 -71.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 0.0 110.046 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.39 30.64 0.46 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 55' ' ' ARG . 4.2 t -89.56 -26.29 20.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.295 . . . . 0.0 109.509 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mt -101.81 173.66 6.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.648 -0.657 . . . . 0.0 109.866 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.617 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -121.31 109.47 14.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 mtt -74.45 144.5 44.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 110.507 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.749 . . . . 0.0 109.015 179.311 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.04 167.33 18.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.082 -1.011 . . . . 0.0 109.738 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -154.31 177.87 10.65 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.245 -0.909 . . . . 0.0 109.124 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -114.43 -5.25 12.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.819 -0.55 . . . . 0.0 109.54 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 67.1 m -153.39 126.56 8.5 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.748 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.617 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 5.9 mm-40 -43.51 -24.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.672 -0.642 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 ttt180 -66.5 -33.23 75.22 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.99 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 8.1 m-20 -86.09 -33.34 20.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.051 -1.031 . . . . 0.0 108.278 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.444 ' CD2' ' C ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -76.48 -31.8 57.98 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.445 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 22.1 tp60 -72.78 -33.86 66.57 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -19.8 61.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -73.41 -45.3 55.48 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.761 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 mm -58.72 -51.2 74.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.501 0.667 . . . . 0.0 109.703 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 4.6 m-20 -70.59 -18.47 62.89 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.784 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 14.7 m170 -87.19 -27.34 23.07 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.099 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.67 -25.96 2.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.064 -1.023 . . . . 0.0 112.488 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.506 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.5 m-70 . . . . . 0 C--N 1.301 -1.502 0 O-C-N 120.995 -1.066 . . . . 0.0 108.968 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.212 0.529 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.9 t -46.53 146.29 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.84 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.09 -27.2 28.41 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.442 -0.786 . . . . 0.0 109.874 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -53.25 3.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.766 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.556 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 6.5 m -74.65 -27.6 60.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.76 7.69 70.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.03 158.28 34.38 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.296 -1.12 . . . . 0.0 108.564 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.77 96.44 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.852 1.701 . . . . 0.0 112.484 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.5 mt -41.26 104.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.395 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -76.37 -32.13 58.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.01 146.64 29.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -83.05 104.38 13.21 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.81 -1.181 . . . . 0.0 110.818 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.58 91.0 1.16 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 21' ' ' LYS . 8.8 ttt-85 -77.65 134.56 38.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.828 -0.807 . . . . 0.0 110.114 -178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.568 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 6.0 mtp -123.61 130.66 53.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.867 -0.521 . . . . 0.0 109.761 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -113.14 156.85 42.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.77 2.1 42.08 Favored 'Cis proline' 0 N--CA 1.491 1.353 0 C-N-CA 124.087 -1.214 . . . . 0.0 111.328 -0.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.603 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -53.93 -36.31 62.65 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.2 OUTLIER 65.6 26.88 11.58 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.603 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 4.7 m170 -93.63 -172.15 2.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.534 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -144.71 151.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.93 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 41.6 m-85 -162.85 166.77 23.66 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.556 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -55.44 111.75 0.96 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.47 -1.292 . . . . 0.0 107.938 178.646 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -46.3 -21.0 0.13 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 109.767 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.8 t70 -74.36 -37.64 63.42 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.542 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -83.69 -22.61 32.0 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 108.515 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.71 -34.23 71.71 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.8 pt -80.97 -36.09 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 121.141 -0.974 . . . . 0.0 108.919 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.56 -37.27 86.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.86 -33.81 72.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -34.88 70.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--N 1.303 -1.417 0 O-C-N 121.042 -1.036 . . . . 0.0 108.64 179.754 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.1 ptp . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 122.167 0.984 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.73 142.46 98.19 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -54.6 -34.18 81.97 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.532 1.488 . . . . 0.0 112.411 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.12 -43.22 0.8 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.043 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 2.4 m -86.26 -12.98 48.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.371 . . . . 0.0 110.549 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t 48.16 37.47 8.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 0.0 109.029 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.92 161.1 39.33 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.384 -0.822 . . . . 0.0 109.342 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.32 74.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.377 2.051 . . . . 0.0 111.815 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 45' ' ' ASP . 21.7 t -45.25 100.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -0.832 . . . . 0.0 110.031 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 18' ' ' ILE . 4.9 tt0 -66.07 -61.33 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.405 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -151.6 136.78 17.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.94 179.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.3 146.68 6.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.822 -1.174 . . . . 0.0 109.724 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.05 153.67 45.61 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.427 0.632 . . . . 0.0 109.991 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.55 142.53 30.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 165.55 28.08 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 155.68 23.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 0.0 108.937 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.5 ' C ' ' H ' ' A' ' 57' ' ' SER . 10.5 ttp85 -51.56 -62.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 23.66 0.78 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.0 t -86.92 -25.68 24.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.938 -1.331 . . . . 0.0 109.216 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.03 173.89 6.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 15.1 m-85 -119.31 119.39 33.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mtt -80.08 144.49 33.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.268 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.3 mmm-85 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.86 174.72 11.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.711 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 70' ' ' THR . 97.5 m-85 -156.77 -176.29 5.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -116.99 -3.34 11.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.617 -0.677 . . . . 0.0 110.086 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 75' ' ' ARG . 8.1 t -149.32 128.12 12.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 109.716 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -45.66 -23.23 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.4 ttt180 -70.27 -33.16 71.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.363 -0.836 . . . . 0.0 109.687 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.1 m-20 -82.24 -36.7 26.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 tt -73.68 -34.78 65.03 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -70.16 -31.42 68.9 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.97 -19.82 60.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.512 ' ND1' ' OH ' ' A' ' 71' ' ' TYR . 58.6 t60 -73.11 -44.52 60.19 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.594 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.21 -52.04 65.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.48 0.657 . . . . 0.0 109.553 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.44 -18.32 64.4 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 109.647 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 11.7 m170 -86.21 -31.06 21.93 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.69 -1.204 . . . . 0.0 112.21 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -129.6 -21.59 3.1 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.046 -1.034 . . . . 0.0 112.472 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.522 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.5 m-70 . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.056 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.534 0.683 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.0 t -67.97 146.35 53.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.395 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.3 -27.83 38.38 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -99.68 -44.97 5.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.599 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 4.5 m -84.7 -20.31 31.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.41 3.49 25.94 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.67 157.36 37.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.331 -1.1 . . . . 0.0 108.801 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.91 123.12 12.81 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.0 1.8 . . . . 0.0 111.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.3 mt -75.89 103.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.64 -0.662 . . . . 0.0 110.575 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.414 ' HZ2' ' CB ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -72.69 -30.81 64.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -147.05 143.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -75.36 110.42 9.7 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.995 -1.066 . . . . 0.0 111.113 -178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -80.12 80.72 1.59 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.442 HH21 ' CG ' ' A' ' 21' ' ' LYS . 7.3 ttt-85 -66.55 131.15 45.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 122.112 -0.64 . . . . 0.0 110.239 -178.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.422 ' O ' ' N ' ' A' ' 21' ' ' LYS . 19.7 mtp -116.91 134.5 54.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.874 -0.516 . . . . 0.0 110.103 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -120.25 157.58 53.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.58 -2.19 47.13 Favored 'Cis proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.107 -1.205 . . . . 0.0 112.146 -0.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.583 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 7.1 t -52.8 -36.92 59.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.442 ' CG ' HH21 ' A' ' 16' ' ' ARG . 2.0 tttp 74.94 27.55 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 1.4 m80 -95.58 -178.24 4.34 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -145.71 153.5 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.868 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 34.9 m-85 -161.46 166.24 27.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -48.97 113.03 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.699 179.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -50.88 -18.02 0.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.347 -0.846 . . . . 0.0 109.883 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' CB ' ' HZ2' ' A' ' 12' ' ' LYS . 35.9 t70 -79.82 -33.04 40.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -85.34 -23.97 27.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.626 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.66 69.35 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -85.44 -34.03 8.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.146 -0.971 . . . . 0.0 108.957 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.69 -22.75 60.86 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.803 -1.159 . . . . 0.0 107.979 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.608 ' HD1' ' CG ' ' A' ' 41' ' ' PRO . 35.6 m170 -83.79 -36.46 23.54 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.234 -0.916 . . . . 0.0 108.869 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -34.53 66.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 109.441 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.228 -179.384 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.405 ' O ' ' C ' ' A' ' 40' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -41.07 104.79 0.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.684 -0.635 . . . . 0.0 109.98 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.608 ' CG ' ' HD1' ' A' ' 32' ' ' HIS . 40.2 Cg_exo -52.62 -16.23 5.25 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.444 1.429 . . . . 0.0 111.757 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.33 -44.24 2.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.541 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.601 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 2.8 m -106.99 -26.11 11.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.316 -1.108 . . . . 0.0 110.528 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.88 56.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.118 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.34 161.02 43.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.25 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.468 2.112 . . . . 0.0 112.073 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 88.8 t -58.0 105.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.235 -0.915 . . . . 0.0 109.07 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -68.67 -65.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -0.988 . . . . 0.0 108.774 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.46 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.39 125.49 9.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.01 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.2 mt -81.39 145.08 9.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 109.172 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.12 145.93 40.05 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.787 0.803 . . . . 0.0 110.095 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.97 143.72 26.66 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.333 0.587 . . . . 0.0 109.762 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 161.04 41.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 109.469 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.527 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -84.86 166.92 16.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.528 ' CG ' ' H ' ' A' ' 56' ' ' GLY . 8.4 ptp180 -58.81 -58.54 8.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.18 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -75.38 23.79 1.48 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 54' ' ' THR . 16.5 m -86.1 -14.67 43.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.108 -1.23 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt -135.4 172.45 13.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.452 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 18.9 m-85 -114.96 122.65 46.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 mmt -84.79 144.31 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.668 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.242 179.77 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.456 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.705 0.764 . . . . 0.0 110.742 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.5 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -89.41 -173.48 4.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.407 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 70' ' ' THR . 66.3 m-85 -154.89 171.31 19.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.224 -0.922 . . . . 0.0 108.671 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.14 -2.18 21.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.4 -0.812 . . . . 0.0 110.946 -178.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 74' ' ' GLN . 1.4 p -160.66 134.42 6.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.242 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -42.9 -29.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -65.35 -34.36 78.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.439 -0.788 . . . . 0.0 110.425 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -83.9 -35.41 24.11 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 108.288 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.414 ' CD2' ' C ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -75.94 -31.6 59.16 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 74' ' ' GLN . 22.3 tp60 -73.77 -33.78 64.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.66 61.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 5.5 t60 -72.73 -51.53 18.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.196 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.6 mm -51.66 -53.05 18.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.666 -0.646 . . . . 0.0 109.657 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.07 -19.07 64.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.104 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 14.1 m170 -87.08 -28.15 22.72 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.723 -1.191 . . . . 0.0 112.031 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -129.42 -23.42 2.93 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.454 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 4.8 m-70 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 0.0 109.27 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.422 ' H2 ' ' HH ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 11' ' ' ILE . 5.1 m-70 -96.9 -66.07 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 109.299 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -76.72 124.02 27.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 109.997 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 9' ' ' LEU . 4.4 m -46.0 145.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -82.36 -26.61 32.75 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 -33.31 12.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 110.567 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -104.33 -25.4 12.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -0.898 . . . . 0.0 110.83 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.26 -9.24 49.03 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 5.7 mp -73.28 158.45 86.75 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.993 -1.298 . . . . 0.0 108.819 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -68.15 104.34 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.8 1.667 . . . . 0.0 112.883 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 2' ' ' HIS . 78.4 mt -50.99 120.15 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.43 0.633 . . . . 0.0 110.236 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -88.31 -27.07 21.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.69 144.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.422 ' HH ' ' H2 ' ' A' ' 1' ' ' VAL . 3.3 m-30 -80.78 100.11 8.6 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.802 -1.186 . . . . 0.0 110.453 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 95.1 1.64 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.9 ttt-85 -80.89 137.28 36.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.037 -0.684 . . . . 0.0 110.168 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 9.7 mtp -121.74 134.18 54.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.122 0.486 . . . . 0.0 110.238 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -114.37 155.9 45.17 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.69 2.97 52.47 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.145 -1.19 . . . . 0.0 111.364 -0.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.3 t -56.74 -33.48 66.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.537 -0.727 . . . . 0.0 109.389 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 66.93 26.69 9.12 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.592 ' HE2' ' HE ' ' A' ' 69' ' ' ARG . 33.8 m170 -97.49 162.49 13.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.902 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -118.07 160.79 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.157 0.98 . . . . 0.0 111.019 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 93.5 m-85 -164.53 -165.23 0.91 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -85.06 113.12 21.24 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -47.67 -16.38 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.973 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 25' ' ' CYS . 7.4 t70 -82.73 -50.68 8.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.027 -1.046 . . . . 0.0 109.488 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.0 m -78.86 -20.85 48.56 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.81 -1.182 . . . . 0.0 108.096 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.93 71.33 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.7 pt -80.32 -33.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 121.001 -1.062 . . . . 0.0 108.793 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.9 mt -64.0 -34.37 77.86 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.876 -1.13 . . . . 0.0 107.988 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.17 -42.52 72.36 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.94 95.82 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -70.69 -19.74 62.75 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -81.43 -54.68 5.25 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.557 -0.714 . . . . 0.0 110.256 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -117.05 -30.45 1.94 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 1.3 t70 70.83 13.99 7.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.288 -1.125 . . . . 0.0 109.826 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.67 36.32 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.028 -1.045 . . . . 0.0 110.861 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 39' ' ' MET . 10.8 ptm -145.81 118.08 8.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.987 -1.071 . . . . 0.0 110.248 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.2 t -62.12 139.8 96.03 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.77 . . . . 0.0 108.981 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.69 -36.97 20.08 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.875 1.716 . . . . 0.0 112.416 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.89 -36.94 0.79 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 -14.16 52.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.281 . . . . 0.0 110.277 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 t 47.65 36.02 5.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.077 -1.015 . . . . 0.0 109.464 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.33 161.11 38.15 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 108.786 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.73 73.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.153 1.902 . . . . 0.0 111.884 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 45' ' ' ASP . 59.0 t -47.16 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 0.0 109.501 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -66.72 -62.79 1.27 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.161 -0.962 . . . . 0.0 108.517 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.03 134.31 17.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.799 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -94.34 145.97 7.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.616 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.09 150.79 44.75 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.438 0.637 . . . . 0.0 109.781 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -94.91 150.12 20.51 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.566 -0.709 . . . . 0.0 109.75 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.87 168.26 25.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.267 -0.895 . . . . 0.0 109.69 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.524 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -80.64 157.43 25.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.308 -0.87 . . . . 0.0 108.828 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -75.5 26.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.052 . . . . 0.0 109.864 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -144.29 13.91 2.08 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.434 ' OG ' ' OG1' ' A' ' 54' ' ' THR . 0.7 OUTLIER -97.11 -19.05 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.777 -0.837 . . . . 0.0 110.365 -179.042 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 mt -110.81 165.4 11.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.539 -0.726 . . . . 0.0 109.784 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 24.4 m-85 -119.19 113.88 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.0 mtp -80.61 144.41 32.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.726 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.74 143.21 33.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.4 t -141.44 74.44 1.46 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.812 . . . . 0.0 109.567 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mm -101.14 -61.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.551 -0.718 . . . . 0.0 109.397 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.459 ' CG2' ' N ' ' A' ' 65' ' ' GLN . 8.4 p -158.61 169.22 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.47 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 64' ' ' VAL . 3.9 tt0 49.38 -159.96 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.15 60.03 1.37 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.68 95.14 8.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -1.179 . . . . 0.0 109.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -110.66 40.27 2.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.592 ' HE ' ' HE2' ' A' ' 22' ' ' HIS . 13.3 mmt85 -75.35 93.66 2.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.438 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -74.15 176.35 6.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.72 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 70' ' ' THR . 78.4 m-85 -159.05 -170.87 3.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.86 -11.43 14.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 110.278 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 74' ' ' GLN . 3.5 m -150.91 133.5 15.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.975 -1.078 . . . . 0.0 109.343 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 73' ' ' SER . 2.1 tp60 -44.12 -31.93 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -61.66 -31.98 72.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 110.496 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.02 -35.62 23.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 108.639 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.83 -34.35 62.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.682 HE22 HD21 ' A' ' 82' ' ' ASN . 0.9 OUTLIER -68.17 -39.01 82.67 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.108 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.543 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -66.02 -21.55 66.4 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -76.05 -36.91 58.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.919 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.414 ' H ' HG12 ' A' ' 81' ' ' ILE . 6.6 mm -62.05 -53.28 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 110.038 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.682 HD21 HE22 ' A' ' 78' ' ' GLN . 3.8 p30 -72.18 -19.02 61.82 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.68 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 34.6 m170 -85.71 -25.9 26.21 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.525 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -129.97 -20.11 3.16 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.278 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.461 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 8.5 m-70 -106.78 -47.64 3.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.398 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.0 ttt 51.03 60.09 4.14 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER 63.9 29.18 14.59 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.615 0.722 . . . . 0.0 109.238 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 87' ' ' ARG . . . 73.97 -63.91 0.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.5 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.539 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.522 ' O ' ' CZ ' ' A' ' 14' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.501 0.667 . . . . 0.0 109.407 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.493 ' N ' ' CG2' ' A' ' 1' ' ' VAL . 0.0 OUTLIER -95.37 -56.23 2.78 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.539 -0.725 . . . . 0.0 109.196 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -76.54 109.32 10.18 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.271 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.3 t -46.37 146.37 1.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 110.073 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -18.56 39.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.458 -0.776 . . . . 0.0 109.303 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.03 -51.23 3.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.3 m -84.14 -14.65 49.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.406 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.24 9.13 14.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.23 158.62 33.68 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.343 -1.092 . . . . 0.0 108.693 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.73 101.53 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.989 1.793 . . . . 0.0 112.267 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 2' ' ' HIS . 74.2 mt -50.27 120.74 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.514 0.673 . . . . 0.0 110.578 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.32 -31.66 20.06 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.06 141.89 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 1' ' ' VAL . 3.4 m-85 -81.74 102.03 10.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.544 -1.347 . . . . 0.0 110.688 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -75.54 85.74 0.84 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.588 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.5 ttt-85 -69.33 134.87 49.62 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 122.09 -0.653 . . . . 0.0 110.454 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 21' ' ' LYS . 9.4 mmm -118.4 132.42 56.26 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -116.24 156.46 47.07 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.72 -1.74 47.83 Favored 'Cis proline' 0 N--CA 1.49 1.285 0 C-N-CA 124.137 -1.193 . . . . 0.0 111.533 -0.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.04 -34.16 28.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.588 ' CG ' HH21 ' A' ' 16' ' ' ARG . 3.4 ttmt 67.68 25.86 8.04 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -94.16 179.77 5.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.2 m -144.54 153.27 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 110.788 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 73.9 m-85 -158.42 170.34 22.44 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -55.61 113.63 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.039 -1.465 . . . . 0.0 108.171 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.463 ' CE2' ' CD ' ' A' ' 52' ' ' GLN . 35.5 t80 -49.43 -11.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.855 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -74.56 -44.5 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.021 -1.049 . . . . 0.0 108.831 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -25.48 38.77 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.886 -1.133 . . . . 0.0 108.119 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.69 83.58 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.486 -0.885 . . . . 0.0 108.702 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.5 pt -78.86 -34.95 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.024 -1.047 . . . . 0.0 108.918 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.62 -21.9 66.62 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.267 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -80.09 -40.68 27.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.9 -29.82 62.27 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.465 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -76.46 -34.44 58.7 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.102 -0.999 . . . . 0.0 108.424 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -81.44 10.1 6.29 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.354 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.71 51.14 40.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 39' ' ' MET . 0.6 OUTLIER -97.63 -39.78 8.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.498 -1.001 . . . . 0.0 109.827 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt 50.61 59.91 4.24 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.35 1.071 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 37' ' ' ASP . 15.4 ptm -151.56 124.06 8.38 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.853 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.529 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -64.03 124.36 85.0 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.076 -1.015 . . . . 0.0 109.758 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -44.31 -22.86 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.127 1.885 . . . . 0.0 113.068 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.22 -64.65 0.87 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 44' ' ' SER . 62.9 m -69.69 -43.65 72.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.232 -1.158 . . . . 0.0 108.564 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.6 p 76.9 57.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.832 -0.543 . . . . 0.0 111.622 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.443 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 174.82 -48.19 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.386 -1.446 . . . . 0.0 112.117 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 45' ' ' ASP . 64.9 Cg_endo -86.47 51.44 2.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.57 2.18 . . . . 0.0 115.706 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -95.35 117.28 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.263 -1.523 . . . . 0.0 109.211 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -98.27 -65.55 0.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.426 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -141.75 137.94 31.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mt -92.45 145.9 7.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.737 -1.227 . . . . 0.0 109.696 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -137.28 149.0 46.79 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.755 0.788 . . . . 0.0 109.844 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 32.0 mt-30 -94.74 136.15 35.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.831 -0.543 . . . . 0.0 110.03 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.96 155.62 48.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.619 -0.675 . . . . 0.0 110.027 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.75 158.2 22.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.35 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.527 ' C ' ' H ' ' A' ' 57' ' ' SER . 7.8 ttp180 -49.33 -69.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -0.98 . . . . 0.0 109.988 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.32 27.52 0.57 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.527 ' H ' ' C ' ' A' ' 55' ' ' ARG . 17.0 t -85.05 -27.94 26.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.909 -1.347 . . . . 0.0 108.858 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -112.43 173.73 6.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 17.6 m-85 -113.27 120.54 41.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.852 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 mtp -81.65 144.66 31.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 109.916 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.3 t -73.47 139.36 45.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.362 -0.836 . . . . 0.0 109.479 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.0 m -98.95 -25.96 14.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.12 142.74 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.883 . . . . 0.0 109.583 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 66' ' ' GLY . 52.7 t 50.72 92.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.577 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -53.94 -12.38 0.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.387 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 64' ' ' VAL . . . -72.64 -53.6 8.27 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 144.04 56.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -1.15 . . . . 0.0 109.465 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' THR . 6.0 ptpt -154.41 34.36 0.42 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.335 -0.853 . . . . 0.0 109.127 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 70' ' ' THR . 12.0 mmt-85 -67.06 74.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.513 ' H ' ' HG1' ' A' ' 70' ' ' THR . 0.0 OUTLIER -48.19 173.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 109.424 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.81 -173.75 4.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -116.65 -5.15 11.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.695 -0.628 . . . . 0.0 109.804 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -145.81 125.62 13.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.942 . . . . 0.0 109.061 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -45.38 -22.69 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.6 tmm_? -69.86 -36.32 75.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 110.129 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -82.57 -33.95 27.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 tp -70.1 -38.29 75.62 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -67.52 -30.43 70.08 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.48 -20.98 62.0 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.54 ' C ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -78.09 -41.58 34.82 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.355 -1.338 . . . . 0.0 108.429 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 86' ' ' MET . 3.8 mm -56.3 -54.98 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 109.281 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.497 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 5.8 p30 -69.35 -23.56 63.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.526 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.9 m170 -87.68 -11.73 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.189 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -115.37 -49.95 2.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.264 -0.897 . . . . 0.0 112.858 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.492 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -139.15 -24.66 0.88 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.214 -178.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' ILE . 3.6 ttm 55.06 38.38 30.41 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 109.582 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.4 mtp85 -90.17 0.6 57.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.171 -0.956 . . . . 0.0 109.443 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.24 150.81 0.79 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.016 -1.436 . . . . 0.0 109.52 -179.959 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 3' ' ' PHE . 19.0 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.576 ' ND1' ' NH1' ' A' ' 55' ' ' ARG . 37.8 t60 65.07 -58.06 0.27 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.298 0.571 . . . . 0.0 109.975 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 1' ' ' VAL . 32.5 m-85 -74.14 107.99 6.67 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.33 -0.856 . . . . 0.0 109.318 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.9 t -45.95 146.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.818 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.8 -25.43 40.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -48.8 4.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.278 -0.889 . . . . 0.0 110.301 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.4 m -78.07 -15.61 58.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.83 13.06 12.03 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.66 158.75 31.2 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.546 -0.973 . . . . 0.0 108.48 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -65.85 103.45 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.088 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 2' ' ' HIS . 71.0 mt -49.47 116.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.336 0.589 . . . . 0.0 110.447 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 -31.72 33.94 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.57 145.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -73.99 102.07 4.04 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.491 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.13 85.72 1.11 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH2' ' OG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -71.28 141.44 50.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.904 -0.762 . . . . 0.0 110.519 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 21' ' ' LYS . 11.4 mtp -129.58 132.84 46.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.756 -0.59 . . . . 0.0 109.887 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -118.03 156.03 50.66 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.83 3.58 41.46 Favored 'Cis proline' 0 N--CA 1.492 1.385 0 C-N-CA 124.112 -1.203 . . . . 0.0 111.799 -0.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -55.39 -37.04 67.05 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.427 -0.795 . . . . 0.0 109.008 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' O ' ' NH2' ' A' ' 16' ' ' ARG . 3.0 tttm 68.78 29.14 5.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 4.9 m80 -100.41 -174.75 2.73 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.759 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.572 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -141.66 155.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.396 -0.815 . . . . 0.0 110.998 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.8 m-85 -164.17 168.3 19.11 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 112.61 1.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.193 -1.403 . . . . 0.0 108.008 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -49.63 -31.3 10.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 0.0 109.883 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -39.99 84.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.566 ' SG ' ' CE1' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -81.38 -23.66 37.52 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.21 -35.89 74.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.517 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.1 pt -86.7 -35.13 8.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.163 -0.961 . . . . 0.0 109.419 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.71 -23.82 60.91 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.333 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.566 ' CE1' ' SG ' ' A' ' 28' ' ' CYS . 40.7 m170 -78.44 -55.45 5.21 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.24 -32.31 66.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.388 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -80.74 -26.86 37.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.034 -1.041 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -79.35 -5.67 55.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 110.334 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.6 32.57 3.35 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.607 ' C ' ' H ' ' A' ' 39' ' ' MET . 0.8 OUTLIER -132.04 56.68 1.81 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.72 33.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.723 0.773 . . . . 0.0 108.921 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.607 ' H ' ' C ' ' A' ' 37' ' ' ASP . 7.4 mtm -131.72 137.27 48.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -38.72 102.91 0.26 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.049 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' CG ' ' HD1' ' A' ' 32' ' ' HIS . 51.3 Cg_exo -50.56 -19.48 5.0 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.796 1.664 . . . . 0.0 112.33 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.15 -37.21 2.95 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.71 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.0 m -104.84 -31.63 9.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -1.113 . . . . 0.0 110.319 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 75.59 63.02 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.079 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.8 160.31 67.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.88 90.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.553 2.169 . . . . 0.0 112.38 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.49 94.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 108.687 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ILE . 5.3 tt0 -61.75 -62.85 1.51 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.191 -0.943 . . . . 0.0 108.638 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.413 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.78 139.07 22.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.273 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.54 143.11 13.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.826 -1.171 . . . . 0.0 109.844 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -136.73 141.14 43.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.785 0.802 . . . . 0.0 110.025 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -85.52 149.2 25.54 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.329 0.585 . . . . 0.0 109.669 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.86 165.93 27.45 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.32 169.78 10.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.772 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.576 ' NH1' ' ND1' ' A' ' 2' ' ' HIS . 11.0 ttm-85 -90.38 74.86 6.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.398 1.095 . . . . 0.0 108.649 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.82 4.42 0.1 Allowed Glycine 0 C--N 1.288 -2.113 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.6 m -90.23 -34.0 15.96 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.089 -1.242 . . . . 0.0 109.536 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.23 173.88 6.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.701 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -134.66 128.5 33.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.673 -0.642 . . . . 0.0 109.521 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.08 144.73 29.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.537 -0.727 . . . . 0.0 110.577 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.418 ' CB ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -64.61 111.39 2.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 109.371 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 64' ' ' VAL . 0.4 OUTLIER -45.56 -65.77 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.398 -0.814 . . . . 0.0 109.993 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.421 ' CG2' ' CE1' ' A' ' 85' ' ' HIS . 3.4 mt -45.0 93.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.558 -0.714 . . . . 0.0 109.515 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.601 ' CG2' ' H ' ' A' ' 65' ' ' GLN . 9.0 p -63.53 -120.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.856 . . . . 0.0 109.395 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.601 ' H ' ' CG2' ' A' ' 64' ' ' VAL . 8.5 tt0 58.58 60.19 2.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.141 -0.975 . . . . 0.0 109.277 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.38 51.02 18.75 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 37.6 m -146.6 -111.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -1.13 . . . . 0.0 109.522 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp 48.29 42.11 17.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.71 HH11 HH22 ' A' ' 84' ' ' ARG . 68.5 mtp180 -91.75 112.76 24.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.139 -0.976 . . . . 0.0 109.778 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.527 ' OG1' ' NH2' ' A' ' 16' ' ' ARG . 1.2 p -56.18 170.01 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 69' ' ' ARG . 37.2 m-85 -158.0 170.01 23.27 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -108.03 -5.65 16.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.742 -0.598 . . . . 0.0 109.727 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.3 t -158.57 129.49 6.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.2 tp60 -42.27 -26.15 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.331 0.586 . . . . 0.0 109.439 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 tmt_? -64.17 -34.79 78.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -83.17 -36.52 24.65 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 108.41 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.34 -33.15 67.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.437 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 23.3 tp60 -69.99 -33.32 71.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.532 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.34 61.43 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.418 ' CD2' ' CB ' ' A' ' 61' ' ' CYS . 26.3 t60 -74.22 -44.12 54.44 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.471 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 86' ' ' MET . 2.8 mm -60.18 -53.53 47.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.549 -0.72 . . . . 0.0 109.196 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 14.8 m-20 -64.65 -22.51 66.99 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.22 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 18.1 m170 -87.41 -12.24 46.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.125 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.71 HH22 HH11 ' A' ' 69' ' ' ARG . 15.3 mmt-85 -120.9 -43.45 2.46 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.25 -0.906 . . . . 0.0 112.866 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.634 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -153.15 -25.17 0.15 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.592 -1.317 . . . . 0.0 110.244 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' ILE . 1.3 ttt 66.04 38.99 4.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 109.62 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -91.96 -166.79 1.63 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.42 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.03 96.9 1.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.936 -1.48 . . . . 0.0 109.594 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.495 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 83.1 t60 -173.93 -88.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' A' ' 2' ' ' HIS . 36.7 m-85 -160.54 106.05 1.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.46 -0.775 . . . . 0.0 110.21 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.567 ' SG ' ' N ' ' A' ' 8' ' ' GLY . 10.4 p -51.56 143.89 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.39 -0.819 . . . . 0.0 110.057 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.85 -4.48 57.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -85.46 -33.27 21.91 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -135.68 -15.96 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.621 -0.674 . . . . 0.0 110.488 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.567 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.09 14.31 64.68 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.212 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.52 156.62 37.32 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.088 -1.243 . . . . 0.0 108.432 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.97 136.52 66.18 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.778 1.652 . . . . 0.0 111.788 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.0 mt -88.17 93.79 4.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.61 0.719 . . . . 0.0 110.313 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -69.34 -36.35 76.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.23 142.72 36.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -73.31 106.04 4.96 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.135 -0.978 . . . . 0.0 111.123 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.79 81.27 0.77 Allowed Glycine 0 C--N 1.297 -1.616 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.525 HH12 ' C ' ' A' ' 21' ' ' LYS . 19.8 ttm-85 -65.8 133.01 50.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.942 -0.74 . . . . 0.0 109.164 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.533 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 31.3 mtp -119.12 134.62 55.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 110.566 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.445 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -118.75 156.5 51.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.88 -1.32 43.76 Favored 'Cis proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.962 -1.266 . . . . 0.0 111.32 0.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -49.87 -41.2 44.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.525 ' C ' HH12 ' A' ' 16' ' ' ARG . 5.4 ttmt 74.08 27.96 1.51 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.605 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 23.3 m80 -99.82 -175.99 3.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.486 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 2.9 m -145.3 153.55 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.171 -0.956 . . . . 0.0 111.376 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 66.3 m-85 -154.23 -149.94 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -90.54 107.81 19.4 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.558 ' CD2' ' CG ' ' A' ' 52' ' ' GLN . 51.2 t80 -48.34 -13.48 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 109.832 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -83.05 -48.95 10.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 109.703 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 3.4 m -79.91 -23.15 42.0 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 108.361 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' ' CD1' ' A' ' 50' ' ' ILE . . . -68.31 -35.25 77.54 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.4 pt -81.75 -34.34 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 O-C-N 120.948 -1.095 . . . . 0.0 109.241 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.62 -23.94 63.58 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.854 -1.139 . . . . 0.0 108.406 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.419 ' CE1' ' OD2' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -80.24 -40.4 27.11 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.185 -0.947 . . . . 0.0 108.833 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -31.24 63.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -82.83 -26.4 31.73 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -81.94 -79.23 0.18 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.973 -1.079 . . . . 0.0 110.242 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.1 40.9 0.17 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 39' ' ' MET . 1.8 m-20 -133.9 57.3 1.81 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.636 0.731 . . . . 0.0 109.088 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.96 32.88 0.06 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.613 ' H ' ' C ' ' A' ' 37' ' ' ASP . 1.9 mtt -127.37 167.73 15.8 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 42' ' ' GLY . 10.6 t -102.74 74.49 0.17 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.804 -0.56 . . . . 0.0 111.008 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -35.3 -21.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.517 2.145 . . . . 0.0 114.034 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -75.34 -35.48 47.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.605 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.9 m -125.81 -33.46 2.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 122.019 -0.695 . . . . 0.0 109.424 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' CYS . 2.8 p 83.99 78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.904 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.66 160.03 48.91 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.22 81.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.014 1.809 . . . . 0.0 111.612 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.4 t -48.49 101.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 108.728 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -61.53 1.74 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.3 122.97 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.292 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.472 ' CD1' ' O ' ' A' ' 29' ' ' ALA . 6.8 mt -79.89 147.41 6.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.876 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -139.03 162.54 34.69 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.605 0.717 . . . . 0.0 110.559 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.558 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 45.7 mt-30 -99.12 134.51 41.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.77 -0.581 . . . . 0.0 110.539 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.25 155.28 47.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.51 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.38 155.86 17.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.833 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.562 ' C ' ' H ' ' A' ' 57' ' ' SER . 1.1 ptm180 -51.61 -55.44 19.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.815 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.56 7.69 0.94 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.562 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -103.61 -8.21 20.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.39 -1.065 . . . . 0.0 109.741 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.8 mt -130.99 169.09 16.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 110.098 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 44.8 m-85 -122.59 122.35 38.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.5 mtt -87.64 144.83 26.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 0.0 110.336 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 51.7 t -89.79 143.27 26.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.634 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.4 m -95.91 -58.21 2.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 109.563 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.4 mt -45.69 133.95 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 109.747 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.491 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 65.6 t 47.11 76.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.353 -0.842 . . . . 0.0 109.498 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -49.02 -13.28 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 109.362 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . -59.81 -52.04 55.37 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 69' ' ' ARG . 8.0 p -53.6 -60.39 3.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER 48.82 11.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 109.747 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 67' ' ' CYS . 83.4 mtt-85 -60.93 110.04 1.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.951 . . . . 0.0 109.324 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.523 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.19 175.82 10.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 70' ' ' THR . 88.6 m-85 -157.49 -164.63 1.61 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.378 -0.826 . . . . 0.0 108.941 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.519 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -116.31 -9.52 11.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.766 -0.584 . . . . 0.0 110.106 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 75' ' ' ARG . 62.7 m -147.22 128.45 14.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.653 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.24 -18.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.22 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' SER . 7.6 tmm_? -74.25 -33.91 63.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.695 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.94 -35.78 25.73 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.8 -33.95 64.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -71.03 -30.58 66.82 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.547 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.48 -21.15 61.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.38 -39.83 62.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.174 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.442 HD13 HG22 ' A' ' 81' ' ' ILE . 28.0 mm -57.58 -59.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.871 0.843 . . . . 0.0 110.029 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.463 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.0 p30 -67.44 -20.11 65.46 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.555 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 37.5 m170 -86.94 -13.46 44.63 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.7 mmt-85 -124.79 -41.03 2.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.177 -0.952 . . . . 0.0 112.334 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 86' ' ' MET . 5.4 m-70 -97.25 -46.58 6.06 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.609 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 85' ' ' HIS . 0.2 OUTLIER 40.29 30.53 0.08 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.31 0.576 . . . . 0.0 110.087 179.201 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 85' ' ' HIS . 12.0 ttp85 -101.37 18.03 21.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.655 -0.653 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.24 149.9 0.94 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.563 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.662 ' CG2' ' H ' ' A' ' 2' ' ' HIS . 9.9 p . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.662 ' H ' ' CG2' ' A' ' 1' ' ' VAL . 0.6 OUTLIER -144.28 51.68 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.711 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 3.0 t80 -158.46 102.55 1.74 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 t -45.66 146.18 1.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.881 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -27.62 18.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.443 -0.786 . . . . 0.0 109.452 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.7 -38.78 10.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.09 -28.64 14.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.463 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.51 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.73 4.73 90.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.92 156.29 40.69 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.122 -1.222 . . . . 0.0 108.654 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.11 138.28 85.6 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.914 1.742 . . . . 0.0 112.089 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.607 ' C ' ' H ' ' A' ' 13' ' ' VAL . 40.5 mt -84.7 -67.4 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.642 -0.661 . . . . 0.0 111.002 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.0 -32.71 0.24 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.607 ' H ' ' C ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -145.17 120.06 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -67.21 113.26 5.0 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.655 -0.653 . . . . 0.0 110.863 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.75 82.2 1.67 Allowed Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.61 ' NH2' ' HZ2' ' A' ' 21' ' ' LYS . 4.0 ttt-85 -64.9 133.99 53.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 122.141 -0.623 . . . . 0.0 109.946 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.5 mtp -118.09 133.58 55.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.079 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.87 156.78 49.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.43 1.24 56.47 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.017 0.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 5.7 t -54.68 -38.04 66.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.407 -0.808 . . . . 0.0 109.13 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.61 ' HZ2' ' NH2' ' A' ' 16' ' ' ARG . 5.4 tttm 76.56 29.33 0.68 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.592 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 2.6 m80 -101.58 -179.17 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -145.88 155.31 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.033 -1.042 . . . . 0.0 110.97 -179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 51.2 m-85 -159.71 167.12 29.1 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 27' ' ' ASP . 20.4 p -51.68 110.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.212 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -49.67 -10.92 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.622 -0.674 . . . . 0.0 110.356 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.1 m-20 -78.65 -44.31 24.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.725 -1.234 . . . . 0.0 109.51 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -80.51 -25.35 38.79 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 108.196 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.43 -37.71 88.46 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.7 pt -82.57 -34.55 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.629 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.15 -19.48 59.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.151 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.18 -54.06 6.98 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.27 -0.894 . . . . 0.0 109.161 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -67.62 -30.97 70.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -74.73 -29.76 61.27 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.024 -1.047 . . . . 0.0 109.071 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -82.25 -79.27 0.18 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.142 -0.974 . . . . 0.0 109.819 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.74 31.93 0.11 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.579 ' C ' ' H ' ' A' ' 39' ' ' MET . 1.4 m-20 -125.63 52.85 1.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.809 0.814 . . . . 0.0 108.874 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.12 31.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.579 ' H ' ' C ' ' A' ' 37' ' ' ASP . 0.4 OUTLIER -128.4 139.02 52.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.849 -0.532 . . . . 0.0 109.567 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -42.87 106.12 0.46 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.0 109.621 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.47 -21.92 8.17 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.568 1.512 . . . . 0.0 112.124 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.21 -42.12 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.747 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.8 m -100.88 -30.33 11.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -1.159 . . . . 0.0 110.608 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.19 57.04 0.09 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 109.06 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.48 160.96 48.33 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.609 -0.682 . . . . 0.0 109.209 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.08 89.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.538 2.158 . . . . 0.0 112.048 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.45 101.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.187 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.55 -66.22 0.57 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.437 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -151.35 134.8 16.17 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.485 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.26 145.81 7.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.666 -1.271 . . . . 0.0 109.107 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.53 146.82 44.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.75 142.16 27.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.774 -0.579 . . . . 0.0 109.605 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.38 159.07 44.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.355 -0.841 . . . . 0.0 110.204 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.467 ' H ' ' HG1' ' A' ' 54' ' ' THR . 0.0 OUTLIER -76.38 162.82 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.05 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.567 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -66.32 -60.32 2.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 110.064 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.39 25.89 0.58 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.567 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.3 t -91.17 -23.6 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.4 173.45 6.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.734 -0.604 . . . . 0.0 109.71 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -117.08 119.91 36.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.4 mmt -75.9 144.52 41.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 110.341 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 t -84.85 143.22 29.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.035 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.6 m -146.38 74.04 1.35 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 109.791 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 24.4 mm -105.55 -75.6 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.562 -0.712 . . . . 0.0 109.216 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' CG2' ' H ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -93.78 -99.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.469 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.468 ' CG ' ' O ' ' A' ' 65' ' ' GLN . 1.4 tt0 -168.21 35.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.345 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -146.24 -34.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 40.9 t -64.44 170.93 3.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -1.158 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.593 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 11.1 pttt 179.3 29.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.363 -0.836 . . . . 0.0 109.185 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.81 117.19 20.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.101 -1.0 . . . . 0.0 109.439 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -82.71 174.79 10.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.954 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' A' ' 70' ' ' THR . 98.2 m-85 -158.31 -177.92 6.9 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.546 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -113.9 -2.7 13.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.587 -0.695 . . . . 0.0 110.549 -178.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.483 ' HG ' ' C ' ' A' ' 72' ' ' LEU . 1.5 m -154.57 131.39 10.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.814 -1.179 . . . . 0.0 109.865 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.3 tp60 -43.39 -30.18 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -63.77 -35.05 79.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.509 -0.745 . . . . 0.0 110.131 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.1 m-20 -81.19 -37.82 28.07 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.995 0.903 . . . . 0.0 108.705 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 tt -74.43 -31.07 62.16 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLN . 22.6 tp60 -71.07 -33.73 70.52 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.31 -19.92 61.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.416 ' ND1' ' OH ' ' A' ' 71' ' ' TYR . 77.7 t60 -72.67 -47.52 46.75 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.601 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mm -56.17 -51.05 67.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.688 -0.633 . . . . 0.0 109.61 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.05 -18.66 62.56 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.867 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.0 m170 -87.67 -27.32 22.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.075 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -23.82 2.96 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.485 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 5.4 m-70 -102.19 -47.36 4.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.163 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.2 ttt 41.28 33.8 0.29 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.426 0.632 . . . . 0.0 110.079 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ttt-85 -86.04 0.51 53.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.379 -0.826 . . . . 0.0 109.41 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.33 139.74 6.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.87 . . . . 0.0 109.453 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.53 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 11' ' ' ILE . 4.4 m-70 -95.98 -56.95 2.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -0.817 . . . . 0.0 109.658 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.43 109.13 8.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.895 . . . . 0.0 109.624 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.8 t -46.93 146.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.874 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.43 -24.11 39.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.447 -0.783 . . . . 0.0 109.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -60.95 1.44 Allowed 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.375 -0.828 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 7.3 m -68.27 -14.93 63.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 110.291 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.49 11.33 5.12 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 152.49 37.83 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.988 . . . . 0.0 108.572 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.76 100.37 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.729 1.619 . . . . 0.0 112.259 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 2' ' ' HIS . 77.8 mt -47.37 117.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.681 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -83.14 -32.08 26.84 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.12 143.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -73.19 100.71 3.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 120.852 -1.155 . . . . 0.0 111.032 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -76.53 86.86 0.93 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.46 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.6 ttt-85 -77.79 141.43 39.22 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.761 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.553 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 11.2 mtp -128.72 132.45 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.968 -0.457 . . . . 0.0 109.949 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.6 156.22 45.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.73 4.08 46.07 Favored 'Cis proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.344 -0.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.2 t -55.81 -35.36 66.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.509 -0.745 . . . . 0.0 109.122 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 17' ' ' MET . 4.5 tttt 66.62 27.77 9.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 27.0 m170 -93.54 -173.3 3.15 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.478 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.553 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -142.89 156.68 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 110.346 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 85.7 m-85 -165.66 166.26 18.14 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -57.68 114.75 2.41 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -47.65 -21.27 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.016 -1.052 . . . . 0.0 109.808 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.36 -39.87 62.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.061 -1.024 . . . . 0.0 108.248 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.537 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.02 -22.29 33.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.53 -34.28 72.11 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.4 pt -80.52 -35.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 121.104 -0.998 . . . . 0.0 108.67 178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.57 -38.81 91.57 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.693 -1.203 . . . . 0.0 107.876 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.26 -34.88 73.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -35.78 76.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.835 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -75.69 -21.59 57.45 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 108.704 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -81.96 -73.08 0.4 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.416 -0.802 . . . . 0.0 110.545 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -92.54 -36.78 6.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 1.9 t0 75.2 13.41 3.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.398 -1.06 . . . . 0.0 110.284 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.29 29.45 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.836 -1.165 . . . . 0.0 111.356 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.7 ptp -141.73 130.41 22.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.954 -1.091 . . . . 0.0 110.157 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.539 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 1.5 t -71.0 136.65 84.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -45.81 -46.68 15.07 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.911 1.741 . . . . 0.0 113.074 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.08 4.26 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.214 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 -14.97 25.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.257 . . . . 0.0 110.586 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 p 48.48 38.18 10.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -92.22 161.1 33.86 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.357 -0.84 . . . . 0.0 108.999 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLN . 19.6 Cg_endo -59.73 71.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.2 1.933 . . . . 0.0 112.068 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 45' ' ' ASP . 61.2 t -44.99 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.17 -0.956 . . . . 0.0 109.724 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' PRO . 3.7 tt0 -65.61 -61.74 1.92 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.069 -1.019 . . . . 0.0 108.344 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -148.76 137.53 21.39 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.769 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mt -94.78 147.31 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.641 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -140.53 154.48 46.56 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.29 0.567 . . . . 0.0 109.706 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.22 138.47 45.52 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.25 0.548 . . . . 0.0 109.692 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.69 165.97 25.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -82.88 157.89 22.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.853 . . . . 0.0 109.091 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -72.53 31.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -146.79 14.28 1.54 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.9 m -97.21 -28.63 14.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.702 -0.881 . . . . 0.0 110.404 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.11 172.42 7.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.607 -0.683 . . . . 0.0 109.783 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 41.7 m-85 -116.89 124.1 48.64 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -86.44 144.55 27.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.91 . . . . 0.0 110.393 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.585 ' N ' ' SD ' ' A' ' 60' ' ' MET . 42.1 t -95.91 109.75 22.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.483 -0.761 . . . . 0.0 109.125 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -102.52 51.21 0.81 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.466 -0.771 . . . . 0.0 109.969 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.409 ' CG2' ' HD1' ' A' ' 85' ' ' HIS . 3.7 mm -95.63 -46.87 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 109.263 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.507 ' CG2' ' H ' ' A' ' 65' ' ' GLN . 14.6 p -157.98 175.88 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 0.0 109.425 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.507 ' H ' ' CG2' ' A' ' 64' ' ' VAL . 36.5 mt-30 -75.36 -17.63 60.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.91 5.71 84.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.7 m -46.37 160.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -1.115 . . . . 0.0 109.528 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.706 ' HZ2' HH21 ' A' ' 84' ' ' ARG . 11.6 mttp -77.36 -70.53 0.46 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 109.889 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -175.61 -150.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.098 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.476 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -90.56 -173.84 3.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.6 ' HH ' ' CG ' ' A' ' 80' ' ' HIS . 95.6 m-85 -152.39 178.29 9.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.991 . . . . 0.0 108.903 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.539 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.33 -10.04 14.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.715 -0.615 . . . . 0.0 109.743 -179.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 75' ' ' ARG . 48.2 t -153.18 132.29 12.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.002 . . . . 0.0 109.91 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.54 -22.08 0.43 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.103 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.8 ttt-85 -70.89 -32.51 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -83.52 -34.67 25.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 tt -75.68 -33.88 60.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.438 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 20.6 tp60 -70.3 -33.58 71.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.545 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.84 -19.32 60.77 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.6 ' CG ' ' HH ' ' A' ' 71' ' ' TYR . 24.3 t60 -74.81 -44.76 47.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.531 -1.267 . . . . 0.0 108.605 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.9 mm -56.73 -53.3 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.722 0.772 . . . . 0.0 109.443 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 3.7 m-20 -69.38 -19.72 63.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.215 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 18.4 m170 -87.49 -25.92 23.46 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.781 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.706 HH21 ' HZ2' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -129.64 -34.24 1.79 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.066 -1.021 . . . . 0.0 112.651 -177.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 7.6 m-70 -94.01 -51.54 4.81 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.917 -1.114 . . . . 0.0 109.001 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 86' ' ' MET . 0.0 OUTLIER 40.93 35.03 0.31 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.466 0.65 . . . . 0.0 109.782 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.27 113.54 0.23 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.42 155.27 1.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.367 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.525 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 65.2 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.797 0.808 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.673 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -121.52 24.81 9.69 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -76.9 112.77 13.87 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.662 -1.274 . . . . 0.0 109.18 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.2 t -45.76 146.39 1.16 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 109.991 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.64 -25.92 32.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.599 -0.688 . . . . 0.0 109.71 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.66 -42.63 7.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 m -90.55 -29.7 17.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.061 -1.024 . . . . 0.0 110.666 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 1.36 87.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.88 158.8 49.97 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 108.502 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -68.54 97.73 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.878 1.719 . . . . 0.0 112.5 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.509 ' N ' ' O ' ' A' ' 2' ' ' HIS . 97.0 mt -41.68 113.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -82.97 -32.71 26.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -133.14 147.01 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.05 104.49 16.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.822 -1.174 . . . . 0.0 111.114 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.4 91.27 1.15 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.542 ' NH2' ' O ' ' A' ' 21' ' ' LYS . 2.5 tpt85 -74.63 135.84 41.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.082 -0.657 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.539 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 8.3 mtp -126.34 132.2 51.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.921 -0.487 . . . . 0.0 109.766 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.423 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.28 156.33 48.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.63 3.8 40.11 Favored 'Cis proline' 0 N--CA 1.49 1.321 0 C-N-CA 124.07 -1.221 . . . . 0.0 111.112 -0.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.07 -32.01 61.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' NH2' ' A' ' 16' ' ' ARG . 1.8 mttp 59.52 31.09 20.76 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.592 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 9.3 m170 -96.16 -173.15 2.72 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.591 -0.693 . . . . 0.0 109.374 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.488 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -147.36 149.0 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 110.58 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 37.1 m-85 -158.35 170.6 21.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -59.31 113.89 2.38 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 117.887 -1.525 . . . . 0.0 107.222 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -46.31 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 110.367 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.1 m-20 -78.93 -41.14 30.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.001 -1.062 . . . . 0.0 108.724 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -80.35 -22.08 41.76 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.0 -1.062 . . . . 0.0 108.57 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.84 -29.06 65.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 pt -89.14 -28.5 5.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.658 -1.276 . . . . 0.0 108.955 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.4 mt -66.77 -35.89 81.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.09 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -76.27 -44.38 37.46 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.607 ' N ' ' CG ' ' A' ' 32' ' ' HIS . 1.2 pt-20 -52.31 -32.74 39.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -83.56 -29.92 27.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.274 -0.891 . . . . 0.0 109.56 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -75.75 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 110.904 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -78.32 -41.98 15.89 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 2.5 t0 77.78 8.19 2.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.917 . . . . 0.0 110.211 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.71 43.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.001 -1.062 . . . . 0.0 111.157 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 39' ' ' MET . 11.9 ptm -148.82 122.38 9.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.577 -1.327 . . . . 0.0 110.49 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.2 143.18 97.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 108.995 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.18 -38.11 95.49 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.125 1.217 . . . . 0.0 112.076 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.33 -45.38 1.35 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.61 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -89.48 -10.76 45.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.817 -1.402 . . . . 0.0 110.732 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t 48.37 37.48 8.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 108.842 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -89.56 161.1 40.34 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.406 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.2 76.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.488 2.125 . . . . 0.0 111.71 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' ASP . 17.3 t -48.97 109.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.283 -0.885 . . . . 0.0 109.983 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -72.03 -62.25 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 108.56 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.423 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.78 134.5 16.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.692 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mt -92.79 144.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.819 -1.176 . . . . 0.0 109.88 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -140.8 146.47 37.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.448 0.642 . . . . 0.0 109.44 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -91.27 150.88 21.13 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.584 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.87 167.84 26.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.489 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -90.49 165.27 13.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.362 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -59.5 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -0.969 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.66 18.9 22.88 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 54' ' ' THR . 50.9 m -85.16 -21.23 29.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.052 -1.263 . . . . 0.0 108.999 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.06 173.1 11.56 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 6.3 m-85 -117.92 109.41 16.48 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.572 -0.705 . . . . 0.0 110.425 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -71.92 144.77 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 0.0 110.138 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.521 ' SG ' ' CE1' ' A' ' 80' ' ' HIS . 44.7 t -95.88 143.1 27.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.824 . . . . 0.0 109.555 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.54 -17.9 37.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 108.958 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.412 ' CG2' ' CE1' ' A' ' 85' ' ' HIS . 53.5 mt -94.25 92.42 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.453 -0.78 . . . . 0.0 109.293 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 65' ' ' GLN . 12.4 m -69.99 -166.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.626 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.431 ' CB ' ' O ' ' A' ' 64' ' ' VAL . 1.8 tt0 71.09 105.82 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.71 63.2 4.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.518 ' C ' ' H ' ' A' ' 69' ' ' ARG . 11.6 t -148.02 118.98 7.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -1.127 . . . . 0.0 109.299 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 70' ' ' THR . 9.9 tttt -50.55 -11.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.321 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 67' ' ' CYS . 5.4 mtp180 63.91 -75.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.768 . . . . 0.0 111.018 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.492 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 7.8 p -94.22 158.56 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 110.867 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.641 ' HH ' ' CG ' ' A' ' 80' ' ' HIS . 75.7 m-85 -152.1 173.35 15.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.567 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -100.92 -10.78 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.586 -178.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -162.12 138.99 8.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.807 -1.183 . . . . 0.0 110.519 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -42.99 -31.17 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.41 0.624 . . . . 0.0 109.752 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -66.27 -32.28 73.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.443 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.34 -33.56 22.03 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.52 ' O ' ' ND1' ' A' ' 80' ' ' HIS . 0.2 OUTLIER -75.48 -35.18 60.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -72.63 -34.3 67.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.82 -19.64 62.65 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.641 ' CG ' ' HH ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -77.76 -40.99 39.1 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.396 -1.322 . . . . 0.0 108.641 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 86' ' ' MET . 3.8 mm -55.71 -54.77 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 108.405 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.48 -26.28 66.29 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.772 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -89.97 -11.97 40.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.579 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -112.19 -54.6 2.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.226 -0.921 . . . . 0.0 112.945 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.412 ' CE1' ' CG2' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -134.53 -26.89 1.38 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -178.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.515 ' N ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER 56.89 50.95 11.42 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.595 -0.691 . . . . 0.0 109.474 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.1 -21.51 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 109.64 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' A' ' 86' ' ' MET . . . -48.16 120.87 3.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.492 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.661 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -100.7 24.05 9.63 Favored 'General case' 0 C--O 1.201 -1.474 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -74.64 114.9 13.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.707 -1.246 . . . . 0.0 110.009 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.3 t -45.54 146.74 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.214 -0.928 . . . . 0.0 109.987 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -36.15 66.89 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -54.32 2.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.51 ' C ' ' H ' ' A' ' 9' ' ' LEU . 4.0 m -66.05 -13.87 60.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.094 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 4.72 0.47 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 7' ' ' CYS . 5.4 mp -88.96 157.87 47.97 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.249 . . . . 0.0 108.475 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.04 99.29 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.854 1.703 . . . . 0.0 112.539 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 2' ' ' HIS . 88.1 mt -47.06 121.43 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -142.45 145.3 23.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -77.39 105.91 8.81 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.714 -1.241 . . . . 0.0 111.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.18 79.88 1.44 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 51' ' ' GLU . 11.5 ttt-85 -58.15 136.71 57.29 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.835 -0.803 . . . . 0.0 109.483 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.556 ' SD ' ' SG ' ' A' ' 40' ' ' CYS . 25.0 ttm -121.59 137.93 54.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.541 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -127.41 156.85 74.39 Favored Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 -0.34 38.15 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 C-N-CA 124.225 -1.156 . . . . 0.0 112.047 0.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 1.9 t -55.88 -36.82 68.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.1 OUTLIER 74.04 26.92 1.65 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.59 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 2.1 m170 -95.45 -169.25 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -146.44 153.89 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 109.979 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.2 m-85 -159.09 163.01 36.61 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.56 113.08 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.218 -1.393 . . . . 0.0 107.864 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -53.73 -19.18 3.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.453 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.41 -37.07 26.06 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.772 -1.205 . . . . 0.0 108.292 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.532 ' O ' ' CG ' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -83.2 -25.51 31.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.5 -32.26 72.12 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 pt -87.99 -33.87 6.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.189 -0.944 . . . . 0.0 109.211 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.39 -26.66 58.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.056 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 28' ' ' CYS . 18.2 m170 -76.74 -50.21 14.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.213 -0.929 . . . . 0.0 108.684 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.33 -27.97 68.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.34 -28.34 38.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.665 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -79.78 5.22 14.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.071 -1.018 . . . . 0.0 110.05 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.23 35.76 5.15 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 39' ' ' MET . 0.5 OUTLIER -130.12 53.69 1.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.822 -0.811 . . . . 0.0 108.894 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.4 28.92 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.606 -0.683 . . . . 0.0 109.201 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.58 ' H ' ' C ' ' A' ' 37' ' ' ASP . 2.7 mtt -123.2 123.82 41.64 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.32 0.581 . . . . 0.0 109.492 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.556 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -37.1 102.1 0.23 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 122.017 -0.427 . . . . 0.0 111.088 -178.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.65 -14.55 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.667 1.578 . . . . 0.0 111.54 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.1 -38.61 4.02 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.192 -1.004 . . . . 0.0 110.835 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.4 m -120.54 -21.31 6.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.415 -1.05 . . . . 0.0 110.771 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 73.97 55.53 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.142 -179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.95 161.42 30.96 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' GLN . 13.1 Cg_endo -58.7 83.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.389 2.059 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.6 t -51.69 97.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.205 -0.934 . . . . 0.0 109.07 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' PRO . 8.1 mt-30 -64.11 -64.0 1.0 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.274 -0.891 . . . . 0.0 108.984 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.458 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.27 126.66 7.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.554 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.32 145.03 7.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 110.25 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' ARG . 24.5 mt-10 -137.31 151.5 48.71 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.766 0.793 . . . . 0.0 110.185 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -90.49 147.61 23.28 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.692 -0.63 . . . . 0.0 109.714 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -152.15 167.39 28.68 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.427 ' OG1' ' OG ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -81.62 163.79 22.31 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.143 -0.973 . . . . 0.0 109.002 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.538 ' C ' ' H ' ' A' ' 57' ' ' SER . 4.6 mtm180 -66.74 -69.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 110.671 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.99 28.36 0.3 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.637 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 55' ' ' ARG . 32.5 m -93.25 -36.9 12.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.277 . . . . 0.0 109.798 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 mt -99.14 173.34 6.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.731 . . . . 0.0 109.915 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.06 106.8 14.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 ttt -72.19 144.41 48.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 t -73.45 143.35 46.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 109.454 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -142.93 64.49 1.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 109.615 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.4 mm -101.51 -75.51 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.49 -0.757 . . . . 0.0 109.496 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.08 -96.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.392 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -168.63 31.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.318 -0.864 . . . . 0.0 109.344 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.89 -34.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.2 t -65.21 143.05 58.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -1.187 . . . . 0.0 109.591 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -154.79 38.67 0.42 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.33 -0.856 . . . . 0.0 108.91 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -76.13 97.73 4.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.521 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -62.23 177.99 0.43 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 70' ' ' THR . 26.5 m-85 -162.51 179.44 7.77 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.536 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.49 -7.93 15.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 109.834 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' ARG . 40.5 t -157.52 130.03 7.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.022 -1.049 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -42.73 -27.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.648 -0.657 . . . . 0.0 109.308 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.4 tmt_? -64.01 -34.96 79.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 110.535 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' CG ' ' CD1' ' A' ' 71' ' ' TYR . 27.3 t0 -83.11 -35.61 25.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 108.626 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.39 -32.67 64.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 74' ' ' GLN . 22.4 tp60 -69.08 -35.25 76.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.561 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.89 -20.35 62.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -74.52 -44.09 52.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.004 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.0 mm -58.02 -50.61 77.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.484 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.459 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.8 p30 -74.79 -18.56 60.45 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.796 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 35.1 m170 -86.19 -24.37 26.13 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.568 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.28 -26.59 2.55 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.108 -0.995 . . . . 0.0 112.115 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.486 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 6.2 m-70 -100.05 -49.01 4.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 109.064 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.4 ttt 40.16 32.92 0.14 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.396 0.617 . . . . 0.0 110.108 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -91.68 -1.71 57.32 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.442 -0.786 . . . . 0.0 109.497 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.3 -58.54 4.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.558 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.529 ' CG2' ' N ' ' A' ' 2' ' ' HIS . 1.5 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.52 0.676 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.688 ' HD1' HH21 ' A' ' 55' ' ' ARG . 0.6 OUTLIER -91.44 -58.38 2.46 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.43 -0.794 . . . . 0.0 109.102 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -81.24 120.63 25.14 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.973 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -44.69 146.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 110.249 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.65 -23.52 36.89 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' NZ ' ' SG ' ' A' ' 7' ' ' CYS . 2.4 ttpt -98.6 -50.68 4.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 110.518 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' SG ' ' NZ ' ' A' ' 6' ' ' LYS . 2.0 m -87.32 -17.78 31.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 111.16 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.01 -1.81 9.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.73 158.63 70.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.144 -1.209 . . . . 0.0 108.749 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.01 102.92 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.941 1.761 . . . . 0.0 112.938 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 2' ' ' HIS . 84.3 mt -49.73 125.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.513 0.673 . . . . 0.0 110.37 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -91.49 -29.41 17.02 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.83 143.75 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.405 ' CE2' ' N ' ' A' ' 1' ' ' VAL . 3.1 m-85 -79.8 103.93 10.03 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -76.05 81.84 1.02 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.839 -2.504 . . . . 0.0 106.839 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.5 ttt-85 -64.76 131.55 47.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.31 0.576 . . . . 0.0 110.286 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.515 ' O ' ' N ' ' A' ' 21' ' ' LYS . 16.6 mtp -117.55 132.2 56.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.987 -0.445 . . . . 0.0 110.347 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -117.87 156.6 49.79 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.97 2.58 48.59 Favored 'Cis proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.154 -1.186 . . . . 0.0 111.289 -0.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -56.27 -36.91 69.12 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.624 -0.673 . . . . 0.0 109.294 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 17' ' ' MET . 5.0 ttmt 73.52 25.77 2.06 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -95.09 -179.06 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.195 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.478 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.3 m -146.33 151.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.083 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 31.6 m-85 -158.74 168.28 27.27 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.49 ' C ' ' H ' ' A' ' 27' ' ' ASP . 2.8 m -53.07 115.47 1.89 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.936 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -50.9 -11.83 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -76.72 -46.97 23.32 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.14 -0.975 . . . . 0.0 109.042 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.84 -22.96 45.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.998 -1.064 . . . . 0.0 108.412 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.466 ' O ' ' CD1' ' A' ' 50' ' ' ILE . . . -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.3 pt -80.02 -33.7 14.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.039 -1.038 . . . . 0.0 108.986 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.428 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 24.1 mt -67.11 -23.94 65.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.123 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.457 ' ND1' ' OD2' ' A' ' 37' ' ' ASP . 1.2 m-70 -82.75 -34.77 27.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -27.07 44.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.518 -0.738 . . . . 0.0 109.06 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -83.3 -35.23 25.42 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.218 -0.927 . . . . 0.0 109.249 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 31' ' ' LEU . 17.5 mmtm -73.82 -9.57 58.78 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.379 -0.826 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.29 33.06 15.0 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.457 ' OD2' ' ND1' ' A' ' 32' ' ' HIS . 4.6 m-20 -79.92 -44.47 20.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.182 -1.187 . . . . 0.0 109.392 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt 46.7 46.03 14.74 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.185 0.993 . . . . 0.0 109.542 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 ptm -147.17 139.06 24.31 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.447 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' SER . 51.9 t -71.34 114.57 28.96 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.863 . . . . 0.0 109.32 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -49.41 -15.56 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.426 1.417 . . . . 0.0 111.856 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.95 -63.92 0.84 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 44' ' ' SER . 4.0 m -90.4 -22.13 21.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.3 p 74.27 36.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.18 157.18 34.3 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 85.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.442 2.095 . . . . 0.0 112.016 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 5.2 m -55.08 104.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.1 tt0 -48.07 -54.94 11.45 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.041 -1.037 . . . . 0.0 108.353 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.438 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -159.04 135.51 9.25 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.796 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.466 ' CD1' ' O ' ' A' ' 29' ' ' ALA . 3.0 mt -87.7 145.97 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.887 -1.133 . . . . 0.0 109.599 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -138.77 152.97 48.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.518 0.675 . . . . 0.0 109.731 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -96.38 139.14 32.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.74 -0.6 . . . . 0.0 109.877 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.19 161.05 39.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.498 ' H ' ' HG1' ' A' ' 54' ' ' THR . 0.0 OUTLIER -80.4 157.92 26.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.279 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.688 HH21 ' HD1' ' A' ' 2' ' ' HIS . 68.1 mtp180 -53.51 -72.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.235 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.58 30.06 0.36 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 55' ' ' ARG . 19.6 t -86.86 -31.17 20.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.947 -1.325 . . . . 0.0 109.289 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -99.29 173.62 6.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 23.0 m-85 -118.59 117.31 28.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.8 mtt -79.55 144.59 33.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.335 -0.853 . . . . 0.0 110.751 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.44 141.48 36.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 m -141.0 75.86 1.52 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.361 -0.837 . . . . 0.0 109.6 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.6 mm -94.41 -70.84 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.831 . . . . 0.0 109.5 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.3 m -143.89 179.79 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.361 -0.837 . . . . 0.0 109.507 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.463 ' CG ' ' N ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER 47.13 -111.97 0.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 109.508 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 65' ' ' GLN . . . -148.13 31.6 1.3 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.4 t -47.35 131.87 13.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -1.192 . . . . 0.0 109.365 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -137.62 40.74 2.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.522 -0.736 . . . . 0.0 109.373 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -80.12 102.8 9.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 109.234 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -80.22 176.02 10.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 110.012 -179.565 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.529 ' CG ' ' O ' ' A' ' 70' ' ' THR . 87.4 m-85 -158.29 -168.39 2.45 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.476 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -119.89 -6.75 10.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.643 -179.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -146.2 127.98 15.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 108.847 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -47.06 -26.0 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -66.35 -31.13 71.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.479 -0.763 . . . . 0.0 109.919 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.68 -34.39 24.98 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.1 -35.27 59.39 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.715 HE22 HD21 ' A' ' 82' ' ' ASN . 0.3 OUTLIER -67.09 -39.74 86.83 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.544 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -66.65 -20.75 66.06 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.13 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -74.8 -40.03 61.36 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.837 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mm -60.15 -52.11 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.654 -0.654 . . . . 0.0 110.379 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.715 HD21 HE22 ' A' ' 78' ' ' GLN . 2.6 p30 -74.55 -18.09 60.64 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.036 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 35.1 m170 -85.85 -26.58 25.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.532 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -128.72 -26.11 2.75 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.856 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.476 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 6.7 m-70 -98.77 -49.16 4.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.037 -1.04 . . . . 0.0 109.026 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.429 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.1 ttt 38.74 31.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.57 0.7 . . . . 0.0 110.158 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' C ' ' H ' ' A' ' 89' ' ' GLY . 3.3 mtp85 -87.94 -1.45 57.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -0.822 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.11 -12.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.175 -0.953 . . . . 0.0 109.49 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 87' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.316 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.6 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 3' ' ' PHE . 28.3 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.8 t60 65.26 -59.77 0.26 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.318 0.58 . . . . 0.0 109.871 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 1' ' ' VAL . 7.7 m-85 -73.22 107.77 5.73 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.425 -0.797 . . . . 0.0 109.698 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 8' ' ' GLY . 8.6 p -46.83 128.46 10.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 109.874 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.72 -13.1 60.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.24 -40.29 45.42 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.19 -0.944 . . . . 0.0 109.302 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.48 -21.11 4.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.762 -0.586 . . . . 0.0 110.708 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.71 15.93 60.76 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.26 155.47 38.82 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.295 -1.121 . . . . 0.0 108.496 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.5 109.92 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.904 1.736 . . . . 0.0 112.154 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.1 mt -58.12 112.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.559 0.695 . . . . 0.0 110.466 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -82.12 -33.55 29.61 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.85 137.5 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -76.35 104.81 7.05 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.95 -1.094 . . . . 0.0 110.652 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -78.35 86.44 1.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -70.49 133.43 46.8 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 122.146 -0.62 . . . . 0.0 111.023 -178.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' LYS . 2.7 mmm -118.91 135.25 54.68 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.456 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -119.2 153.32 53.21 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.95 -4.78 44.38 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 124.276 -1.135 . . . . 0.0 111.621 0.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' A' ' 22' ' ' HIS . 6.4 t -48.18 -30.21 4.43 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 6.7 mtmm 60.29 28.93 18.57 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.406 ' CD2' ' SG ' ' A' ' 20' ' ' CYS . 28.3 m170 -93.86 173.05 7.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.545 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 13.7 m -136.67 151.22 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.707 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 83.4 m-85 -160.9 159.71 30.03 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -47.19 110.27 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -47.06 -16.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.697 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -77.54 -44.82 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.069 . . . . 0.0 108.848 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 36.7 m -79.12 -21.0 47.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.899 -1.126 . . . . 0.0 108.0 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.3 78.2 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 pt -76.11 -33.52 24.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 108.781 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.6 mt -65.4 -39.7 92.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.618 -1.233 . . . . 0.0 107.681 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -71.97 -25.35 61.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.363 -0.836 . . . . 0.0 108.771 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 37' ' ' ASP . 0.5 OUTLIER -79.27 -36.89 39.07 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.087 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -75.95 -18.58 59.28 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.888 -1.133 . . . . 0.0 108.129 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -80.55 -36.76 32.58 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.477 -0.764 . . . . 0.0 109.583 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.61 -34.55 0.22 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.4 OUTLIER 67.44 29.07 7.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.394 -1.062 . . . . 0.0 109.707 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -172.46 31.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.24 -0.912 . . . . 0.0 110.674 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.446 ' CG ' ' O ' ' A' ' 39' ' ' MET . 10.2 ptm -149.46 120.02 7.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.0 -1.062 . . . . 0.0 110.973 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -69.23 129.53 91.83 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.52 -29.35 2.1 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.22 1.946 . . . . 0.0 113.623 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.54 -63.68 1.02 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 44' ' ' SER . 70.8 m -67.55 -45.08 76.71 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.432 -1.04 . . . . 0.0 109.025 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 76.98 53.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.709 -0.62 . . . . 0.0 111.412 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.456 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.2 OUTLIER 176.38 -48.59 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.489 -1.382 . . . . 0.0 112.205 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 45' ' ' ASP . 84.6 Cg_endo -83.48 46.28 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.637 2.225 . . . . 0.0 116.095 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.0 t -92.95 118.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.272 -1.517 . . . . 0.0 109.397 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -101.74 -64.51 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.456 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.51 144.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.7 -1.25 . . . . 0.0 110.289 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -139.22 140.53 37.78 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.894 0.854 . . . . 0.0 109.943 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -85.27 147.06 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.7 162.01 38.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.442 -0.786 . . . . 0.0 109.882 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.84 162.03 19.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.547 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -50.96 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.44 27.32 0.46 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.5 t -81.77 -18.8 42.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.991 -1.3 . . . . 0.0 109.06 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mt -117.69 173.58 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 16.5 m-85 -118.22 117.0 27.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mmt -79.41 144.61 33.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.78 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.13 139.35 34.91 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 m -141.04 76.28 1.54 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -0.8 . . . . 0.0 109.549 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.4 mm -97.21 -68.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.479 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.53 -79.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.537 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -178.75 -25.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.96 -39.32 5.22 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -48.04 157.55 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.168 -1.195 . . . . 0.0 109.565 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.73 28.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.367 -0.833 . . . . 0.0 108.927 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.476 ' NH1' ' OH ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -76.48 125.38 29.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 0.0 109.778 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.545 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -92.76 175.37 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 70' ' ' THR . 98.4 m-85 -157.56 -174.73 5.01 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -115.63 -6.06 12.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.634 -0.666 . . . . 0.0 110.078 -178.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 76' ' ' ASP . 24.3 p -150.19 130.5 13.72 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.021 . . . . 0.0 109.606 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 78' ' ' GLN . 9.8 mm-40 -44.17 -31.01 0.86 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -62.24 -33.25 74.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 0.0 109.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.8 m-20 -82.98 -36.97 24.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 108.726 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 tt -75.13 -30.75 60.9 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 74' ' ' GLN . 23.9 tp60 -71.4 -34.52 70.44 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.18 -19.99 62.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -72.8 -47.51 45.9 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.671 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.5 mm -56.56 -51.08 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -70.46 -18.95 62.99 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.774 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.2 m170 -87.45 -27.87 22.45 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.828 -1.149 . . . . 0.0 112.151 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 -16.67 4.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.977 -1.077 . . . . 0.0 112.157 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.5 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.3 m-70 -111.35 -45.41 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.3 ttt 42.02 34.86 0.49 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.378 0.609 . . . . 0.0 109.952 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -172.11 117.17 0.37 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 109.446 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.65 159.1 28.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.525 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.52 0.676 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.479 ' CG ' ' N ' ' A' ' 3' ' ' PHE . 13.6 t-160 -174.63 -94.38 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.682 -0.636 . . . . 0.0 109.318 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -161.12 105.23 1.32 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.832 . . . . 0.0 111.012 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 41.8 t -46.62 146.17 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.57 -27.03 18.44 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 110.513 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.75 -38.96 11.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 110.069 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 m -93.19 -29.87 15.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.529 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.72 11.56 82.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.93 156.66 36.3 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.464 -1.021 . . . . 0.0 108.541 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.58 142.5 71.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.951 1.767 . . . . 0.0 111.668 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.0 mt -95.39 73.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.521 -0.737 . . . . 0.0 110.77 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.42 -37.46 7.69 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.52 142.32 20.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -70.9 107.98 4.3 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.599 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -73.44 80.79 0.74 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.585 ' NH1' ' SG ' ' A' ' 53' ' ' CYS . 0.0 OUTLIER -61.07 141.96 57.01 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.027 -0.69 . . . . 0.0 109.932 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 21' ' ' LYS . 6.9 mtp -130.7 126.31 36.19 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.511 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.6 OUTLIER -115.06 158.06 41.87 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.25 -2.06 50.24 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.446 -0.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 9.7 t -57.4 -35.61 70.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 109.336 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' MET . 7.5 ttmt 75.92 29.57 0.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.41 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -94.04 164.44 13.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 33.2 m -131.44 148.03 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.334 -0.854 . . . . 0.0 110.888 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 42.1 m-85 -154.92 168.78 25.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -51.17 109.15 0.3 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.42 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.471 ' CE2' ' CD ' ' A' ' 52' ' ' GLN . 38.2 t80 -47.13 -20.44 0.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.495 -0.753 . . . . 0.0 109.78 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -74.89 -35.48 62.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 25' ' ' CYS . 12.3 p -82.46 -27.19 32.02 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' N ' ' SG ' ' A' ' 28' ' ' CYS . . . -67.67 -37.04 81.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.902 . . . . 0.0 108.629 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.5 pt -83.06 -34.61 11.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mt -73.72 -22.81 59.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.755 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 37' ' ' ASP . 6.7 m-70 -79.78 -42.93 23.44 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.183 -0.948 . . . . 0.0 108.778 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -75.05 -29.12 60.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -78.94 -30.8 44.87 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.025 -1.047 . . . . 0.0 108.926 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -77.62 -5.92 51.99 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.351 -0.843 . . . . 0.0 109.754 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.57 34.16 4.52 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 39' ' ' MET . 4.0 t70 -137.69 56.49 1.76 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.638 -0.919 . . . . 0.0 109.221 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.0 15.75 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.384 -0.822 . . . . 0.0 109.884 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.542 ' H ' ' C ' ' A' ' 37' ' ' ASP . 1.2 mtt -92.19 133.4 35.83 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.073 -1.017 . . . . 0.0 109.452 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.531 ' O ' ' N ' ' A' ' 44' ' ' SER . 43.9 t -45.3 107.82 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.66 -17.14 2.76 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.262 1.308 . . . . 0.0 111.71 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.46 -50.77 1.51 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.431 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 44' ' ' SER . 69.8 m -92.48 -28.98 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.245 . . . . 0.0 109.942 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.7 p 75.69 46.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.6 160.05 64.76 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.1 94.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.532 2.154 . . . . 0.0 112.181 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.478 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 10.5 m -59.49 108.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' ILE . 2.5 tt0 -47.97 -56.23 8.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.476 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -160.66 132.41 5.87 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.903 0.859 . . . . 0.0 108.979 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.25 145.23 8.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.815 -1.178 . . . . 0.0 109.508 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -138.59 156.67 47.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.842 0.829 . . . . 0.0 110.321 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.471 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 21.9 mt-30 -95.67 134.71 38.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.89 -0.506 . . . . 0.0 110.027 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.585 ' SG ' ' NH1' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -133.4 153.31 51.71 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.364 0.602 . . . . 0.0 109.987 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.439 ' O ' ' OG ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -83.59 158.64 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.795 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 57' ' ' SER . 15.5 ttp85 -48.62 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.442 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.21 28.65 0.26 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.869 -1.158 . . . . 0.0 110.329 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 55' ' ' ARG . 55.3 p -90.19 -19.11 24.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.337 . . . . 0.0 109.592 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.6 mt -119.49 173.61 6.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.774 -0.579 . . . . 0.0 109.989 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 26.4 m-85 -116.32 119.8 36.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mtt -85.43 144.49 27.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 t -97.93 143.34 28.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.494 -0.754 . . . . 0.0 109.358 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.0 p -140.95 74.45 1.46 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 109.608 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.467 ' CG2' ' HD1' ' A' ' 85' ' ' HIS . 3.4 mm -105.49 -74.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.637 -0.664 . . . . 0.0 109.373 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.66 12.13 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.418 ' O ' ' NE2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER 58.35 43.28 20.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.17 -53.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.0 152.19 45.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.133 . . . . 0.0 109.452 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.536 ' H ' HH11 ' A' ' 69' ' ' ARG . 13.6 tttt -151.23 43.13 0.77 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.205 -0.934 . . . . 0.0 109.424 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.536 HH11 ' H ' ' A' ' 68' ' ' LYS . 11.5 mpt_? -80.49 86.02 5.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.914 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -60.44 177.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.606 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 70' ' ' THR . 57.6 m-85 -160.92 -167.4 1.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.419 -0.8 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -114.63 -8.21 12.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.68 -0.638 . . . . 0.0 110.13 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' ARG . 72.6 m -147.45 127.97 14.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 109.626 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -45.9 -19.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 109.126 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.1 ttt-85 -71.37 -33.63 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.77 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.5 -37.68 24.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.66 -34.46 64.94 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 10.2 tp60 -70.54 -30.51 67.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.06 -21.19 61.56 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -76.66 -35.86 57.7 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.794 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.8 mm -63.92 -51.29 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.445 -0.784 . . . . 0.0 109.695 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.472 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.2 p30 -74.23 -19.05 60.65 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.718 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 37.9 m170 -86.46 -23.04 26.15 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.781 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 -26.56 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.995 -1.066 . . . . 0.0 111.926 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.498 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 6.3 m-70 -100.41 -49.87 4.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 108.964 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' HIS . 1.3 ttp 41.71 32.72 0.27 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.402 0.62 . . . . 0.0 109.868 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -157.33 18.27 0.28 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.56 140.98 5.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.49 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.553 179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.487 ' O ' ' CD2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.7 t60 64.38 -56.64 0.25 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.221 0.534 . . . . 0.0 109.986 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.487 ' CD2' ' O ' ' A' ' 1' ' ' VAL . 0.5 OUTLIER -74.37 112.23 10.33 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.425 -0.797 . . . . 0.0 109.158 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.1 t -48.02 146.5 2.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.061 -1.024 . . . . 0.0 109.87 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.54 -24.06 45.86 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -64.88 1.01 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.426 -0.797 . . . . 0.0 109.441 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 12.5 m -61.14 -22.0 64.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.21 9.48 29.68 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -101.2 157.81 32.97 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.37 -1.077 . . . . 0.0 108.773 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.73 105.87 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.879 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 60.9 mt -53.5 122.67 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.473 0.654 . . . . 0.0 110.594 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -31.18 22.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.5 t -138.22 145.29 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.477 ' OH ' ' CE ' ' A' ' 60' ' ' MET . 3.2 m-30 -76.78 98.61 4.86 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.792 -1.193 . . . . 0.0 110.893 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 88.24 0.86 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -76.79 141.42 40.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.976 -0.72 . . . . 0.0 110.322 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.524 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 15.4 mtp -129.38 132.98 47.16 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.167 0.508 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.402 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -116.19 156.36 47.11 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.87 2.64 48.0 Favored 'Cis proline' 0 N--CA 1.491 1.324 0 C-N-CA 124.164 -1.182 . . . . 0.0 111.316 -0.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -53.09 -40.11 63.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 tttp 71.59 31.22 2.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.551 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 9.1 m170 -104.63 174.14 6.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.567 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -128.95 159.8 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.619 0.723 . . . . 0.0 110.349 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 74.6 m-85 -166.26 174.06 9.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.57 115.41 4.24 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.619 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -49.44 -21.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 109.946 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.7 -41.23 60.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.03 -1.044 . . . . 0.0 108.568 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.492 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.13 -22.0 33.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.21 -33.52 71.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 pt -80.22 -37.02 17.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 121.044 -1.035 . . . . 0.0 108.621 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.27 -36.01 78.86 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.004 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -70.02 -39.94 75.52 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -74.68 -19.82 60.11 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.196 -0.94 . . . . 0.0 108.859 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -72.54 0.42 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.869 . . . . 0.0 110.311 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -96.95 -33.71 5.95 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 1.7 t70 75.34 13.12 3.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.366 -1.079 . . . . 0.0 109.851 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.31 35.24 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.01 -1.056 . . . . 0.0 111.031 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 39' ' ' MET . 10.2 ptm -145.26 117.92 8.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.929 -1.107 . . . . 0.0 110.508 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -62.22 143.3 95.45 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -52.93 -36.19 74.05 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.55 1.5 . . . . 0.0 112.044 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.56 -45.46 0.78 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.551 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 3.2 m -81.61 -15.91 53.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.993 -1.298 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t 49.37 36.75 10.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -90.61 161.18 37.18 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.016 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.99 75.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.297 1.998 . . . . 0.0 112.012 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ASP . 37.9 t -47.35 99.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.018 -1.051 . . . . 0.0 109.489 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.5 tt0 -67.31 -61.02 2.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 108.583 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -150.1 135.34 18.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.015 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mt -93.83 146.68 6.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.953 -1.092 . . . . 0.0 109.845 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -141.38 141.38 33.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.98 142.82 27.75 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.645 -0.659 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 169.26 19.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.296 -0.877 . . . . 0.0 109.847 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.531 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -87.13 162.12 17.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.873 . . . . 0.0 109.583 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 55' ' ' ARG . 1.1 ttp180 -70.04 38.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.021 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -153.27 17.55 0.69 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.74 -27.33 12.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.875 . . . . 0.0 110.243 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 mt -113.0 172.32 7.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.57 -0.706 . . . . 0.0 110.017 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 19.5 m-85 -129.37 120.39 25.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.477 ' CE ' ' OH ' ' A' ' 14' ' ' TYR . 1.8 mpt? -81.77 144.76 30.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.245 -0.91 . . . . 0.0 110.628 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 54.1 t -71.83 142.95 49.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.456 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 m -86.97 11.19 14.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.129 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.7 mm -96.3 168.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.414 -0.803 . . . . 0.0 109.007 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.34 178.24 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 109.622 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 58.69 80.91 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.445 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.99 64.46 1.53 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 35.2 t -169.55 -129.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -1.131 . . . . 0.0 109.422 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 3.9 tttp 73.51 27.92 1.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.72 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -93.18 126.96 38.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.52 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -91.94 179.32 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.497 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 70' ' ' THR . 61.8 m-85 -158.37 -169.74 2.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.391 -0.818 . . . . 0.0 109.069 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -111.92 -9.71 14.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.673 -0.642 . . . . 0.0 110.191 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.6 t -152.9 133.84 14.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.969 -1.082 . . . . 0.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 78' ' ' GLN . 5.1 mm-40 -44.96 -30.11 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.9 -34.9 79.0 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.014 0.911 . . . . 0.0 109.786 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.7 m-20 -83.39 -33.97 25.65 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.15 -0.969 . . . . 0.0 108.556 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.91 -34.17 62.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.455 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 11.7 tp60 -70.25 -32.04 69.7 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.09 -20.84 61.59 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.408 ' CD2' ' SG ' ' A' ' 61' ' ' CYS . 0.3 OUTLIER -76.47 -38.77 54.85 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.013 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.539 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 5.3 mm -62.11 -54.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.46 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 4.8 p30 -69.21 -20.1 63.97 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.651 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 36.8 m170 -86.88 -13.37 45.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.515 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -122.21 -40.51 2.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.099 -1.001 . . . . 0.0 113.468 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.03 -27.73 0.47 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.856 -1.152 . . . . 0.0 110.143 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER 63.05 34.72 13.61 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.546 -0.721 . . . . 0.0 109.567 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.86 172.33 7.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.432 -0.792 . . . . 0.0 109.347 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.45 -66.6 0.83 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 3' ' ' PHE . 6.8 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.7 t60 65.77 -56.07 0.35 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.288 0.566 . . . . 0.0 109.946 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 1' ' ' VAL . 58.1 m-85 -74.96 108.1 7.47 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.116 -0.99 . . . . 0.0 109.001 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.2 t -45.97 146.17 1.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.546 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.03 -27.44 24.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -91.64 -44.34 9.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 110.095 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.9 m -87.94 -27.03 22.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 110.334 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.71 11.4 83.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.14 158.19 32.24 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -1.044 . . . . 0.0 108.882 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.35 106.39 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.961 1.774 . . . . 0.0 112.128 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.0 mt -54.23 105.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.875 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -71.78 -36.49 70.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.02 141.94 28.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -73.22 112.12 8.97 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.965 -1.084 . . . . 0.0 111.106 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -77.72 78.01 1.55 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.444 HH12 ' C ' ' A' ' 21' ' ' LYS . 4.0 tpt85 -58.23 140.53 52.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 122.155 -0.615 . . . . 0.0 110.235 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.5 mtp -130.04 129.01 43.1 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -120.89 156.22 56.76 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.69 0.53 52.94 Favored 'Cis proline' 0 N--CA 1.49 1.268 0 C-N-CA 124.191 -1.17 . . . . 0.0 112.084 0.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.4 t -54.9 -29.68 56.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 109.12 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' C ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER 68.83 25.98 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.658 ' HE2' ' NH2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -95.37 175.52 6.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.675 -0.641 . . . . 0.0 109.37 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -144.98 153.42 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.817 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 26.5 m-85 -159.58 168.14 26.83 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -48.79 111.78 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.86 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -49.12 -18.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.391 -0.818 . . . . 0.0 109.098 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 25' ' ' CYS . 29.3 t0 -77.23 -36.37 54.72 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -82.86 -25.78 32.24 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.25 -36.97 77.72 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.1 pt -80.57 -35.01 14.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.986 -1.071 . . . . 0.0 109.323 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -67.83 -22.17 65.16 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.516 -1.273 . . . . 0.0 107.965 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.471 ' O ' ' N ' ' A' ' 37' ' ' ASP . 1.3 m-70 -82.3 -35.24 28.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -74.39 -31.8 62.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.662 -0.649 . . . . 0.0 109.603 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -85.2 -32.11 22.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.158 -0.964 . . . . 0.0 110.137 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -75.66 -7.21 53.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 0.0 110.025 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.27 34.39 6.14 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 39' ' ' MET . 3.5 m-20 -132.74 55.47 1.89 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.88 15.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.46 -0.775 . . . . 0.0 110.132 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.55 ' H ' ' C ' ' A' ' 37' ' ' ASP . 57.9 mtp -94.28 133.28 37.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.983 -1.073 . . . . 0.0 109.704 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 44' ' ' SER . 42.6 t -43.92 106.89 0.54 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.4 -17.22 4.02 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.305 1.337 . . . . 0.0 111.754 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.85 -47.71 2.63 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.394 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.512 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 62.1 m -99.37 -30.0 12.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 78.35 52.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.706 -0.622 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.41 158.47 75.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 109.068 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.71 100.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.605 2.203 . . . . 0.0 112.586 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.494 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 12.7 m -68.31 106.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -49.24 -54.81 14.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.774 -1.204 . . . . 0.0 108.28 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.451 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -159.6 125.34 4.24 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.475 178.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.2 mt -78.94 144.83 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.917 -1.114 . . . . 0.0 109.096 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -138.93 153.24 48.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.917 0.865 . . . . 0.0 110.0 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -96.36 138.55 33.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.88 -0.512 . . . . 0.0 109.776 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 158.91 43.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.902 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.77 158.3 24.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.55 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.543 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -50.87 -71.0 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 110.142 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.28 27.62 0.44 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 55' ' ' ARG . 9.4 t -86.9 -25.18 24.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.87 -1.37 . . . . 0.0 109.125 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.8 mt -115.35 173.72 6.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.48 116.24 30.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.781 -0.574 . . . . 0.0 109.727 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.7 tpt -79.46 144.48 33.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.544 ' SG ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -76.41 129.69 36.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.823 . . . . 0.0 109.159 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 t -107.8 -16.03 14.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.544 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 1.3 mp -47.54 -55.31 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.0 t -146.31 124.51 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -50.52 -16.92 0.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.312 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.74 -56.51 20.82 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 151.13 27.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -1.104 . . . . 0.0 109.511 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.551 ' H ' ' HE ' ' A' ' 69' ' ' ARG . 32.8 mttp -153.68 42.33 0.55 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.196 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.658 ' NH2' ' HE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.35 93.92 4.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.189 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.63 171.5 5.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.079 -1.013 . . . . 0.0 109.563 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -154.36 -174.45 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.373 -0.83 . . . . 0.0 108.796 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -118.61 -4.79 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.617 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -147.45 123.41 10.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.229 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 73' ' ' SER . 0.5 OUTLIER -44.39 -21.55 0.05 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.4 ttt180 -68.81 -37.0 78.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.403 -0.81 . . . . 0.0 109.649 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.41 -35.66 34.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.47 -32.96 66.65 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.7 tp60 -69.28 -30.91 69.11 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -74.82 -19.93 59.98 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -71.8 -47.46 53.16 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.749 -1.18 . . . . 0.0 108.207 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.9 mm -56.85 -55.77 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.644 0.735 . . . . 0.0 109.586 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -64.64 -18.24 64.76 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 10.9 m170 -85.47 -32.39 22.29 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.924 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -130.61 -25.02 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.175 -0.953 . . . . 0.0 112.685 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.512 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 3.8 m-70 -98.96 -49.7 4.44 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 109.023 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.491 ' SD ' ' O ' ' A' ' 86' ' ' MET . 0.0 OUTLIER 41.54 35.0 0.42 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.368 0.604 . . . . 0.0 109.815 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -178.96 119.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.442 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -170.98 50.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 CA-C-O 117.942 -1.477 . . . . 0.0 109.545 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.543 ' H2 ' ' HH ' ' A' ' 14' ' ' TYR . 34.9 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -92.64 -45.24 8.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.228 -0.92 . . . . 0.0 109.308 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -77.1 111.47 12.72 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 109.48 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.0 t -46.36 146.53 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.631 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.28 -28.33 38.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.373 -0.829 . . . . 0.0 109.711 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 -59.4 1.75 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.464 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 13.1 m -60.06 -28.62 67.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.14 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.2 73.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.3 158.37 31.89 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.432 -1.04 . . . . 0.0 108.638 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.17 100.04 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.855 1.703 . . . . 0.0 112.233 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 2' ' ' HIS . 89.5 mt -45.67 115.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.94 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.7 -32.28 25.62 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.87 140.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.543 ' HH ' ' H2 ' ' A' ' 1' ' ' VAL . 4.0 m-85 -76.76 103.85 6.94 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.819 -1.175 . . . . 0.0 110.835 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 84.29 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.494 HH21 ' CG ' ' A' ' 21' ' ' LYS . 6.2 ttt-85 -66.73 130.98 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 122.223 -0.575 . . . . 0.0 110.166 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' LYS . 16.7 mtp -117.0 132.62 56.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.879 -0.513 . . . . 0.0 110.279 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.453 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -115.81 156.75 46.06 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.55 -1.54 51.83 Favored 'Cis proline' 0 N--CA 1.492 1.405 0 C-N-CA 124.119 -1.201 . . . . 0.0 111.958 -0.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.5 t -54.19 -31.58 53.32 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.2 OUTLIER 68.79 24.85 6.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.453 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.72 179.96 5.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.2 m -146.32 150.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 34.6 m-85 -159.09 169.71 23.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.5 114.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.206 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.492 ' CD2' ' CG ' ' A' ' 52' ' ' GLN . 34.1 t80 -52.22 -15.3 0.57 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.339 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -41.14 63.55 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.464 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 p -81.23 -27.63 35.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.7 -35.99 81.44 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 108.809 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.3 pt -79.91 -34.48 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.129 -1.029 . . . . 0.0 108.873 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.9 mt -64.0 -24.86 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.204 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.559 ' HD1' ' CB ' ' A' ' 37' ' ' ASP . 10.8 m-70 -80.63 -40.71 25.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -23.34 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.395 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -80.72 -36.49 32.06 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.261 -0.899 . . . . 0.0 108.584 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -78.04 -10.95 59.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.503 -0.748 . . . . 0.0 109.317 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.61 31.53 13.01 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.559 ' CB ' ' HD1' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -88.76 -40.76 12.98 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.279 -1.13 . . . . 0.0 109.221 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 42.95 23.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.522 -0.736 . . . . 0.0 110.24 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.499 ' SD ' ' OD1' ' A' ' 37' ' ' ASP . 3.7 ptt? -112.05 135.43 52.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.772 -0.58 . . . . 0.0 109.605 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.6 t -64.01 114.3 13.22 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 109.002 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -54.68 -12.3 4.33 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.199 1.266 . . . . 0.0 111.554 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.74 -59.76 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 44' ' ' SER . 3.8 m -92.34 -24.55 18.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.226 -1.161 . . . . 0.0 109.969 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER 74.86 40.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.3 157.11 43.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.69 97.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.5 2.133 . . . . 0.0 112.228 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.469 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 4.5 m -68.99 112.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -55.36 -53.66 53.44 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 108.897 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.453 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -157.68 133.67 9.37 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.791 -1.163 . . . . 0.0 109.787 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.1 mt -87.17 145.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 120.981 -1.074 . . . . 0.0 109.353 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -138.34 153.84 48.97 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.706 0.765 . . . . 0.0 109.764 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.492 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 33.0 mt-30 -95.17 139.4 31.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.663 -0.648 . . . . 0.0 110.084 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 m -139.89 157.8 45.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.661 -0.649 . . . . 0.0 109.859 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 158.67 21.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.798 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.548 ' C ' ' H ' ' A' ' 57' ' ' SER . 36.9 ttp85 -49.92 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -0.873 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.82 29.08 0.39 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.548 ' H ' ' C ' ' A' ' 55' ' ' ARG . 10.8 t -85.62 -27.69 25.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.95 -1.324 . . . . 0.0 108.914 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mt -107.59 173.54 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.472 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 24.8 m-85 -118.15 119.61 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -80.51 144.11 32.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.6 t -103.71 101.44 11.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.664 -0.648 . . . . 0.0 109.467 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.7 t -86.7 -23.8 25.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.7 mt -45.24 130.69 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.801 . . . . 0.0 109.75 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 65' ' ' GLN . 61.2 t 52.66 95.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.421 -0.8 . . . . 0.0 109.376 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 64' ' ' VAL . 14.1 mm100 -49.34 175.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.382 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.88 -47.03 3.15 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.8 163.47 17.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -1.162 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -173.0 41.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 109.189 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.666 HH22 ' NH2' ' A' ' 84' ' ' ARG . 49.3 mtt180 -78.58 112.04 15.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -77.33 175.71 9.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.567 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.535 ' CG ' ' O ' ' A' ' 70' ' ' THR . 92.1 m-85 -157.84 -170.66 3.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -118.46 -5.75 10.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.671 -0.643 . . . . 0.0 109.676 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.3 m -149.41 129.88 13.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.982 . . . . 0.0 109.431 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.472 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 6.6 mm-40 -47.28 -24.46 0.75 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 109.046 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -68.16 -32.77 73.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 109.115 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 m-20 -81.62 -36.38 28.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -75.41 -33.41 60.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 74' ' ' GLN . 24.4 tp60 -68.41 -33.36 74.08 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.22 -21.17 62.17 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -74.85 -38.22 62.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.028 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.42 -52.62 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.146 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.488 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.8 p30 -72.37 -18.84 61.71 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.753 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 38.9 m170 -86.65 -26.7 24.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.464 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.666 ' NH2' HH22 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -130.51 -14.3 3.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.154 -0.966 . . . . 0.0 112.053 -178.077 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 10.2 m-70 -112.27 -44.48 3.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.117 -0.989 . . . . 0.0 109.828 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.469 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 6.2 ttm 47.81 53.22 11.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.452 -0.78 . . . . 0.0 109.163 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 86' ' ' MET . 0.5 OUTLIER 76.35 106.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.656 -0.652 . . . . 0.0 109.343 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -46.45 -76.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.444 -0.785 . . . . 0.0 109.57 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.54 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.501 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 0.4 OUTLIER -97.78 53.63 1.12 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.614 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.516 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -158.31 105.69 1.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.506 -0.746 . . . . 0.0 109.257 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 9' ' ' LEU . 4.0 m -46.45 146.3 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 108.988 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -25.88 21.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.35 -31.27 13.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.417 -0.802 . . . . 0.0 110.369 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -24.43 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.838 . . . . 0.0 110.646 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . 78.93 -0.44 78.49 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.082 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.531 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 4.2 mp -79.55 163.96 56.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.075 -1.25 . . . . 0.0 108.258 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.08 133.32 24.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.146 1.231 . . . . 0.0 112.091 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 73.0 mt -81.05 118.09 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.739 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.407 ' CD ' ' H ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -84.53 -29.71 25.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.734 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.96 144.78 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -82.31 99.41 9.33 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.634 -1.291 . . . . 0.0 110.231 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.27 87.59 0.59 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 51' ' ' GLU . 2.4 ttt-85 -64.91 143.5 57.91 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 122.115 -0.638 . . . . 0.0 110.169 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.561 ' SD ' ' SG ' ' A' ' 40' ' ' CYS . 6.8 mtp -125.6 134.33 51.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -122.54 154.18 62.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.72 6.63 37.34 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 124.174 -1.177 . . . . 0.0 111.26 -0.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -55.7 -38.19 69.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.638 -0.663 . . . . 0.0 109.421 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.7 tttp 71.12 24.22 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.591 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 37.6 m170 -100.33 175.55 5.67 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.485 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 1.3 m -143.12 154.03 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.832 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 48.0 m-85 -151.92 -158.36 0.89 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.5 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -81.36 108.92 15.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.463 ' CE2' ' CD ' ' A' ' 52' ' ' GLN . 43.2 t80 -49.84 -11.55 0.06 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.051 -1.031 . . . . 0.0 109.722 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.6 t70 -82.35 -49.29 10.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 108.996 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.9 m -79.4 -22.15 44.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.826 -1.172 . . . . 0.0 108.051 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.87 78.04 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 pt -78.86 -34.01 16.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 121.119 -0.988 . . . . 0.0 108.767 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.9 mt -65.42 -38.7 90.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.832 -1.147 . . . . 0.0 107.995 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -70.54 -31.32 68.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -74.83 -36.24 62.4 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.382 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -73.07 -20.92 60.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.039 -1.038 . . . . 0.0 108.262 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -81.75 -36.96 27.96 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.464 -0.773 . . . . 0.0 110.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -135.02 -34.65 0.25 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER 72.64 20.95 3.65 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.498 -1.001 . . . . 0.0 110.26 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -164.81 41.43 0.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.913 -1.117 . . . . 0.0 110.533 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.5 mtp -148.52 136.37 20.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.901 -1.124 . . . . 0.0 112.163 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.561 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 24.9 t -91.47 112.06 52.3 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -45.95 -19.17 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.86 1.706 . . . . 0.0 112.772 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 -62.51 0.82 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.553 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.5 m -93.83 2.27 56.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -1.157 . . . . 0.0 110.529 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.543 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.6 p 48.45 36.03 6.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 109.566 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.71 161.43 27.6 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.299 -0.876 . . . . 0.0 109.003 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' GLN . 20.2 Cg_endo -62.93 80.67 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.344 2.029 . . . . 0.0 111.976 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.5 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 5.6 m -52.96 98.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -50.6 -51.12 51.43 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.519 -1.363 . . . . 0.0 108.202 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.475 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -158.55 123.19 4.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.668 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.1 mt -81.05 144.91 9.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 120.797 -1.19 . . . . 0.0 109.168 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 16' ' ' ARG . 28.0 mt-10 -138.97 151.17 46.64 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.702 0.763 . . . . 0.0 110.363 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 19.5 mt-30 -85.72 143.29 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.347 0.594 . . . . 0.0 110.071 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.44 159.32 42.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.478 -0.764 . . . . 0.0 109.471 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.429 ' OG1' ' OG ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -80.81 166.41 20.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.333 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 57' ' ' SER . 3.5 tmm_? -68.51 -74.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 110.561 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.15 24.71 0.26 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.365 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 55' ' ' ARG . 3.3 m -92.56 -6.31 49.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.972 -1.31 . . . . 0.0 109.82 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mt -129.03 174.81 9.21 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.621 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -120.67 108.58 14.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.801 -0.562 . . . . 0.0 110.332 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.52 144.74 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.381 -0.825 . . . . 0.0 110.368 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.503 ' SG ' ' CE1' ' A' ' 80' ' ' HIS . 49.6 t -79.82 143.48 34.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.405 -0.81 . . . . 0.0 109.673 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 t -109.85 47.99 0.92 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mt -137.33 -46.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.48 -0.763 . . . . 0.0 109.367 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.7 p -164.16 150.81 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.067 -1.021 . . . . 0.0 109.606 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -81.86 27.79 0.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.654 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.65 -61.38 0.87 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.523 ' O ' ' N ' ' A' ' 69' ' ' ARG . 13.9 p -47.32 167.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 109.36 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 70' ' ' THR . 23.0 mttt -47.99 -12.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.038 -1.039 . . . . 0.0 109.815 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 67' ' ' CYS . 6.7 ttm180 64.24 -67.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 110.775 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 68' ' ' LYS . 2.1 p -94.12 155.0 17.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.647 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.473 ' OH ' ' CG ' ' A' ' 80' ' ' HIS . 72.6 m-85 -149.97 176.98 10.28 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.543 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -103.11 -11.11 18.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.537 -0.727 . . . . 0.0 110.472 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ASP . 58.7 m -160.63 138.05 9.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.801 -1.187 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.621 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 4.9 mm-40 -43.34 -31.64 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.612 -0.68 . . . . 0.0 109.68 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -65.88 -31.68 72.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.415 -0.803 . . . . 0.0 109.962 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 73.6 m-20 -86.22 -32.73 21.01 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.487 ' O ' ' ND1' ' A' ' 80' ' ' HIS . 0.3 OUTLIER -76.83 -35.03 57.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -72.38 -34.73 68.14 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.08 -20.09 62.4 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.537 ' C ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -77.39 -39.12 48.26 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.645 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.509 ' O ' ' N ' ' A' ' 86' ' ' MET . 3.5 mm -58.14 -55.35 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.19 -25.2 66.01 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.604 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -88.78 -11.04 46.07 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.808 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -118.37 -48.62 2.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.152 -0.967 . . . . 0.0 113.355 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -138.72 -22.56 0.97 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 110.002 -178.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' A' ' 86' ' ' MET . 0.0 OUTLIER 54.67 24.2 5.35 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.853 0.835 . . . . 0.0 109.772 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 36.3 ttt-85 -94.14 143.82 26.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 170.77 178.82 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.947 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.474 ' C ' ' CG ' ' A' ' 2' ' ' HIS . 3.6 m . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.474 ' CG ' ' C ' ' A' ' 1' ' ' VAL . 4.2 m-70 66.23 -52.85 0.41 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.752 -0.593 . . . . 0.0 109.962 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -72.2 119.29 16.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.81 . . . . 0.0 110.35 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.6 t -46.26 145.8 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.037 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -21.44 30.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.057 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -39.68 12.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.038 -1.038 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -106.58 -16.98 14.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 111.384 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.43 4.12 68.42 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.429 -1.367 . . . . 0.0 109.979 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.27 157.65 56.06 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.057 -1.261 . . . . 0.0 109.035 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.7 112.16 2.11 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.129 1.886 . . . . 0.0 112.549 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 67.6 mt -61.82 124.86 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.05 -29.25 18.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 t -133.4 145.31 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -82.75 98.73 9.25 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.658 -1.276 . . . . 0.0 110.814 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.69 95.34 1.35 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.597 HH12 ' CB ' ' A' ' 70' ' ' THR . 3.0 tpt180 -81.52 144.83 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.99 -0.712 . . . . 0.0 111.064 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.541 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 5.4 mtp -131.72 130.18 41.61 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.411 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -113.9 157.28 42.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.345 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.48 -1.06 51.67 Favored 'Cis proline' 0 N--CA 1.491 1.344 0 C-N-CA 124.178 -1.176 . . . . 0.0 111.786 -0.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.583 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 14.5 t -52.01 -35.36 46.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.2 OUTLIER 69.3 30.17 4.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.583 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 30.8 m170 -100.22 165.9 11.26 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.876 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -122.64 161.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.942 0.877 . . . . 0.0 110.462 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.541 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 97.3 m-85 -163.55 -164.41 0.92 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -83.9 113.66 21.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -47.53 -14.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.051 -1.03 . . . . 0.0 109.364 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -79.77 -42.96 23.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.5 m -83.08 -23.2 33.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.54 -37.41 77.06 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 pt -74.74 -37.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.468 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 mt -53.5 -38.52 63.78 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -67.05 -42.03 85.48 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.564 -0.71 . . . . 0.0 109.211 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -61.46 -34.0 74.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 108.782 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -77.68 -20.68 53.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.998 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -81.71 -31.71 31.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 110.243 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.18 -25.88 0.08 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 62.64 50.92 3.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -1.112 . . . . 0.0 109.983 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -155.74 9.68 0.27 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.871 -1.143 . . . . 0.0 111.017 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.455 ' CG ' ' O ' ' A' ' 39' ' ' MET . 7.5 ptm -144.5 114.26 7.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.09 -1.007 . . . . 0.0 110.317 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.418 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -57.04 145.89 62.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.86 -38.91 68.85 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.768 1.645 . . . . 0.0 112.61 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.84 -21.8 2.84 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.624 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -15.81 23.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.176 -1.191 . . . . 0.0 110.169 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.9 p 47.63 36.48 5.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -90.93 160.73 37.35 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 108.775 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' GLN . 14.9 Cg_endo -58.27 74.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.131 1.887 . . . . 0.0 112.001 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' ASP . 47.2 t -47.42 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.051 -1.03 . . . . 0.0 109.683 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' PRO . 5.0 tt0 -64.62 -61.06 2.43 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.411 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -150.61 137.64 19.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.911 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mt -94.61 147.21 5.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.805 -1.184 . . . . 0.0 109.6 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -140.68 147.02 38.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.443 0.64 . . . . 0.0 109.826 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -97.02 144.8 26.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.633 -0.667 . . . . 0.0 109.221 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 168.08 25.07 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.012 . . . . 0.0 110.323 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 154.36 22.28 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -57.52 -23.78 52.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 110.081 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.82 21.83 44.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.83 -25.99 14.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -1.135 . . . . 0.0 109.924 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -114.15 172.68 6.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.697 -0.627 . . . . 0.0 109.628 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.504 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 53.4 m-85 -122.19 123.18 40.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 mmt -88.88 145.28 25.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.274 -0.891 . . . . 0.0 110.949 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.53 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 46.9 t -90.34 143.05 27.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.011 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -62.2 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 109.561 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.416 ' CG2' ' CE1' ' A' ' 85' ' ' HIS . 6.3 mt -44.91 120.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.545 -0.722 . . . . 0.0 109.719 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.638 ' CG2' ' H ' ' A' ' 65' ' ' GLN . 9.8 p -92.19 -144.16 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.863 . . . . 0.0 109.447 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.638 ' H ' ' CG2' ' A' ' 64' ' ' VAL . 23.4 tt0 60.8 98.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.044 -1.035 . . . . 0.0 109.487 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.9 57.66 6.72 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.598 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 43.8 t -150.38 -115.49 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.345 -1.091 . . . . 0.0 109.538 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 12.4 mttp 47.83 31.49 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.667 HH12 HH21 ' A' ' 84' ' ' ARG . 19.3 mmm-85 -91.45 117.04 29.35 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.23 -0.919 . . . . 0.0 109.431 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.597 ' CB ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -83.84 174.87 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 70' ' ' THR . 89.8 m-85 -156.18 -166.33 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.366 -0.834 . . . . 0.0 108.819 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.499 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -118.11 -8.81 10.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.678 -0.639 . . . . 0.0 110.046 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 76' ' ' ASP . 17.9 p -145.35 130.0 18.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.514 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.504 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 6.3 mm-40 -47.81 -25.65 1.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 108.699 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -68.4 -32.89 73.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.528 0.68 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 73' ' ' SER . 36.5 m-20 -84.21 -34.52 23.9 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 tt -74.95 -34.05 62.0 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -71.58 -30.22 65.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.06 -20.55 60.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.83 -41.0 53.8 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.724 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.53 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 4.6 mm -61.53 -52.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -64.65 -23.02 67.12 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.482 -0.761 . . . . 0.0 109.023 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 28.7 m170 -88.12 -12.9 42.72 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.531 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.667 HH21 HH12 ' A' ' 69' ' ' ARG . 11.1 mmt180 -118.67 -46.21 2.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 113.067 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.481 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -142.21 -25.97 0.65 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 110.031 -179.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.51 ' N ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER 60.2 35.55 21.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.492 -0.755 . . . . 0.0 109.708 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.9 ttm-85 -95.3 56.67 1.9 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 61.89 149.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.571 -179.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.452 ' O ' ' CZ ' ' A' ' 14' ' ' TYR . 9.9 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.274 0.559 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -90.29 -47.15 7.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.377 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.466 ' O ' ' CD2' ' A' ' 3' ' ' PHE . 13.9 p90 -77.98 106.8 10.08 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.076 -1.015 . . . . 0.0 109.329 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.3 t -45.95 146.29 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.48 ' CG ' ' HZ1' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -83.72 -30.45 26.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 110.624 -179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.45 -40.16 10.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.018 -1.051 . . . . 0.0 110.293 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.546 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 12.6 m -88.55 -25.86 22.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.052 -1.03 . . . . 0.0 110.089 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.42 10.49 70.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 158.29 32.46 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.36 -1.082 . . . . 0.0 108.601 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.02 98.96 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.857 1.704 . . . . 0.0 112.083 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 2' ' ' HIS . 91.5 mt -45.58 110.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.986 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -35.07 40.86 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.0 138.75 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' CZ ' ' O ' ' A' ' 1' ' ' VAL . 3.7 m-85 -78.78 106.96 11.15 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.98 -1.075 . . . . 0.0 110.78 -178.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.58 85.13 0.85 Allowed Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -65.66 130.84 44.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 122.0 -0.706 . . . . 0.0 109.789 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.519 ' O ' ' N ' ' A' ' 21' ' ' LYS . 14.5 mtp -116.27 124.61 50.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.863 -0.523 . . . . 0.0 110.139 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.66 ' CD1' ' N ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -112.76 156.72 42.11 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.95 2.57 48.47 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 124.153 -1.186 . . . . 0.0 111.462 -0.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 1.0 OUTLIER -56.92 -35.81 69.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.549 -0.719 . . . . 0.0 109.433 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 ttmt 74.51 21.97 2.19 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.573 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 3.3 m80 -90.5 178.72 6.03 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.879 -0.729 . . . . 0.0 109.149 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.456 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.3 m -146.57 149.06 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 21.5 m-85 -158.61 170.0 23.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.68 112.7 0.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.77 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -51.16 -15.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.613 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -82.26 -32.7 29.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.546 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -85.68 -26.29 26.05 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 108.651 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.29 -35.09 68.6 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.1 pp -84.46 -34.92 10.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.252 -0.905 . . . . 0.0 108.811 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mt -68.18 -22.97 64.8 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.004 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.39 -40.57 21.1 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.26 -36.74 85.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.475 -0.765 . . . . 0.0 109.91 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' C ' ' H ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -83.01 -27.43 30.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.971 -1.081 . . . . 0.0 109.756 -179.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -78.38 22.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.938 -1.101 . . . . 0.0 109.67 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 34' ' ' LYS . . . 69.97 39.79 74.17 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.606 ' C ' ' H ' ' A' ' 39' ' ' MET . 0.5 OUTLIER -138.16 57.67 1.7 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.553 -0.969 . . . . 0.0 108.91 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -66.07 20.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.816 . . . . 0.0 109.905 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.606 ' H ' ' C ' ' A' ' 37' ' ' ASP . 8.0 ptt? -97.58 159.18 15.08 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.153 -0.967 . . . . 0.0 109.236 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.8 t -74.52 114.6 35.54 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.306 -0.871 . . . . 0.0 109.016 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.51 -17.11 6.2 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.427 1.418 . . . . 0.0 112.349 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.56 -58.63 1.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 3.5 m -93.29 -24.85 18.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -1.169 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.5 p 76.35 41.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.39 158.18 42.08 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.06 92.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.578 2.185 . . . . 0.0 112.141 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.476 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 4.0 m -62.1 111.14 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.037 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -47.17 -58.89 3.57 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.13 -0.981 . . . . 0.0 108.932 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -161.93 125.89 3.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.278 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -74.08 144.71 12.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.817 -1.177 . . . . 0.0 109.745 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -138.94 143.22 38.53 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 109.656 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -83.46 144.87 29.28 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.438 0.637 . . . . 0.0 110.079 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.21 158.86 43.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.795 . . . . 0.0 109.532 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.43 162.35 24.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.226 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.536 ' CG ' ' H ' ' A' ' 56' ' ' GLY . 3.9 ptp85 -66.4 -59.79 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.039 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -72.99 21.27 1.01 Allowed Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -90.29 -17.98 26.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.128 -1.219 . . . . 0.0 109.632 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.5 mt -118.86 173.29 6.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 24.6 m-85 -114.21 117.15 30.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 60' ' ' MET . 1.6 mpt? -82.59 144.47 30.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.344 -0.847 . . . . 0.0 110.346 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.5 102.38 13.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -32.32 32.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.966 . . . . 0.0 110.014 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 64' ' ' VAL . 3.3 mt -43.5 126.62 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.464 -0.772 . . . . 0.0 110.182 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 63' ' ' ILE . 25.3 t 53.54 105.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.686 . . . . 0.0 109.858 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 64' ' ' VAL . 1.1 mt-30 -56.61 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.96 -62.63 2.48 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.22 164.69 25.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -1.139 . . . . 0.0 109.347 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HZ1' ' CG ' ' A' ' 5' ' ' ASP . 14.8 pttt -177.81 38.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.922 . . . . 0.0 109.351 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.662 ' NE ' ' HD1' ' A' ' 80' ' ' HIS . 17.1 mtm180 -75.49 111.43 10.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.186 -0.946 . . . . 0.0 109.382 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.54 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -78.79 176.61 9.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 70' ' ' THR . 93.9 m-85 -158.66 -171.94 3.63 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.517 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -114.68 -7.72 12.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.077 -178.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 76' ' ' ASP . 1.6 m -146.2 126.37 13.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.1 tp60 -43.34 -26.95 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 73' ' ' SER . 5.5 tmm_? -63.95 -35.55 81.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.963 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.2 m-20 -80.85 -38.73 27.68 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.216 -0.928 . . . . 0.0 108.64 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.76 -30.93 64.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.9 tp60 -69.64 -32.66 71.46 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -20.11 61.4 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.662 ' HD1' ' NE ' ' A' ' 69' ' ' ARG . 53.1 t60 -73.04 -44.89 60.18 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.683 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.3 mm -59.36 -50.9 78.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.441 0.639 . . . . 0.0 109.699 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -70.4 -18.79 63.03 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.572 -0.705 . . . . 0.0 109.605 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 15.9 m170 -86.71 -28.45 23.09 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.101 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -128.66 -21.77 3.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.128 -0.983 . . . . 0.0 112.025 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.515 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.5 m-70 -104.9 -46.38 4.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.584 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' HIS . 0.2 OUTLIER 40.72 33.03 0.17 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.437 0.637 . . . . 0.0 110.028 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.471 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 13.4 ttp180 -73.47 -69.38 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.448 -0.782 . . . . 0.0 109.561 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 87' ' ' ARG . . . 72.59 174.63 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.475 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.419 ' CG1' ' H ' ' A' ' 2' ' ' HIS . 1.5 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.4 0.619 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.471 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 0.4 OUTLIER -91.3 54.35 2.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.442 -0.786 . . . . 0.0 109.873 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 1.5 p90 -152.45 108.74 3.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.984 0.897 . . . . 0.0 109.969 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.1 t -46.78 143.03 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 108.463 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 -28.75 19.98 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.013 -1.054 . . . . 0.0 110.464 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -93.86 -38.96 10.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.078 -1.014 . . . . 0.0 110.75 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 -23.46 14.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.94 . . . . 0.0 110.822 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 6.97 88.75 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.322 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.67 152.13 51.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.967 -1.314 . . . . 0.0 108.367 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.62 137.7 81.91 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.749 1.633 . . . . 0.0 112.696 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.9 mt -86.95 116.31 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.075 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -81.92 -28.27 32.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.55 146.74 18.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -78.81 98.56 6.36 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.722 -1.236 . . . . 0.0 110.377 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.55 83.71 0.55 Allowed Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.482 ' N ' ' O ' ' A' ' 51' ' ' GLU . 5.4 ttt-85 -61.52 145.89 50.46 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.305 0.574 . . . . 0.0 110.003 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.491 ' O ' ' N ' ' A' ' 21' ' ' LYS . 5.3 mtp -128.58 133.55 48.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.921 -0.487 . . . . 0.0 110.4 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -122.35 154.75 62.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.13 4.17 48.25 Favored 'Cis proline' 0 N--CA 1.49 1.315 0 C-N-CA 124.219 -1.159 . . . . 0.0 111.493 0.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -56.42 -37.83 70.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.606 -0.684 . . . . 0.0 109.459 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.0 ttmm 74.29 27.39 1.48 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.478 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 13.0 m170 -100.58 177.61 4.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.445 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -145.26 153.3 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.433 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 62.8 m-85 -153.51 -166.85 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.494 ' C ' ' H ' ' A' ' 27' ' ' ASP . 1.6 p -72.6 112.12 8.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -51.55 -11.0 0.11 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.326 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 25' ' ' CYS . 3.2 t70 -77.29 -48.85 16.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.014 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.3 m -78.45 -25.24 45.86 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.78 -1.2 . . . . 0.0 108.222 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.7 -35.68 80.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 108.979 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.9 pt -80.77 -33.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.87 -23.69 66.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -77.38 -53.22 7.94 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.564 -0.71 . . . . 0.0 109.237 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.59 -24.67 64.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -78.53 -35.37 46.3 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 108.559 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -81.54 -2.2 49.03 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.424 -0.797 . . . . 0.0 109.408 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.07 25.76 51.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 39' ' ' MET . 0.5 OUTLIER -81.75 -34.61 30.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.377 -1.072 . . . . 0.0 109.495 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' A' ' 37' ' ' ASP . 9.4 ptmt 33.09 45.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.584 0.706 . . . . 0.0 110.31 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 37' ' ' ASP . 3.9 ptm -130.86 144.3 51.36 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' SER . 46.6 t -77.13 114.55 40.89 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 109.41 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.19 -15.58 1.44 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.691 1.594 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.86 -62.24 0.82 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -92.35 -20.5 21.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -1.122 . . . . 0.0 110.194 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.4 p 72.11 35.45 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.281 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.46 160.77 26.6 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.56 -0.713 . . . . 0.0 109.107 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.08 81.54 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.434 2.089 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 ' O ' ' CG2' ' A' ' 47' ' ' VAL . 4.6 m -52.66 111.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -59.65 -52.21 66.5 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.875 -1.141 . . . . 0.0 108.75 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.58 124.49 6.69 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.795 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mt -84.93 144.86 8.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.836 -1.165 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 16' ' ' ARG . 29.0 mt-10 -137.77 149.79 46.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.621 0.724 . . . . 0.0 109.658 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -95.09 141.71 28.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.703 -0.623 . . . . 0.0 110.016 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 160.53 40.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.423 -0.798 . . . . 0.0 109.766 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 158.6 31.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.559 ' C ' ' H ' ' A' ' 57' ' ' SER . 26.4 ttp85 -56.27 -71.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 0.0 110.046 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.39 30.64 0.46 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 55' ' ' ARG . 4.2 t -89.56 -26.29 20.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.295 . . . . 0.0 109.509 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mt -101.81 173.66 6.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.648 -0.657 . . . . 0.0 109.866 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.617 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -121.31 109.47 14.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 mtt -74.45 144.5 44.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 110.507 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 t -84.83 143.08 29.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.749 . . . . 0.0 109.015 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 t -139.74 75.26 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.365 -0.834 . . . . 0.0 109.985 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.511 ' CG2' ' HD1' ' A' ' 85' ' ' HIS . 3.4 mm -117.82 -84.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.421 ' CG2' ' H ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -95.28 -90.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.371 -0.83 . . . . 0.0 109.426 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' H ' ' CG2' ' A' ' 64' ' ' VAL . 2.3 pt20 -174.09 158.44 3.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.4 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.49 -50.72 4.45 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 1.5 t -47.3 -88.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -1.155 . . . . 0.0 109.449 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 16.0 mttt 53.77 38.35 28.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.72 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -80.01 124.53 28.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 0.0 109.217 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.04 167.33 18.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.082 -1.011 . . . . 0.0 109.738 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -154.31 177.87 10.65 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.245 -0.909 . . . . 0.0 109.124 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -114.43 -5.25 12.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.819 -0.55 . . . . 0.0 109.54 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 67.1 m -153.39 126.56 8.5 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.748 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.617 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 5.9 mm-40 -43.51 -24.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.672 -0.642 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 ttt180 -66.5 -33.23 75.22 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.99 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 8.1 m-20 -86.09 -33.34 20.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.051 -1.031 . . . . 0.0 108.278 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.444 ' CD2' ' C ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -76.48 -31.8 57.98 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.445 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 22.1 tp60 -72.78 -33.86 66.57 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -19.8 61.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -73.41 -45.3 55.48 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.761 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.4 mm -58.72 -51.2 74.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.501 0.667 . . . . 0.0 109.703 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 4.6 m-20 -70.59 -18.47 62.89 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.784 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 14.7 m170 -87.19 -27.34 23.07 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.099 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.67 -25.96 2.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.064 -1.023 . . . . 0.0 112.488 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.511 ' HD1' ' CG2' ' A' ' 63' ' ' ILE . 4.5 m-70 -100.19 -49.2 4.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.995 -1.066 . . . . 0.0 108.968 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 ttt 42.87 33.85 0.54 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.374 0.607 . . . . 0.0 109.762 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 13.2 ttp180 -81.54 -22.23 38.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.872 . . . . 0.0 109.622 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 87' ' ' ARG . . . 72.7 10.24 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.43 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.561 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.641 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -96.36 22.78 7.4 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 121.362 -0.836 . . . . 0.0 109.199 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -78.74 110.07 13.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.76 -1.212 . . . . 0.0 109.585 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 49.9 t -46.53 146.29 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.84 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.09 -27.2 28.41 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.442 -0.786 . . . . 0.0 109.874 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -53.25 3.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.766 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.542 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 6.5 m -74.65 -27.6 60.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.76 7.69 70.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.03 158.28 34.38 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.296 -1.12 . . . . 0.0 108.564 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.77 96.44 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.852 1.701 . . . . 0.0 112.484 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.563 ' N ' ' O ' ' A' ' 2' ' ' HIS . 96.5 mt -41.26 104.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.395 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -76.37 -32.13 58.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.01 146.64 29.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -83.05 104.38 13.21 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.81 -1.181 . . . . 0.0 110.818 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.58 91.0 1.16 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 21' ' ' LYS . 8.8 ttt-85 -77.65 134.56 38.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.828 -0.807 . . . . 0.0 110.114 -178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.568 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 6.0 mtp -123.61 130.66 53.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.867 -0.521 . . . . 0.0 109.761 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -113.14 156.85 42.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.77 2.1 42.08 Favored 'Cis proline' 0 N--CA 1.491 1.353 0 C-N-CA 124.087 -1.214 . . . . 0.0 111.328 -0.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -36.31 62.65 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.2 OUTLIER 65.6 26.88 11.58 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.579 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 4.7 m170 -93.63 -172.15 2.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.534 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -144.71 151.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.93 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 41.6 m-85 -162.85 166.77 23.66 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -55.44 111.75 0.96 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.47 -1.292 . . . . 0.0 107.938 178.646 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -46.3 -21.0 0.13 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 109.767 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.8 t70 -74.36 -37.64 63.42 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.542 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -83.69 -22.61 32.0 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 108.515 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.71 -34.23 71.71 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.8 pt -80.97 -36.09 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 121.141 -0.974 . . . . 0.0 108.919 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.56 -37.27 86.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.86 -33.81 72.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -34.88 70.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -73.65 -24.98 60.07 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.042 -1.036 . . . . 0.0 108.64 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -81.99 -74.75 0.33 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.413 -0.805 . . . . 0.0 110.565 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -87.15 -38.88 7.63 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 2.3 t0 74.04 13.79 4.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -1.113 . . . . 0.0 110.014 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -173.58 35.62 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.928 -1.108 . . . . 0.0 111.277 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.1 ptp -148.21 126.53 12.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.676 -1.265 . . . . 0.0 110.455 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.73 142.46 98.19 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -54.6 -34.18 81.97 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.532 1.488 . . . . 0.0 112.411 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.12 -43.22 0.8 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.043 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.579 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 2.4 m -86.26 -12.98 48.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.371 . . . . 0.0 110.549 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t 48.16 37.47 8.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 0.0 109.029 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.92 161.1 39.33 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.384 -0.822 . . . . 0.0 109.342 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.32 74.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.377 2.051 . . . . 0.0 111.815 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 45' ' ' ASP . 21.7 t -45.25 100.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -0.832 . . . . 0.0 110.031 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 18' ' ' ILE . 4.9 tt0 -66.07 -61.33 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.405 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -151.6 136.78 17.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.94 179.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.3 146.68 6.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.822 -1.174 . . . . 0.0 109.724 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.05 153.67 45.61 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.427 0.632 . . . . 0.0 109.991 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.55 142.53 30.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 165.55 28.08 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 155.68 23.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 0.0 108.937 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.5 ' C ' ' H ' ' A' ' 57' ' ' SER . 10.5 ttp85 -51.56 -62.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 23.66 0.78 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.0 t -86.92 -25.68 24.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.938 -1.331 . . . . 0.0 109.216 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.03 173.89 6.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 15.1 m-85 -119.31 119.39 33.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mtt -80.08 144.49 33.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER -99.23 94.86 6.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.268 179.535 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 m -79.9 -22.73 42.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.928 . . . . 0.0 109.435 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.1 mt -44.46 143.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.557 -0.714 . . . . 0.0 109.84 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.531 ' CG2' ' HD1' ' A' ' 85' ' ' HIS . 47.6 t 51.86 94.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.39 -0.819 . . . . 0.0 109.457 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -56.86 90.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . -179.87 -51.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.96 166.39 12.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -1.1 . . . . 0.0 109.519 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -162.87 46.39 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.264 -0.897 . . . . 0.0 109.447 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.3 mmm-85 -81.08 121.98 26.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.934 . . . . 0.0 109.297 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.86 174.72 11.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.711 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 70' ' ' THR . 97.5 m-85 -156.77 -176.29 5.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -116.99 -3.34 11.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.617 -0.677 . . . . 0.0 110.086 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 75' ' ' ARG . 8.1 t -149.32 128.12 12.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 109.716 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -45.66 -23.23 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.4 ttt180 -70.27 -33.16 71.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.363 -0.836 . . . . 0.0 109.687 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.1 m-20 -82.24 -36.7 26.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 tt -73.68 -34.78 65.03 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -70.16 -31.42 68.9 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.97 -19.82 60.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.512 ' ND1' ' OH ' ' A' ' 71' ' ' TYR . 58.6 t60 -73.11 -44.52 60.19 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.594 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.21 -52.04 65.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.48 0.657 . . . . 0.0 109.553 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.44 -18.32 64.4 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 109.647 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 11.7 m170 -86.21 -31.06 21.93 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.69 -1.204 . . . . 0.0 112.21 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -129.6 -21.59 3.1 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.046 -1.034 . . . . 0.0 112.472 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.531 ' HD1' ' CG2' ' A' ' 64' ' ' VAL . 4.5 m-70 -102.28 -47.21 4.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.056 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.4 ttt 43.25 34.44 0.7 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.295 0.569 . . . . 0.0 109.768 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -147.01 116.07 6.9 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.311 -0.868 . . . . 0.0 109.464 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 175.55 162.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 109.473 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.603 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -173.73 -88.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.415 -0.803 . . . . 0.0 109.465 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -158.39 129.22 6.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 110.243 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.0 t -67.97 146.35 53.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.395 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.3 -27.83 38.38 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -99.68 -44.97 5.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.599 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -84.7 -20.31 31.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.41 3.49 25.94 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.67 157.36 37.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.331 -1.1 . . . . 0.0 108.801 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.91 123.12 12.81 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.0 1.8 . . . . 0.0 111.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.3 mt -75.89 103.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.64 -0.662 . . . . 0.0 110.575 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' HZ2' ' CB ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -72.69 -30.81 64.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -147.05 143.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -75.36 110.42 9.7 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.995 -1.066 . . . . 0.0 111.113 -178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -80.12 80.72 1.59 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.442 HH21 ' CG ' ' A' ' 21' ' ' LYS . 7.3 ttt-85 -66.55 131.15 45.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 122.112 -0.64 . . . . 0.0 110.239 -178.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.422 ' O ' ' N ' ' A' ' 21' ' ' LYS . 19.7 mtp -116.91 134.5 54.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.874 -0.516 . . . . 0.0 110.103 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -120.25 157.58 53.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.58 -2.19 47.13 Favored 'Cis proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.107 -1.205 . . . . 0.0 112.146 -0.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 7.1 t -52.8 -36.92 59.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.442 ' CG ' HH21 ' A' ' 16' ' ' ARG . 2.0 tttp 74.94 27.55 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.594 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 1.4 m80 -95.58 -178.24 4.34 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -145.71 153.5 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.868 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 34.9 m-85 -161.46 166.24 27.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -48.97 113.03 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.699 179.569 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -50.88 -18.02 0.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.347 -0.846 . . . . 0.0 109.883 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' CB ' ' HZ2' ' A' ' 12' ' ' LYS . 35.9 t70 -79.82 -33.04 40.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.519 ' O ' ' CG ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -85.34 -23.97 27.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.626 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.66 69.35 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -85.44 -34.03 8.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.146 -0.971 . . . . 0.0 108.957 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.69 -22.75 60.86 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.803 -1.159 . . . . 0.0 107.979 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.608 ' HD1' ' CG ' ' A' ' 41' ' ' PRO . 35.6 m170 -83.79 -36.46 23.54 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.234 -0.916 . . . . 0.0 108.869 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -34.53 66.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 109.441 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -84.93 -28.76 25.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.228 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -68.52 -15.84 63.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.987 -1.071 . . . . 0.0 109.709 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.59 31.38 2.57 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 39' ' ' MET . 6.4 t70 -131.47 57.79 1.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.61 34.91 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.725 0.774 . . . . 0.0 108.974 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.609 ' H ' ' C ' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -126.61 135.58 51.41 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -41.07 104.79 0.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.684 -0.635 . . . . 0.0 109.98 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.608 ' CG ' ' HD1' ' A' ' 32' ' ' HIS . 40.2 Cg_exo -52.62 -16.23 5.25 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.444 1.429 . . . . 0.0 111.757 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.33 -44.24 2.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.541 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 2.8 m -106.99 -26.11 11.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.316 -1.108 . . . . 0.0 110.528 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.88 56.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.118 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.34 161.02 43.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.25 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.468 2.112 . . . . 0.0 112.073 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 88.8 t -58.0 105.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.235 -0.915 . . . . 0.0 109.07 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -68.67 -65.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -0.988 . . . . 0.0 108.774 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.46 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.39 125.49 9.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.01 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.2 mt -81.39 145.08 9.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 109.172 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.12 145.93 40.05 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.787 0.803 . . . . 0.0 110.095 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.97 143.72 26.66 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.333 0.587 . . . . 0.0 109.762 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 161.04 41.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 109.469 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.527 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -84.86 166.92 16.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.528 ' CG ' ' H ' ' A' ' 56' ' ' GLY . 8.4 ptp180 -58.81 -58.54 8.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.18 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -75.38 23.79 1.48 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.527 ' OG ' ' N ' ' A' ' 54' ' ' THR . 16.5 m -86.1 -14.67 43.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.108 -1.23 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt -135.4 172.45 13.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.452 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 18.9 m-85 -114.96 122.65 46.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 mmt -84.79 144.31 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.668 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.7 t -78.23 143.4 37.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.242 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 t -128.23 67.99 1.35 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.551 -0.718 . . . . 0.0 109.796 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.542 ' CG2' ' HD1' ' A' ' 85' ' ' HIS . 3.8 mm -126.81 -20.46 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -170.37 140.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.363 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -48.66 137.81 11.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.246 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.78 77.46 0.2 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.59 -171.48 3.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -1.108 . . . . 0.0 109.906 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.65 -59.82 4.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.417 -0.802 . . . . 0.0 109.672 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.456 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.3 OUTLIER -179.88 -168.95 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.742 -179.395 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.5 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -89.41 -173.48 4.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.407 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 70' ' ' THR . 66.3 m-85 -154.89 171.31 19.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.224 -0.922 . . . . 0.0 108.671 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.14 -2.18 21.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.4 -0.812 . . . . 0.0 110.946 -178.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 74' ' ' GLN . 1.4 p -160.66 134.42 6.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.242 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -42.9 -29.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -65.35 -34.36 78.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.439 -0.788 . . . . 0.0 110.425 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -83.9 -35.41 24.11 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 108.288 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' CD2' ' C ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -75.94 -31.6 59.16 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 74' ' ' GLN . 22.3 tp60 -73.77 -33.78 64.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.66 61.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.543 ' CE1' ' NE2' ' A' ' 85' ' ' HIS . 5.5 t60 -72.73 -51.53 18.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.196 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.6 mm -51.66 -53.05 18.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.666 -0.646 . . . . 0.0 109.657 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.07 -19.07 64.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.104 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 14.1 m170 -87.08 -28.15 22.72 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.723 -1.191 . . . . 0.0 112.031 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -129.42 -23.42 2.93 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.454 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.543 ' NE2' ' CE1' ' A' ' 80' ' ' HIS . 4.8 m-70 -104.34 -47.27 4.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 0.0 109.27 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER 43.87 35.86 1.21 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.292 0.568 . . . . 0.0 109.866 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.2 ttp85 -174.55 154.88 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.53 140.99 50.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.543 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.965 0.412 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 4.4 m -46.0 145.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -82.36 -26.61 32.75 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 -33.31 12.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 110.567 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -104.33 -25.4 12.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -0.898 . . . . 0.0 110.83 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.26 -9.24 49.03 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.28 158.45 86.75 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.993 -1.298 . . . . 0.0 108.819 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -68.15 104.34 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.8 1.667 . . . . 0.0 112.883 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.611 HG23 ' HA ' ' A' ' 25' ' ' CYS . 78.4 mt -50.99 120.15 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.43 0.633 . . . . 0.0 110.236 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -88.31 -27.07 21.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.69 144.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -80.78 100.11 8.6 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.802 -1.186 . . . . 0.0 110.453 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 95.1 1.64 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.414 HH21 ' HG3' ' A' ' 21' ' ' LYS . 18.9 ttt-85 -80.89 137.28 36.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.037 -0.684 . . . . 0.0 110.168 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 9.7 mtp -121.74 134.18 54.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.122 0.486 . . . . 0.0 110.238 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.664 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -114.37 155.9 45.17 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.69 2.97 52.47 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.145 -1.19 . . . . 0.0 111.364 -0.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.3 t -56.74 -33.48 66.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.537 -0.727 . . . . 0.0 109.389 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 66.93 26.69 9.12 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 33.8 m170 -97.49 162.49 13.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.902 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -118.07 160.79 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.157 0.98 . . . . 0.0 111.019 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 93.5 m-85 -164.53 -165.23 0.91 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.611 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -85.06 113.12 21.24 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.715 ' O ' HG23 ' A' ' 30' ' ' ILE . 41.0 t80 -47.67 -16.38 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.973 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 25' ' ' CYS . 7.4 t70 -82.73 -50.68 8.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.027 -1.046 . . . . 0.0 109.488 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 3.0 m -78.86 -20.85 48.56 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.81 -1.182 . . . . 0.0 108.096 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.93 71.33 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.715 HG23 ' O ' ' A' ' 26' ' ' TYR . 40.7 pt -80.32 -33.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 121.001 -1.062 . . . . 0.0 108.793 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 28' ' ' CYS . 14.9 mt -64.0 -34.37 77.86 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.876 -1.13 . . . . 0.0 107.988 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.17 -42.52 72.36 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.94 95.82 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 mttp . . . . . 0 C--N 1.303 -1.431 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.218 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.46 ' O ' ' CG ' ' A' ' 39' ' ' MET . 10.8 ptm . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.556 0.693 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.451 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 1.2 t -62.12 139.8 96.03 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.77 . . . . 0.0 108.981 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.69 -36.97 20.08 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.875 1.716 . . . . 0.0 112.416 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.89 -36.94 0.79 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.601 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -83.6 -14.16 52.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.281 . . . . 0.0 110.277 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 t 47.65 36.02 5.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.077 -1.015 . . . . 0.0 109.464 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.33 161.11 38.15 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 108.786 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.73 73.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.153 1.902 . . . . 0.0 111.884 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 45' ' ' ASP . 59.0 t -47.16 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 0.0 109.501 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -66.72 -62.79 1.27 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.161 -0.962 . . . . 0.0 108.517 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -150.03 134.31 17.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.799 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -94.34 145.97 7.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.616 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.09 150.79 44.75 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.438 0.637 . . . . 0.0 109.781 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -94.91 150.12 20.51 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.566 -0.709 . . . . 0.0 109.75 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.87 168.26 25.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.267 -0.895 . . . . 0.0 109.69 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -80.64 157.43 25.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.308 -0.87 . . . . 0.0 108.828 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -75.5 26.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.052 . . . . 0.0 109.864 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -144.29 13.91 2.08 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.11 -19.05 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.777 -0.837 . . . . 0.0 110.365 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 mt -110.81 165.4 11.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.539 -0.726 . . . . 0.0 109.784 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 24.4 m-85 -119.19 113.88 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.0 mtp -80.61 144.41 32.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.726 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -74.15 176.35 6.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.72 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.698 ' C ' HD23 ' A' ' 72' ' ' LEU . 78.4 m-85 -159.05 -170.87 3.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.86 -11.43 14.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 110.278 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 74' ' ' GLN . 3.5 m -150.91 133.5 15.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.975 -1.078 . . . . 0.0 109.343 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 73' ' ' SER . 1.2 tp-100 -44.12 -31.93 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -61.66 -31.98 72.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 110.496 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.02 -35.62 23.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 108.639 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.83 -34.35 62.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 82' ' ' ASN . 0.7 OUTLIER -68.17 -39.01 82.67 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.108 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 82' ' ' ASN . . . -66.02 -21.55 66.4 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.608 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 25.8 t60 -76.05 -36.91 58.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.919 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.6 mm -62.05 -53.28 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 110.038 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.732 HD22 ' HA ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -72.18 -19.02 61.82 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.68 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.5 m-70 -85.71 -25.9 26.21 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.525 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -129.97 -20.11 3.16 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.278 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.608 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 8.5 m-70 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.398 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.599 ' HA ' HD11 ' A' ' 11' ' ' ILE . 4.3 t -46.37 146.37 1.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 110.073 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -18.56 39.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.458 -0.776 . . . . 0.0 109.303 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.03 -51.23 3.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 10.3 m -84.14 -14.65 49.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.406 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.24 9.13 14.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.23 158.62 33.68 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.343 -1.092 . . . . 0.0 108.693 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.73 101.53 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.989 1.793 . . . . 0.0 112.267 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 4' ' ' CYS . 74.2 mt -50.27 120.74 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.514 0.673 . . . . 0.0 110.578 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.32 -31.66 20.06 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.06 141.89 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -81.74 102.03 10.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.544 -1.347 . . . . 0.0 110.688 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -75.54 85.74 0.84 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.604 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.5 ttt-85 -69.33 134.87 49.62 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 122.09 -0.653 . . . . 0.0 110.454 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 21' ' ' LYS . 9.4 mmm -118.4 132.42 56.26 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.652 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -116.24 156.46 47.07 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.72 -1.74 47.83 Favored 'Cis proline' 0 N--CA 1.49 1.285 0 C-N-CA 124.137 -1.193 . . . . 0.0 111.533 -0.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.581 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -51.04 -34.16 28.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.604 ' CG ' HH21 ' A' ' 16' ' ' ARG . 3.4 ttmt 67.68 25.86 8.04 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.581 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 21.3 m170 -94.16 179.77 5.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.2 m -144.54 153.27 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 110.788 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 73.9 m-85 -158.42 170.34 22.44 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -55.61 113.63 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.039 -1.465 . . . . 0.0 108.171 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 30' ' ' ILE . 35.5 t80 -49.43 -11.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.855 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -74.56 -44.5 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.021 -1.049 . . . . 0.0 108.831 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -80.49 -25.48 38.77 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.886 -1.133 . . . . 0.0 108.119 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.3 -36.69 83.58 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.486 -0.885 . . . . 0.0 108.702 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 26' ' ' TYR . 42.5 pt -78.86 -34.95 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.024 -1.047 . . . . 0.0 108.918 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.62 -21.9 66.62 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.267 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -80.09 -40.68 27.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.9 -29.82 62.27 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.465 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 C--N 1.305 -1.365 0 O-C-N 121.102 -0.999 . . . . 0.0 108.424 179.698 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.445 ' O ' ' CG ' ' A' ' 39' ' ' MET . 15.4 ptm . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.261 0.553 . . . . 0.0 109.853 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.554 ' N ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.03 124.36 85.0 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.076 -1.015 . . . . 0.0 109.758 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -44.31 -22.86 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.127 1.885 . . . . 0.0 113.068 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.22 -64.65 0.87 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 62.9 m -69.69 -43.65 72.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.232 -1.158 . . . . 0.0 108.564 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.6 p 76.9 57.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.832 -0.543 . . . . 0.0 111.622 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.443 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 174.82 -48.19 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.386 -1.446 . . . . 0.0 112.117 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 45' ' ' ASP . 64.9 Cg_endo -86.47 51.44 2.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.57 2.18 . . . . 0.0 115.706 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 40' ' ' CYS . 1.8 t -95.35 117.28 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.263 -1.523 . . . . 0.0 109.211 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -98.27 -65.55 0.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.652 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -141.75 137.94 31.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.497 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.9 mt -92.45 145.9 7.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.737 -1.227 . . . . 0.0 109.696 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -137.28 149.0 46.79 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.755 0.788 . . . . 0.0 109.844 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 32.0 mt-30 -94.74 136.15 35.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.831 -0.543 . . . . 0.0 110.03 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.96 155.62 48.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.619 -0.675 . . . . 0.0 110.027 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.75 158.2 22.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.35 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 57' ' ' SER . 7.8 ttp180 -49.33 -69.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -0.98 . . . . 0.0 109.988 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.32 27.52 0.57 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 55' ' ' ARG . 17.0 t -85.05 -27.94 26.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.909 -1.347 . . . . 0.0 108.858 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -112.43 173.73 6.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 17.6 m-85 -113.27 120.54 41.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.852 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 mtp -81.65 144.66 31.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 109.916 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' NE2' ' A' ' 80' ' ' HIS . 50.3 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.362 -0.836 . . . . 0.0 109.479 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 70' ' ' THR . 12.0 mmt-85 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -48.19 173.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 109.424 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.761 ' C ' HD23 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -158.81 -173.75 4.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.761 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -116.65 -5.15 11.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.695 -0.628 . . . . 0.0 109.804 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -145.81 125.62 13.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.942 . . . . 0.0 109.061 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -45.38 -22.69 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.6 tmm_? -69.86 -36.32 75.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 110.129 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -82.57 -33.95 27.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 tp -70.1 -38.29 75.62 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -67.52 -30.43 70.08 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.48 -20.98 62.0 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.591 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -78.09 -41.58 34.82 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.355 -1.338 . . . . 0.0 108.429 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.8 mm -56.3 -54.98 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 109.281 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 79' ' ' ALA . 5.8 p30 -69.35 -23.56 63.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.526 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.8 m-70 -87.68 -11.73 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.189 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -115.37 -49.95 2.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.264 -0.897 . . . . 0.0 112.858 -177.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.214 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 4.9 t -45.95 146.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.818 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.8 -25.43 40.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -48.8 4.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.278 -0.889 . . . . 0.0 110.301 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 10.4 m -78.07 -15.61 58.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.83 13.06 12.03 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.66 158.75 31.2 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.546 -0.973 . . . . 0.0 108.48 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -65.85 103.45 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.088 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 4' ' ' CYS . 71.0 mt -49.47 116.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.336 0.589 . . . . 0.0 110.447 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 -31.72 33.94 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.57 145.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -73.99 102.07 4.04 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.491 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.13 85.72 1.11 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -71.28 141.44 50.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.904 -0.762 . . . . 0.0 110.519 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 21' ' ' LYS . 11.4 mtp -129.58 132.84 46.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.756 -0.59 . . . . 0.0 109.887 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.646 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -118.03 156.03 50.66 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.83 3.58 41.46 Favored 'Cis proline' 0 N--CA 1.492 1.385 0 C-N-CA 124.112 -1.203 . . . . 0.0 111.799 -0.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -55.39 -37.04 67.05 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.427 -0.795 . . . . 0.0 109.008 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HZ2' HD21 ' A' ' 72' ' ' LEU . 3.0 tttm 68.78 29.14 5.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 4.9 m80 -100.41 -174.75 2.73 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.759 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.572 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -141.66 155.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.396 -0.815 . . . . 0.0 110.998 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.8 m-85 -164.17 168.3 19.11 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -55.43 112.61 1.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.193 -1.403 . . . . 0.0 108.008 178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 30' ' ' ILE . 48.6 t80 -49.63 -31.3 10.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 0.0 109.883 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -39.99 84.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -81.38 -23.66 37.52 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.21 -35.89 74.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.517 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 26' ' ' TYR . 19.1 pt -86.7 -35.13 8.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.163 -0.961 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.71 -23.82 60.91 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.333 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.566 ' CE1' ' SG ' ' A' ' 28' ' ' CYS . 40.7 m170 -78.44 -55.45 5.21 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.24 -32.31 66.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.388 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 mttm . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.034 -1.041 . . . . 0.0 109.367 179.751 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.585 ' HA ' HG23 ' A' ' 47' ' ' VAL . 7.4 mtm . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -38.72 102.91 0.26 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.049 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.56 -19.48 5.0 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.796 1.664 . . . . 0.0 112.33 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.15 -37.21 2.95 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.71 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.0 m -104.84 -31.63 9.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -1.113 . . . . 0.0 110.319 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 75.59 63.02 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.079 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.432 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -130.8 160.31 67.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.88 90.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.553 2.169 . . . . 0.0 112.38 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 39' ' ' MET . 97.5 t -60.49 94.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 108.687 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ILE . 5.3 tt0 -61.75 -62.85 1.51 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.191 -0.943 . . . . 0.0 108.638 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.646 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.78 139.07 22.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.273 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.54 143.11 13.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.826 -1.171 . . . . 0.0 109.844 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -136.73 141.14 43.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.785 0.802 . . . . 0.0 110.025 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -85.52 149.2 25.54 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.329 0.585 . . . . 0.0 109.669 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.51 ' SG ' HD21 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -145.86 165.93 27.45 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.32 169.78 10.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.772 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -90.38 74.86 6.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.398 1.095 . . . . 0.0 108.649 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.82 4.42 0.1 Allowed Glycine 0 C--N 1.288 -2.113 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.442 ' C ' HD23 ' A' ' 58' ' ' LEU . 20.6 m -90.23 -34.0 15.96 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.089 -1.242 . . . . 0.0 109.536 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.526 ' N ' HD23 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -100.23 173.88 6.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.701 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -134.66 128.5 33.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.673 -0.642 . . . . 0.0 109.521 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.08 144.73 29.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.537 -0.727 . . . . 0.0 110.577 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' CB ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 109.371 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.745 HH11 HH22 ' A' ' 84' ' ' ARG . 68.5 mtp180 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.254 0.549 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.527 ' OG1' ' NH2' ' A' ' 16' ' ' ARG . 1.2 p -56.18 170.01 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.686 ' C ' HD23 ' A' ' 72' ' ' LEU . 37.2 m-85 -158.0 170.01 23.27 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -108.03 -5.65 16.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.742 -0.598 . . . . 0.0 109.727 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.3 t -158.57 129.49 6.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 73' ' ' SER . 1.1 tp-100 -42.27 -26.15 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.331 0.586 . . . . 0.0 109.439 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 tmt_? -64.17 -34.79 78.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -83.17 -36.52 24.65 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 108.41 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.34 -33.15 67.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 74' ' ' GLN . 23.3 tp60 -69.99 -33.32 71.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.532 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.34 61.43 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.424 ' CD2' ' CB ' ' A' ' 61' ' ' CYS . 26.3 t60 -74.22 -44.12 54.44 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.471 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.495 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.8 mm -60.18 -53.53 47.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.549 -0.72 . . . . 0.0 109.196 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -64.65 -22.51 66.99 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.22 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 18.1 m170 -87.41 -12.24 46.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.125 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.745 HH22 HH11 ' A' ' 69' ' ' ARG . 15.3 mmt-85 -120.9 -43.45 2.46 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.25 -0.906 . . . . 0.0 112.866 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.419 ' ND1' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.773 0 O-C-N 120.592 -1.317 . . . . 0.0 110.244 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.318 0.58 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.652 ' HA ' HD11 ' A' ' 11' ' ' ILE . 10.4 p -51.56 143.89 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.39 -0.819 . . . . 0.0 110.057 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.85 -4.48 57.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -85.46 -33.27 21.91 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' HG ' ' CB ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -135.68 -15.96 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.621 -0.674 . . . . 0.0 110.488 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.567 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.09 14.31 64.68 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.212 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.52 156.62 37.32 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.088 -1.243 . . . . 0.0 108.432 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.97 136.52 66.18 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.778 1.652 . . . . 0.0 111.788 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 4' ' ' CYS . 79.0 mt -88.17 93.79 4.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.61 0.719 . . . . 0.0 110.313 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -69.34 -36.35 76.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.23 142.72 36.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.603 ' CD2' HD12 ' A' ' 58' ' ' LEU . 19.3 m-85 -73.31 106.04 4.96 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.135 -0.978 . . . . 0.0 111.123 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.79 81.27 0.77 Allowed Glycine 0 C--N 1.297 -1.616 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 21' ' ' LYS . 19.8 ttm-85 -65.8 133.01 50.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.942 -0.74 . . . . 0.0 109.164 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.533 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 31.3 mtp -119.12 134.62 55.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 110.566 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -118.75 156.5 51.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.88 -1.32 43.76 Favored 'Cis proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.962 -1.266 . . . . 0.0 111.32 0.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.604 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -49.87 -41.2 44.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.54 ' C ' HH12 ' A' ' 16' ' ' ARG . 5.4 ttmt 74.08 27.96 1.51 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.618 ' CE1' ' HG ' ' A' ' 43' ' ' CYS . 23.3 m80 -99.82 -175.99 3.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.486 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 2.9 m -145.3 153.55 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.171 -0.956 . . . . 0.0 111.376 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 66.3 m-85 -154.23 -149.94 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -90.54 107.81 19.4 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.124 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 30' ' ' ILE . 51.2 t80 -48.34 -13.48 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 109.832 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -83.05 -48.95 10.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 109.703 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 3.4 m -79.91 -23.15 42.0 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 108.361 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' ' CD1' ' A' ' 50' ' ' ILE . . . -68.31 -35.25 77.54 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' TYR . 38.4 pt -81.75 -34.34 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 O-C-N 120.948 -1.095 . . . . 0.0 109.241 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.62 -23.94 63.58 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.854 -1.139 . . . . 0.0 108.406 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.24 -40.4 27.11 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.185 -0.947 . . . . 0.0 108.833 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -31.24 63.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.1 mttt . . . . . 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 -179.427 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 42' ' ' GLY . 10.6 t -102.74 74.49 0.17 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.804 -0.56 . . . . 0.0 111.008 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -35.3 -21.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.517 2.145 . . . . 0.0 114.034 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -75.34 -35.48 47.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.618 ' HG ' ' CE1' ' A' ' 22' ' ' HIS . 1.9 m -125.81 -33.46 2.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 122.019 -0.695 . . . . 0.0 109.424 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' CYS . 2.8 p 83.99 78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.904 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.66 160.03 48.91 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.22 81.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.014 1.809 . . . . 0.0 111.612 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.4 t -48.49 101.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 108.728 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -61.53 1.74 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.459 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.3 122.97 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.292 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.472 ' CD1' ' O ' ' A' ' 29' ' ' ALA . 6.8 mt -79.89 147.41 6.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.876 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -139.03 162.54 34.69 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.605 0.717 . . . . 0.0 110.559 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.558 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 45.7 mt-30 -99.12 134.51 41.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.77 -0.581 . . . . 0.0 110.539 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.25 155.28 47.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.51 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.38 155.86 17.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.833 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 57' ' ' SER . 1.1 ptm180 -51.61 -55.44 19.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.815 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.56 7.69 0.94 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -103.61 -8.21 20.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.39 -1.065 . . . . 0.0 109.741 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.603 HD12 ' CD2' ' A' ' 14' ' ' TYR . 26.8 mt -130.99 169.09 16.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 110.098 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 44.8 m-85 -122.59 122.35 38.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.5 mtt -87.64 144.83 26.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 0.0 110.336 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 51.7 t . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.634 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.523 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.19 175.82 10.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.776 ' C ' HD23 ' A' ' 72' ' ' LEU . 88.6 m-85 -157.49 -164.63 1.61 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.378 -0.826 . . . . 0.0 108.941 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.776 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -116.31 -9.52 11.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.766 -0.584 . . . . 0.0 110.106 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 75' ' ' ARG . 62.7 m -147.22 128.45 14.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.653 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -46.24 -18.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.22 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' SER . 7.6 tmm_? -74.25 -33.91 63.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.695 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.94 -35.78 25.73 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.8 -33.95 64.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -71.03 -30.58 66.82 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.547 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.48 -21.15 61.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.428 ' HD1' ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -74.38 -39.83 62.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.174 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.402 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 28.0 mm -57.58 -59.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.871 0.843 . . . . 0.0 110.029 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.426 HD21 ' HA ' ' A' ' 79' ' ' ALA . 11.0 p30 -67.44 -20.11 65.46 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.555 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.6 m-70 -86.94 -13.46 44.63 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.428 ' HG3' ' HD1' ' A' ' 80' ' ' HIS . 15.7 mmt-85 -124.79 -41.03 2.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.177 -0.952 . . . . 0.0 112.334 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.1 m80 . . . . . 0 C--N 1.301 -1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.609 -179.689 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 3.0 t80 . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 t -45.66 146.18 1.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.881 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -27.62 18.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.443 -0.786 . . . . 0.0 109.452 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.7 -38.78 10.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.9 m -96.09 -28.64 14.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.463 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.51 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.73 4.73 90.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.92 156.29 40.69 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.122 -1.222 . . . . 0.0 108.654 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.11 138.28 85.6 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.914 1.742 . . . . 0.0 112.089 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.594 HG23 ' HA ' ' A' ' 25' ' ' CYS . 40.5 mt -84.7 -67.4 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.642 -0.661 . . . . 0.0 111.002 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.0 -32.71 0.24 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.577 ' H ' ' C ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -145.17 120.06 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.409 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.4 m-85 -67.21 113.26 5.0 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.655 -0.653 . . . . 0.0 110.863 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.75 82.2 1.67 Allowed Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.404 HH21 ' HG3' ' A' ' 21' ' ' LYS . 4.0 ttt-85 -64.9 133.99 53.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 122.141 -0.623 . . . . 0.0 109.946 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.5 mtp -118.09 133.58 55.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.079 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.66 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.87 156.78 49.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.43 1.24 56.47 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.017 0.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.547 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 5.7 t -54.68 -38.04 66.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.407 -0.808 . . . . 0.0 109.13 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 5.4 tttm 76.56 29.33 0.68 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.599 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 2.6 m80 -101.58 -179.17 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -145.88 155.31 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.033 -1.042 . . . . 0.0 110.97 -179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 51.2 m-85 -159.71 167.12 29.1 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.594 ' HA ' HG23 ' A' ' 11' ' ' ILE . 20.4 p -51.68 110.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.212 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 30' ' ' ILE . 39.2 t80 -49.67 -10.92 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.622 -0.674 . . . . 0.0 110.356 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.1 m-20 -78.65 -44.31 24.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.725 -1.234 . . . . 0.0 109.51 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 p -80.51 -25.35 38.79 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 108.196 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -64.43 -37.71 88.46 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 26' ' ' TYR . 40.7 pt -82.57 -34.55 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.629 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.15 -19.48 59.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.151 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.18 -54.06 6.98 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.27 -0.894 . . . . 0.0 109.161 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -67.62 -30.97 70.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 mttp . . . . . 0 C--N 1.307 -1.27 0 O-C-N 121.024 -1.047 . . . . 0.0 109.071 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.55 ' HA ' HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -42.87 106.12 0.46 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.0 109.621 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.47 -21.92 8.17 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.568 1.512 . . . . 0.0 112.124 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.21 -42.12 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.747 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.599 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 4.8 m -100.88 -30.33 11.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -1.159 . . . . 0.0 110.608 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.19 57.04 0.09 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 109.06 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.3 OUTLIER -123.48 160.96 48.33 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.609 -0.682 . . . . 0.0 109.209 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.08 89.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.538 2.158 . . . . 0.0 112.048 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 39' ' ' MET . 98.5 t -57.45 101.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.187 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.55 -66.22 0.57 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.66 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -151.35 134.8 16.17 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.485 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.521 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.5 mt -88.26 145.81 7.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.666 -1.271 . . . . 0.0 109.107 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.53 146.82 44.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.75 142.16 27.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.774 -0.579 . . . . 0.0 109.605 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.38 159.07 44.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.355 -0.841 . . . . 0.0 110.204 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.38 162.82 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.05 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.524 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -66.32 -60.32 2.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 110.064 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.39 25.89 0.58 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.3 t -91.17 -23.6 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.4 173.45 6.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.734 -0.604 . . . . 0.0 109.71 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -117.08 119.91 36.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.4 mmt -75.9 144.52 41.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 110.341 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.035 179.493 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -82.71 174.79 10.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.954 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.726 ' C ' HD23 ' A' ' 72' ' ' LEU . 98.2 m-85 -158.31 -177.92 6.9 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.9 -2.7 13.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.587 -0.695 . . . . 0.0 110.549 -178.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ASP . 1.5 m -154.57 131.39 10.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.814 -1.179 . . . . 0.0 109.865 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 78' ' ' GLN . 0.9 OUTLIER -43.39 -30.18 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -63.77 -35.05 79.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.509 -0.745 . . . . 0.0 110.131 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.1 m-20 -81.19 -37.82 28.07 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.995 0.903 . . . . 0.0 108.705 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 tt -74.43 -31.07 62.16 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLN . 22.6 tp60 -71.07 -33.73 70.52 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.31 -19.92 61.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -72.67 -47.52 46.75 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.601 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.5 mm -56.17 -51.05 67.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.688 -0.633 . . . . 0.0 109.61 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -71.05 -18.66 62.56 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.867 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.0 m170 -87.67 -27.32 22.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.075 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -23.82 2.96 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 5.4 m-70 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.163 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.615 ' HA ' HD11 ' A' ' 11' ' ' ILE . 48.8 t -46.93 146.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.874 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.43 -24.11 39.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.447 -0.783 . . . . 0.0 109.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -60.95 1.44 Allowed 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.375 -0.828 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 7.3 m -68.27 -14.93 63.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 110.291 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.49 11.33 5.12 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 152.49 37.83 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.988 . . . . 0.0 108.572 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.76 100.37 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.729 1.619 . . . . 0.0 112.259 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 4' ' ' CYS . 77.8 mt -47.37 117.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.681 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -83.14 -32.08 26.84 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.12 143.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -73.19 100.71 3.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 120.852 -1.155 . . . . 0.0 111.032 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -76.53 86.86 0.93 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.479 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.6 ttt-85 -77.79 141.43 39.22 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.761 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.553 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 11.2 mtp -128.72 132.45 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.968 -0.457 . . . . 0.0 109.949 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.664 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -114.6 156.22 45.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.73 4.08 46.07 Favored 'Cis proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.344 -0.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.2 t -55.81 -35.36 66.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.509 -0.745 . . . . 0.0 109.122 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 72' ' ' LEU . 4.5 tttt 66.62 27.77 9.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.605 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 27.0 m170 -93.54 -173.3 3.15 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.478 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.553 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -142.89 156.68 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 110.346 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 85.7 m-85 -165.66 166.26 18.14 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -57.68 114.75 2.41 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.553 ' O ' HG23 ' A' ' 30' ' ' ILE . 43.9 t80 -47.65 -21.27 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.016 -1.052 . . . . 0.0 109.808 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.36 -39.87 62.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.061 -1.024 . . . . 0.0 108.248 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.537 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.02 -22.29 33.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.53 -34.28 72.11 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 26' ' ' TYR . 45.4 pt -80.52 -35.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 121.104 -0.998 . . . . 0.0 108.67 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 28' ' ' CYS . 34.9 mt -62.57 -38.81 91.57 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.693 -1.203 . . . . 0.0 107.876 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.26 -34.88 73.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -35.78 76.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.835 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mttt . . . . . 0 C--N 1.302 -1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 108.704 179.623 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.7 ptp . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.881 0.848 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 1.5 t -71.0 136.65 84.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -45.81 -46.68 15.07 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.911 1.741 . . . . 0.0 113.074 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.08 4.26 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.214 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.605 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -94.07 -14.97 25.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.257 . . . . 0.0 110.586 -178.818 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 p 48.48 38.18 10.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -92.22 161.1 33.86 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.357 -0.84 . . . . 0.0 108.999 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLN . 19.6 Cg_endo -59.73 71.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.2 1.933 . . . . 0.0 112.068 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 45' ' ' ASP . 61.2 t -44.99 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.17 -0.956 . . . . 0.0 109.724 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' PRO . 3.7 tt0 -65.61 -61.74 1.92 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.069 -1.019 . . . . 0.0 108.344 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -148.76 137.53 21.39 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.769 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -94.78 147.31 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.641 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -140.53 154.48 46.56 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.29 0.567 . . . . 0.0 109.706 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.22 138.47 45.52 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.25 0.548 . . . . 0.0 109.692 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.69 165.97 25.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -82.88 157.89 22.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.853 . . . . 0.0 109.091 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -72.53 31.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -146.79 14.28 1.54 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.52 ' C ' HD23 ' A' ' 58' ' ' LEU . 62.9 m -97.21 -28.63 14.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.702 -0.881 . . . . 0.0 110.404 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -114.11 172.42 7.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.607 -0.683 . . . . 0.0 109.783 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.421 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 41.7 m-85 -116.89 124.1 48.64 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -86.44 144.55 27.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.91 . . . . 0.0 110.393 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.585 ' N ' ' SD ' ' A' ' 60' ' ' MET . 42.1 t . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.483 -0.761 . . . . 0.0 109.125 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.594 0.712 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.476 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -90.56 -173.84 3.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.22 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.701 ' C ' HD23 ' A' ' 72' ' ' LEU . 95.6 m-85 -152.39 178.29 9.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.991 . . . . 0.0 108.903 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.705 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.33 -10.04 14.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.715 -0.615 . . . . 0.0 109.743 -179.107 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 75' ' ' ARG . 48.2 t -153.18 132.29 12.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.002 . . . . 0.0 109.91 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -47.54 -22.08 0.43 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.103 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.8 ttt-85 -70.89 -32.51 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -83.52 -34.67 25.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 tt -75.68 -33.88 60.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -70.3 -33.58 71.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.545 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.84 -19.32 60.77 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.629 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 24.3 t60 -74.81 -44.76 47.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.531 -1.267 . . . . 0.0 108.605 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.538 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.9 mm -56.73 -53.3 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.722 0.772 . . . . 0.0 109.443 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -69.38 -19.72 63.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.215 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -87.49 -25.92 23.46 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.781 -178.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.64 -34.24 1.79 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.066 -1.021 . . . . 0.0 112.651 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.629 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 7.6 m-70 . . . . . 0 C--N 1.297 -1.679 0 O-C-N 120.917 -1.114 . . . . 0.0 109.001 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.624 ' HA ' HD11 ' A' ' 11' ' ' ILE . 13.2 t -45.76 146.39 1.16 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 109.991 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.64 -25.92 32.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.599 -0.688 . . . . 0.0 109.71 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.66 -42.63 7.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 48.1 m -90.55 -29.7 17.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.061 -1.024 . . . . 0.0 110.666 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 1.36 87.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.88 158.8 49.97 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 108.502 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -68.54 97.73 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.878 1.719 . . . . 0.0 112.5 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.624 HD11 ' HA ' ' A' ' 4' ' ' CYS . 97.0 mt -41.68 113.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -82.97 -32.71 26.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 11' ' ' ILE . 1.6 t -133.14 147.01 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.05 104.49 16.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.822 -1.174 . . . . 0.0 111.114 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.4 91.27 1.15 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.542 ' NH2' ' O ' ' A' ' 21' ' ' LYS . 2.5 tpt85 -74.63 135.84 41.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.082 -0.657 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.539 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 8.3 mtp -126.34 132.2 51.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.921 -0.487 . . . . 0.0 109.766 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.651 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.28 156.33 48.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.63 3.8 40.11 Favored 'Cis proline' 0 N--CA 1.49 1.321 0 C-N-CA 124.07 -1.221 . . . . 0.0 111.112 -0.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.6 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -55.07 -32.01 61.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' NH2' ' A' ' 16' ' ' ARG . 1.8 mttp 59.52 31.09 20.76 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.606 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 9.3 m170 -96.16 -173.15 2.72 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.591 -0.693 . . . . 0.0 109.374 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.488 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -147.36 149.0 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 110.58 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 37.1 m-85 -158.35 170.6 21.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -59.31 113.89 2.38 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 117.887 -1.525 . . . . 0.0 107.222 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -46.31 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 110.367 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.1 m-20 -78.93 -41.14 30.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.001 -1.062 . . . . 0.0 108.724 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -80.35 -22.08 41.76 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.0 -1.062 . . . . 0.0 108.57 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.632 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.84 -29.06 65.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 pt -89.14 -28.5 5.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.658 -1.276 . . . . 0.0 108.955 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 28' ' ' CYS . 24.4 mt -66.77 -35.89 81.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.09 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -76.27 -44.38 37.46 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.607 ' N ' ' CG ' ' A' ' 32' ' ' HIS . 1.2 pt-20 -52.31 -32.74 39.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 mttm . . . . . 0 C--N 1.304 -1.381 0 O-C-N 121.274 -0.891 . . . . 0.0 109.56 179.659 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 39' ' ' MET . 11.9 ptm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.607 0.717 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.408 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.8 OUTLIER -63.2 143.18 97.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 108.995 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.18 -38.11 95.49 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.125 1.217 . . . . 0.0 112.076 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.33 -45.38 1.35 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.61 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.606 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -89.48 -10.76 45.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.817 -1.402 . . . . 0.0 110.732 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t 48.37 37.48 8.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 108.842 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -89.56 161.1 40.34 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.406 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.2 76.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.488 2.125 . . . . 0.0 111.71 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' ASP . 17.3 t -48.97 109.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.283 -0.885 . . . . 0.0 109.983 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -72.03 -62.25 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 108.56 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.651 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.78 134.5 16.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.692 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.632 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -92.79 144.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.819 -1.176 . . . . 0.0 109.88 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -140.8 146.47 37.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.448 0.642 . . . . 0.0 109.44 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -91.27 150.88 21.13 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.584 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.87 167.84 26.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.466 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -90.49 165.27 13.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.362 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -59.5 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -0.969 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.66 18.9 22.88 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.741 ' O ' HD23 ' A' ' 58' ' ' LEU . 50.9 m -85.16 -21.23 29.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.052 -1.263 . . . . 0.0 108.999 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -132.06 173.1 11.56 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 6.3 m-85 -117.92 109.41 16.48 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.572 -0.705 . . . . 0.0 110.425 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -71.92 144.77 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 0.0 110.138 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.588 ' SG ' ' NE2' ' A' ' 80' ' ' HIS . 44.7 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.824 . . . . 0.0 109.555 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.863 0.363 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.492 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 7.8 p -94.22 158.56 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 110.867 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.597 ' C ' HD23 ' A' ' 72' ' ' LEU . 75.7 m-85 -152.1 173.35 15.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.756 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -100.92 -10.78 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.586 -178.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -162.12 138.99 8.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.807 -1.183 . . . . 0.0 110.519 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -42.99 -31.17 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.41 0.624 . . . . 0.0 109.752 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -66.27 -32.28 73.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.443 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.34 -33.56 22.03 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.2 OUTLIER -75.48 -35.18 60.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.017 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.65 ' N ' HD23 ' A' ' 77' ' ' LEU . 52.5 tp60 -72.63 -34.3 67.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.82 -19.64 62.65 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.588 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -77.76 -40.99 39.1 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.396 -1.322 . . . . 0.0 108.641 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.526 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.8 mm -55.71 -54.77 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 108.405 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.48 -26.28 66.29 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.772 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -89.97 -11.97 40.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.579 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -112.19 -54.6 2.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.226 -0.921 . . . . 0.0 112.945 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.233 0.539 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.614 ' HA ' HD11 ' A' ' 11' ' ' ILE . 44.3 t -45.54 146.74 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.214 -0.928 . . . . 0.0 109.987 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -36.15 66.89 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -54.32 2.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 4.0 m -66.05 -13.87 60.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.094 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 4.72 0.47 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 7' ' ' CYS . 5.4 mp -88.96 157.87 47.97 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.249 . . . . 0.0 108.475 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.04 99.29 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.854 1.703 . . . . 0.0 112.539 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' A' ' 4' ' ' CYS . 88.1 mt -47.06 121.43 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -142.45 145.3 23.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -77.39 105.91 8.81 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.714 -1.241 . . . . 0.0 111.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.18 79.88 1.44 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 51' ' ' GLU . 11.5 ttt-85 -58.15 136.71 57.29 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.835 -0.803 . . . . 0.0 109.483 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.774 ' SD ' HG22 ' A' ' 47' ' ' VAL . 25.0 ttm -121.59 137.93 54.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.541 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -127.41 156.85 74.39 Favored Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 -0.34 38.15 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 C-N-CA 124.225 -1.156 . . . . 0.0 112.047 0.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 1.9 t -55.88 -36.82 68.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.1 OUTLIER 74.04 26.92 1.65 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.59 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 2.1 m170 -95.45 -169.25 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -146.44 153.89 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 109.979 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.2 m-85 -159.09 163.01 36.61 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -50.56 113.08 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.218 -1.393 . . . . 0.0 107.864 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -53.73 -19.18 3.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.453 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.41 -37.07 26.06 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.772 -1.205 . . . . 0.0 108.292 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -83.2 -25.51 31.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -68.5 -32.26 72.12 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 pt -87.99 -33.87 6.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.189 -0.944 . . . . 0.0 109.211 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.39 -26.66 58.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.056 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 28' ' ' CYS . 18.2 m170 -76.74 -50.21 14.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.213 -0.929 . . . . 0.0 108.684 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.33 -27.97 68.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.3 mttt . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.665 -179.845 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 40' ' ' CYS . 2.7 mtt . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.32 0.581 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.53 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -37.1 102.1 0.23 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 122.017 -0.427 . . . . 0.0 111.088 -178.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.65 -14.55 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.667 1.578 . . . . 0.0 111.54 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.1 -38.61 4.02 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.192 -1.004 . . . . 0.0 110.835 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.4 m -120.54 -21.31 6.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.415 -1.05 . . . . 0.0 110.771 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 73.97 55.53 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.142 -179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.95 161.42 30.96 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' GLN . 13.1 Cg_endo -58.7 83.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.389 2.059 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' SD ' ' A' ' 17' ' ' MET . 89.6 t -51.69 97.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.205 -0.934 . . . . 0.0 109.07 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' PRO . 8.1 mt-30 -64.11 -64.0 1.0 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.274 -0.891 . . . . 0.0 108.984 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.46 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.27 126.66 7.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.554 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.426 HG21 ' HB1' ' A' ' 29' ' ' ALA . 1.9 mt -88.32 145.03 7.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 110.25 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' ARG . 24.5 mt-10 -137.31 151.5 48.71 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.766 0.793 . . . . 0.0 110.185 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -90.49 147.61 23.28 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.692 -0.63 . . . . 0.0 109.714 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -152.15 167.39 28.68 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.62 163.79 22.31 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.143 -0.973 . . . . 0.0 109.002 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' C ' ' H ' ' A' ' 57' ' ' SER . 4.6 mtm180 -66.74 -69.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 110.671 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.99 28.36 0.3 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.637 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 55' ' ' ARG . 32.5 m -93.25 -36.9 12.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.277 . . . . 0.0 109.798 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 58' ' ' LEU . 1.2 mt -99.14 173.34 6.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.731 . . . . 0.0 109.915 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.06 106.8 14.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 ttt -72.19 144.41 48.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 109.454 179.681 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.184 0.516 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.521 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -62.23 177.99 0.43 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.7 ' C ' HD23 ' A' ' 72' ' ' LEU . 26.5 m-85 -162.51 179.44 7.77 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.7 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -109.49 -7.93 15.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 109.834 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' ARG . 40.5 t -157.52 130.03 7.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.022 -1.049 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 73' ' ' SER . 0.3 OUTLIER -42.73 -27.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.648 -0.657 . . . . 0.0 109.308 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.4 tmt_? -64.01 -34.96 79.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 110.535 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' CG ' ' CD1' ' A' ' 71' ' ' TYR . 27.3 t0 -83.11 -35.61 25.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 108.626 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.39 -32.67 64.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -69.08 -35.25 76.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.561 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.89 -20.35 62.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -74.52 -44.09 52.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.004 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' N ' ' A' ' 81' ' ' ILE . 3.0 mm -58.02 -50.61 77.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.484 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.426 HD21 ' HA ' ' A' ' 79' ' ' ALA . 11.8 p30 -74.79 -18.56 60.45 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.796 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.6 m-70 -86.19 -24.37 26.13 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.568 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.28 -26.59 2.55 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.108 -0.995 . . . . 0.0 112.115 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.486 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 6.2 m-70 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 109.064 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.111 0.482 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -44.69 146.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 110.249 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.65 -23.52 36.89 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' NZ ' ' SG ' ' A' ' 7' ' ' CYS . 2.4 ttpt -98.6 -50.68 4.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 110.518 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.423 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 2.0 m -87.32 -17.78 31.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 111.16 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.01 -1.81 9.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.73 158.63 70.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.144 -1.209 . . . . 0.0 108.749 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.01 102.92 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.941 1.761 . . . . 0.0 112.938 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.613 HG23 ' HA ' ' A' ' 25' ' ' CYS . 84.3 mt -49.73 125.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.513 0.673 . . . . 0.0 110.37 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -91.49 -29.41 17.02 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.83 143.75 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -79.8 103.93 10.03 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.05 81.84 1.02 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.839 -2.504 . . . . 0.0 106.839 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 21' ' ' LYS . 8.5 ttt-85 -64.76 131.55 47.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.31 0.576 . . . . 0.0 110.286 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.599 ' CE ' HG11 ' A' ' 47' ' ' VAL . 16.6 mtp -117.55 132.2 56.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.987 -0.445 . . . . 0.0 110.347 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.672 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.87 156.6 49.79 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.97 2.58 48.59 Favored 'Cis proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.154 -1.186 . . . . 0.0 111.289 -0.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.631 ' HG ' ' HD1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -56.27 -36.91 69.12 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.624 -0.673 . . . . 0.0 109.294 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.529 ' HZ3' ' HE1' ' A' ' 71' ' ' TYR . 5.0 ttmt 73.52 25.77 2.06 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.631 ' HD1' ' HG ' ' A' ' 20' ' ' CYS . 24.7 m80 -95.09 -179.06 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.195 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.478 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.3 m -146.33 151.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.083 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 31.6 m-85 -158.74 168.28 27.27 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.613 ' HA ' HG23 ' A' ' 11' ' ' ILE . 2.8 m -53.07 115.47 1.89 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.936 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.692 ' O ' HG23 ' A' ' 30' ' ' ILE . 38.3 t80 -50.9 -11.83 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' N ' ' C ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -76.72 -46.97 23.32 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.14 -0.975 . . . . 0.0 109.042 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.423 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 m -78.84 -22.96 45.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.998 -1.064 . . . . 0.0 108.412 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.697 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.692 HG23 ' O ' ' A' ' 26' ' ' TYR . 41.3 pt -80.02 -33.7 14.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.039 -1.038 . . . . 0.0 108.986 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.11 -23.94 65.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.123 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -82.75 -34.77 27.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -27.07 44.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.518 -0.738 . . . . 0.0 109.06 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mttp . . . . . 0 N--CA 1.486 1.351 0 O-C-N 121.218 -0.927 . . . . 0.0 109.249 -179.796 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 ptm . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' SER . 51.9 t -71.34 114.57 28.96 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.863 . . . . 0.0 109.32 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -49.41 -15.56 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.426 1.417 . . . . 0.0 111.856 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.95 -63.92 0.84 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.0 m -90.4 -22.13 21.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.3 p 74.27 36.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' H ' ' HB3' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -103.18 157.18 34.3 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 85.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.442 2.095 . . . . 0.0 112.016 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 47' ' ' VAL . 5.2 m -55.08 104.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.1 tt0 -48.07 -54.94 11.45 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.041 -1.037 . . . . 0.0 108.353 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.672 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -159.04 135.51 9.25 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.796 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.697 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.0 mt -87.7 145.97 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.887 -1.133 . . . . 0.0 109.599 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -138.77 152.97 48.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.518 0.675 . . . . 0.0 109.731 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -96.38 139.14 32.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.74 -0.6 . . . . 0.0 109.877 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.19 161.05 39.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.4 157.92 26.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.279 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 57' ' ' SER . 68.1 mtp180 -53.51 -72.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.235 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.58 30.06 0.36 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 55' ' ' ARG . 19.6 t -86.86 -31.17 20.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.947 -1.325 . . . . 0.0 109.289 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -99.29 173.62 6.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 23.0 m-85 -118.59 117.31 28.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.8 mtt -79.55 144.59 33.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.335 -0.853 . . . . 0.0 110.751 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -80.22 176.02 10.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 110.012 -179.565 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.824 ' C ' HD23 ' A' ' 72' ' ' LEU . 87.4 m-85 -158.29 -168.39 2.45 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.824 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -119.89 -6.75 10.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.643 -179.257 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -146.2 127.98 15.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 108.847 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -47.06 -26.0 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -66.35 -31.13 71.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.479 -0.763 . . . . 0.0 109.919 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.68 -34.39 24.98 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.1 -35.27 59.39 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.455 ' NE2' ' OD1' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -67.09 -39.74 86.83 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.716 ' HA ' HD22 ' A' ' 82' ' ' ASN . . . -66.65 -20.75 66.06 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.13 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.477 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 61.7 t60 -74.8 -40.03 61.36 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.837 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mm -60.15 -52.11 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.654 -0.654 . . . . 0.0 110.379 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.716 HD22 ' HA ' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -74.55 -18.09 60.64 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.036 -178.176 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.6 m-70 -85.85 -26.58 25.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.532 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -128.72 -26.11 2.75 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.856 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.477 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 6.7 m-70 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.037 -1.04 . . . . 0.0 109.026 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 8' ' ' GLY . 8.6 p -46.83 128.46 10.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 109.874 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.72 -13.1 60.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.24 -40.29 45.42 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.19 -0.944 . . . . 0.0 109.302 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -124.48 -21.11 4.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.762 -0.586 . . . . 0.0 110.708 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.71 15.93 60.76 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.26 155.47 38.82 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.295 -1.121 . . . . 0.0 108.496 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.5 109.92 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.904 1.736 . . . . 0.0 112.154 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 4' ' ' CYS . 64.1 mt -58.12 112.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.559 0.695 . . . . 0.0 110.466 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -82.12 -33.55 29.61 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.85 137.5 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -76.35 104.81 7.05 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.95 -1.094 . . . . 0.0 110.652 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -78.35 86.44 1.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -70.49 133.43 46.8 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 122.146 -0.62 . . . . 0.0 111.023 -178.058 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' LYS . 2.7 mmm -118.91 135.25 54.68 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -119.2 153.32 53.21 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.95 -4.78 44.38 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 124.276 -1.135 . . . . 0.0 111.621 0.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t -48.18 -30.21 4.43 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 6.7 mtmm 60.29 28.93 18.57 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.592 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 28.3 m170 -93.86 173.05 7.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.545 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 13.7 m -136.67 151.22 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.707 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 83.4 m-85 -160.9 159.71 30.03 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -47.19 110.27 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.589 ' O ' HG23 ' A' ' 30' ' ' ILE . 32.6 t80 -47.06 -16.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.697 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -77.54 -44.82 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.069 . . . . 0.0 108.848 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.473 ' HA ' HD12 ' A' ' 31' ' ' LEU . 36.7 m -79.12 -21.0 47.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.899 -1.126 . . . . 0.0 108.0 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.3 78.2 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 26' ' ' TYR . 48.6 pt -76.11 -33.52 24.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 108.781 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 28' ' ' CYS . 30.6 mt -65.4 -39.7 92.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.618 -1.233 . . . . 0.0 107.681 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -71.97 -25.35 61.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.363 -0.836 . . . . 0.0 108.771 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.27 -36.89 39.07 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.087 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 C--N 1.303 -1.425 0 O-C-N 120.888 -1.133 . . . . 0.0 108.129 179.248 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.446 ' O ' ' CG ' ' A' ' 39' ' ' MET . 10.2 ptm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.512 0.672 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -69.23 129.53 91.83 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.52 -29.35 2.1 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.22 1.946 . . . . 0.0 113.623 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.54 -63.68 1.02 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 44' ' ' SER . 70.8 m -67.55 -45.08 76.71 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.432 -1.04 . . . . 0.0 109.025 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 76.98 53.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.709 -0.62 . . . . 0.0 111.412 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.476 ' H ' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER 176.38 -48.59 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.489 -1.382 . . . . 0.0 112.205 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' H ' ' A' ' 45' ' ' ASP . 84.6 Cg_endo -83.48 46.28 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.637 2.225 . . . . 0.0 116.095 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 40' ' ' CYS . 2.0 t -92.95 118.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.272 -1.517 . . . . 0.0 109.397 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -101.74 -64.51 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.266 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.477 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.161 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.51 144.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.7 -1.25 . . . . 0.0 110.289 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -139.22 140.53 37.78 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.894 0.854 . . . . 0.0 109.943 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -85.27 147.06 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.7 162.01 38.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.442 -0.786 . . . . 0.0 109.882 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.84 162.03 19.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -50.96 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.44 27.32 0.46 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.5 t -81.77 -18.8 42.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.991 -1.3 . . . . 0.0 109.06 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mt -117.69 173.58 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.505 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 16.5 m-85 -118.22 117.0 27.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mmt -79.41 144.61 33.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.78 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.476 ' NH1' ' OH ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.25 0.548 . . . . 0.0 109.778 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.545 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -92.76 175.37 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.753 ' C ' HD23 ' A' ' 72' ' ' LEU . 98.4 m-85 -157.56 -174.73 5.01 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -115.63 -6.06 12.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.634 -0.666 . . . . 0.0 110.078 -178.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 76' ' ' ASP . 24.3 p -150.19 130.5 13.72 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.021 . . . . 0.0 109.606 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 78' ' ' GLN . 11.4 mm100 -44.17 -31.01 0.86 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -62.24 -33.25 74.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 0.0 109.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.8 m-20 -82.98 -36.97 24.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 108.726 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 tt -75.13 -30.75 60.9 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 74' ' ' GLN . 5.9 tp-100 -71.4 -34.52 70.44 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.18 -19.99 62.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.41 ' HD1' ' HH ' ' A' ' 71' ' ' TYR . 78.3 t60 -72.8 -47.51 45.9 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.671 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.5 mm -56.56 -51.08 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -70.46 -18.95 62.99 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.774 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.2 m170 -87.45 -27.87 22.45 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.828 -1.149 . . . . 0.0 112.151 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 -16.67 4.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.977 -1.077 . . . . 0.0 112.157 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 4.3 m-70 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.98 0.419 . . . . 0.0 111.012 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.657 ' HA ' HD11 ' A' ' 11' ' ' ILE . 41.8 t -46.62 146.17 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.57 -27.03 18.44 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 110.513 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.75 -38.96 11.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 110.069 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 11.5 m -93.19 -29.87 15.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.529 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.72 11.56 82.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.93 156.66 36.3 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.464 -1.021 . . . . 0.0 108.541 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.58 142.5 71.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.951 1.767 . . . . 0.0 111.668 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 4' ' ' CYS . 93.0 mt -95.39 73.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.521 -0.737 . . . . 0.0 110.77 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.42 -37.46 7.69 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.52 142.32 20.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -70.9 107.98 4.3 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.599 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -73.44 80.79 0.74 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 1.024 HH21 HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -61.07 141.96 57.01 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.027 -0.69 . . . . 0.0 109.932 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.576 ' CE ' HG11 ' A' ' 47' ' ' VAL . 6.9 mtp -130.7 126.31 36.19 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.655 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -115.06 158.06 41.87 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.25 -2.06 50.24 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.446 -0.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.594 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 9.7 t -57.4 -35.61 70.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 109.336 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' MET . 7.5 ttmt 75.92 29.57 0.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.594 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -94.04 164.44 13.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 58' ' ' LEU . 33.2 m -131.44 148.03 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.334 -0.854 . . . . 0.0 110.888 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 42.1 m-85 -154.92 168.78 25.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.517 ' HG ' ' HG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -51.17 109.15 0.3 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.42 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.471 ' CE2' ' CD ' ' A' ' 52' ' ' GLN . 38.2 t80 -47.13 -20.44 0.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.495 -0.753 . . . . 0.0 109.78 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -74.89 -35.48 62.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 12.3 p -82.46 -27.19 32.02 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -67.67 -37.04 81.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.902 . . . . 0.0 108.629 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 26' ' ' TYR . 25.5 pt -83.06 -34.61 11.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mt -73.72 -22.81 59.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.755 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -79.78 -42.93 23.44 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.183 -0.948 . . . . 0.0 108.778 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -75.05 -29.12 60.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.7 mttt . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.025 -1.047 . . . . 0.0 108.926 179.77 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' SER . 43.9 t -45.3 107.82 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.66 -17.14 2.76 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.262 1.308 . . . . 0.0 111.71 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.46 -50.77 1.51 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.431 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.577 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 69.8 m -92.48 -28.98 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.245 . . . . 0.0 109.942 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' CYS . 1.7 p 75.69 46.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.6 160.05 64.76 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.1 94.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.532 2.154 . . . . 0.0 112.181 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 47' ' ' VAL . 10.5 m -59.49 108.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' ILE . 2.5 tt0 -47.97 -56.23 8.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.655 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -160.66 132.41 5.87 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.903 0.859 . . . . 0.0 108.979 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.498 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.0 mt -84.25 145.23 8.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.815 -1.178 . . . . 0.0 109.508 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -138.59 156.67 47.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.842 0.829 . . . . 0.0 110.321 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.471 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 21.9 mt-30 -95.67 134.71 38.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.89 -0.506 . . . . 0.0 110.027 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.585 ' SG ' ' NH1' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -133.4 153.31 51.71 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.364 0.602 . . . . 0.0 109.987 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.59 158.64 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.795 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 57' ' ' SER . 15.5 ttp85 -48.62 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.442 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.21 28.65 0.26 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.869 -1.158 . . . . 0.0 110.329 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 55' ' ' ARG . 55.3 p -90.19 -19.11 24.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.337 . . . . 0.0 109.592 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.489 ' CD1' HG11 ' A' ' 23' ' ' VAL . 7.6 mt -119.49 173.61 6.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.774 -0.579 . . . . 0.0 109.989 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.441 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 26.4 m-85 -116.32 119.8 36.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mtt -85.43 144.49 27.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.494 -0.754 . . . . 0.0 109.358 179.614 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.495 ' O ' ' CE2' ' A' ' 71' ' ' TYR . 11.5 mpt_? . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -60.44 177.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.606 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.755 ' C ' HD23 ' A' ' 72' ' ' LEU . 57.6 m-85 -160.92 -167.4 1.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.419 -0.8 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.024 HD22 HH21 ' A' ' 16' ' ' ARG . 0.1 OUTLIER -114.63 -8.21 12.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.68 -0.638 . . . . 0.0 110.13 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' ARG . 72.6 m -147.45 127.97 14.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 109.626 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 1.5 tp-100 -45.9 -19.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 109.126 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.1 ttt-85 -71.37 -33.63 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.77 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.5 -37.68 24.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.66 -34.46 64.94 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 5.0 tp-100 -70.54 -30.51 67.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.06 -21.19 61.56 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.62 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 16.4 t60 -76.66 -35.86 57.7 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.794 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.439 ' H ' HG12 ' A' ' 81' ' ' ILE . 5.8 mm -63.92 -51.29 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.445 -0.784 . . . . 0.0 109.695 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 79' ' ' ALA . 11.2 p30 -74.23 -19.05 60.65 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.718 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.6 m-70 -86.46 -23.04 26.15 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.781 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 -26.56 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.995 -1.066 . . . . 0.0 111.926 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.62 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 6.3 m-70 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 108.964 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 6.1 t -48.02 146.5 2.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.061 -1.024 . . . . 0.0 109.87 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.54 -24.06 45.86 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -64.88 1.01 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.426 -0.797 . . . . 0.0 109.441 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 12.5 m -61.14 -22.0 64.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.21 9.48 29.68 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -101.2 157.81 32.97 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.37 -1.077 . . . . 0.0 108.773 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.73 105.87 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.879 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 4' ' ' CYS . 60.9 mt -53.5 122.67 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.473 0.654 . . . . 0.0 110.594 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.403 ' CD ' ' H ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -86.0 -31.18 22.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.5 t -138.22 145.29 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.477 ' OH ' ' CE ' ' A' ' 60' ' ' MET . 3.2 m-30 -76.78 98.61 4.86 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.792 -1.193 . . . . 0.0 110.893 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 88.24 0.86 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -76.79 141.42 40.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.976 -0.72 . . . . 0.0 110.322 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.524 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 15.4 mtp -129.38 132.98 47.16 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.167 0.508 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.666 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -116.19 156.36 47.11 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.87 2.64 48.0 Favored 'Cis proline' 0 N--CA 1.491 1.324 0 C-N-CA 124.164 -1.182 . . . . 0.0 111.316 -0.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -53.09 -40.11 63.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 tttp 71.59 31.22 2.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.598 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 9.1 m170 -104.63 174.14 6.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.567 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -128.95 159.8 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.619 0.723 . . . . 0.0 110.349 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 74.6 m-85 -166.26 174.06 9.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -62.57 115.41 4.24 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.619 178.062 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.581 ' O ' HG23 ' A' ' 30' ' ' ILE . 45.0 t80 -49.44 -21.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 109.946 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.7 -41.23 60.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.03 -1.044 . . . . 0.0 108.568 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.502 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.13 -22.0 33.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.21 -33.52 71.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 26' ' ' TYR . 49.3 pt -80.22 -37.02 17.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 121.044 -1.035 . . . . 0.0 108.621 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.27 -36.01 78.86 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.004 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -70.02 -39.94 75.52 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mttt . . . . . 0 C--N 1.304 -1.395 0 O-C-N 121.196 -0.94 . . . . 0.0 108.859 179.779 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 39' ' ' MET . 10.2 ptm . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.675 0.75 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -62.22 143.3 95.45 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -52.93 -36.19 74.05 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.55 1.5 . . . . 0.0 112.044 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.56 -45.46 0.78 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.598 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 3.2 m -81.61 -15.91 53.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.993 -1.298 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t 49.37 36.75 10.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -90.61 161.18 37.18 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.016 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.99 75.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.297 1.998 . . . . 0.0 112.012 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ASP . 37.9 t -47.35 99.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.018 -1.051 . . . . 0.0 109.489 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.5 tt0 -67.31 -61.02 2.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 108.583 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.666 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -150.1 135.34 18.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.015 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.424 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.2 mt -93.83 146.68 6.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.953 -1.092 . . . . 0.0 109.845 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -141.38 141.38 33.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.98 142.82 27.75 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.645 -0.659 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 169.26 19.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.296 -0.877 . . . . 0.0 109.847 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -87.13 162.12 17.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.873 . . . . 0.0 109.583 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 55' ' ' ARG . 1.1 ttp180 -70.04 38.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.021 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -153.27 17.55 0.69 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.74 -27.33 12.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.875 . . . . 0.0 110.243 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 mt -113.0 172.32 7.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.57 -0.706 . . . . 0.0 110.017 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 19.5 m-85 -129.37 120.39 25.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.477 ' CE ' ' OH ' ' A' ' 14' ' ' TYR . 1.8 mpt? -81.77 144.76 30.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.245 -0.91 . . . . 0.0 110.628 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 54.1 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.456 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.52 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -91.94 179.32 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.497 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.725 ' C ' HD23 ' A' ' 72' ' ' LEU . 61.8 m-85 -158.37 -169.74 2.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.391 -0.818 . . . . 0.0 109.069 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -111.92 -9.71 14.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.673 -0.642 . . . . 0.0 110.191 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.6 t -152.9 133.84 14.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.969 -1.082 . . . . 0.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 73' ' ' SER . 13.0 mm100 -44.96 -30.11 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.9 -34.9 79.0 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.014 0.911 . . . . 0.0 109.786 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.7 m-20 -83.39 -33.97 25.65 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.15 -0.969 . . . . 0.0 108.556 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -74.91 -34.17 62.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.479 ' N ' HD23 ' A' ' 77' ' ' LEU . 4.0 tp-100 -70.25 -32.04 69.7 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.09 -20.84 61.59 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.3 OUTLIER -76.47 -38.77 54.85 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.013 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.539 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 5.3 mm -62.11 -54.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 4.8 p30 -69.21 -20.1 63.97 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.651 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.6 m-70 -86.88 -13.37 45.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.515 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.41 ' HG3' ' HD1' ' A' ' 80' ' ' HIS . 13.1 mmt180 -122.21 -40.51 2.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.099 -1.001 . . . . 0.0 113.468 -177.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 120.856 -1.152 . . . . 0.0 110.143 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HA ' HD11 ' A' ' 11' ' ' ILE . 17.2 t -45.97 146.17 1.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.546 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.03 -27.44 24.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -91.64 -44.34 9.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 110.095 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 12.9 m -87.94 -27.03 22.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 110.334 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.71 11.4 83.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.14 158.19 32.24 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -1.044 . . . . 0.0 108.882 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.35 106.39 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.961 1.774 . . . . 0.0 112.128 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 4' ' ' CYS . 79.0 mt -54.23 105.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.875 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -71.78 -36.49 70.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.02 141.94 28.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -73.22 112.12 8.97 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.965 -1.084 . . . . 0.0 111.106 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -77.72 78.01 1.55 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.461 HH12 ' C ' ' A' ' 21' ' ' LYS . 4.0 tpt85 -58.23 140.53 52.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 122.155 -0.615 . . . . 0.0 110.235 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.534 ' CE ' HG11 ' A' ' 47' ' ' VAL . 5.5 mtp -130.04 129.01 43.1 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -120.89 156.22 56.76 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.69 0.53 52.94 Favored 'Cis proline' 0 N--CA 1.49 1.268 0 C-N-CA 124.191 -1.17 . . . . 0.0 112.084 0.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.569 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 35.4 t -54.9 -29.68 56.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 109.12 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' C ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER 68.83 25.98 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.575 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -95.37 175.52 6.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.675 -0.641 . . . . 0.0 109.37 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -144.98 153.42 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.817 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 26.5 m-85 -159.58 168.14 26.83 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -48.79 111.78 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.86 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 30' ' ' ILE . 35.8 t80 -49.12 -18.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.391 -0.818 . . . . 0.0 109.098 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 25' ' ' CYS . 29.3 t0 -77.23 -36.37 54.72 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -82.86 -25.78 32.24 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -69.25 -36.97 77.72 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 26' ' ' TYR . 32.1 pt -80.57 -35.01 14.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.986 -1.071 . . . . 0.0 109.323 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -67.83 -22.17 65.16 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.516 -1.273 . . . . 0.0 107.965 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -82.3 -35.24 28.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -74.39 -31.8 62.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.662 -0.649 . . . . 0.0 109.603 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 mttt . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.158 -0.964 . . . . 0.0 110.137 -179.312 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.9 mtp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 44' ' ' SER . 42.6 t -43.92 106.89 0.54 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.4 -17.22 4.02 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.305 1.337 . . . . 0.0 111.754 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.85 -47.71 2.63 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.394 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.575 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 62.1 m -99.37 -30.0 12.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 78.35 52.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.706 -0.622 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.41 158.47 75.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 109.068 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.71 100.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.605 2.203 . . . . 0.0 112.586 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 47' ' ' VAL . 12.7 m -68.31 106.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -49.24 -54.81 14.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.774 -1.204 . . . . 0.0 108.28 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.482 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -159.6 125.34 4.24 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.475 178.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.49 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.2 mt -78.94 144.83 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.917 -1.114 . . . . 0.0 109.096 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -138.93 153.24 48.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.917 0.865 . . . . 0.0 110.0 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -96.36 138.55 33.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.88 -0.512 . . . . 0.0 109.776 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 158.91 43.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.902 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.77 158.3 24.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.55 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -50.87 -71.0 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 110.142 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.28 27.62 0.44 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 55' ' ' ARG . 9.4 t -86.9 -25.18 24.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.87 -1.37 . . . . 0.0 109.125 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.8 mt -115.35 173.72 6.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.48 116.24 30.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.781 -0.574 . . . . 0.0 109.727 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.7 tpt -79.46 144.48 33.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.823 . . . . 0.0 109.159 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.544 ' NE ' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.63 171.5 5.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.079 -1.013 . . . . 0.0 109.563 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.783 ' C ' HD23 ' A' ' 72' ' ' LEU . 1.9 m-85 -154.36 -174.45 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.373 -0.83 . . . . 0.0 108.796 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.783 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -118.61 -4.79 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.617 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -147.45 123.41 10.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.229 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 73' ' ' SER . 1.3 tp-100 -44.39 -21.55 0.05 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.4 ttt180 -68.81 -37.0 78.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.403 -0.81 . . . . 0.0 109.649 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.41 -35.66 34.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.47 -32.96 66.65 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.7 tp60 -69.28 -30.91 69.11 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -74.82 -19.93 59.98 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -71.8 -47.46 53.16 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.749 -1.18 . . . . 0.0 108.207 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.471 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.9 mm -56.85 -55.77 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.644 0.735 . . . . 0.0 109.586 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -64.64 -18.24 64.76 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -85.47 -32.39 22.29 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.924 -178.407 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -130.61 -25.02 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.175 -0.953 . . . . 0.0 112.685 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.512 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 3.8 m-70 . . . . . 0 C--N 1.302 -1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 109.023 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.638 ' HA ' HD11 ' A' ' 11' ' ' ILE . 48.0 t -46.36 146.53 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.631 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.28 -28.33 38.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.373 -0.829 . . . . 0.0 109.711 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 -59.4 1.75 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 13.1 m -60.06 -28.62 67.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.14 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.2 73.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.3 158.37 31.89 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.432 -1.04 . . . . 0.0 108.638 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.17 100.04 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.855 1.703 . . . . 0.0 112.233 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 4' ' ' CYS . 89.5 mt -45.67 115.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.94 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.7 -32.28 25.62 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.87 140.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -76.76 103.85 6.94 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.819 -1.175 . . . . 0.0 110.835 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 84.29 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.511 HH21 ' CG ' ' A' ' 21' ' ' LYS . 6.2 ttt-85 -66.73 130.98 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 122.223 -0.575 . . . . 0.0 110.166 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.643 ' CE ' HG11 ' A' ' 47' ' ' VAL . 16.7 mtp -117.0 132.62 56.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.879 -0.513 . . . . 0.0 110.279 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.679 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -115.81 156.75 46.06 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.55 -1.54 51.83 Favored 'Cis proline' 0 N--CA 1.492 1.405 0 C-N-CA 124.119 -1.201 . . . . 0.0 111.958 -0.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.447 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 3.5 t -54.19 -31.58 53.32 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.2 OUTLIER 68.79 24.85 6.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.453 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.72 179.96 5.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.2 m -146.32 150.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 34.6 m-85 -159.09 169.71 23.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -52.5 114.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.206 179.341 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 30' ' ' ILE . 34.1 t80 -52.22 -15.3 0.57 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.339 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -41.14 63.55 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.548 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 p -81.23 -27.63 35.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.7 -35.99 81.44 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 108.809 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.3 pt -79.91 -34.48 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.129 -1.029 . . . . 0.0 108.873 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.9 mt -64.0 -24.86 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.204 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -80.63 -40.71 25.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -23.34 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.395 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mttt . . . . . 0 N--CA 1.486 1.37 0 O-C-N 121.261 -0.899 . . . . 0.0 108.584 179.513 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.6 t -64.01 114.3 13.22 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 109.002 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -54.68 -12.3 4.33 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.199 1.266 . . . . 0.0 111.554 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.74 -59.76 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 44' ' ' SER . 3.8 m -92.34 -24.55 18.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.226 -1.161 . . . . 0.0 109.969 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER 74.86 40.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.3 157.11 43.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.69 97.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.5 2.133 . . . . 0.0 112.228 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.643 HG11 ' CE ' ' A' ' 17' ' ' MET . 4.5 m -68.99 112.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -55.36 -53.66 53.44 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 108.897 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.679 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -157.68 133.67 9.37 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.791 -1.163 . . . . 0.0 109.787 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.715 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.1 mt -87.17 145.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 120.981 -1.074 . . . . 0.0 109.353 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -138.34 153.84 48.97 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.706 0.765 . . . . 0.0 109.764 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.492 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 7.7 mt-30 -95.17 139.4 31.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.663 -0.648 . . . . 0.0 110.084 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 m -139.89 157.8 45.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.661 -0.649 . . . . 0.0 109.859 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 158.67 21.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.798 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.51 ' C ' ' H ' ' A' ' 57' ' ' SER . 36.9 ttp85 -49.92 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -0.873 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.82 29.08 0.39 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 55' ' ' ARG . 10.8 t -85.62 -27.69 25.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.95 -1.324 . . . . 0.0 108.914 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mt -107.59 173.54 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 24.8 m-85 -118.15 119.61 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -80.51 144.11 32.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.664 -0.648 . . . . 0.0 109.467 179.858 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.689 ' NH1' ' HE ' ' A' ' 84' ' ' ARG . 49.3 mtt180 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -77.33 175.71 9.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.567 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.798 ' C ' HD23 ' A' ' 72' ' ' LEU . 92.1 m-85 -157.84 -170.66 3.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -118.46 -5.75 10.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.671 -0.643 . . . . 0.0 109.676 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.3 m -149.41 129.88 13.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.982 . . . . 0.0 109.431 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -47.28 -24.46 0.75 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 109.046 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -68.16 -32.77 73.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 109.115 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 m-20 -81.62 -36.38 28.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -75.41 -33.41 60.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -68.41 -33.36 74.08 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.22 -21.17 62.17 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.44 ' CD2' ' HE2' ' A' ' 85' ' ' HIS . 45.9 t60 -74.85 -38.22 62.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.028 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.42 -52.62 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.146 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.428 HD21 ' HA ' ' A' ' 79' ' ' ALA . 11.8 p30 -72.37 -18.84 61.71 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.753 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.7 m-70 -86.65 -26.7 24.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.464 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.689 ' HE ' ' NH1' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -130.51 -14.3 3.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.154 -0.966 . . . . 0.0 112.053 -178.077 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.44 ' HE2' ' CD2' ' A' ' 80' ' ' HIS . 10.2 m-70 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.117 -0.989 . . . . 0.0 109.828 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.516 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 4.0 m -46.45 146.3 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 108.988 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -25.88 21.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.35 -31.27 13.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.417 -0.802 . . . . 0.0 110.369 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -24.43 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.838 . . . . 0.0 110.646 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . 78.93 -0.44 78.49 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.082 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.531 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 4.2 mp -79.55 163.96 56.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.075 -1.25 . . . . 0.0 108.258 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.08 133.32 24.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.146 1.231 . . . . 0.0 112.091 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.534 HG23 ' HA ' ' A' ' 25' ' ' CYS . 73.0 mt -81.05 118.09 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.739 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.484 ' CD ' ' H ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -84.53 -29.71 25.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.734 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.96 144.78 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.53 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.3 m-85 -82.31 99.41 9.33 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.634 -1.291 . . . . 0.0 110.231 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.27 87.59 0.59 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.47 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.4 ttt-85 -64.91 143.5 57.91 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 122.115 -0.638 . . . . 0.0 110.169 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' LYS . 6.8 mtp -125.6 134.33 51.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -122.54 154.18 62.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.72 6.63 37.34 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 124.174 -1.177 . . . . 0.0 111.26 -0.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.596 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -55.7 -38.19 69.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.638 -0.663 . . . . 0.0 109.421 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.7 tttp 71.12 24.22 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.596 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 37.6 m170 -100.33 175.55 5.67 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 14' ' ' TYR . 1.3 m -143.12 154.03 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.832 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 48.0 m-85 -151.92 -158.36 0.89 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.727 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -81.36 108.92 15.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.732 ' O ' HG23 ' A' ' 30' ' ' ILE . 43.2 t80 -49.84 -11.55 0.06 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.051 -1.031 . . . . 0.0 109.722 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.6 t70 -82.35 -49.29 10.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 108.996 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.727 ' HG ' ' HG ' ' A' ' 25' ' ' CYS . 3.9 m -79.4 -22.15 44.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.826 -1.172 . . . . 0.0 108.051 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.87 78.04 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.732 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.4 pt -78.86 -34.01 16.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 121.119 -0.988 . . . . 0.0 108.767 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 28' ' ' CYS . 18.9 mt -65.42 -38.7 90.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.832 -1.147 . . . . 0.0 107.995 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -70.54 -31.32 68.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.83 -36.24 62.4 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mttm . . . . . 0 C--N 1.303 -1.45 0 O-C-N 121.039 -1.038 . . . . 0.0 108.262 179.236 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.432 ' C ' HG13 ' A' ' 47' ' ' VAL . 19.5 mtp . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 121.94 0.876 . . . . 0.0 112.163 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 44' ' ' SER . 24.9 t -91.47 112.06 52.3 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -45.95 -19.17 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.86 1.706 . . . . 0.0 112.772 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 -62.51 0.82 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.5 m -93.83 2.27 56.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -1.157 . . . . 0.0 110.529 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.6 p 48.45 36.03 6.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 109.566 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.444 ' H ' ' HB3' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -95.71 161.43 27.6 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.299 -0.876 . . . . 0.0 109.003 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' GLN . 20.2 Cg_endo -62.93 80.67 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.344 2.029 . . . . 0.0 111.976 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 47' ' ' VAL . 5.6 m -52.96 98.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -50.6 -51.12 51.43 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.519 -1.363 . . . . 0.0 108.202 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.475 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -158.55 123.19 4.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.668 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.1 mt -81.05 144.91 9.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 120.797 -1.19 . . . . 0.0 109.168 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 16' ' ' ARG . 28.0 mt-10 -138.97 151.17 46.64 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.702 0.763 . . . . 0.0 110.363 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 19.5 mt-30 -85.72 143.29 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.347 0.594 . . . . 0.0 110.071 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.44 159.32 42.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.478 -0.764 . . . . 0.0 109.471 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.81 166.41 20.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.333 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.525 ' C ' ' H ' ' A' ' 57' ' ' SER . 3.5 tmm_? -68.51 -74.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 110.561 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.15 24.71 0.26 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.365 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.635 ' O ' HD23 ' A' ' 58' ' ' LEU . 3.3 m -92.56 -6.31 49.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.972 -1.31 . . . . 0.0 109.82 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 57' ' ' SER . 6.3 mt -129.03 174.81 9.21 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.471 ' CD2' ' OE1' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -120.67 108.58 14.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.801 -0.562 . . . . 0.0 110.332 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.52 144.74 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.381 -0.825 . . . . 0.0 110.368 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.592 ' HG ' ' CE1' ' A' ' 80' ' ' HIS . 49.6 t . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.405 -0.81 . . . . 0.0 109.673 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.941 0.4 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.47 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 2.1 p -94.12 155.0 17.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.647 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.636 ' C ' HD23 ' A' ' 72' ' ' LEU . 72.6 m-85 -149.97 176.98 10.28 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -103.11 -11.11 18.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.537 -0.727 . . . . 0.0 110.472 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ASP . 58.7 m -160.63 138.05 9.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.801 -1.187 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.471 ' OE1' ' CD2' ' A' ' 59' ' ' PHE . 12.8 mm100 -43.34 -31.64 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.612 -0.68 . . . . 0.0 109.68 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -65.88 -31.68 72.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.415 -0.803 . . . . 0.0 109.962 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 73.6 m-20 -86.22 -32.73 21.01 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -76.83 -35.03 57.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.637 ' N ' HD23 ' A' ' 77' ' ' LEU . 40.1 tp60 -72.38 -34.73 68.14 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.08 -20.09 62.4 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.592 ' CE1' ' HG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -77.39 -39.12 48.26 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.645 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.517 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.5 mm -58.14 -55.35 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.19 -25.2 66.01 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.604 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -88.78 -11.04 46.07 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.808 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -118.37 -48.62 2.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.152 -0.967 . . . . 0.0 113.355 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 110.002 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.569 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.362 0.601 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 6.6 t -46.26 145.8 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.037 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -21.44 30.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.057 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -39.68 12.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.038 -1.038 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -106.58 -16.98 14.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 111.384 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.43 4.12 68.42 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.429 -1.367 . . . . 0.0 109.979 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.27 157.65 56.06 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.057 -1.261 . . . . 0.0 109.035 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.7 112.16 2.11 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.129 1.886 . . . . 0.0 112.549 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.488 HD11 ' HA ' ' A' ' 4' ' ' CYS . 67.6 mt -61.82 124.86 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.05 -29.25 18.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 t -133.4 145.31 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD2' HG11 ' A' ' 23' ' ' VAL . 3.2 m-30 -82.75 98.73 9.25 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.658 -1.276 . . . . 0.0 110.814 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.69 95.34 1.35 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.611 HH12 ' CB ' ' A' ' 70' ' ' THR . 3.0 tpt180 -81.52 144.83 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.99 -0.712 . . . . 0.0 111.064 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.541 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 5.4 mtp -131.72 130.18 41.61 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.663 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -113.9 157.28 42.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.345 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.48 -1.06 51.67 Favored 'Cis proline' 0 N--CA 1.491 1.344 0 C-N-CA 124.178 -1.176 . . . . 0.0 111.786 -0.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.596 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 14.5 t -52.01 -35.36 46.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.2 OUTLIER 69.3 30.17 4.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.596 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 30.8 m170 -100.22 165.9 11.26 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.876 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -122.64 161.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.942 0.877 . . . . 0.0 110.462 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.541 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 97.3 m-85 -163.55 -164.41 0.92 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -83.9 113.66 21.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.649 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.754 ' O ' HG23 ' A' ' 30' ' ' ILE . 41.1 t80 -47.53 -14.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.051 -1.03 . . . . 0.0 109.364 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -79.77 -42.96 23.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.465 ' HA ' HD12 ' A' ' 31' ' ' LEU . 54.5 m -83.08 -23.2 33.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -69.54 -37.41 77.06 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 26' ' ' TYR . 46.4 pt -74.74 -37.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.468 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 28' ' ' CYS . 9.0 mt -53.5 -38.52 63.78 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -67.05 -42.03 85.48 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.564 -0.71 . . . . 0.0 109.211 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' A' ' 50' ' ' ILE . 1.1 pt-20 -61.46 -34.0 74.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 108.782 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mttm . . . . . 0 C--N 1.302 -1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.998 179.619 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.455 ' O ' ' CG ' ' A' ' 39' ' ' MET . 7.5 ptm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.503 0.668 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.503 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -57.04 145.89 62.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.86 -38.91 68.85 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.768 1.645 . . . . 0.0 112.61 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.84 -21.8 2.84 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.624 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.586 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -94.49 -15.81 23.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.176 -1.191 . . . . 0.0 110.169 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.9 p 47.63 36.48 5.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.503 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.3 OUTLIER -90.93 160.73 37.35 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 108.775 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' GLN . 14.9 Cg_endo -58.27 74.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.131 1.887 . . . . 0.0 112.001 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' ASP . 47.2 t -47.42 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.051 -1.03 . . . . 0.0 109.683 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' PRO . 5.0 tt0 -64.62 -61.06 2.43 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.663 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -150.61 137.64 19.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.911 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.579 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -94.61 147.21 5.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.805 -1.184 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -140.68 147.02 38.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.443 0.64 . . . . 0.0 109.826 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -97.02 144.8 26.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.633 -0.667 . . . . 0.0 109.221 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 168.08 25.07 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.012 . . . . 0.0 110.323 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 154.36 22.28 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -57.52 -23.78 52.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 110.081 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.82 21.83 44.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.83 -25.99 14.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -1.135 . . . . 0.0 109.924 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -114.15 172.68 6.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.697 -0.627 . . . . 0.0 109.628 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -122.19 123.18 40.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 mmt -88.88 145.28 25.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.274 -0.891 . . . . 0.0 110.949 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.58 ' SG ' ' NE2' ' A' ' 80' ' ' HIS . 46.9 t . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.011 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.688 HH12 HH21 ' A' ' 84' ' ' ARG . 19.3 mmm-85 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.611 ' CB ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -83.84 174.87 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.813 ' C ' HD23 ' A' ' 72' ' ' LEU . 89.8 m-85 -156.18 -166.33 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.366 -0.834 . . . . 0.0 108.819 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.813 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -118.11 -8.81 10.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.678 -0.639 . . . . 0.0 110.046 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 76' ' ' ASP . 17.9 p -145.35 130.0 18.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.514 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -47.81 -25.65 1.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 108.699 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -68.4 -32.89 73.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.528 0.68 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 73' ' ' SER . 36.5 m-20 -84.21 -34.52 23.9 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 tt -74.95 -34.05 62.0 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.58 -30.22 65.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.06 -20.55 60.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.58 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -75.83 -41.0 53.8 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.724 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.53 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 4.6 mm -61.53 -52.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -64.65 -23.02 67.12 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.482 -0.761 . . . . 0.0 109.023 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 28.7 m170 -88.12 -12.9 42.72 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.531 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.688 HH21 HH12 ' A' ' 69' ' ' ARG . 11.1 mmt180 -118.67 -46.21 2.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 113.067 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 110.031 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.466 ' O ' ' CD2' ' A' ' 3' ' ' PHE . 13.9 p90 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.619 ' HA ' HD11 ' A' ' 11' ' ' ILE . 43.3 t -45.95 146.29 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.72 -30.45 26.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 110.624 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.45 -40.16 10.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.018 -1.051 . . . . 0.0 110.293 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 12.6 m -88.55 -25.86 22.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.052 -1.03 . . . . 0.0 110.089 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.42 10.49 70.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 158.29 32.46 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.36 -1.082 . . . . 0.0 108.601 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.02 98.96 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.857 1.704 . . . . 0.0 112.083 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' HA ' ' A' ' 4' ' ' CYS . 91.5 mt -45.58 110.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.986 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -35.07 40.86 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.0 138.75 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -78.78 106.96 11.15 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.98 -1.075 . . . . 0.0 110.78 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.58 85.13 0.85 Allowed Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -65.66 130.84 44.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 122.0 -0.706 . . . . 0.0 109.789 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.631 ' CE ' HG11 ' A' ' 47' ' ' VAL . 14.5 mtp -116.27 124.61 50.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.863 -0.523 . . . . 0.0 110.139 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.817 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -112.76 156.72 42.11 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.95 2.57 48.47 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 124.153 -1.186 . . . . 0.0 111.462 -0.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.581 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 1.0 OUTLIER -56.92 -35.81 69.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.549 -0.719 . . . . 0.0 109.433 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 ttmt 74.51 21.97 2.19 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.586 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 3.3 m80 -90.5 178.72 6.03 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.879 -0.729 . . . . 0.0 109.149 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.456 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.3 m -146.57 149.06 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 21.5 m-85 -158.61 170.0 23.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -50.68 112.7 0.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.77 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 30' ' ' ILE . 40.6 t80 -51.16 -15.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.613 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -82.26 -32.7 29.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.546 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -85.68 -26.29 26.05 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 108.651 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.493 ' HB1' HD13 ' A' ' 50' ' ' ILE . . . -72.29 -35.09 68.6 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 26' ' ' TYR . 2.1 pp -84.46 -34.92 10.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.252 -0.905 . . . . 0.0 108.811 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.548 HD23 ' HD3' ' A' ' 34' ' ' LYS . 7.6 mt -68.18 -22.97 64.8 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.004 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.39 -40.57 21.1 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.26 -36.74 85.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.475 -0.765 . . . . 0.0 109.91 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HD3' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.971 -1.081 . . . . 0.0 109.756 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.0 ptt? . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.8 t -74.52 114.6 35.54 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.306 -0.871 . . . . 0.0 109.016 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.51 -17.11 6.2 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.427 1.418 . . . . 0.0 112.349 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.56 -58.63 1.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.586 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 3.5 m -93.29 -24.85 18.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -1.169 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.5 p 76.35 41.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.39 158.18 42.08 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.06 92.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.578 2.185 . . . . 0.0 112.141 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 47' ' ' VAL . 4.0 m -62.1 111.14 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.037 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -47.17 -58.89 3.57 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.13 -0.981 . . . . 0.0 108.932 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' HD11 ' A' ' 18' ' ' ILE . 31.3 ptt180 -161.93 125.89 3.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.278 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.493 HD13 ' HB1' ' A' ' 29' ' ' ALA . 3.3 mt -74.08 144.71 12.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.817 -1.177 . . . . 0.0 109.745 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -138.94 143.22 38.53 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 109.656 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -83.46 144.87 29.28 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.438 0.637 . . . . 0.0 110.079 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.21 158.86 43.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.795 . . . . 0.0 109.532 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.43 162.35 24.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.226 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 57' ' ' SER . 3.9 ptp85 -66.4 -59.79 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.039 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.497 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -72.99 21.27 1.01 Allowed Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -90.29 -17.98 26.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.128 -1.219 . . . . 0.0 109.632 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.5 mt -118.86 173.29 6.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 24.6 m-85 -114.21 117.15 30.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 60' ' ' MET . 1.6 mpt? -82.59 144.47 30.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.344 -0.847 . . . . 0.0 110.346 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.593 ' NE ' ' ND1' ' A' ' 80' ' ' HIS . 17.1 mtm180 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.54 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -78.79 176.61 9.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.74 ' C ' HD23 ' A' ' 72' ' ' LEU . 93.9 m-85 -158.66 -171.94 3.63 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.74 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -114.68 -7.72 12.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.077 -178.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 76' ' ' ASP . 1.6 m -146.2 126.37 13.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.3 tp-100 -43.34 -26.95 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 73' ' ' SER . 5.5 tmm_? -63.95 -35.55 81.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.963 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.2 m-20 -80.85 -38.73 27.68 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.216 -0.928 . . . . 0.0 108.64 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.76 -30.93 64.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.9 tp60 -69.64 -32.66 71.46 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -20.11 61.4 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.593 ' ND1' ' NE ' ' A' ' 69' ' ' ARG . 53.1 t60 -73.04 -44.89 60.18 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.683 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 81' ' ' ILE . 3.3 mm -59.36 -50.9 78.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.441 0.639 . . . . 0.0 109.699 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -70.4 -18.79 63.03 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.572 -0.705 . . . . 0.0 109.605 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -86.71 -28.45 23.09 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.101 -178.54 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -128.66 -21.77 3.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.128 -0.983 . . . . 0.0 112.025 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 4.5 m-70 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.584 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 1.5 p90 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.984 0.897 . . . . 0.0 109.969 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 37.1 t -46.78 143.03 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 108.463 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 -28.75 19.98 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.013 -1.054 . . . . 0.0 110.464 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -93.86 -38.96 10.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.078 -1.014 . . . . 0.0 110.75 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -100.03 -23.46 14.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.94 . . . . 0.0 110.822 -179.186 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 6.97 88.75 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.322 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.67 152.13 51.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.967 -1.314 . . . . 0.0 108.367 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.62 137.7 81.91 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.749 1.633 . . . . 0.0 112.696 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.633 HG23 ' HA ' ' A' ' 25' ' ' CYS . 71.9 mt -86.95 116.31 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.075 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -81.92 -28.27 32.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.55 146.74 18.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.474 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.1 m-85 -78.81 98.56 6.36 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.722 -1.236 . . . . 0.0 110.377 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.55 83.71 0.55 Allowed Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' GLU . 5.4 ttt-85 -61.52 145.89 50.46 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.305 0.574 . . . . 0.0 110.003 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.569 ' CE ' HG11 ' A' ' 47' ' ' VAL . 5.3 mtp -128.58 133.55 48.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.921 -0.487 . . . . 0.0 110.4 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -122.35 154.75 62.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.13 4.17 48.25 Favored 'Cis proline' 0 N--CA 1.49 1.315 0 C-N-CA 124.219 -1.159 . . . . 0.0 111.493 0.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.59 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -56.42 -37.83 70.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.606 -0.684 . . . . 0.0 109.459 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.0 ttmm 74.29 27.39 1.48 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.59 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 13.0 m170 -100.58 177.61 4.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.474 HG21 ' CD2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -145.26 153.3 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.433 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 62.8 m-85 -153.51 -166.85 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.633 ' HA ' HG23 ' A' ' 11' ' ' ILE . 1.6 p -72.6 112.12 8.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.79 ' O ' HG23 ' A' ' 30' ' ' ILE . 34.0 t80 -51.55 -11.0 0.11 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.326 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.2 t70 -77.29 -48.85 16.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.014 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 31.3 m -78.45 -25.24 45.86 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.78 -1.2 . . . . 0.0 108.222 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.7 -35.68 80.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 108.979 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 26' ' ' TYR . 36.9 pt -80.77 -33.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.87 -23.69 66.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -77.38 -53.22 7.94 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.564 -0.71 . . . . 0.0 109.237 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.59 -24.67 64.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 mttm . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 108.559 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.9 ptm . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' SER . 46.6 t -77.13 114.55 40.89 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 109.41 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.19 -15.58 1.44 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.691 1.594 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.86 -62.24 0.82 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -92.35 -20.5 21.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -1.122 . . . . 0.0 110.194 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.4 p 72.11 35.45 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.281 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.46 160.77 26.6 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.56 -0.713 . . . . 0.0 109.107 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.08 81.54 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.434 2.089 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 47' ' ' VAL . 4.6 m -52.66 111.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -59.65 -52.21 66.5 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.875 -1.141 . . . . 0.0 108.75 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.58 124.49 6.69 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.795 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.571 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.9 mt -84.93 144.86 8.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.836 -1.165 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 16' ' ' ARG . 29.0 mt-10 -137.77 149.79 46.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.621 0.724 . . . . 0.0 109.658 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -95.09 141.71 28.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.703 -0.623 . . . . 0.0 110.016 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 160.53 40.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.423 -0.798 . . . . 0.0 109.766 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 158.6 31.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 57' ' ' SER . 26.4 ttp85 -56.27 -71.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 0.0 110.046 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.39 30.64 0.46 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 55' ' ' ARG . 4.2 t -89.56 -26.29 20.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.295 . . . . 0.0 109.509 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mt -101.81 173.66 6.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.648 -0.657 . . . . 0.0 109.866 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CE2' ' CD ' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -121.31 109.47 14.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 mtt -74.45 144.5 44.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 110.507 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.749 . . . . 0.0 109.015 179.311 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.04 167.33 18.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.082 -1.011 . . . . 0.0 109.738 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.746 ' C ' HD23 ' A' ' 72' ' ' LEU . 31.6 m-85 -154.31 177.87 10.65 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.245 -0.909 . . . . 0.0 109.124 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.746 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -114.43 -5.25 12.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.819 -0.55 . . . . 0.0 109.54 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 67.1 m -153.39 126.56 8.5 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.748 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.468 ' CD ' ' CE2' ' A' ' 59' ' ' PHE . 13.3 mm100 -43.51 -24.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.672 -0.642 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 ttt180 -66.5 -33.23 75.22 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.99 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 8.1 m-20 -86.09 -33.34 20.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.051 -1.031 . . . . 0.0 108.278 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.2 OUTLIER -76.48 -31.8 57.98 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.445 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.663 ' N ' HD23 ' A' ' 77' ' ' LEU . 5.9 tp-100 -72.78 -33.86 66.57 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -19.8 61.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.402 ' CD2' ' HE2' ' A' ' 85' ' ' HIS . 66.1 t60 -73.41 -45.3 55.48 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.761 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.4 mm -58.72 -51.2 74.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.501 0.667 . . . . 0.0 109.703 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.59 -18.47 62.89 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.784 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -87.19 -27.34 23.07 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.099 -178.482 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.67 -25.96 2.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.064 -1.023 . . . . 0.0 112.488 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.506 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 4.5 m-70 . . . . . 0 C--N 1.301 -1.502 0 O-C-N 120.995 -1.066 . . . . 0.0 108.968 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.212 0.529 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.623 ' HA ' HD11 ' A' ' 11' ' ' ILE . 49.9 t -46.53 146.29 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.84 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.09 -27.2 28.41 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.442 -0.786 . . . . 0.0 109.874 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -53.25 3.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.766 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.556 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 6.5 m -74.65 -27.6 60.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.76 7.69 70.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.03 158.28 34.38 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.296 -1.12 . . . . 0.0 108.564 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.77 96.44 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.852 1.701 . . . . 0.0 112.484 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 4' ' ' CYS . 96.5 mt -41.26 104.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.395 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -76.37 -32.13 58.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.01 146.64 29.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -83.05 104.38 13.21 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.81 -1.181 . . . . 0.0 110.818 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.58 91.0 1.16 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.424 HH21 ' CG ' ' A' ' 21' ' ' LYS . 8.8 ttt-85 -77.65 134.56 38.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.828 -0.807 . . . . 0.0 110.114 -178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.568 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 6.0 mtp -123.61 130.66 53.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.867 -0.521 . . . . 0.0 109.761 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.663 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -113.14 156.85 42.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.77 2.1 42.08 Favored 'Cis proline' 0 N--CA 1.491 1.353 0 C-N-CA 124.087 -1.214 . . . . 0.0 111.328 -0.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.529 ' HG ' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -53.93 -36.31 62.65 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.2 OUTLIER 65.6 26.88 11.58 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.594 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 4.7 m170 -93.63 -172.15 2.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.534 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -144.71 151.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.93 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 41.6 m-85 -162.85 166.77 23.66 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.556 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -55.44 111.75 0.96 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.47 -1.292 . . . . 0.0 107.938 178.646 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.499 ' O ' HG23 ' A' ' 30' ' ' ILE . 46.3 t80 -46.3 -21.0 0.13 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 109.767 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.8 t70 -74.36 -37.64 63.42 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.542 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -83.69 -22.61 32.0 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 108.515 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.71 -34.23 71.71 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.8 pt -80.97 -36.09 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 121.141 -0.974 . . . . 0.0 108.919 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 31' ' ' LEU . 78.7 mt -64.56 -37.27 86.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.86 -33.81 72.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -34.88 70.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--N 1.303 -1.417 0 O-C-N 121.042 -1.036 . . . . 0.0 108.64 179.754 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.1 ptp . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 122.167 0.984 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.8 OUTLIER -65.73 142.46 98.19 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -54.6 -34.18 81.97 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.532 1.488 . . . . 0.0 112.411 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.12 -43.22 0.8 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.043 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 2.4 m -86.26 -12.98 48.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.371 . . . . 0.0 110.549 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t 48.16 37.47 8.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 0.0 109.029 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.92 161.1 39.33 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.384 -0.822 . . . . 0.0 109.342 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.32 74.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.377 2.051 . . . . 0.0 111.815 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 45' ' ' ASP . 21.7 t -45.25 100.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -0.832 . . . . 0.0 110.031 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 18' ' ' ILE . 4.9 tt0 -66.07 -61.33 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.663 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -151.6 136.78 17.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.94 179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.1 mt -94.3 146.68 6.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.822 -1.174 . . . . 0.0 109.724 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.05 153.67 45.61 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.427 0.632 . . . . 0.0 109.991 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.55 142.53 30.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 165.55 28.08 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 155.68 23.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 0.0 108.937 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 57' ' ' SER . 10.5 ttp85 -51.56 -62.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 23.66 0.78 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.0 t -86.92 -25.68 24.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.938 -1.331 . . . . 0.0 109.216 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.03 173.89 6.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.512 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 15.1 m-85 -119.31 119.39 33.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mtt -80.08 144.49 33.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.483 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.268 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.3 mmm-85 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.86 174.72 11.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.711 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.765 ' C ' HD23 ' A' ' 72' ' ' LEU . 97.5 m-85 -156.77 -176.29 5.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.765 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -116.99 -3.34 11.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.617 -0.677 . . . . 0.0 110.086 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 75' ' ' ARG . 8.1 t -149.32 128.12 12.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 109.716 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.66 -23.23 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.4 ttt180 -70.27 -33.16 71.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.363 -0.836 . . . . 0.0 109.687 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.1 m-20 -82.24 -36.7 26.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 tt -73.68 -34.78 65.03 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -70.16 -31.42 68.9 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.97 -19.82 60.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.587 ' HD1' ' HH ' ' A' ' 71' ' ' TYR . 58.6 t60 -73.11 -44.52 60.19 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.594 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.8 mm -60.21 -52.04 65.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.48 0.657 . . . . 0.0 109.553 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -68.44 -18.32 64.4 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 109.647 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -86.21 -31.06 21.93 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.69 -1.204 . . . . 0.0 112.21 -178.4 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -129.6 -21.59 3.1 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.046 -1.034 . . . . 0.0 112.472 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.522 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 4.5 m-70 . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.056 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.534 0.683 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.665 ' HA ' HD11 ' A' ' 11' ' ' ILE . 52.0 t -67.97 146.35 53.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.395 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.3 -27.83 38.38 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -99.68 -44.97 5.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.599 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 4.5 m -84.7 -20.31 31.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.41 3.49 25.94 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.67 157.36 37.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.331 -1.1 . . . . 0.0 108.801 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.91 123.12 12.81 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.0 1.8 . . . . 0.0 111.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.665 HD11 ' HA ' ' A' ' 4' ' ' CYS . 75.3 mt -75.89 103.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.64 -0.662 . . . . 0.0 110.575 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -30.81 64.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -147.05 143.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -75.36 110.42 9.7 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.995 -1.066 . . . . 0.0 111.113 -178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -80.12 80.72 1.59 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.455 HH21 ' CG ' ' A' ' 21' ' ' LYS . 7.3 ttt-85 -66.55 131.15 45.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 122.112 -0.64 . . . . 0.0 110.239 -178.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.422 ' O ' ' N ' ' A' ' 21' ' ' LYS . 19.7 mtp -116.91 134.5 54.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.874 -0.516 . . . . 0.0 110.103 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -120.25 157.58 53.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.58 -2.19 47.13 Favored 'Cis proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.107 -1.205 . . . . 0.0 112.146 -0.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.519 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 7.1 t -52.8 -36.92 59.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.636 ' HE3' HD21 ' A' ' 72' ' ' LEU . 2.0 tttp 74.94 27.55 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 1.4 m80 -95.58 -178.24 4.34 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -145.71 153.5 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.868 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 34.9 m-85 -161.46 166.24 27.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -48.97 113.03 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.699 179.569 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -50.88 -18.02 0.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.347 -0.846 . . . . 0.0 109.883 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.427 ' O ' HD12 ' A' ' 31' ' ' LEU . 35.9 t70 -79.82 -33.04 40.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -85.34 -23.97 27.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.626 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.541 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -72.07 -35.66 69.35 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -85.44 -34.03 8.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.146 -0.971 . . . . 0.0 108.957 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.483 HD23 ' HD3' ' A' ' 34' ' ' LYS . 7.8 mt -72.69 -22.75 60.86 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.803 -1.159 . . . . 0.0 107.979 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 28' ' ' CYS . 35.6 m170 -83.79 -36.46 23.54 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.234 -0.916 . . . . 0.0 108.869 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -34.53 66.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 109.441 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HD3' HD23 ' A' ' 31' ' ' LEU . 12.9 ptmt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.228 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.523 ' HA ' HG23 ' A' ' 47' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -41.07 104.79 0.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.684 -0.635 . . . . 0.0 109.98 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -52.62 -16.23 5.25 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.444 1.429 . . . . 0.0 111.757 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.33 -44.24 2.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.541 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.601 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 2.8 m -106.99 -26.11 11.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.316 -1.108 . . . . 0.0 110.528 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.88 56.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.118 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.34 161.02 43.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.25 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.468 2.112 . . . . 0.0 112.073 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 39' ' ' MET . 88.8 t -58.0 105.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.235 -0.915 . . . . 0.0 109.07 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -68.67 -65.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -0.988 . . . . 0.0 108.774 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.467 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.39 125.49 9.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.01 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.541 HG21 ' HB1' ' A' ' 29' ' ' ALA . 4.2 mt -81.39 145.08 9.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 109.172 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.12 145.93 40.05 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.787 0.803 . . . . 0.0 110.095 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.97 143.72 26.66 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.333 0.587 . . . . 0.0 109.762 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 161.04 41.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 109.469 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.527 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -84.86 166.92 16.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.487 ' CG ' ' H ' ' A' ' 56' ' ' GLY . 8.4 ptp180 -58.81 -58.54 8.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.18 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.487 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -75.38 23.79 1.48 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.811 ' O ' HD23 ' A' ' 58' ' ' LEU . 16.5 m -86.1 -14.67 43.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.108 -1.23 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 57' ' ' SER . 1.1 mt -135.4 172.45 13.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.452 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 18.9 m-85 -114.96 122.65 46.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 mmt -84.79 144.31 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.668 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.242 179.77 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.467 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.705 0.764 . . . . 0.0 110.742 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.5 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -89.41 -173.48 4.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.407 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.612 ' C ' HD23 ' A' ' 72' ' ' LEU . 66.3 m-85 -154.89 171.31 19.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.224 -0.922 . . . . 0.0 108.671 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.14 -2.18 21.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.4 -0.812 . . . . 0.0 110.946 -178.162 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 74' ' ' GLN . 1.4 p -160.66 134.42 6.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.242 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -42.9 -29.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -65.35 -34.36 78.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.439 -0.788 . . . . 0.0 110.425 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -83.9 -35.41 24.11 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 108.288 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.617 HD23 ' C ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -75.94 -31.6 59.16 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.575 ' N ' HD23 ' A' ' 77' ' ' LEU . 5.9 tp-100 -73.77 -33.78 64.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.66 61.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 5.5 t60 -72.73 -51.53 18.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.196 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.588 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.6 mm -51.66 -53.05 18.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.666 -0.646 . . . . 0.0 109.657 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.07 -19.07 64.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.104 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -87.08 -28.15 22.72 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.723 -1.191 . . . . 0.0 112.031 -178.487 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -129.42 -23.42 2.93 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.454 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 4.8 m-70 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 0.0 109.27 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 11' ' ' ILE . 3.4 m80 -96.9 -66.07 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 109.299 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -76.72 124.02 27.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 109.997 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 9' ' ' LEU . 4.4 m -46.0 145.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -82.36 -26.61 32.75 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 -33.31 12.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 110.567 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -104.33 -25.4 12.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -0.898 . . . . 0.0 110.83 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.26 -9.24 49.03 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 5.7 mp -73.28 158.45 86.75 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.993 -1.298 . . . . 0.0 108.819 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -68.15 104.34 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.8 1.667 . . . . 0.0 112.883 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.611 HG23 ' HA ' ' A' ' 25' ' ' CYS . 78.4 mt -50.99 120.15 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.43 0.633 . . . . 0.0 110.236 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -88.31 -27.07 21.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.69 144.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -80.78 100.11 8.6 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.802 -1.186 . . . . 0.0 110.453 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 95.1 1.64 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.414 HH21 ' HG3' ' A' ' 21' ' ' LYS . 18.9 ttt-85 -80.89 137.28 36.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.037 -0.684 . . . . 0.0 110.168 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 9.7 mtp -121.74 134.18 54.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.122 0.486 . . . . 0.0 110.238 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.664 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -114.37 155.9 45.17 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.69 2.97 52.47 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.145 -1.19 . . . . 0.0 111.364 -0.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.3 t -56.74 -33.48 66.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.537 -0.727 . . . . 0.0 109.389 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 66.93 26.69 9.12 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.585 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 33.8 m170 -97.49 162.49 13.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.902 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -118.07 160.79 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.157 0.98 . . . . 0.0 111.019 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 93.5 m-85 -164.53 -165.23 0.91 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.611 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -85.06 113.12 21.24 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.715 ' O ' HG23 ' A' ' 30' ' ' ILE . 41.0 t80 -47.67 -16.38 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.973 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 25' ' ' CYS . 7.4 t70 -82.73 -50.68 8.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.027 -1.046 . . . . 0.0 109.488 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.417 ' HA ' HD12 ' A' ' 31' ' ' LEU . 3.0 m -78.86 -20.85 48.56 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.81 -1.182 . . . . 0.0 108.096 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.93 71.33 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.715 HG23 ' O ' ' A' ' 26' ' ' TYR . 40.7 pt -80.32 -33.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 121.001 -1.062 . . . . 0.0 108.793 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 28' ' ' CYS . 14.9 mt -64.0 -34.37 77.86 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.876 -1.13 . . . . 0.0 107.988 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.17 -42.52 72.36 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.94 95.82 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -70.69 -19.74 62.75 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -81.43 -54.68 5.25 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.557 -0.714 . . . . 0.0 110.256 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -117.05 -30.45 1.94 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 1.3 t70 70.83 13.99 7.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.288 -1.125 . . . . 0.0 109.826 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.67 36.32 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.028 -1.045 . . . . 0.0 110.861 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.46 ' O ' ' CG ' ' A' ' 39' ' ' MET . 10.8 ptm -145.81 118.08 8.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.987 -1.071 . . . . 0.0 110.248 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.451 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 1.2 t -62.12 139.8 96.03 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.77 . . . . 0.0 108.981 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.69 -36.97 20.08 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.875 1.716 . . . . 0.0 112.416 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.89 -36.94 0.79 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 -14.16 52.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.281 . . . . 0.0 110.277 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 t 47.65 36.02 5.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.077 -1.015 . . . . 0.0 109.464 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.33 161.11 38.15 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 108.786 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.73 73.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.153 1.902 . . . . 0.0 111.884 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 45' ' ' ASP . 59.0 t -47.16 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 0.0 109.501 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -66.72 -62.79 1.27 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.161 -0.962 . . . . 0.0 108.517 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -150.03 134.31 17.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.799 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -94.34 145.97 7.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.616 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.09 150.79 44.75 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.438 0.637 . . . . 0.0 109.781 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -94.91 150.12 20.51 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.566 -0.709 . . . . 0.0 109.75 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.87 168.26 25.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.267 -0.895 . . . . 0.0 109.69 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -80.64 157.43 25.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.308 -0.87 . . . . 0.0 108.828 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -75.5 26.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.052 . . . . 0.0 109.864 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -144.29 13.91 2.08 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.11 -19.05 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.777 -0.837 . . . . 0.0 110.365 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 mt -110.81 165.4 11.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.539 -0.726 . . . . 0.0 109.784 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 24.4 m-85 -119.19 113.88 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.0 mtp -80.61 144.41 32.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.726 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.74 143.21 33.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.4 t -141.44 74.44 1.46 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.812 . . . . 0.0 109.567 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mm -101.14 -61.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.551 -0.718 . . . . 0.0 109.397 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.645 HG22 ' N ' ' A' ' 65' ' ' GLN . 8.4 p -158.61 169.22 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.47 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.645 ' N ' HG22 ' A' ' 64' ' ' VAL . 3.9 tt0 49.38 -159.96 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.15 60.03 1.37 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.68 95.14 8.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -1.179 . . . . 0.0 109.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -110.66 40.27 2.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -75.35 93.66 2.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.438 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -74.15 176.35 6.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.72 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.698 ' C ' HD23 ' A' ' 72' ' ' LEU . 78.4 m-85 -159.05 -170.87 3.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.86 -11.43 14.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 110.278 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 74' ' ' GLN . 3.5 m -150.91 133.5 15.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.975 -1.078 . . . . 0.0 109.343 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 73' ' ' SER . 1.2 tp-100 -44.12 -31.93 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -61.66 -31.98 72.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 110.496 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.02 -35.62 23.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 108.639 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.83 -34.35 62.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 82' ' ' ASN . 0.7 OUTLIER -68.17 -39.01 82.67 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 82' ' ' ASN . . . -66.02 -21.55 66.4 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -76.05 -36.91 58.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.919 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.6 mm -62.05 -53.28 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 110.038 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.732 HD22 ' HA ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -72.18 -19.02 61.82 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.68 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.5 m-70 -85.71 -25.9 26.21 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.525 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -129.97 -20.11 3.16 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.278 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 8.5 m-70 -106.78 -47.64 3.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.398 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.0 ttt 51.03 60.09 4.14 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.65 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 0.0 OUTLIER 63.9 29.18 14.59 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.615 0.722 . . . . 0.0 109.238 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 87' ' ' ARG . . . 73.97 -63.91 0.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.5 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.539 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.522 ' O ' ' CZ ' ' A' ' 14' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.501 0.667 . . . . 0.0 109.407 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.493 ' N ' ' CG2' ' A' ' 1' ' ' VAL . 0.0 OUTLIER -95.37 -56.23 2.78 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.539 -0.725 . . . . 0.0 109.196 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -76.54 109.32 10.18 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.271 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.599 ' HA ' HD11 ' A' ' 11' ' ' ILE . 4.3 t -46.37 146.37 1.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 110.073 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -18.56 39.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.458 -0.776 . . . . 0.0 109.303 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.03 -51.23 3.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.3 m -84.14 -14.65 49.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.406 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.24 9.13 14.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.23 158.62 33.68 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.343 -1.092 . . . . 0.0 108.693 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.73 101.53 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.989 1.793 . . . . 0.0 112.267 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 4' ' ' CYS . 74.2 mt -50.27 120.74 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.514 0.673 . . . . 0.0 110.578 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.32 -31.66 20.06 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.06 141.89 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 1' ' ' VAL . 3.4 m-85 -81.74 102.03 10.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.544 -1.347 . . . . 0.0 110.688 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -75.54 85.74 0.84 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.604 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.5 ttt-85 -69.33 134.87 49.62 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 122.09 -0.653 . . . . 0.0 110.454 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 21' ' ' LYS . 9.4 mmm -118.4 132.42 56.26 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.652 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -116.24 156.46 47.07 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.72 -1.74 47.83 Favored 'Cis proline' 0 N--CA 1.49 1.285 0 C-N-CA 124.137 -1.193 . . . . 0.0 111.533 -0.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.04 -34.16 28.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.604 ' CG ' HH21 ' A' ' 16' ' ' ARG . 3.4 ttmt 67.68 25.86 8.04 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -94.16 179.77 5.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.2 m -144.54 153.27 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 110.788 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 73.9 m-85 -158.42 170.34 22.44 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -55.61 113.63 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.039 -1.465 . . . . 0.0 108.171 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 30' ' ' ILE . 35.5 t80 -49.43 -11.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.855 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -74.56 -44.5 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.021 -1.049 . . . . 0.0 108.831 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -25.48 38.77 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.886 -1.133 . . . . 0.0 108.119 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.3 -36.69 83.58 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.486 -0.885 . . . . 0.0 108.702 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 26' ' ' TYR . 42.5 pt -78.86 -34.95 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.024 -1.047 . . . . 0.0 108.918 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.62 -21.9 66.62 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.267 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -80.09 -40.68 27.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.9 -29.82 62.27 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.465 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -76.46 -34.44 58.7 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.102 -0.999 . . . . 0.0 108.424 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -81.44 10.1 6.29 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.354 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.71 51.14 40.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 39' ' ' MET . 0.6 OUTLIER -97.63 -39.78 8.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.498 -1.001 . . . . 0.0 109.827 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt 50.61 59.91 4.24 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.35 1.071 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 37' ' ' ASP . 15.4 ptm -151.56 124.06 8.38 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.853 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.554 ' N ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.03 124.36 85.0 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.076 -1.015 . . . . 0.0 109.758 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -44.31 -22.86 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.127 1.885 . . . . 0.0 113.068 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.22 -64.65 0.87 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 44' ' ' SER . 62.9 m -69.69 -43.65 72.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.232 -1.158 . . . . 0.0 108.564 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.6 p 76.9 57.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.832 -0.543 . . . . 0.0 111.622 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.443 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 174.82 -48.19 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.386 -1.446 . . . . 0.0 112.117 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 45' ' ' ASP . 64.9 Cg_endo -86.47 51.44 2.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.57 2.18 . . . . 0.0 115.706 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 40' ' ' CYS . 1.8 t -95.35 117.28 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.263 -1.523 . . . . 0.0 109.211 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -98.27 -65.55 0.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.652 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -141.75 137.94 31.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.497 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.9 mt -92.45 145.9 7.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.737 -1.227 . . . . 0.0 109.696 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -137.28 149.0 46.79 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.755 0.788 . . . . 0.0 109.844 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 32.0 mt-30 -94.74 136.15 35.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.831 -0.543 . . . . 0.0 110.03 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.96 155.62 48.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.619 -0.675 . . . . 0.0 110.027 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.75 158.2 22.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.35 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 57' ' ' SER . 7.8 ttp180 -49.33 -69.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -0.98 . . . . 0.0 109.988 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.32 27.52 0.57 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 55' ' ' ARG . 17.0 t -85.05 -27.94 26.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.909 -1.347 . . . . 0.0 108.858 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -112.43 173.73 6.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 17.6 m-85 -113.27 120.54 41.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.852 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 mtp -81.65 144.66 31.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 109.916 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.3 t -73.47 139.36 45.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.362 -0.836 . . . . 0.0 109.479 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.0 m -98.95 -25.96 14.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.786 HG22 HG23 ' A' ' 64' ' ' VAL . 70.1 mt -84.12 142.74 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.883 . . . . 0.0 109.583 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.786 HG23 HG22 ' A' ' 63' ' ' ILE . 52.7 t 50.72 92.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.577 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -53.94 -12.38 0.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.387 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.64 -53.6 8.27 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 144.04 56.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -1.15 . . . . 0.0 109.465 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' THR . 6.0 ptpt -154.41 34.36 0.42 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.335 -0.853 . . . . 0.0 109.127 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 70' ' ' THR . 12.0 mmt-85 -67.06 74.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -48.19 173.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 109.424 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.761 ' C ' HD23 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -158.81 -173.75 4.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.761 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -116.65 -5.15 11.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.695 -0.628 . . . . 0.0 109.804 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -145.81 125.62 13.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.942 . . . . 0.0 109.061 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -45.38 -22.69 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.6 tmm_? -69.86 -36.32 75.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 110.129 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -82.57 -33.95 27.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' HG ' ' HD1' ' A' ' 80' ' ' HIS . 10.0 tp -70.1 -38.29 75.62 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -67.52 -30.43 70.08 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.48 -20.98 62.0 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.54 ' C ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -78.09 -41.58 34.82 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.355 -1.338 . . . . 0.0 108.429 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.8 mm -56.3 -54.98 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 109.281 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 79' ' ' ALA . 5.8 p30 -69.35 -23.56 63.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.526 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.8 m-70 -87.68 -11.73 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.189 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -115.37 -49.95 2.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.264 -0.897 . . . . 0.0 112.858 -177.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -139.15 -24.66 0.88 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.214 -178.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' ILE . 3.6 ttm 55.06 38.38 30.41 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 109.582 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HB2' HG21 ' A' ' 63' ' ' ILE . 13.4 mtp85 -90.17 0.6 57.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.171 -0.956 . . . . 0.0 109.443 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -47.24 150.81 0.79 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.016 -1.436 . . . . 0.0 109.52 -179.959 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.597 HG12 ' SD ' ' A' ' 60' ' ' MET . 19.0 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.576 ' ND1' ' NH1' ' A' ' 55' ' ' ARG . 37.8 t60 65.07 -58.06 0.27 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.298 0.571 . . . . 0.0 109.975 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 1' ' ' VAL . 32.5 m-85 -74.14 107.99 6.67 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.33 -0.856 . . . . 0.0 109.318 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.55 ' HA ' HD11 ' A' ' 11' ' ' ILE . 4.9 t -45.95 146.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.818 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.8 -25.43 40.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -48.8 4.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.278 -0.889 . . . . 0.0 110.301 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.4 m -78.07 -15.61 58.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.83 13.06 12.03 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.66 158.75 31.2 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.546 -0.973 . . . . 0.0 108.48 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -65.85 103.45 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.088 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 4' ' ' CYS . 71.0 mt -49.47 116.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.336 0.589 . . . . 0.0 110.447 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 -31.72 33.94 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.57 145.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -73.99 102.07 4.04 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.491 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.13 85.72 1.11 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -71.28 141.44 50.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.904 -0.762 . . . . 0.0 110.519 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 21' ' ' LYS . 11.4 mtp -129.58 132.84 46.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.756 -0.59 . . . . 0.0 109.887 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.646 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -118.03 156.03 50.66 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.83 3.58 41.46 Favored 'Cis proline' 0 N--CA 1.492 1.385 0 C-N-CA 124.112 -1.203 . . . . 0.0 111.799 -0.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -55.39 -37.04 67.05 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.427 -0.795 . . . . 0.0 109.008 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HZ2' HD21 ' A' ' 72' ' ' LEU . 3.0 tttm 68.78 29.14 5.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 4.9 m80 -100.41 -174.75 2.73 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.759 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.572 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -141.66 155.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.396 -0.815 . . . . 0.0 110.998 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.8 m-85 -164.17 168.3 19.11 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.417 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -55.43 112.61 1.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.193 -1.403 . . . . 0.0 108.008 178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 30' ' ' ILE . 48.6 t80 -49.63 -31.3 10.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 0.0 109.883 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -39.99 84.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.566 ' SG ' ' CE1' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -81.38 -23.66 37.52 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.21 -35.89 74.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.517 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 26' ' ' TYR . 19.1 pt -86.7 -35.13 8.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.163 -0.961 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.71 -23.82 60.91 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.333 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.566 ' CE1' ' SG ' ' A' ' 28' ' ' CYS . 40.7 m170 -78.44 -55.45 5.21 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.24 -32.31 66.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.388 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -80.74 -26.86 37.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.034 -1.041 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -79.35 -5.67 55.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 110.334 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.6 32.57 3.35 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.567 ' C ' ' H ' ' A' ' 39' ' ' MET . 0.8 OUTLIER -132.04 56.68 1.81 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.72 33.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.723 0.773 . . . . 0.0 108.921 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.585 ' HA ' HG23 ' A' ' 47' ' ' VAL . 7.4 mtm -131.72 137.27 48.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -38.72 102.91 0.26 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.049 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.56 -19.48 5.0 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.796 1.664 . . . . 0.0 112.33 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.15 -37.21 2.95 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.71 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.0 m -104.84 -31.63 9.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -1.113 . . . . 0.0 110.319 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 75.59 63.02 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.079 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.432 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -130.8 160.31 67.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.88 90.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.553 2.169 . . . . 0.0 112.38 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 39' ' ' MET . 97.5 t -60.49 94.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 108.687 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ILE . 5.3 tt0 -61.75 -62.85 1.51 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.191 -0.943 . . . . 0.0 108.638 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.646 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.78 139.07 22.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.273 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.54 143.11 13.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.826 -1.171 . . . . 0.0 109.844 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -136.73 141.14 43.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.785 0.802 . . . . 0.0 110.025 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -85.52 149.2 25.54 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.329 0.585 . . . . 0.0 109.669 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.51 ' SG ' HD21 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -145.86 165.93 27.45 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.32 169.78 10.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.772 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.576 ' NH1' ' ND1' ' A' ' 2' ' ' HIS . 11.0 ttm-85 -90.38 74.86 6.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.398 1.095 . . . . 0.0 108.649 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.82 4.42 0.1 Allowed Glycine 0 C--N 1.288 -2.113 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.442 ' C ' HD23 ' A' ' 58' ' ' LEU . 20.6 m -90.23 -34.0 15.96 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.089 -1.242 . . . . 0.0 109.536 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.526 ' N ' HD23 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -100.23 173.88 6.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.701 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -134.66 128.5 33.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.673 -0.642 . . . . 0.0 109.521 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.597 ' SD ' HG12 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -101.08 144.73 29.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.537 -0.727 . . . . 0.0 110.577 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.418 ' CB ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -64.61 111.39 2.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 109.371 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 64' ' ' VAL . 0.4 OUTLIER -45.56 -65.77 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.398 -0.814 . . . . 0.0 109.993 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.421 ' CG2' ' CE1' ' A' ' 85' ' ' HIS . 3.4 mt -45.0 93.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.558 -0.714 . . . . 0.0 109.515 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.752 HG22 ' H ' ' A' ' 65' ' ' GLN . 9.0 p -63.53 -120.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.856 . . . . 0.0 109.395 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.752 ' H ' HG22 ' A' ' 64' ' ' VAL . 8.5 tt0 58.58 60.19 2.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.141 -0.975 . . . . 0.0 109.277 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.38 51.02 18.75 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.408 ' CB ' ' HE2' ' A' ' 80' ' ' HIS . 37.6 m -146.6 -111.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -1.13 . . . . 0.0 109.522 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp 48.29 42.11 17.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.745 HH11 HH22 ' A' ' 84' ' ' ARG . 68.5 mtp180 -91.75 112.76 24.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.139 -0.976 . . . . 0.0 109.778 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.527 ' OG1' ' NH2' ' A' ' 16' ' ' ARG . 1.2 p -56.18 170.01 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.686 ' C ' HD23 ' A' ' 72' ' ' LEU . 37.2 m-85 -158.0 170.01 23.27 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.728 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -108.03 -5.65 16.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.742 -0.598 . . . . 0.0 109.727 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.3 t -158.57 129.49 6.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 73' ' ' SER . 1.1 tp-100 -42.27 -26.15 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.331 0.586 . . . . 0.0 109.439 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 tmt_? -64.17 -34.79 78.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -83.17 -36.52 24.65 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 108.41 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.34 -33.15 67.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.437 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 23.3 tp60 -69.99 -33.32 71.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.532 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.34 61.43 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.418 ' CD2' ' CB ' ' A' ' 61' ' ' CYS . 26.3 t60 -74.22 -44.12 54.44 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.471 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 86' ' ' MET . 2.8 mm -60.18 -53.53 47.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.549 -0.72 . . . . 0.0 109.196 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 14.8 m-20 -64.65 -22.51 66.99 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.22 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 18.1 m170 -87.41 -12.24 46.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.125 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.745 HH22 HH11 ' A' ' 69' ' ' ARG . 15.3 mmt-85 -120.9 -43.45 2.46 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.25 -0.906 . . . . 0.0 112.866 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.634 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -153.15 -25.17 0.15 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.592 -1.317 . . . . 0.0 110.244 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' ILE . 1.3 ttt 66.04 38.99 4.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 109.62 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -91.96 -166.79 1.63 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.42 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.03 96.9 1.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.936 -1.48 . . . . 0.0 109.594 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 11' ' ' ILE . 2.9 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.495 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 38.7 t-80 -173.93 -88.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' A' ' 2' ' ' HIS . 36.7 m-85 -160.54 106.05 1.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.46 -0.775 . . . . 0.0 110.21 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.652 ' HA ' HD11 ' A' ' 11' ' ' ILE . 10.4 p -51.56 143.89 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.39 -0.819 . . . . 0.0 110.057 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.85 -4.48 57.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -85.46 -33.27 21.91 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -135.68 -15.96 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.621 -0.674 . . . . 0.0 110.488 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.567 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.09 14.31 64.68 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.212 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.52 156.62 37.32 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.088 -1.243 . . . . 0.0 108.432 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.97 136.52 66.18 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.778 1.652 . . . . 0.0 111.788 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 4' ' ' CYS . 79.0 mt -88.17 93.79 4.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.61 0.719 . . . . 0.0 110.313 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -69.34 -36.35 76.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.23 142.72 36.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.603 ' CD2' HD12 ' A' ' 58' ' ' LEU . 19.3 m-85 -73.31 106.04 4.96 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.135 -0.978 . . . . 0.0 111.123 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.79 81.27 0.77 Allowed Glycine 0 C--N 1.297 -1.616 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 21' ' ' LYS . 19.8 ttm-85 -65.8 133.01 50.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.942 -0.74 . . . . 0.0 109.164 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.533 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 31.3 mtp -119.12 134.62 55.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 110.566 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -118.75 156.5 51.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.88 -1.32 43.76 Favored 'Cis proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.962 -1.266 . . . . 0.0 111.32 0.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -49.87 -41.2 44.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.54 ' C ' HH12 ' A' ' 16' ' ' ARG . 5.4 ttmt 74.08 27.96 1.51 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.605 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 23.3 m80 -99.82 -175.99 3.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.486 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 2.9 m -145.3 153.55 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.171 -0.956 . . . . 0.0 111.376 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 66.3 m-85 -154.23 -149.94 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -90.54 107.81 19.4 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 30' ' ' ILE . 51.2 t80 -48.34 -13.48 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 109.832 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -83.05 -48.95 10.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 109.703 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 3.4 m -79.91 -23.15 42.0 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 108.361 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' ' CD1' ' A' ' 50' ' ' ILE . . . -68.31 -35.25 77.54 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' TYR . 38.4 pt -81.75 -34.34 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 O-C-N 120.948 -1.095 . . . . 0.0 109.241 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.62 -23.94 63.58 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.854 -1.139 . . . . 0.0 108.406 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.419 ' CE1' ' OD2' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -80.24 -40.4 27.11 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.185 -0.947 . . . . 0.0 108.833 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -31.24 63.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -82.83 -26.4 31.73 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -81.94 -79.23 0.18 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.973 -1.079 . . . . 0.0 110.242 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.1 40.9 0.17 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 39' ' ' MET . 1.8 m-20 -133.9 57.3 1.81 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.636 0.731 . . . . 0.0 109.088 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.96 32.88 0.06 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.571 ' H ' ' C ' ' A' ' 37' ' ' ASP . 1.9 mtt -127.37 167.73 15.8 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 42' ' ' GLY . 10.6 t -102.74 74.49 0.17 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.804 -0.56 . . . . 0.0 111.008 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -35.3 -21.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.517 2.145 . . . . 0.0 114.034 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -75.34 -35.48 47.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.605 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.9 m -125.81 -33.46 2.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 122.019 -0.695 . . . . 0.0 109.424 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' CYS . 2.8 p 83.99 78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.904 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.66 160.03 48.91 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.22 81.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.014 1.809 . . . . 0.0 111.612 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.4 t -48.49 101.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 108.728 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -61.53 1.74 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.459 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.3 122.97 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.292 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.472 ' CD1' ' O ' ' A' ' 29' ' ' ALA . 6.8 mt -79.89 147.41 6.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.876 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -139.03 162.54 34.69 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.605 0.717 . . . . 0.0 110.559 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.558 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 45.7 mt-30 -99.12 134.51 41.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.77 -0.581 . . . . 0.0 110.539 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.25 155.28 47.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.51 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.38 155.86 17.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.833 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 57' ' ' SER . 1.1 ptm180 -51.61 -55.44 19.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.815 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.56 7.69 0.94 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -103.61 -8.21 20.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.39 -1.065 . . . . 0.0 109.741 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.603 HD12 ' CD2' ' A' ' 14' ' ' TYR . 26.8 mt -130.99 169.09 16.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 110.098 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 44.8 m-85 -122.59 122.35 38.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.5 mtt -87.64 144.83 26.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 0.0 110.336 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 51.7 t -89.79 143.27 26.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.634 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.4 m -95.91 -58.21 2.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 109.563 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.4 mt -45.69 133.95 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 109.747 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 64' ' ' VAL . 65.6 t 47.11 76.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.353 -0.842 . . . . 0.0 109.498 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -49.02 -13.28 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 109.362 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . -59.81 -52.04 55.37 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 69' ' ' ARG . 8.0 p -53.6 -60.39 3.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER 48.82 11.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 109.747 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 67' ' ' CYS . 83.4 mtt-85 -60.93 110.04 1.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.951 . . . . 0.0 109.324 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.523 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.19 175.82 10.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.776 ' C ' HD23 ' A' ' 72' ' ' LEU . 88.6 m-85 -157.49 -164.63 1.61 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.378 -0.826 . . . . 0.0 108.941 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.776 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -116.31 -9.52 11.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.766 -0.584 . . . . 0.0 110.106 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 75' ' ' ARG . 62.7 m -147.22 128.45 14.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.653 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -46.24 -18.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.22 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' SER . 7.6 tmm_? -74.25 -33.91 63.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.695 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.94 -35.78 25.73 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.8 -33.95 64.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -71.03 -30.58 66.82 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.547 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.48 -21.15 61.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.428 ' HD1' ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -74.38 -39.83 62.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.174 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.41 HG23 ' HD2' ' A' ' 85' ' ' HIS . 28.0 mm -57.58 -59.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.871 0.843 . . . . 0.0 110.029 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.426 HD21 ' HA ' ' A' ' 79' ' ' ALA . 11.0 p30 -67.44 -20.11 65.46 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.555 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.6 m-70 -86.94 -13.46 44.63 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.428 ' HG3' ' HD1' ' A' ' 80' ' ' HIS . 15.7 mmt-85 -124.79 -41.03 2.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.177 -0.952 . . . . 0.0 112.334 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 86' ' ' MET . 5.4 m-70 -97.25 -46.58 6.06 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.609 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 85' ' ' HIS . 0.2 OUTLIER 40.29 30.53 0.08 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.31 0.576 . . . . 0.0 110.087 179.201 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 85' ' ' HIS . 12.0 ttp85 -101.37 18.03 21.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.655 -0.653 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.24 149.9 0.94 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.563 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 1.037 HG22 ' H ' ' A' ' 2' ' ' HIS . 9.9 p . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 1.037 ' H ' HG22 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -144.28 51.68 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.711 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 3.0 t80 -158.46 102.55 1.74 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 t -45.66 146.18 1.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.881 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -27.62 18.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.443 -0.786 . . . . 0.0 109.452 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.7 -38.78 10.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.09 -28.64 14.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.463 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.51 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.73 4.73 90.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.92 156.29 40.69 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.122 -1.222 . . . . 0.0 108.654 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.11 138.28 85.6 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.914 1.742 . . . . 0.0 112.089 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.594 HG23 ' HA ' ' A' ' 25' ' ' CYS . 40.5 mt -84.7 -67.4 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.642 -0.661 . . . . 0.0 111.002 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.0 -32.71 0.24 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.577 ' H ' ' C ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -145.17 120.06 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.409 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.4 m-85 -67.21 113.26 5.0 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.655 -0.653 . . . . 0.0 110.863 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.75 82.2 1.67 Allowed Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.404 HH21 ' HG3' ' A' ' 21' ' ' LYS . 4.0 ttt-85 -64.9 133.99 53.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 122.141 -0.623 . . . . 0.0 109.946 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.5 mtp -118.09 133.58 55.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.079 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.66 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.87 156.78 49.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.43 1.24 56.47 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.017 0.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 5.7 t -54.68 -38.04 66.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.407 -0.808 . . . . 0.0 109.13 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 5.4 tttm 76.56 29.33 0.68 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.592 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 2.6 m80 -101.58 -179.17 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -145.88 155.31 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.033 -1.042 . . . . 0.0 110.97 -179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 51.2 m-85 -159.71 167.12 29.1 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.594 ' HA ' HG23 ' A' ' 11' ' ' ILE . 20.4 p -51.68 110.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.212 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 30' ' ' ILE . 39.2 t80 -49.67 -10.92 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.622 -0.674 . . . . 0.0 110.356 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.1 m-20 -78.65 -44.31 24.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.725 -1.234 . . . . 0.0 109.51 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -80.51 -25.35 38.79 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 108.196 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -64.43 -37.71 88.46 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 26' ' ' TYR . 40.7 pt -82.57 -34.55 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.629 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.15 -19.48 59.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.151 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.18 -54.06 6.98 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.27 -0.894 . . . . 0.0 109.161 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -67.62 -30.97 70.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -74.73 -29.76 61.27 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.024 -1.047 . . . . 0.0 109.071 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -82.25 -79.27 0.18 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.142 -0.974 . . . . 0.0 109.819 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.74 31.93 0.11 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.548 ' C ' ' H ' ' A' ' 39' ' ' MET . 1.4 m-20 -125.63 52.85 1.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.809 0.814 . . . . 0.0 108.874 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.12 31.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.55 ' HA ' HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -128.4 139.02 52.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.849 -0.532 . . . . 0.0 109.567 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -42.87 106.12 0.46 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.0 109.621 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.47 -21.92 8.17 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.568 1.512 . . . . 0.0 112.124 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.21 -42.12 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.747 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.8 m -100.88 -30.33 11.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -1.159 . . . . 0.0 110.608 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.19 57.04 0.09 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 109.06 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.3 OUTLIER -123.48 160.96 48.33 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.609 -0.682 . . . . 0.0 109.209 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.08 89.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.538 2.158 . . . . 0.0 112.048 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 39' ' ' MET . 98.5 t -57.45 101.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.187 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.55 -66.22 0.57 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.66 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -151.35 134.8 16.17 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.485 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.521 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.5 mt -88.26 145.81 7.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.666 -1.271 . . . . 0.0 109.107 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.53 146.82 44.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.75 142.16 27.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.774 -0.579 . . . . 0.0 109.605 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.38 159.07 44.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.355 -0.841 . . . . 0.0 110.204 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.38 162.82 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.05 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.524 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -66.32 -60.32 2.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 110.064 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.39 25.89 0.58 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.3 t -91.17 -23.6 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.4 173.45 6.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.734 -0.604 . . . . 0.0 109.71 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -117.08 119.91 36.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.4 mmt -75.9 144.52 41.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 110.341 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 t -84.85 143.22 29.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.035 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.6 m -146.38 74.04 1.35 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 109.791 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.438 HD11 HD12 ' A' ' 81' ' ' ILE . 24.4 mm -105.55 -75.6 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.562 -0.712 . . . . 0.0 109.216 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -93.78 -99.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.469 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.481 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.4 tt0 -168.21 35.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.345 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -146.24 -34.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 40.9 t -64.44 170.93 3.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -1.158 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.593 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 11.1 pttt 179.3 29.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.363 -0.836 . . . . 0.0 109.185 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.81 117.19 20.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.101 -1.0 . . . . 0.0 109.439 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -82.71 174.79 10.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.954 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.726 ' C ' HD23 ' A' ' 72' ' ' LEU . 98.2 m-85 -158.31 -177.92 6.9 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.9 -2.7 13.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.587 -0.695 . . . . 0.0 110.549 -178.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ASP . 1.5 m -154.57 131.39 10.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.814 -1.179 . . . . 0.0 109.865 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 78' ' ' GLN . 0.9 OUTLIER -43.39 -30.18 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -63.77 -35.05 79.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.509 -0.745 . . . . 0.0 110.131 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.1 m-20 -81.19 -37.82 28.07 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.995 0.903 . . . . 0.0 108.705 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 tt -74.43 -31.07 62.16 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLN . 22.6 tp60 -71.07 -33.73 70.52 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.31 -19.92 61.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -72.67 -47.52 46.75 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.601 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.5 mm -56.17 -51.05 67.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.688 -0.633 . . . . 0.0 109.61 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -71.05 -18.66 62.56 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.867 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.0 m170 -87.67 -27.32 22.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.075 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -23.82 2.96 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 5.4 m-70 -102.19 -47.36 4.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.163 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.2 ttt 41.28 33.8 0.29 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.426 0.632 . . . . 0.0 110.079 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ttt-85 -86.04 0.51 53.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.379 -0.826 . . . . 0.0 109.41 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.33 139.74 6.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.87 . . . . 0.0 109.453 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.53 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 11' ' ' ILE . 4.4 m-70 -95.98 -56.95 2.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -0.817 . . . . 0.0 109.658 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.43 109.13 8.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.895 . . . . 0.0 109.624 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.615 ' HA ' HD11 ' A' ' 11' ' ' ILE . 48.8 t -46.93 146.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.874 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.43 -24.11 39.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.447 -0.783 . . . . 0.0 109.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -60.95 1.44 Allowed 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.375 -0.828 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 7.3 m -68.27 -14.93 63.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 110.291 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.49 11.33 5.12 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 152.49 37.83 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.988 . . . . 0.0 108.572 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.76 100.37 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.729 1.619 . . . . 0.0 112.259 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 4' ' ' CYS . 77.8 mt -47.37 117.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.681 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -83.14 -32.08 26.84 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.12 143.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -73.19 100.71 3.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 120.852 -1.155 . . . . 0.0 111.032 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -76.53 86.86 0.93 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.479 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.6 ttt-85 -77.79 141.43 39.22 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.761 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.553 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 11.2 mtp -128.72 132.45 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.968 -0.457 . . . . 0.0 109.949 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.664 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -114.6 156.22 45.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.73 4.08 46.07 Favored 'Cis proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.344 -0.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.2 t -55.81 -35.36 66.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.509 -0.745 . . . . 0.0 109.122 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 72' ' ' LEU . 4.5 tttt 66.62 27.77 9.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 27.0 m170 -93.54 -173.3 3.15 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.478 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.553 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -142.89 156.68 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 110.346 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 85.7 m-85 -165.66 166.26 18.14 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.443 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -57.68 114.75 2.41 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.553 ' O ' HG23 ' A' ' 30' ' ' ILE . 43.9 t80 -47.65 -21.27 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.016 -1.052 . . . . 0.0 109.808 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.36 -39.87 62.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.061 -1.024 . . . . 0.0 108.248 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.537 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.02 -22.29 33.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.53 -34.28 72.11 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 26' ' ' TYR . 45.4 pt -80.52 -35.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 121.104 -0.998 . . . . 0.0 108.67 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 28' ' ' CYS . 34.9 mt -62.57 -38.81 91.57 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.693 -1.203 . . . . 0.0 107.876 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.26 -34.88 73.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -35.78 76.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.835 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -75.69 -21.59 57.45 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 108.704 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -81.96 -73.08 0.4 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.416 -0.802 . . . . 0.0 110.545 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -92.54 -36.78 6.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 1.9 t0 75.2 13.41 3.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.398 -1.06 . . . . 0.0 110.284 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.29 29.45 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.836 -1.165 . . . . 0.0 111.356 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.7 ptp -141.73 130.41 22.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.954 -1.091 . . . . 0.0 110.157 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.539 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 1.5 t -71.0 136.65 84.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -45.81 -46.68 15.07 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.911 1.741 . . . . 0.0 113.074 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.08 4.26 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.214 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 -14.97 25.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.257 . . . . 0.0 110.586 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 p 48.48 38.18 10.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -92.22 161.1 33.86 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.357 -0.84 . . . . 0.0 108.999 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLN . 19.6 Cg_endo -59.73 71.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.2 1.933 . . . . 0.0 112.068 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 45' ' ' ASP . 61.2 t -44.99 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.17 -0.956 . . . . 0.0 109.724 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' PRO . 3.7 tt0 -65.61 -61.74 1.92 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.069 -1.019 . . . . 0.0 108.344 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -148.76 137.53 21.39 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.769 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -94.78 147.31 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.641 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -140.53 154.48 46.56 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.29 0.567 . . . . 0.0 109.706 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.22 138.47 45.52 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.25 0.548 . . . . 0.0 109.692 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.69 165.97 25.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -82.88 157.89 22.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.853 . . . . 0.0 109.091 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -72.53 31.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -146.79 14.28 1.54 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.52 ' C ' HD23 ' A' ' 58' ' ' LEU . 62.9 m -97.21 -28.63 14.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.702 -0.881 . . . . 0.0 110.404 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -114.11 172.42 7.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.607 -0.683 . . . . 0.0 109.783 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.421 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 41.7 m-85 -116.89 124.1 48.64 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -86.44 144.55 27.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.91 . . . . 0.0 110.393 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.585 ' N ' ' SD ' ' A' ' 60' ' ' MET . 42.1 t -95.91 109.75 22.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.483 -0.761 . . . . 0.0 109.125 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -102.52 51.21 0.81 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.466 -0.771 . . . . 0.0 109.969 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.618 HG21 ' ND1' ' A' ' 85' ' ' HIS . 3.7 mm -95.63 -46.87 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 109.263 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.689 HG22 ' N ' ' A' ' 65' ' ' GLN . 14.6 p -157.98 175.88 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 0.0 109.425 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.689 ' N ' HG22 ' A' ' 64' ' ' VAL . 36.5 mt-30 -75.36 -17.63 60.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.403 ' H ' HG13 ' A' ' 64' ' ' VAL . . . -88.91 5.71 84.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.7 m -46.37 160.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -1.115 . . . . 0.0 109.528 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.764 ' HZ1' HH21 ' A' ' 84' ' ' ARG . 11.6 mttp -77.36 -70.53 0.46 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 109.889 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -175.61 -150.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.098 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.476 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -90.56 -173.84 3.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.22 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.701 ' C ' HD23 ' A' ' 72' ' ' LEU . 95.6 m-85 -152.39 178.29 9.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.991 . . . . 0.0 108.903 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.705 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.33 -10.04 14.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.715 -0.615 . . . . 0.0 109.743 -179.107 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 75' ' ' ARG . 48.2 t -153.18 132.29 12.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.002 . . . . 0.0 109.91 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -47.54 -22.08 0.43 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.103 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.8 ttt-85 -70.89 -32.51 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -83.52 -34.67 25.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 tt -75.68 -33.88 60.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -70.3 -33.58 71.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.545 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.84 -19.32 60.77 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.519 ' CG ' ' OH ' ' A' ' 71' ' ' TYR . 24.3 t60 -74.81 -44.76 47.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.531 -1.267 . . . . 0.0 108.605 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.538 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.9 mm -56.73 -53.3 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.722 0.772 . . . . 0.0 109.443 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -69.38 -19.72 63.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.215 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -87.49 -25.92 23.46 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.781 -178.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.764 HH21 ' HZ1' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -129.64 -34.24 1.79 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.066 -1.021 . . . . 0.0 112.651 -177.33 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.618 ' ND1' HG21 ' A' ' 63' ' ' ILE . 7.6 m-70 -94.01 -51.54 4.81 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.917 -1.114 . . . . 0.0 109.001 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.498 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER 40.93 35.03 0.31 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.466 0.65 . . . . 0.0 109.782 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.27 113.54 0.23 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.42 155.27 1.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.367 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.525 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.652 ' O ' HG12 ' A' ' 1' ' ' VAL . 65.2 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.797 0.808 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.509 ' O ' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -121.52 24.81 9.69 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -76.9 112.77 13.87 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.662 -1.274 . . . . 0.0 109.18 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.624 ' HA ' HD11 ' A' ' 11' ' ' ILE . 13.2 t -45.76 146.39 1.16 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 109.991 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.64 -25.92 32.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.599 -0.688 . . . . 0.0 109.71 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.66 -42.63 7.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 m -90.55 -29.7 17.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.061 -1.024 . . . . 0.0 110.666 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 1.36 87.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.88 158.8 49.97 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 108.502 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -68.54 97.73 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.878 1.719 . . . . 0.0 112.5 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.624 HD11 ' HA ' ' A' ' 4' ' ' CYS . 97.0 mt -41.68 113.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -82.97 -32.71 26.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 11' ' ' ILE . 1.6 t -133.14 147.01 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.05 104.49 16.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.822 -1.174 . . . . 0.0 111.114 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.4 91.27 1.15 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.542 ' NH2' ' O ' ' A' ' 21' ' ' LYS . 2.5 tpt85 -74.63 135.84 41.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.082 -0.657 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.539 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 8.3 mtp -126.34 132.2 51.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.921 -0.487 . . . . 0.0 109.766 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.651 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.28 156.33 48.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.63 3.8 40.11 Favored 'Cis proline' 0 N--CA 1.49 1.321 0 C-N-CA 124.07 -1.221 . . . . 0.0 111.112 -0.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.07 -32.01 61.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' NH2' ' A' ' 16' ' ' ARG . 1.8 mttp 59.52 31.09 20.76 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.592 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 9.3 m170 -96.16 -173.15 2.72 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.591 -0.693 . . . . 0.0 109.374 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.488 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -147.36 149.0 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 110.58 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 37.1 m-85 -158.35 170.6 21.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -59.31 113.89 2.38 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 117.887 -1.525 . . . . 0.0 107.222 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -46.31 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 110.367 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.1 m-20 -78.93 -41.14 30.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.001 -1.062 . . . . 0.0 108.724 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HA ' HD12 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -80.35 -22.08 41.76 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.0 -1.062 . . . . 0.0 108.57 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.632 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.84 -29.06 65.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 pt -89.14 -28.5 5.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.658 -1.276 . . . . 0.0 108.955 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 28' ' ' CYS . 24.4 mt -66.77 -35.89 81.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.09 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -76.27 -44.38 37.46 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.607 ' N ' ' CG ' ' A' ' 32' ' ' HIS . 1.2 pt-20 -52.31 -32.74 39.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -83.56 -29.92 27.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.274 -0.891 . . . . 0.0 109.56 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -75.75 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 110.904 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -78.32 -41.98 15.89 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 2.5 t0 77.78 8.19 2.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.917 . . . . 0.0 110.211 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.71 43.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.001 -1.062 . . . . 0.0 111.157 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 39' ' ' MET . 11.9 ptm -148.82 122.38 9.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.577 -1.327 . . . . 0.0 110.49 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.408 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.8 OUTLIER -63.2 143.18 97.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 108.995 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.18 -38.11 95.49 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.125 1.217 . . . . 0.0 112.076 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.33 -45.38 1.35 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.61 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -89.48 -10.76 45.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.817 -1.402 . . . . 0.0 110.732 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t 48.37 37.48 8.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 108.842 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -89.56 161.1 40.34 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.406 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.2 76.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.488 2.125 . . . . 0.0 111.71 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' ASP . 17.3 t -48.97 109.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.283 -0.885 . . . . 0.0 109.983 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -72.03 -62.25 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 108.56 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.651 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.78 134.5 16.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.692 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.632 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -92.79 144.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.819 -1.176 . . . . 0.0 109.88 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -140.8 146.47 37.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.448 0.642 . . . . 0.0 109.44 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -91.27 150.88 21.13 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.584 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.87 167.84 26.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.466 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -90.49 165.27 13.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.362 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -59.5 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -0.969 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.66 18.9 22.88 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.741 ' O ' HD23 ' A' ' 58' ' ' LEU . 50.9 m -85.16 -21.23 29.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.052 -1.263 . . . . 0.0 108.999 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -132.06 173.1 11.56 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 6.3 m-85 -117.92 109.41 16.48 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.572 -0.705 . . . . 0.0 110.425 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -71.92 144.77 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 0.0 110.138 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.521 ' SG ' ' CE1' ' A' ' 80' ' ' HIS . 44.7 t -95.88 143.1 27.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.824 . . . . 0.0 109.555 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.54 -17.9 37.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 108.958 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.443 ' CG2' ' CD2' ' A' ' 85' ' ' HIS . 53.5 mt -94.25 92.42 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.453 -0.78 . . . . 0.0 109.293 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 65' ' ' GLN . 12.4 m -69.99 -166.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.626 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.431 ' CB ' ' O ' ' A' ' 64' ' ' VAL . 1.8 tt0 71.09 105.82 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.71 63.2 4.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.474 ' C ' ' H ' ' A' ' 69' ' ' ARG . 11.6 t -148.02 118.98 7.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -1.127 . . . . 0.0 109.299 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 70' ' ' THR . 9.9 tttt -50.55 -11.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.321 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 67' ' ' CYS . 5.4 mtp180 63.91 -75.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.768 . . . . 0.0 111.018 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.492 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 7.8 p -94.22 158.56 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 110.867 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.597 ' C ' HD23 ' A' ' 72' ' ' LEU . 75.7 m-85 -152.1 173.35 15.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.756 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -100.92 -10.78 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.586 -178.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -162.12 138.99 8.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.807 -1.183 . . . . 0.0 110.519 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -42.99 -31.17 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.41 0.624 . . . . 0.0 109.752 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -66.27 -32.28 73.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.443 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.34 -33.56 22.03 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.2 OUTLIER -75.48 -35.18 60.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.017 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.65 ' N ' HD23 ' A' ' 77' ' ' LEU . 52.5 tp60 -72.63 -34.3 67.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.82 -19.64 62.65 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.526 ' NE2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -77.76 -40.99 39.1 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.396 -1.322 . . . . 0.0 108.641 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.526 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.8 mm -55.71 -54.77 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 108.405 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.48 -26.28 66.29 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.772 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -89.97 -11.97 40.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.579 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -112.19 -54.6 2.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.226 -0.921 . . . . 0.0 112.945 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.443 ' CD2' ' CG2' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -134.53 -26.89 1.38 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -178.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.515 ' N ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER 56.89 50.95 11.42 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.595 -0.691 . . . . 0.0 109.474 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.1 -21.51 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 109.64 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' A' ' 86' ' ' MET . . . -48.16 120.87 3.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.492 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.74 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -100.7 24.05 9.63 Favored 'General case' 0 C--O 1.201 -1.474 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -74.64 114.9 13.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.707 -1.246 . . . . 0.0 110.009 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.614 ' HA ' HD11 ' A' ' 11' ' ' ILE . 44.3 t -45.54 146.74 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.214 -0.928 . . . . 0.0 109.987 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -36.15 66.89 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -54.32 2.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.477 ' C ' ' H ' ' A' ' 9' ' ' LEU . 4.0 m -66.05 -13.87 60.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.094 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 4.72 0.47 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 7' ' ' CYS . 5.4 mp -88.96 157.87 47.97 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.249 . . . . 0.0 108.475 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.04 99.29 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.854 1.703 . . . . 0.0 112.539 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' A' ' 4' ' ' CYS . 88.1 mt -47.06 121.43 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -142.45 145.3 23.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -77.39 105.91 8.81 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.714 -1.241 . . . . 0.0 111.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.18 79.88 1.44 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 51' ' ' GLU . 11.5 ttt-85 -58.15 136.71 57.29 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.835 -0.803 . . . . 0.0 109.483 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.774 ' SD ' HG22 ' A' ' 47' ' ' VAL . 25.0 ttm -121.59 137.93 54.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.541 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -127.41 156.85 74.39 Favored Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 -0.34 38.15 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 C-N-CA 124.225 -1.156 . . . . 0.0 112.047 0.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 1.9 t -55.88 -36.82 68.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.1 OUTLIER 74.04 26.92 1.65 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.59 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 2.1 m170 -95.45 -169.25 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -146.44 153.89 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 109.979 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.2 m-85 -159.09 163.01 36.61 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -50.56 113.08 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.218 -1.393 . . . . 0.0 107.864 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -53.73 -19.18 3.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.453 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.41 -37.07 26.06 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.772 -1.205 . . . . 0.0 108.292 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.532 ' O ' ' CG ' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -83.2 -25.51 31.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -68.5 -32.26 72.12 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 pt -87.99 -33.87 6.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.189 -0.944 . . . . 0.0 109.211 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.39 -26.66 58.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.056 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 28' ' ' CYS . 18.2 m170 -76.74 -50.21 14.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.213 -0.929 . . . . 0.0 108.684 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.33 -27.97 68.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.34 -28.34 38.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.665 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -79.78 5.22 14.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.071 -1.018 . . . . 0.0 110.05 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.23 35.76 5.15 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 39' ' ' MET . 0.5 OUTLIER -130.12 53.69 1.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.822 -0.811 . . . . 0.0 108.894 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -72.4 28.92 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.606 -0.683 . . . . 0.0 109.201 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.56 ' H ' ' C ' ' A' ' 37' ' ' ASP . 2.7 mtt -123.2 123.82 41.64 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.32 0.581 . . . . 0.0 109.492 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.556 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -37.1 102.1 0.23 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 122.017 -0.427 . . . . 0.0 111.088 -178.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.65 -14.55 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.667 1.578 . . . . 0.0 111.54 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.1 -38.61 4.02 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.192 -1.004 . . . . 0.0 110.835 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.4 m -120.54 -21.31 6.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.415 -1.05 . . . . 0.0 110.771 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 73.97 55.53 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.142 -179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.95 161.42 30.96 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' GLN . 13.1 Cg_endo -58.7 83.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.389 2.059 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' SD ' ' A' ' 17' ' ' MET . 89.6 t -51.69 97.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.205 -0.934 . . . . 0.0 109.07 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' PRO . 8.1 mt-30 -64.11 -64.0 1.0 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.274 -0.891 . . . . 0.0 108.984 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.46 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.27 126.66 7.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.554 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.426 HG21 ' HB1' ' A' ' 29' ' ' ALA . 1.9 mt -88.32 145.03 7.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 110.25 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' ARG . 24.5 mt-10 -137.31 151.5 48.71 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.766 0.793 . . . . 0.0 110.185 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -90.49 147.61 23.28 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.692 -0.63 . . . . 0.0 109.714 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -152.15 167.39 28.68 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.62 163.79 22.31 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.143 -0.973 . . . . 0.0 109.002 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' C ' ' H ' ' A' ' 57' ' ' SER . 4.6 mtm180 -66.74 -69.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 110.671 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.99 28.36 0.3 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.637 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 55' ' ' ARG . 32.5 m -93.25 -36.9 12.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.277 . . . . 0.0 109.798 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 58' ' ' LEU . 1.2 mt -99.14 173.34 6.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.731 . . . . 0.0 109.915 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.06 106.8 14.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 ttt -72.19 144.41 48.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 t -73.45 143.35 46.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 109.454 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -142.93 64.49 1.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 109.615 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.427 HD11 HD12 ' A' ' 81' ' ' ILE . 20.4 mm -101.51 -75.51 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.49 -0.757 . . . . 0.0 109.496 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -90.08 -96.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.392 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.428 ' H ' HG23 ' A' ' 64' ' ' VAL . 3.4 tt0 -168.63 31.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.318 -0.864 . . . . 0.0 109.344 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.89 -34.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.2 t -65.21 143.05 58.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -1.187 . . . . 0.0 109.591 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -154.79 38.67 0.42 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.33 -0.856 . . . . 0.0 108.91 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -76.13 97.73 4.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.521 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -62.23 177.99 0.43 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.7 ' C ' HD23 ' A' ' 72' ' ' LEU . 26.5 m-85 -162.51 179.44 7.77 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.7 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -109.49 -7.93 15.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 109.834 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' ARG . 40.5 t -157.52 130.03 7.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.022 -1.049 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 73' ' ' SER . 0.3 OUTLIER -42.73 -27.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.648 -0.657 . . . . 0.0 109.308 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.4 tmt_? -64.01 -34.96 79.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 110.535 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' CG ' ' CD1' ' A' ' 71' ' ' TYR . 27.3 t0 -83.11 -35.61 25.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 108.626 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.39 -32.67 64.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -69.08 -35.25 76.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.561 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.89 -20.35 62.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -74.52 -44.09 52.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.004 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' N ' ' A' ' 81' ' ' ILE . 3.0 mm -58.02 -50.61 77.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.484 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.426 HD21 ' HA ' ' A' ' 79' ' ' ALA . 11.8 p30 -74.79 -18.56 60.45 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.796 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.6 m-70 -86.19 -24.37 26.13 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.568 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.28 -26.59 2.55 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.108 -0.995 . . . . 0.0 112.115 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.486 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 6.2 m-70 -100.05 -49.01 4.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 109.064 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.4 ttt 40.16 32.92 0.14 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.396 0.617 . . . . 0.0 110.108 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -91.68 -1.71 57.32 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.442 -0.786 . . . . 0.0 109.497 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.3 -58.54 4.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.558 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 2' ' ' HIS . 1.5 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.52 0.676 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.535 ' N ' HG22 ' A' ' 1' ' ' VAL . 0.6 OUTLIER -91.44 -58.38 2.46 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.43 -0.794 . . . . 0.0 109.102 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -81.24 120.63 25.14 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.973 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -44.69 146.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 110.249 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.65 -23.52 36.89 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' NZ ' ' SG ' ' A' ' 7' ' ' CYS . 2.4 ttpt -98.6 -50.68 4.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 110.518 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' SG ' ' NZ ' ' A' ' 6' ' ' LYS . 2.0 m -87.32 -17.78 31.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 111.16 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.01 -1.81 9.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.73 158.63 70.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.144 -1.209 . . . . 0.0 108.749 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.01 102.92 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.941 1.761 . . . . 0.0 112.938 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.613 HG23 ' HA ' ' A' ' 25' ' ' CYS . 84.3 mt -49.73 125.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.513 0.673 . . . . 0.0 110.37 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -91.49 -29.41 17.02 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.83 143.75 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -79.8 103.93 10.03 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.05 81.84 1.02 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.839 -2.504 . . . . 0.0 106.839 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 21' ' ' LYS . 8.5 ttt-85 -64.76 131.55 47.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.31 0.576 . . . . 0.0 110.286 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.599 ' CE ' HG11 ' A' ' 47' ' ' VAL . 16.6 mtp -117.55 132.2 56.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.987 -0.445 . . . . 0.0 110.347 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.672 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.87 156.6 49.79 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.97 2.58 48.59 Favored 'Cis proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.154 -1.186 . . . . 0.0 111.289 -0.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.476 ' CB ' ' HD1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -56.27 -36.91 69.12 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.624 -0.673 . . . . 0.0 109.294 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.529 ' HZ3' ' HE1' ' A' ' 71' ' ' TYR . 5.0 ttmt 73.52 25.77 2.06 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.476 ' HD1' ' CB ' ' A' ' 20' ' ' CYS . 24.7 m80 -95.09 -179.06 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.195 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.478 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.3 m -146.33 151.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.083 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 31.6 m-85 -158.74 168.28 27.27 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.613 ' HA ' HG23 ' A' ' 11' ' ' ILE . 2.8 m -53.07 115.47 1.89 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.936 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.692 ' O ' HG23 ' A' ' 30' ' ' ILE . 38.3 t80 -50.9 -11.83 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' N ' ' C ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -76.72 -46.97 23.32 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.14 -0.975 . . . . 0.0 109.042 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.84 -22.96 45.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.998 -1.064 . . . . 0.0 108.412 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.697 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.692 HG23 ' O ' ' A' ' 26' ' ' TYR . 41.3 pt -80.02 -33.7 14.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.039 -1.038 . . . . 0.0 108.986 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.428 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 24.1 mt -67.11 -23.94 65.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.123 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.457 ' ND1' ' OD2' ' A' ' 37' ' ' ASP . 1.2 m-70 -82.75 -34.77 27.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -27.07 44.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.518 -0.738 . . . . 0.0 109.06 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -83.3 -35.23 25.42 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.218 -0.927 . . . . 0.0 109.249 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 31' ' ' LEU . 17.5 mmtm -73.82 -9.57 58.78 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.379 -0.826 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.29 33.06 15.0 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.457 ' OD2' ' ND1' ' A' ' 32' ' ' HIS . 4.6 m-20 -79.92 -44.47 20.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.182 -1.187 . . . . 0.0 109.392 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt 46.7 46.03 14.74 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.185 0.993 . . . . 0.0 109.542 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 ptm -147.17 139.06 24.31 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.447 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' SER . 51.9 t -71.34 114.57 28.96 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.863 . . . . 0.0 109.32 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -49.41 -15.56 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.426 1.417 . . . . 0.0 111.856 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.95 -63.92 0.84 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 44' ' ' SER . 4.0 m -90.4 -22.13 21.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.3 p 74.27 36.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' H ' ' HB3' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -103.18 157.18 34.3 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 85.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.442 2.095 . . . . 0.0 112.016 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 47' ' ' VAL . 5.2 m -55.08 104.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.1 tt0 -48.07 -54.94 11.45 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.041 -1.037 . . . . 0.0 108.353 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.672 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -159.04 135.51 9.25 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.796 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.697 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.0 mt -87.7 145.97 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.887 -1.133 . . . . 0.0 109.599 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -138.77 152.97 48.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.518 0.675 . . . . 0.0 109.731 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -96.38 139.14 32.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.74 -0.6 . . . . 0.0 109.877 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.19 161.05 39.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.4 157.92 26.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.279 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 57' ' ' SER . 68.1 mtp180 -53.51 -72.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.235 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.58 30.06 0.36 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 55' ' ' ARG . 19.6 t -86.86 -31.17 20.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.947 -1.325 . . . . 0.0 109.289 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -99.29 173.62 6.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 23.0 m-85 -118.59 117.31 28.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.8 mtt -79.55 144.59 33.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.335 -0.853 . . . . 0.0 110.751 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.44 141.48 36.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 m -141.0 75.86 1.52 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.361 -0.837 . . . . 0.0 109.6 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.663 HG22 HG13 ' A' ' 64' ' ' VAL . 15.6 mm -94.41 -70.84 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.831 . . . . 0.0 109.5 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG13 HG22 ' A' ' 63' ' ' ILE . 2.3 m -143.89 179.79 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.361 -0.837 . . . . 0.0 109.507 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.463 ' CG ' ' N ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER 47.13 -111.97 0.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 109.508 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 65' ' ' GLN . . . -148.13 31.6 1.3 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.4 t -47.35 131.87 13.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -1.192 . . . . 0.0 109.365 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -137.62 40.74 2.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.522 -0.736 . . . . 0.0 109.373 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -80.12 102.8 9.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 109.234 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -80.22 176.02 10.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 110.012 -179.565 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.824 ' C ' HD23 ' A' ' 72' ' ' LEU . 87.4 m-85 -158.29 -168.39 2.45 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.824 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -119.89 -6.75 10.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.643 -179.257 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -146.2 127.98 15.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 108.847 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -47.06 -26.0 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -66.35 -31.13 71.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.479 -0.763 . . . . 0.0 109.919 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.68 -34.39 24.98 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.1 -35.27 59.39 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.455 ' NE2' ' OD1' ' A' ' 82' ' ' ASN . 0.6 OUTLIER -67.09 -39.74 86.83 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.716 ' HA ' HD22 ' A' ' 82' ' ' ASN . . . -66.65 -20.75 66.06 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.13 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -74.8 -40.03 61.36 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.837 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.501 HD12 HD11 ' A' ' 63' ' ' ILE . 3.6 mm -60.15 -52.11 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.654 -0.654 . . . . 0.0 110.379 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.716 HD22 ' HA ' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -74.55 -18.09 60.64 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.036 -178.176 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.6 m-70 -85.85 -26.58 25.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.532 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -128.72 -26.11 2.75 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.856 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.476 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 6.7 m-70 -98.77 -49.16 4.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.037 -1.04 . . . . 0.0 109.026 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.429 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.1 ttt 38.74 31.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.57 0.7 . . . . 0.0 110.158 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 89' ' ' GLY . 3.3 mtp85 -87.94 -1.45 57.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -0.822 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.11 -12.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.175 -0.953 . . . . 0.0 109.49 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 87' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.316 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.6 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 3' ' ' PHE . 28.3 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.8 t60 65.26 -59.77 0.26 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.318 0.58 . . . . 0.0 109.871 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 1' ' ' VAL . 7.7 m-85 -73.22 107.77 5.73 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.425 -0.797 . . . . 0.0 109.698 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 8' ' ' GLY . 8.6 p -46.83 128.46 10.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 109.874 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.72 -13.1 60.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.24 -40.29 45.42 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.19 -0.944 . . . . 0.0 109.302 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.48 -21.11 4.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.762 -0.586 . . . . 0.0 110.708 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.71 15.93 60.76 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.26 155.47 38.82 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.295 -1.121 . . . . 0.0 108.496 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.5 109.92 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.904 1.736 . . . . 0.0 112.154 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 4' ' ' CYS . 64.1 mt -58.12 112.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.559 0.695 . . . . 0.0 110.466 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -82.12 -33.55 29.61 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.85 137.5 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -76.35 104.81 7.05 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.95 -1.094 . . . . 0.0 110.652 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -78.35 86.44 1.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -70.49 133.43 46.8 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 122.146 -0.62 . . . . 0.0 111.023 -178.058 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' LYS . 2.7 mmm -118.91 135.25 54.68 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -119.2 153.32 53.21 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.95 -4.78 44.38 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 124.276 -1.135 . . . . 0.0 111.621 0.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' A' ' 22' ' ' HIS . 6.4 t -48.18 -30.21 4.43 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 6.7 mtmm 60.29 28.93 18.57 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.406 ' CD2' ' SG ' ' A' ' 20' ' ' CYS . 28.3 m170 -93.86 173.05 7.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.545 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 13.7 m -136.67 151.22 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.707 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 83.4 m-85 -160.9 159.71 30.03 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -47.19 110.27 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.589 ' O ' HG23 ' A' ' 30' ' ' ILE . 32.6 t80 -47.06 -16.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.697 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -77.54 -44.82 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.069 . . . . 0.0 108.848 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.473 ' HA ' HD12 ' A' ' 31' ' ' LEU . 36.7 m -79.12 -21.0 47.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.899 -1.126 . . . . 0.0 108.0 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.3 78.2 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 26' ' ' TYR . 48.6 pt -76.11 -33.52 24.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 108.781 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 28' ' ' CYS . 30.6 mt -65.4 -39.7 92.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.618 -1.233 . . . . 0.0 107.681 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -71.97 -25.35 61.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.363 -0.836 . . . . 0.0 108.771 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 37' ' ' ASP . 0.5 OUTLIER -79.27 -36.89 39.07 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.087 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -75.95 -18.58 59.28 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.888 -1.133 . . . . 0.0 108.129 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -80.55 -36.76 32.58 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.477 -0.764 . . . . 0.0 109.583 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.61 -34.55 0.22 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.4 OUTLIER 67.44 29.07 7.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.394 -1.062 . . . . 0.0 109.707 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -172.46 31.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.24 -0.912 . . . . 0.0 110.674 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.446 ' O ' ' CG ' ' A' ' 39' ' ' MET . 10.2 ptm -149.46 120.02 7.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.0 -1.062 . . . . 0.0 110.973 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -69.23 129.53 91.83 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.52 -29.35 2.1 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.22 1.946 . . . . 0.0 113.623 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.54 -63.68 1.02 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 44' ' ' SER . 70.8 m -67.55 -45.08 76.71 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.432 -1.04 . . . . 0.0 109.025 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 76.98 53.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.709 -0.62 . . . . 0.0 111.412 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.476 ' H ' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER 176.38 -48.59 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.489 -1.382 . . . . 0.0 112.205 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' H ' ' A' ' 45' ' ' ASP . 84.6 Cg_endo -83.48 46.28 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.637 2.225 . . . . 0.0 116.095 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 40' ' ' CYS . 2.0 t -92.95 118.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.272 -1.517 . . . . 0.0 109.397 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -101.74 -64.51 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.266 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.477 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.161 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.51 144.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.7 -1.25 . . . . 0.0 110.289 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -139.22 140.53 37.78 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.894 0.854 . . . . 0.0 109.943 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -85.27 147.06 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.7 162.01 38.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.442 -0.786 . . . . 0.0 109.882 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.84 162.03 19.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -50.96 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.44 27.32 0.46 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.5 t -81.77 -18.8 42.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.991 -1.3 . . . . 0.0 109.06 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mt -117.69 173.58 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.505 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 16.5 m-85 -118.22 117.0 27.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mmt -79.41 144.61 33.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.78 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.13 139.35 34.91 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 m -141.04 76.28 1.54 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -0.8 . . . . 0.0 109.549 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.421 HD11 HD12 ' A' ' 81' ' ' ILE . 15.4 mm -97.21 -68.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.479 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.53 -79.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.537 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -178.75 -25.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.96 -39.32 5.22 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -48.04 157.55 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.168 -1.195 . . . . 0.0 109.565 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.73 28.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.367 -0.833 . . . . 0.0 108.927 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.476 ' NH1' ' OH ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -76.48 125.38 29.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 0.0 109.778 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.545 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -92.76 175.37 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.753 ' C ' HD23 ' A' ' 72' ' ' LEU . 98.4 m-85 -157.56 -174.73 5.01 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -115.63 -6.06 12.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.634 -0.666 . . . . 0.0 110.078 -178.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 76' ' ' ASP . 24.3 p -150.19 130.5 13.72 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.021 . . . . 0.0 109.606 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 78' ' ' GLN . 11.4 mm100 -44.17 -31.01 0.86 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -62.24 -33.25 74.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 0.0 109.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.8 m-20 -82.98 -36.97 24.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 108.726 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 tt -75.13 -30.75 60.9 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 74' ' ' GLN . 5.9 tp-100 -71.4 -34.52 70.44 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.18 -19.99 62.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -72.8 -47.51 45.9 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.671 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.511 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.5 mm -56.56 -51.08 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -70.46 -18.95 62.99 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.774 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.2 m170 -87.45 -27.87 22.45 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.828 -1.149 . . . . 0.0 112.151 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 -16.67 4.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.977 -1.077 . . . . 0.0 112.157 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 4.3 m-70 -111.35 -45.41 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.3 ttt 42.02 34.86 0.49 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.378 0.609 . . . . 0.0 109.952 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -172.11 117.17 0.37 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 109.446 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.65 159.1 28.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.525 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.52 0.676 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.479 ' CG ' ' N ' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -174.63 -94.38 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.682 -0.636 . . . . 0.0 109.318 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -161.12 105.23 1.32 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.832 . . . . 0.0 111.012 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.657 ' HA ' HD11 ' A' ' 11' ' ' ILE . 41.8 t -46.62 146.17 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.57 -27.03 18.44 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 110.513 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.75 -38.96 11.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 110.069 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 m -93.19 -29.87 15.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.529 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.72 11.56 82.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.93 156.66 36.3 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.464 -1.021 . . . . 0.0 108.541 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.58 142.5 71.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.951 1.767 . . . . 0.0 111.668 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 4' ' ' CYS . 93.0 mt -95.39 73.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.521 -0.737 . . . . 0.0 110.77 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.42 -37.46 7.69 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.52 142.32 20.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -70.9 107.98 4.3 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.599 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -73.44 80.79 0.74 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 1.024 HH21 HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -61.07 141.96 57.01 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.027 -0.69 . . . . 0.0 109.932 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.576 ' CE ' HG11 ' A' ' 47' ' ' VAL . 6.9 mtp -130.7 126.31 36.19 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.655 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -115.06 158.06 41.87 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.25 -2.06 50.24 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.446 -0.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 9.7 t -57.4 -35.61 70.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 109.336 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' MET . 7.5 ttmt 75.92 29.57 0.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.41 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -94.04 164.44 13.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 58' ' ' LEU . 33.2 m -131.44 148.03 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.334 -0.854 . . . . 0.0 110.888 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 42.1 m-85 -154.92 168.78 25.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -51.17 109.15 0.3 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.42 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.471 ' CE2' ' CD ' ' A' ' 52' ' ' GLN . 38.2 t80 -47.13 -20.44 0.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.495 -0.753 . . . . 0.0 109.78 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -74.89 -35.48 62.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 25' ' ' CYS . 12.3 p -82.46 -27.19 32.02 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -67.67 -37.04 81.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.902 . . . . 0.0 108.629 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 26' ' ' TYR . 25.5 pt -83.06 -34.61 11.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mt -73.72 -22.81 59.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.755 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 37' ' ' ASP . 6.7 m-70 -79.78 -42.93 23.44 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.183 -0.948 . . . . 0.0 108.778 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -75.05 -29.12 60.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -78.94 -30.8 44.87 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.025 -1.047 . . . . 0.0 108.926 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -77.62 -5.92 51.99 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.351 -0.843 . . . . 0.0 109.754 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.57 34.16 4.52 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 39' ' ' MET . 4.0 t70 -137.69 56.49 1.76 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.638 -0.919 . . . . 0.0 109.221 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -68.0 15.75 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.384 -0.822 . . . . 0.0 109.884 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.517 ' H ' ' C ' ' A' ' 37' ' ' ASP . 1.2 mtt -92.19 133.4 35.83 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.073 -1.017 . . . . 0.0 109.452 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' SER . 43.9 t -45.3 107.82 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.66 -17.14 2.76 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.262 1.308 . . . . 0.0 111.71 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.46 -50.77 1.51 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.431 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 44' ' ' SER . 69.8 m -92.48 -28.98 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.245 . . . . 0.0 109.942 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' CYS . 1.7 p 75.69 46.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.6 160.05 64.76 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.1 94.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.532 2.154 . . . . 0.0 112.181 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 47' ' ' VAL . 10.5 m -59.49 108.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' ILE . 2.5 tt0 -47.97 -56.23 8.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.655 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -160.66 132.41 5.87 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.903 0.859 . . . . 0.0 108.979 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.498 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.0 mt -84.25 145.23 8.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.815 -1.178 . . . . 0.0 109.508 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -138.59 156.67 47.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.842 0.829 . . . . 0.0 110.321 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.471 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 21.9 mt-30 -95.67 134.71 38.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.89 -0.506 . . . . 0.0 110.027 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.585 ' SG ' ' NH1' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -133.4 153.31 51.71 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.364 0.602 . . . . 0.0 109.987 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.59 158.64 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.795 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 57' ' ' SER . 15.5 ttp85 -48.62 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.442 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.21 28.65 0.26 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.869 -1.158 . . . . 0.0 110.329 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 55' ' ' ARG . 55.3 p -90.19 -19.11 24.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.337 . . . . 0.0 109.592 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.489 ' CD1' HG11 ' A' ' 23' ' ' VAL . 7.6 mt -119.49 173.61 6.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.774 -0.579 . . . . 0.0 109.989 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.441 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 26.4 m-85 -116.32 119.8 36.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mtt -85.43 144.49 27.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 t -97.93 143.34 28.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.494 -0.754 . . . . 0.0 109.358 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.0 p -140.95 74.45 1.46 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 109.608 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.413 HG21 ' ND1' ' A' ' 85' ' ' HIS . 3.4 mm -105.49 -74.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.637 -0.664 . . . . 0.0 109.373 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.66 12.13 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.418 ' NE2' ' O ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER 58.35 43.28 20.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.17 -53.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.0 152.19 45.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.133 . . . . 0.0 109.452 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.562 ' H ' HH11 ' A' ' 69' ' ' ARG . 13.6 tttt -151.23 43.13 0.77 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.205 -0.934 . . . . 0.0 109.424 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.562 HH11 ' H ' ' A' ' 68' ' ' LYS . 11.5 mpt_? -80.49 86.02 5.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.914 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -60.44 177.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.606 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.755 ' C ' HD23 ' A' ' 72' ' ' LEU . 57.6 m-85 -160.92 -167.4 1.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.419 -0.8 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.024 HD22 HH21 ' A' ' 16' ' ' ARG . 0.1 OUTLIER -114.63 -8.21 12.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.68 -0.638 . . . . 0.0 110.13 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' ARG . 72.6 m -147.45 127.97 14.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 109.626 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 1.5 tp-100 -45.9 -19.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 109.126 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.1 ttt-85 -71.37 -33.63 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.77 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.5 -37.68 24.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.66 -34.46 64.94 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 5.0 tp-100 -70.54 -30.51 67.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.06 -21.19 61.56 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -76.66 -35.86 57.7 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.794 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.439 ' H ' HG12 ' A' ' 81' ' ' ILE . 5.8 mm -63.92 -51.29 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.445 -0.784 . . . . 0.0 109.695 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 79' ' ' ALA . 11.2 p30 -74.23 -19.05 60.65 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.718 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.6 m-70 -86.46 -23.04 26.15 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.781 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 -26.56 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.995 -1.066 . . . . 0.0 111.926 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.498 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 6.3 m-70 -100.41 -49.87 4.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 108.964 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' HIS . 1.3 ttp 41.71 32.72 0.27 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.402 0.62 . . . . 0.0 109.868 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -157.33 18.27 0.28 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.56 140.98 5.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.49 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.553 179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.7 t60 64.38 -56.64 0.25 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.221 0.534 . . . . 0.0 109.986 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 1' ' ' VAL . 0.5 OUTLIER -74.37 112.23 10.33 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.425 -0.797 . . . . 0.0 109.158 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HA ' HD11 ' A' ' 11' ' ' ILE . 6.1 t -48.02 146.5 2.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.061 -1.024 . . . . 0.0 109.87 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.54 -24.06 45.86 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -64.88 1.01 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.426 -0.797 . . . . 0.0 109.441 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 12.5 m -61.14 -22.0 64.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.21 9.48 29.68 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -101.2 157.81 32.97 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.37 -1.077 . . . . 0.0 108.773 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.73 105.87 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.879 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 4' ' ' CYS . 60.9 mt -53.5 122.67 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.473 0.654 . . . . 0.0 110.594 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' CD ' ' H ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -86.0 -31.18 22.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.5 t -138.22 145.29 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.477 ' OH ' ' CE ' ' A' ' 60' ' ' MET . 3.2 m-30 -76.78 98.61 4.86 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.792 -1.193 . . . . 0.0 110.893 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 88.24 0.86 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -76.79 141.42 40.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.976 -0.72 . . . . 0.0 110.322 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.524 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 15.4 mtp -129.38 132.98 47.16 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.167 0.508 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.666 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -116.19 156.36 47.11 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.87 2.64 48.0 Favored 'Cis proline' 0 N--CA 1.491 1.324 0 C-N-CA 124.164 -1.182 . . . . 0.0 111.316 -0.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -53.09 -40.11 63.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 tttp 71.59 31.22 2.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.551 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 9.1 m170 -104.63 174.14 6.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.567 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -128.95 159.8 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.619 0.723 . . . . 0.0 110.349 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 74.6 m-85 -166.26 174.06 9.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -62.57 115.41 4.24 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.619 178.062 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.581 ' O ' HG23 ' A' ' 30' ' ' ILE . 45.0 t80 -49.44 -21.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 109.946 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.7 -41.23 60.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.03 -1.044 . . . . 0.0 108.568 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.492 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.13 -22.0 33.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.21 -33.52 71.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 26' ' ' TYR . 49.3 pt -80.22 -37.02 17.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 121.044 -1.035 . . . . 0.0 108.621 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.27 -36.01 78.86 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.004 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -70.02 -39.94 75.52 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -74.68 -19.82 60.11 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.196 -0.94 . . . . 0.0 108.859 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -72.54 0.42 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.869 . . . . 0.0 110.311 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -96.95 -33.71 5.95 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 1.7 t70 75.34 13.12 3.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.366 -1.079 . . . . 0.0 109.851 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.31 35.24 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.01 -1.056 . . . . 0.0 111.031 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 39' ' ' MET . 10.2 ptm -145.26 117.92 8.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.929 -1.107 . . . . 0.0 110.508 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -62.22 143.3 95.45 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -52.93 -36.19 74.05 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.55 1.5 . . . . 0.0 112.044 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.56 -45.46 0.78 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.551 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 3.2 m -81.61 -15.91 53.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.993 -1.298 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t 49.37 36.75 10.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -90.61 161.18 37.18 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.016 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.99 75.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.297 1.998 . . . . 0.0 112.012 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ASP . 37.9 t -47.35 99.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.018 -1.051 . . . . 0.0 109.489 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.5 tt0 -67.31 -61.02 2.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 108.583 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.666 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -150.1 135.34 18.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.015 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.424 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.2 mt -93.83 146.68 6.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.953 -1.092 . . . . 0.0 109.845 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -141.38 141.38 33.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.98 142.82 27.75 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.645 -0.659 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 169.26 19.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.296 -0.877 . . . . 0.0 109.847 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -87.13 162.12 17.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.873 . . . . 0.0 109.583 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 55' ' ' ARG . 1.1 ttp180 -70.04 38.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.021 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -153.27 17.55 0.69 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.74 -27.33 12.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.875 . . . . 0.0 110.243 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 mt -113.0 172.32 7.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.57 -0.706 . . . . 0.0 110.017 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 19.5 m-85 -129.37 120.39 25.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.477 ' CE ' ' OH ' ' A' ' 14' ' ' TYR . 1.8 mpt? -81.77 144.76 30.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.245 -0.91 . . . . 0.0 110.628 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 54.1 t -71.83 142.95 49.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.456 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 m -86.97 11.19 14.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.129 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 64' ' ' VAL . 3.7 mm -96.3 168.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.414 -0.803 . . . . 0.0 109.007 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.572 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -142.34 178.24 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 109.622 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 58.69 80.91 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.445 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.99 64.46 1.53 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 35.2 t -169.55 -129.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -1.131 . . . . 0.0 109.422 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 3.9 tttp 73.51 27.92 1.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.72 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -93.18 126.96 38.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.52 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -91.94 179.32 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.497 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.725 ' C ' HD23 ' A' ' 72' ' ' LEU . 61.8 m-85 -158.37 -169.74 2.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.391 -0.818 . . . . 0.0 109.069 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -111.92 -9.71 14.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.673 -0.642 . . . . 0.0 110.191 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.6 t -152.9 133.84 14.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.969 -1.082 . . . . 0.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 73' ' ' SER . 13.0 mm100 -44.96 -30.11 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.9 -34.9 79.0 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.014 0.911 . . . . 0.0 109.786 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.7 m-20 -83.39 -33.97 25.65 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.15 -0.969 . . . . 0.0 108.556 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -74.91 -34.17 62.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.479 ' N ' HD23 ' A' ' 77' ' ' LEU . 4.0 tp-100 -70.25 -32.04 69.7 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.09 -20.84 61.59 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.413 ' CD2' HD13 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -76.47 -38.77 54.85 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.013 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.539 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 5.3 mm -62.11 -54.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 4.8 p30 -69.21 -20.1 63.97 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.651 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.6 m-70 -86.88 -13.37 45.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.515 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.41 ' HG3' ' HD1' ' A' ' 80' ' ' HIS . 13.1 mmt180 -122.21 -40.51 2.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.099 -1.001 . . . . 0.0 113.468 -177.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.49 ' CE1' HG21 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -145.03 -27.73 0.47 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.856 -1.152 . . . . 0.0 110.143 -178.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER 63.05 34.72 13.61 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.546 -0.721 . . . . 0.0 109.567 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.86 172.33 7.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.432 -0.792 . . . . 0.0 109.347 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.45 -66.6 0.83 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 3' ' ' PHE . 6.8 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.7 t60 65.77 -56.07 0.35 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.288 0.566 . . . . 0.0 109.946 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 1' ' ' VAL . 58.1 m-85 -74.96 108.1 7.47 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.116 -0.99 . . . . 0.0 109.001 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HA ' HD11 ' A' ' 11' ' ' ILE . 17.2 t -45.97 146.17 1.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.546 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.03 -27.44 24.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -91.64 -44.34 9.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 110.095 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.9 m -87.94 -27.03 22.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 110.334 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.71 11.4 83.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.14 158.19 32.24 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -1.044 . . . . 0.0 108.882 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.35 106.39 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.961 1.774 . . . . 0.0 112.128 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 4' ' ' CYS . 79.0 mt -54.23 105.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.875 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -71.78 -36.49 70.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.02 141.94 28.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -73.22 112.12 8.97 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.965 -1.084 . . . . 0.0 111.106 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -77.72 78.01 1.55 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.461 HH12 ' C ' ' A' ' 21' ' ' LYS . 4.0 tpt85 -58.23 140.53 52.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 122.155 -0.615 . . . . 0.0 110.235 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.534 ' CE ' HG11 ' A' ' 47' ' ' VAL . 5.5 mtp -130.04 129.01 43.1 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -120.89 156.22 56.76 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.69 0.53 52.94 Favored 'Cis proline' 0 N--CA 1.49 1.268 0 C-N-CA 124.191 -1.17 . . . . 0.0 112.084 0.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.4 t -54.9 -29.68 56.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 109.12 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' C ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER 68.83 25.98 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.684 ' HE2' ' NH2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -95.37 175.52 6.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.675 -0.641 . . . . 0.0 109.37 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -144.98 153.42 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.817 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 26.5 m-85 -159.58 168.14 26.83 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -48.79 111.78 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.86 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 30' ' ' ILE . 35.8 t80 -49.12 -18.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.391 -0.818 . . . . 0.0 109.098 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 25' ' ' CYS . 29.3 t0 -77.23 -36.37 54.72 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -82.86 -25.78 32.24 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -69.25 -36.97 77.72 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 26' ' ' TYR . 32.1 pt -80.57 -35.01 14.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.986 -1.071 . . . . 0.0 109.323 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -67.83 -22.17 65.16 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.516 -1.273 . . . . 0.0 107.965 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.412 ' O ' ' N ' ' A' ' 37' ' ' ASP . 1.3 m-70 -82.3 -35.24 28.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -74.39 -31.8 62.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.662 -0.649 . . . . 0.0 109.603 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -85.2 -32.11 22.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.158 -0.964 . . . . 0.0 110.137 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -75.66 -7.21 53.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 0.0 110.025 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.27 34.39 6.14 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 39' ' ' MET . 3.5 m-20 -132.74 55.47 1.89 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.722 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -65.88 15.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.46 -0.775 . . . . 0.0 110.132 -179.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.537 ' H ' ' C ' ' A' ' 37' ' ' ASP . 57.9 mtp -94.28 133.28 37.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.983 -1.073 . . . . 0.0 109.704 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 44' ' ' SER . 42.6 t -43.92 106.89 0.54 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.4 -17.22 4.02 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.305 1.337 . . . . 0.0 111.754 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.85 -47.71 2.63 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.394 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.512 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 62.1 m -99.37 -30.0 12.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 78.35 52.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.706 -0.622 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.41 158.47 75.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 109.068 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.71 100.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.605 2.203 . . . . 0.0 112.586 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 38' ' ' LYS . 12.7 m -68.31 106.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -49.24 -54.81 14.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.774 -1.204 . . . . 0.0 108.28 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.482 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -159.6 125.34 4.24 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.475 178.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.49 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.2 mt -78.94 144.83 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.917 -1.114 . . . . 0.0 109.096 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -138.93 153.24 48.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.917 0.865 . . . . 0.0 110.0 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -96.36 138.55 33.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.88 -0.512 . . . . 0.0 109.776 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 158.91 43.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.902 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.77 158.3 24.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.55 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -50.87 -71.0 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 110.142 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.28 27.62 0.44 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 55' ' ' ARG . 9.4 t -86.9 -25.18 24.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.87 -1.37 . . . . 0.0 109.125 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.8 mt -115.35 173.72 6.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.48 116.24 30.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.781 -0.574 . . . . 0.0 109.727 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.7 tpt -79.46 144.48 33.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.544 ' SG ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -76.41 129.69 36.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.823 . . . . 0.0 109.159 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 t -107.8 -16.03 14.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 63' ' ' ILE . 1.3 mp -47.54 -55.31 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.904 HG12 ' H ' ' A' ' 66' ' ' GLY . 75.0 t -146.31 124.51 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -50.52 -16.92 0.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.312 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.904 ' H ' HG12 ' A' ' 64' ' ' VAL . . . -62.74 -56.51 20.82 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 151.13 27.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -1.104 . . . . 0.0 109.511 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.659 ' H ' ' HE ' ' A' ' 69' ' ' ARG . 32.8 mttp -153.68 42.33 0.55 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.196 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.684 ' NH2' ' HE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.35 93.92 4.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.189 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.63 171.5 5.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.079 -1.013 . . . . 0.0 109.563 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.783 ' C ' HD23 ' A' ' 72' ' ' LEU . 1.9 m-85 -154.36 -174.45 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.373 -0.83 . . . . 0.0 108.796 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.783 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -118.61 -4.79 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.617 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -147.45 123.41 10.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.229 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 73' ' ' SER . 1.3 tp-100 -44.39 -21.55 0.05 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.4 ttt180 -68.81 -37.0 78.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.403 -0.81 . . . . 0.0 109.649 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.41 -35.66 34.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.47 -32.96 66.65 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.7 tp60 -69.28 -30.91 69.11 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -74.82 -19.93 59.98 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -71.8 -47.46 53.16 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.749 -1.18 . . . . 0.0 108.207 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.471 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.9 mm -56.85 -55.77 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.644 0.735 . . . . 0.0 109.586 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -64.64 -18.24 64.76 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -85.47 -32.39 22.29 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.924 -178.407 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -130.61 -25.02 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.175 -0.953 . . . . 0.0 112.685 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.512 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 3.8 m-70 -98.96 -49.7 4.44 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 109.023 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.491 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER 41.54 35.0 0.42 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.368 0.604 . . . . 0.0 109.815 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -178.96 119.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.442 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -170.98 50.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 CA-C-O 117.942 -1.477 . . . . 0.0 109.545 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.45 ' O ' ' CZ ' ' A' ' 14' ' ' TYR . 34.9 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -92.64 -45.24 8.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.228 -0.92 . . . . 0.0 109.308 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -77.1 111.47 12.72 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 109.48 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.638 ' HA ' HD11 ' A' ' 11' ' ' ILE . 48.0 t -46.36 146.53 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.631 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.28 -28.33 38.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.373 -0.829 . . . . 0.0 109.711 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 -59.4 1.75 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.464 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 13.1 m -60.06 -28.62 67.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.14 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.2 73.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.3 158.37 31.89 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.432 -1.04 . . . . 0.0 108.638 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.17 100.04 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.855 1.703 . . . . 0.0 112.233 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 4' ' ' CYS . 89.5 mt -45.67 115.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.94 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.7 -32.28 25.62 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.87 140.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.45 ' CZ ' ' O ' ' A' ' 1' ' ' VAL . 4.0 m-85 -76.76 103.85 6.94 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.819 -1.175 . . . . 0.0 110.835 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 84.29 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.511 HH21 ' CG ' ' A' ' 21' ' ' LYS . 6.2 ttt-85 -66.73 130.98 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 122.223 -0.575 . . . . 0.0 110.166 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.643 ' CE ' HG11 ' A' ' 47' ' ' VAL . 16.7 mtp -117.0 132.62 56.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.879 -0.513 . . . . 0.0 110.279 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.679 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -115.81 156.75 46.06 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.55 -1.54 51.83 Favored 'Cis proline' 0 N--CA 1.492 1.405 0 C-N-CA 124.119 -1.201 . . . . 0.0 111.958 -0.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.5 t -54.19 -31.58 53.32 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.2 OUTLIER 68.79 24.85 6.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.453 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.72 179.96 5.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.2 m -146.32 150.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 34.6 m-85 -159.09 169.71 23.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.5 114.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.206 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 30' ' ' ILE . 34.1 t80 -52.22 -15.3 0.57 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.339 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -41.14 63.55 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.464 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 p -81.23 -27.63 35.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.7 -35.99 81.44 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 108.809 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.3 pt -79.91 -34.48 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.129 -1.029 . . . . 0.0 108.873 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.9 mt -64.0 -24.86 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.204 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -80.63 -40.71 25.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -23.34 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.395 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -80.72 -36.49 32.06 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.261 -0.899 . . . . 0.0 108.584 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -78.04 -10.95 59.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.503 -0.748 . . . . 0.0 109.317 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.61 31.53 13.01 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.499 ' OD1' ' SD ' ' A' ' 39' ' ' MET . 0.3 OUTLIER -88.76 -40.76 12.98 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.279 -1.13 . . . . 0.0 109.221 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 42.95 23.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.522 -0.736 . . . . 0.0 110.24 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.499 ' SD ' ' OD1' ' A' ' 37' ' ' ASP . 3.7 ptt? -112.05 135.43 52.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.772 -0.58 . . . . 0.0 109.605 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.6 t -64.01 114.3 13.22 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 109.002 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -54.68 -12.3 4.33 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.199 1.266 . . . . 0.0 111.554 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.74 -59.76 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 44' ' ' SER . 3.8 m -92.34 -24.55 18.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.226 -1.161 . . . . 0.0 109.969 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER 74.86 40.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.3 157.11 43.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.69 97.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.5 2.133 . . . . 0.0 112.228 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.643 HG11 ' CE ' ' A' ' 17' ' ' MET . 4.5 m -68.99 112.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -55.36 -53.66 53.44 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 108.897 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.679 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -157.68 133.67 9.37 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.791 -1.163 . . . . 0.0 109.787 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.715 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.1 mt -87.17 145.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 120.981 -1.074 . . . . 0.0 109.353 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -138.34 153.84 48.97 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.706 0.765 . . . . 0.0 109.764 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.492 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 7.7 mt-30 -95.17 139.4 31.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.663 -0.648 . . . . 0.0 110.084 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 m -139.89 157.8 45.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.661 -0.649 . . . . 0.0 109.859 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 158.67 21.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.798 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.51 ' C ' ' H ' ' A' ' 57' ' ' SER . 36.9 ttp85 -49.92 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -0.873 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.82 29.08 0.39 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 55' ' ' ARG . 10.8 t -85.62 -27.69 25.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.95 -1.324 . . . . 0.0 108.914 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mt -107.59 173.54 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 24.8 m-85 -118.15 119.61 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -80.51 144.11 32.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.6 t -103.71 101.44 11.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.664 -0.648 . . . . 0.0 109.467 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.7 t -86.7 -23.8 25.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 81' ' ' ILE . 64.7 mt -45.24 130.69 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.801 . . . . 0.0 109.75 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 65' ' ' GLN . 61.2 t 52.66 95.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.421 -0.8 . . . . 0.0 109.376 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 64' ' ' VAL . 14.1 mm100 -49.34 175.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.382 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.88 -47.03 3.15 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.8 163.47 17.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -1.162 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -173.0 41.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 109.189 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.689 ' NH1' ' HE ' ' A' ' 84' ' ' ARG . 49.3 mtt180 -78.58 112.04 15.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -77.33 175.71 9.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.567 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.798 ' C ' HD23 ' A' ' 72' ' ' LEU . 92.1 m-85 -157.84 -170.66 3.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -118.46 -5.75 10.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.671 -0.643 . . . . 0.0 109.676 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.3 m -149.41 129.88 13.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.982 . . . . 0.0 109.431 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -47.28 -24.46 0.75 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 109.046 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -68.16 -32.77 73.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 109.115 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 m-20 -81.62 -36.38 28.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -75.41 -33.41 60.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -68.41 -33.36 74.08 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.22 -21.17 62.17 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -74.85 -38.22 62.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.028 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 63' ' ' ILE . 9.0 mm -62.42 -52.62 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.146 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.428 HD21 ' HA ' ' A' ' 79' ' ' ALA . 11.8 p30 -72.37 -18.84 61.71 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.753 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 1.7 m-70 -86.65 -26.7 24.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.464 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.689 ' HE ' ' NH1' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -130.51 -14.3 3.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.154 -0.966 . . . . 0.0 112.053 -178.077 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 10.2 m-70 -112.27 -44.48 3.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.117 -0.989 . . . . 0.0 109.828 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.469 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 6.2 ttm 47.81 53.22 11.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.452 -0.78 . . . . 0.0 109.163 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 86' ' ' MET . 0.5 OUTLIER 76.35 106.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.656 -0.652 . . . . 0.0 109.343 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -46.45 -76.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.444 -0.785 . . . . 0.0 109.57 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.54 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.729 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 53.63 1.12 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.614 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.516 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -158.31 105.69 1.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.506 -0.746 . . . . 0.0 109.257 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 9' ' ' LEU . 4.0 m -46.45 146.3 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 108.988 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -25.88 21.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.35 -31.27 13.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.417 -0.802 . . . . 0.0 110.369 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -24.43 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.838 . . . . 0.0 110.646 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . 78.93 -0.44 78.49 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.082 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.531 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 4.2 mp -79.55 163.96 56.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.075 -1.25 . . . . 0.0 108.258 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.08 133.32 24.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.146 1.231 . . . . 0.0 112.091 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 1' ' ' VAL . 73.0 mt -81.05 118.09 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.739 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.484 ' CD ' ' H ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -84.53 -29.71 25.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.734 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.96 144.78 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.53 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.3 m-85 -82.31 99.41 9.33 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.634 -1.291 . . . . 0.0 110.231 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.27 87.59 0.59 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.47 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.4 ttt-85 -64.91 143.5 57.91 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 122.115 -0.638 . . . . 0.0 110.169 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.561 ' SD ' ' SG ' ' A' ' 40' ' ' CYS . 6.8 mtp -125.6 134.33 51.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -122.54 154.18 62.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.72 6.63 37.34 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 124.174 -1.177 . . . . 0.0 111.26 -0.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -55.7 -38.19 69.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.638 -0.663 . . . . 0.0 109.421 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.7 tttp 71.12 24.22 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.591 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 37.6 m170 -100.33 175.55 5.67 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 14' ' ' TYR . 1.3 m -143.12 154.03 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.832 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 48.0 m-85 -151.92 -158.36 0.89 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.534 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -81.36 108.92 15.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.732 ' O ' HG23 ' A' ' 30' ' ' ILE . 43.2 t80 -49.84 -11.55 0.06 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.051 -1.031 . . . . 0.0 109.722 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.6 t70 -82.35 -49.29 10.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 108.996 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.414 ' HA ' HD12 ' A' ' 31' ' ' LEU . 3.9 m -79.4 -22.15 44.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.826 -1.172 . . . . 0.0 108.051 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.87 78.04 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.732 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.4 pt -78.86 -34.01 16.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 121.119 -0.988 . . . . 0.0 108.767 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 28' ' ' CYS . 18.9 mt -65.42 -38.7 90.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.832 -1.147 . . . . 0.0 107.995 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -70.54 -31.32 68.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -74.83 -36.24 62.4 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.382 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -73.07 -20.92 60.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.039 -1.038 . . . . 0.0 108.262 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -81.75 -36.96 27.96 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.464 -0.773 . . . . 0.0 110.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -135.02 -34.65 0.25 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER 72.64 20.95 3.65 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.498 -1.001 . . . . 0.0 110.26 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -164.81 41.43 0.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.913 -1.117 . . . . 0.0 110.533 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.432 ' C ' HG13 ' A' ' 47' ' ' VAL . 19.5 mtp -148.52 136.37 20.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.901 -1.124 . . . . 0.0 112.163 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.561 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 24.9 t -91.47 112.06 52.3 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -45.95 -19.17 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.86 1.706 . . . . 0.0 112.772 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 -62.51 0.82 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.553 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.5 m -93.83 2.27 56.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -1.157 . . . . 0.0 110.529 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.6 p 48.45 36.03 6.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 109.566 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.444 ' H ' ' HB3' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -95.71 161.43 27.6 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.299 -0.876 . . . . 0.0 109.003 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' GLN . 20.2 Cg_endo -62.93 80.67 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.344 2.029 . . . . 0.0 111.976 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 47' ' ' VAL . 5.6 m -52.96 98.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -50.6 -51.12 51.43 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.519 -1.363 . . . . 0.0 108.202 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.475 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -158.55 123.19 4.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.668 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.1 mt -81.05 144.91 9.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 120.797 -1.19 . . . . 0.0 109.168 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 16' ' ' ARG . 28.0 mt-10 -138.97 151.17 46.64 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.702 0.763 . . . . 0.0 110.363 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 19.5 mt-30 -85.72 143.29 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.347 0.594 . . . . 0.0 110.071 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.44 159.32 42.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.478 -0.764 . . . . 0.0 109.471 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.81 166.41 20.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.333 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.525 ' C ' ' H ' ' A' ' 57' ' ' SER . 3.5 tmm_? -68.51 -74.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 110.561 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.15 24.71 0.26 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.365 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.635 ' O ' HD23 ' A' ' 58' ' ' LEU . 3.3 m -92.56 -6.31 49.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.972 -1.31 . . . . 0.0 109.82 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 57' ' ' SER . 6.3 mt -129.03 174.81 9.21 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.471 ' CD2' ' OE1' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -120.67 108.58 14.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.801 -0.562 . . . . 0.0 110.332 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.52 144.74 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.381 -0.825 . . . . 0.0 110.368 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.503 ' SG ' ' CE1' ' A' ' 80' ' ' HIS . 49.6 t -79.82 143.48 34.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.405 -0.81 . . . . 0.0 109.673 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 t -109.85 47.99 0.92 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mt -137.33 -46.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.48 -0.763 . . . . 0.0 109.367 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.509 HG22 ' H ' ' A' ' 66' ' ' GLY . 2.7 p -164.16 150.81 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.067 -1.021 . . . . 0.0 109.606 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -81.86 27.79 0.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.654 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.509 ' H ' HG22 ' A' ' 64' ' ' VAL . . . -98.65 -61.38 0.87 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.523 ' O ' ' N ' ' A' ' 69' ' ' ARG . 13.9 p -47.32 167.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 109.36 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 70' ' ' THR . 23.0 mttt -47.99 -12.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.038 -1.039 . . . . 0.0 109.815 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 67' ' ' CYS . 6.7 ttm180 64.24 -67.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 110.775 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 68' ' ' LYS . 2.1 p -94.12 155.0 17.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.647 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.636 ' C ' HD23 ' A' ' 72' ' ' LEU . 72.6 m-85 -149.97 176.98 10.28 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -103.11 -11.11 18.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.537 -0.727 . . . . 0.0 110.472 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ASP . 58.7 m -160.63 138.05 9.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.801 -1.187 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.471 ' OE1' ' CD2' ' A' ' 59' ' ' PHE . 12.8 mm100 -43.34 -31.64 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.612 -0.68 . . . . 0.0 109.68 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -65.88 -31.68 72.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.415 -0.803 . . . . 0.0 109.962 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 73.6 m-20 -86.22 -32.73 21.01 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -76.83 -35.03 57.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.637 ' N ' HD23 ' A' ' 77' ' ' LEU . 40.1 tp60 -72.38 -34.73 68.14 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.08 -20.09 62.4 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.537 ' C ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -77.39 -39.12 48.26 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.645 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.517 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.5 mm -58.14 -55.35 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.19 -25.2 66.01 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.604 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -88.78 -11.04 46.07 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.808 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -118.37 -48.62 2.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.152 -0.967 . . . . 0.0 113.355 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -138.72 -22.56 0.97 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 110.002 -178.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.545 ' O ' ' SD ' ' A' ' 86' ' ' MET . 0.0 OUTLIER 54.67 24.2 5.35 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.853 0.835 . . . . 0.0 109.772 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.589 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 36.3 ttt-85 -94.14 143.82 26.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 87' ' ' ARG . . . 170.77 178.82 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.947 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.509 ' HB ' ' CE1' ' A' ' 2' ' ' HIS . 3.6 m . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.509 ' CE1' ' HB ' ' A' ' 1' ' ' VAL . 1.2 m80 66.23 -52.85 0.41 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.752 -0.593 . . . . 0.0 109.962 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.569 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -72.2 119.29 16.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.81 . . . . 0.0 110.35 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.488 ' HA ' HD11 ' A' ' 11' ' ' ILE . 6.6 t -46.26 145.8 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.037 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -21.44 30.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.057 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -39.68 12.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.038 -1.038 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -106.58 -16.98 14.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 111.384 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.43 4.12 68.42 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.429 -1.367 . . . . 0.0 109.979 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.27 157.65 56.06 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.057 -1.261 . . . . 0.0 109.035 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.7 112.16 2.11 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.129 1.886 . . . . 0.0 112.549 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.488 HD11 ' HA ' ' A' ' 4' ' ' CYS . 67.6 mt -61.82 124.86 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.05 -29.25 18.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 t -133.4 145.31 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD2' HG11 ' A' ' 23' ' ' VAL . 3.2 m-30 -82.75 98.73 9.25 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.658 -1.276 . . . . 0.0 110.814 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.69 95.34 1.35 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.611 HH12 ' CB ' ' A' ' 70' ' ' THR . 3.0 tpt180 -81.52 144.83 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.99 -0.712 . . . . 0.0 111.064 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.541 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 5.4 mtp -131.72 130.18 41.61 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.663 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -113.9 157.28 42.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.345 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.48 -1.06 51.67 Favored 'Cis proline' 0 N--CA 1.491 1.344 0 C-N-CA 124.178 -1.176 . . . . 0.0 111.786 -0.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.583 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 14.5 t -52.01 -35.36 46.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.2 OUTLIER 69.3 30.17 4.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.583 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 30.8 m170 -100.22 165.9 11.26 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.876 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -122.64 161.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.942 0.877 . . . . 0.0 110.462 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.541 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 97.3 m-85 -163.55 -164.41 0.92 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -83.9 113.66 21.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.649 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.754 ' O ' HG23 ' A' ' 30' ' ' ILE . 41.1 t80 -47.53 -14.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.051 -1.03 . . . . 0.0 109.364 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -79.77 -42.96 23.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.465 ' HA ' HD12 ' A' ' 31' ' ' LEU . 54.5 m -83.08 -23.2 33.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -69.54 -37.41 77.06 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 26' ' ' TYR . 46.4 pt -74.74 -37.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.468 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 28' ' ' CYS . 9.0 mt -53.5 -38.52 63.78 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -67.05 -42.03 85.48 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.564 -0.71 . . . . 0.0 109.211 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' A' ' 50' ' ' ILE . 1.1 pt-20 -61.46 -34.0 74.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 108.782 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -77.68 -20.68 53.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.998 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -81.71 -31.71 31.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 110.243 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.18 -25.88 0.08 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 62.64 50.92 3.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -1.112 . . . . 0.0 109.983 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -155.74 9.68 0.27 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.871 -1.143 . . . . 0.0 111.017 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.455 ' O ' ' CG ' ' A' ' 39' ' ' MET . 7.5 ptm -144.5 114.26 7.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.09 -1.007 . . . . 0.0 110.317 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.503 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -57.04 145.89 62.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.86 -38.91 68.85 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.768 1.645 . . . . 0.0 112.61 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.84 -21.8 2.84 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.624 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.448 ' H ' ' HB3' ' A' ' 40' ' ' CYS . 0.0 OUTLIER -94.49 -15.81 23.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.176 -1.191 . . . . 0.0 110.169 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.9 p 47.63 36.48 5.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.503 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.3 OUTLIER -90.93 160.73 37.35 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 108.775 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' GLN . 14.9 Cg_endo -58.27 74.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.131 1.887 . . . . 0.0 112.001 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' ASP . 47.2 t -47.42 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.051 -1.03 . . . . 0.0 109.683 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' PRO . 5.0 tt0 -64.62 -61.06 2.43 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.663 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -150.61 137.64 19.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.911 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.579 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -94.61 147.21 5.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.805 -1.184 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -140.68 147.02 38.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.443 0.64 . . . . 0.0 109.826 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -97.02 144.8 26.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.633 -0.667 . . . . 0.0 109.221 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 168.08 25.07 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.012 . . . . 0.0 110.323 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 154.36 22.28 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -57.52 -23.78 52.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 110.081 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.82 21.83 44.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.83 -25.99 14.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -1.135 . . . . 0.0 109.924 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -114.15 172.68 6.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.697 -0.627 . . . . 0.0 109.628 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -122.19 123.18 40.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 mmt -88.88 145.28 25.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.274 -0.891 . . . . 0.0 110.949 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.53 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 46.9 t -90.34 143.05 27.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.011 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -62.2 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 109.561 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.702 HG21 ' CD2' ' A' ' 85' ' ' HIS . 6.3 mt -44.91 120.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.545 -0.722 . . . . 0.0 109.719 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.939 HG22 ' H ' ' A' ' 65' ' ' GLN . 9.8 p -92.19 -144.16 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.863 . . . . 0.0 109.447 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.939 ' H ' HG22 ' A' ' 64' ' ' VAL . 23.4 tt0 60.8 98.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.044 -1.035 . . . . 0.0 109.487 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.9 57.66 6.72 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.598 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 43.8 t -150.38 -115.49 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.345 -1.091 . . . . 0.0 109.538 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 12.4 mttp 47.83 31.49 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.688 HH12 HH21 ' A' ' 84' ' ' ARG . 19.3 mmm-85 -91.45 117.04 29.35 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.23 -0.919 . . . . 0.0 109.431 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.611 ' CB ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -83.84 174.87 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.813 ' C ' HD23 ' A' ' 72' ' ' LEU . 89.8 m-85 -156.18 -166.33 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.366 -0.834 . . . . 0.0 108.819 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.813 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -118.11 -8.81 10.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.678 -0.639 . . . . 0.0 110.046 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 76' ' ' ASP . 17.9 p -145.35 130.0 18.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.514 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -47.81 -25.65 1.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 108.699 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -68.4 -32.89 73.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.528 0.68 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 73' ' ' SER . 36.5 m-20 -84.21 -34.52 23.9 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 tt -74.95 -34.05 62.0 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -71.58 -30.22 65.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.06 -20.55 60.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.529 ' CD2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.83 -41.0 53.8 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.724 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.53 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 4.6 mm -61.53 -52.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -64.65 -23.02 67.12 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.482 -0.761 . . . . 0.0 109.023 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 28.7 m170 -88.12 -12.9 42.72 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.531 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.688 HH21 HH12 ' A' ' 69' ' ' ARG . 11.1 mmt180 -118.67 -46.21 2.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 113.067 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.702 ' CD2' HG21 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -142.21 -25.97 0.65 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 110.031 -179.198 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.51 ' N ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER 60.2 35.55 21.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.492 -0.755 . . . . 0.0 109.708 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.9 ttm-85 -95.3 56.67 1.9 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 87' ' ' ARG . . . 61.89 149.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.571 -179.987 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.452 ' O ' ' CZ ' ' A' ' 14' ' ' TYR . 9.9 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.274 0.559 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -90.29 -47.15 7.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.377 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.466 ' O ' ' CD2' ' A' ' 3' ' ' PHE . 13.9 p90 -77.98 106.8 10.08 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.076 -1.015 . . . . 0.0 109.329 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.619 ' HA ' HD11 ' A' ' 11' ' ' ILE . 43.3 t -45.95 146.29 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.476 ' CG ' ' NZ ' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -83.72 -30.45 26.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 110.624 -179.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.45 -40.16 10.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.018 -1.051 . . . . 0.0 110.293 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.546 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 12.6 m -88.55 -25.86 22.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.052 -1.03 . . . . 0.0 110.089 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.42 10.49 70.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 158.29 32.46 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.36 -1.082 . . . . 0.0 108.601 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.02 98.96 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.857 1.704 . . . . 0.0 112.083 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' HA ' ' A' ' 4' ' ' CYS . 91.5 mt -45.58 110.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.986 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -35.07 40.86 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.0 138.75 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' CZ ' ' O ' ' A' ' 1' ' ' VAL . 3.7 m-85 -78.78 106.96 11.15 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.98 -1.075 . . . . 0.0 110.78 -178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.58 85.13 0.85 Allowed Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -65.66 130.84 44.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 122.0 -0.706 . . . . 0.0 109.789 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.631 ' CE ' HG11 ' A' ' 47' ' ' VAL . 14.5 mtp -116.27 124.61 50.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.863 -0.523 . . . . 0.0 110.139 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.817 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -112.76 156.72 42.11 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.95 2.57 48.47 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 124.153 -1.186 . . . . 0.0 111.462 -0.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 1.0 OUTLIER -56.92 -35.81 69.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.549 -0.719 . . . . 0.0 109.433 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 ttmt 74.51 21.97 2.19 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.573 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 3.3 m80 -90.5 178.72 6.03 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.879 -0.729 . . . . 0.0 109.149 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.456 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.3 m -146.57 149.06 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 21.5 m-85 -158.61 170.0 23.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.68 112.7 0.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.77 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 30' ' ' ILE . 40.6 t80 -51.16 -15.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.613 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -82.26 -32.7 29.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.546 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -85.68 -26.29 26.05 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 108.651 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.493 ' HB1' HD13 ' A' ' 50' ' ' ILE . . . -72.29 -35.09 68.6 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 26' ' ' TYR . 2.1 pp -84.46 -34.92 10.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.252 -0.905 . . . . 0.0 108.811 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.548 HD23 ' HD3' ' A' ' 34' ' ' LYS . 7.6 mt -68.18 -22.97 64.8 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.004 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.39 -40.57 21.1 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.26 -36.74 85.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.475 -0.765 . . . . 0.0 109.91 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HD3' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -83.01 -27.43 30.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.971 -1.081 . . . . 0.0 109.756 -179.681 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -78.38 22.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.938 -1.101 . . . . 0.0 109.67 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 34' ' ' LYS . . . 69.97 39.79 74.17 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.595 ' C ' ' H ' ' A' ' 39' ' ' MET . 0.5 OUTLIER -138.16 57.67 1.7 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.553 -0.969 . . . . 0.0 108.91 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.514 ' O ' HG22 ' A' ' 47' ' ' VAL . 4.6 pttt -66.07 20.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.816 . . . . 0.0 109.905 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.595 ' H ' ' C ' ' A' ' 37' ' ' ASP . 8.0 ptt? -97.58 159.18 15.08 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.153 -0.967 . . . . 0.0 109.236 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.8 t -74.52 114.6 35.54 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.306 -0.871 . . . . 0.0 109.016 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.51 -17.11 6.2 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.427 1.418 . . . . 0.0 112.349 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.56 -58.63 1.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 3.5 m -93.29 -24.85 18.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -1.169 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.5 p 76.35 41.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.39 158.18 42.08 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.06 92.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.578 2.185 . . . . 0.0 112.141 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 47' ' ' VAL . 4.0 m -62.1 111.14 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.037 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -47.17 -58.89 3.57 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.13 -0.981 . . . . 0.0 108.932 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' HD11 ' A' ' 18' ' ' ILE . 31.3 ptt180 -161.93 125.89 3.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.278 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.493 HD13 ' HB1' ' A' ' 29' ' ' ALA . 3.3 mt -74.08 144.71 12.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.817 -1.177 . . . . 0.0 109.745 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -138.94 143.22 38.53 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 109.656 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -83.46 144.87 29.28 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.438 0.637 . . . . 0.0 110.079 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.21 158.86 43.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.795 . . . . 0.0 109.532 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.43 162.35 24.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.226 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 57' ' ' SER . 3.9 ptp85 -66.4 -59.79 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.039 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.497 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -72.99 21.27 1.01 Allowed Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -90.29 -17.98 26.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.128 -1.219 . . . . 0.0 109.632 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.5 mt -118.86 173.29 6.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 24.6 m-85 -114.21 117.15 30.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 60' ' ' MET . 1.6 mpt? -82.59 144.47 30.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.344 -0.847 . . . . 0.0 110.346 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.5 102.38 13.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -32.32 32.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.966 . . . . 0.0 110.014 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 81' ' ' ILE . 3.3 mt -43.5 126.62 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.464 -0.772 . . . . 0.0 110.182 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 63' ' ' ILE . 25.3 t 53.54 105.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.686 . . . . 0.0 109.858 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 64' ' ' VAL . 1.1 mt-30 -56.61 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.96 -62.63 2.48 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.22 164.69 25.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -1.139 . . . . 0.0 109.347 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.476 ' NZ ' ' CG ' ' A' ' 5' ' ' ASP . 14.8 pttt -177.81 38.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.922 . . . . 0.0 109.351 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.593 ' NE ' ' ND1' ' A' ' 80' ' ' HIS . 17.1 mtm180 -75.49 111.43 10.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.186 -0.946 . . . . 0.0 109.382 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.54 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -78.79 176.61 9.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.74 ' C ' HD23 ' A' ' 72' ' ' LEU . 93.9 m-85 -158.66 -171.94 3.63 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.74 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -114.68 -7.72 12.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.077 -178.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 76' ' ' ASP . 1.6 m -146.2 126.37 13.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.3 tp-100 -43.34 -26.95 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 73' ' ' SER . 5.5 tmm_? -63.95 -35.55 81.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.963 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.2 m-20 -80.85 -38.73 27.68 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.216 -0.928 . . . . 0.0 108.64 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.76 -30.93 64.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.9 tp60 -69.64 -32.66 71.46 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -20.11 61.4 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.593 ' ND1' ' NE ' ' A' ' 69' ' ' ARG . 53.1 t60 -73.04 -44.89 60.18 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.683 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.502 HD12 HD13 ' A' ' 63' ' ' ILE . 3.3 mm -59.36 -50.9 78.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.441 0.639 . . . . 0.0 109.699 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -70.4 -18.79 63.03 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.572 -0.705 . . . . 0.0 109.605 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -86.71 -28.45 23.09 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.101 -178.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -128.66 -21.77 3.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.128 -0.983 . . . . 0.0 112.025 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 4.5 m-70 -104.9 -46.38 4.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.584 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' HIS . 0.2 OUTLIER 40.72 33.03 0.17 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.437 0.637 . . . . 0.0 110.028 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.653 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 13.4 ttp180 -73.47 -69.38 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.448 -0.782 . . . . 0.0 109.561 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 87' ' ' ARG . . . 72.59 174.63 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.475 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.745 ' O ' HD12 ' A' ' 11' ' ' ILE . 1.5 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.4 0.619 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.578 ' H ' HG12 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -91.3 54.35 2.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.442 -0.786 . . . . 0.0 109.873 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 1.5 p90 -152.45 108.74 3.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.984 0.897 . . . . 0.0 109.969 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.1 t -46.78 143.03 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 108.463 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 -28.75 19.98 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.013 -1.054 . . . . 0.0 110.464 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -93.86 -38.96 10.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.078 -1.014 . . . . 0.0 110.75 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 -23.46 14.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.94 . . . . 0.0 110.822 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 6.97 88.75 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.322 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.67 152.13 51.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.967 -1.314 . . . . 0.0 108.367 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.62 137.7 81.91 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.749 1.633 . . . . 0.0 112.696 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.745 HD12 ' O ' ' A' ' 1' ' ' VAL . 71.9 mt -86.95 116.31 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.075 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -81.92 -28.27 32.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.55 146.74 18.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.474 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.1 m-85 -78.81 98.56 6.36 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.722 -1.236 . . . . 0.0 110.377 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.55 83.71 0.55 Allowed Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' GLU . 5.4 ttt-85 -61.52 145.89 50.46 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.305 0.574 . . . . 0.0 110.003 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.569 ' CE ' HG11 ' A' ' 47' ' ' VAL . 5.3 mtp -128.58 133.55 48.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.921 -0.487 . . . . 0.0 110.4 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -122.35 154.75 62.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.13 4.17 48.25 Favored 'Cis proline' 0 N--CA 1.49 1.315 0 C-N-CA 124.219 -1.159 . . . . 0.0 111.493 0.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -56.42 -37.83 70.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.606 -0.684 . . . . 0.0 109.459 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.0 ttmm 74.29 27.39 1.48 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.478 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 13.0 m170 -100.58 177.61 4.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.474 HG21 ' CD2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -145.26 153.3 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.433 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 62.8 m-85 -153.51 -166.85 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.633 ' HA ' HG23 ' A' ' 11' ' ' ILE . 1.6 p -72.6 112.12 8.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.79 ' O ' HG23 ' A' ' 30' ' ' ILE . 34.0 t80 -51.55 -11.0 0.11 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.326 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.2 t70 -77.29 -48.85 16.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.014 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.3 m -78.45 -25.24 45.86 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.78 -1.2 . . . . 0.0 108.222 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.7 -35.68 80.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 108.979 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 26' ' ' TYR . 36.9 pt -80.77 -33.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.87 -23.69 66.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -77.38 -53.22 7.94 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.564 -0.71 . . . . 0.0 109.237 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.59 -24.67 64.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -78.53 -35.37 46.3 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 108.559 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -81.54 -2.2 49.03 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.424 -0.797 . . . . 0.0 109.408 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.07 25.76 51.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 39' ' ' MET . 0.5 OUTLIER -81.75 -34.61 30.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.377 -1.072 . . . . 0.0 109.495 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' A' ' 37' ' ' ASP . 9.4 ptmt 33.09 45.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.584 0.706 . . . . 0.0 110.31 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 37' ' ' ASP . 3.9 ptm -130.86 144.3 51.36 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' SER . 46.6 t -77.13 114.55 40.89 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 109.41 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.19 -15.58 1.44 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.691 1.594 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.86 -62.24 0.82 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -92.35 -20.5 21.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -1.122 . . . . 0.0 110.194 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.4 p 72.11 35.45 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.281 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.46 160.77 26.6 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.56 -0.713 . . . . 0.0 109.107 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.08 81.54 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.434 2.089 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 47' ' ' VAL . 4.6 m -52.66 111.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -59.65 -52.21 66.5 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.875 -1.141 . . . . 0.0 108.75 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.58 124.49 6.69 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.795 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.571 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.9 mt -84.93 144.86 8.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.836 -1.165 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 16' ' ' ARG . 29.0 mt-10 -137.77 149.79 46.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.621 0.724 . . . . 0.0 109.658 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -95.09 141.71 28.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.703 -0.623 . . . . 0.0 110.016 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 160.53 40.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.423 -0.798 . . . . 0.0 109.766 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 158.6 31.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 57' ' ' SER . 26.4 ttp85 -56.27 -71.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 0.0 110.046 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.39 30.64 0.46 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 55' ' ' ARG . 4.2 t -89.56 -26.29 20.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.295 . . . . 0.0 109.509 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mt -101.81 173.66 6.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.648 -0.657 . . . . 0.0 109.866 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CE2' ' CD ' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -121.31 109.47 14.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 mtt -74.45 144.5 44.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 110.507 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 t -84.83 143.08 29.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.749 . . . . 0.0 109.015 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 t -139.74 75.26 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.365 -0.834 . . . . 0.0 109.985 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.615 HG21 ' HD1' ' A' ' 85' ' ' HIS . 3.4 mm -117.82 -84.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.602 HG23 ' H ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -95.28 -90.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.371 -0.83 . . . . 0.0 109.426 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.602 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.3 pt20 -174.09 158.44 3.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.4 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.49 -50.72 4.45 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 1.5 t -47.3 -88.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -1.155 . . . . 0.0 109.449 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 16.0 mttt 53.77 38.35 28.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.72 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -80.01 124.53 28.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 0.0 109.217 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.04 167.33 18.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.082 -1.011 . . . . 0.0 109.738 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.746 ' C ' HD23 ' A' ' 72' ' ' LEU . 31.6 m-85 -154.31 177.87 10.65 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.245 -0.909 . . . . 0.0 109.124 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.746 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -114.43 -5.25 12.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.819 -0.55 . . . . 0.0 109.54 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 67.1 m -153.39 126.56 8.5 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.748 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.468 ' CD ' ' CE2' ' A' ' 59' ' ' PHE . 13.3 mm100 -43.51 -24.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.672 -0.642 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 ttt180 -66.5 -33.23 75.22 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.99 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 8.1 m-20 -86.09 -33.34 20.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.051 -1.031 . . . . 0.0 108.278 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.2 OUTLIER -76.48 -31.8 57.98 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.445 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.663 ' N ' HD23 ' A' ' 77' ' ' LEU . 5.9 tp-100 -72.78 -33.86 66.57 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -19.8 61.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -73.41 -45.3 55.48 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.761 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.4 mm -58.72 -51.2 74.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.501 0.667 . . . . 0.0 109.703 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.59 -18.47 62.89 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.784 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -87.19 -27.34 23.07 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.099 -178.482 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.67 -25.96 2.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.064 -1.023 . . . . 0.0 112.488 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.615 ' HD1' HG21 ' A' ' 63' ' ' ILE . 4.5 m-70 -100.19 -49.2 4.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.995 -1.066 . . . . 0.0 108.968 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 ttt 42.87 33.85 0.54 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.374 0.607 . . . . 0.0 109.762 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.642 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 13.2 ttp180 -81.54 -22.23 38.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.872 . . . . 0.0 109.622 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 87' ' ' ARG . . . 72.7 10.24 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.43 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.561 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.563 ' O ' ' N ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -96.36 22.78 7.4 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 121.362 -0.836 . . . . 0.0 109.199 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -78.74 110.07 13.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.76 -1.212 . . . . 0.0 109.585 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.623 ' HA ' HD11 ' A' ' 11' ' ' ILE . 49.9 t -46.53 146.29 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.84 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.09 -27.2 28.41 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.442 -0.786 . . . . 0.0 109.874 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -53.25 3.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.766 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.542 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 6.5 m -74.65 -27.6 60.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.76 7.69 70.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.03 158.28 34.38 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.296 -1.12 . . . . 0.0 108.564 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.77 96.44 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.852 1.701 . . . . 0.0 112.484 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 4' ' ' CYS . 96.5 mt -41.26 104.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.395 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -76.37 -32.13 58.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.01 146.64 29.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -83.05 104.38 13.21 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.81 -1.181 . . . . 0.0 110.818 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.58 91.0 1.16 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.424 HH21 ' CG ' ' A' ' 21' ' ' LYS . 8.8 ttt-85 -77.65 134.56 38.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.828 -0.807 . . . . 0.0 110.114 -178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.568 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 6.0 mtp -123.61 130.66 53.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.867 -0.521 . . . . 0.0 109.761 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.663 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -113.14 156.85 42.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.77 2.1 42.08 Favored 'Cis proline' 0 N--CA 1.491 1.353 0 C-N-CA 124.087 -1.214 . . . . 0.0 111.328 -0.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -36.31 62.65 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.2 OUTLIER 65.6 26.88 11.58 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.579 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 4.7 m170 -93.63 -172.15 2.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.534 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -144.71 151.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.93 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 41.6 m-85 -162.85 166.77 23.66 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -55.44 111.75 0.96 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.47 -1.292 . . . . 0.0 107.938 178.646 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.499 ' O ' HG23 ' A' ' 30' ' ' ILE . 46.3 t80 -46.3 -21.0 0.13 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 109.767 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.8 t70 -74.36 -37.64 63.42 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.542 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -83.69 -22.61 32.0 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 108.515 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.71 -34.23 71.71 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.8 pt -80.97 -36.09 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 121.141 -0.974 . . . . 0.0 108.919 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 31' ' ' LEU . 78.7 mt -64.56 -37.27 86.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.86 -33.81 72.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -34.88 70.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -73.65 -24.98 60.07 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.042 -1.036 . . . . 0.0 108.64 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -81.99 -74.75 0.33 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.413 -0.805 . . . . 0.0 110.565 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -87.15 -38.88 7.63 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 2.3 t0 74.04 13.79 4.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -1.113 . . . . 0.0 110.014 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -173.58 35.62 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.928 -1.108 . . . . 0.0 111.277 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.1 ptp -148.21 126.53 12.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.676 -1.265 . . . . 0.0 110.455 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.8 OUTLIER -65.73 142.46 98.19 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -54.6 -34.18 81.97 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.532 1.488 . . . . 0.0 112.411 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.12 -43.22 0.8 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.043 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.579 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 2.4 m -86.26 -12.98 48.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.371 . . . . 0.0 110.549 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t 48.16 37.47 8.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 0.0 109.029 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.92 161.1 39.33 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.384 -0.822 . . . . 0.0 109.342 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.32 74.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.377 2.051 . . . . 0.0 111.815 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 45' ' ' ASP . 21.7 t -45.25 100.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -0.832 . . . . 0.0 110.031 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 18' ' ' ILE . 4.9 tt0 -66.07 -61.33 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.663 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -151.6 136.78 17.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.94 179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.1 mt -94.3 146.68 6.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.822 -1.174 . . . . 0.0 109.724 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.05 153.67 45.61 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.427 0.632 . . . . 0.0 109.991 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.55 142.53 30.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 165.55 28.08 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 155.68 23.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 0.0 108.937 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 57' ' ' SER . 10.5 ttp85 -51.56 -62.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 23.66 0.78 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.0 t -86.92 -25.68 24.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.938 -1.331 . . . . 0.0 109.216 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.03 173.89 6.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.512 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 15.1 m-85 -119.31 119.39 33.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mtt -80.08 144.49 33.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.483 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER -99.23 94.86 6.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.268 179.535 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 m -79.9 -22.73 42.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.928 . . . . 0.0 109.435 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.1 mt -44.46 143.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.557 -0.714 . . . . 0.0 109.84 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 66' ' ' GLY . 47.6 t 51.86 94.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.39 -0.819 . . . . 0.0 109.457 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -56.86 90.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . -179.87 -51.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.96 166.39 12.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -1.1 . . . . 0.0 109.519 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -162.87 46.39 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.264 -0.897 . . . . 0.0 109.447 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.3 mmm-85 -81.08 121.98 26.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.934 . . . . 0.0 109.297 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.86 174.72 11.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.711 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.765 ' C ' HD23 ' A' ' 72' ' ' LEU . 97.5 m-85 -156.77 -176.29 5.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.765 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -116.99 -3.34 11.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.617 -0.677 . . . . 0.0 110.086 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 75' ' ' ARG . 8.1 t -149.32 128.12 12.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 109.716 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.66 -23.23 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.4 ttt180 -70.27 -33.16 71.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.363 -0.836 . . . . 0.0 109.687 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.1 m-20 -82.24 -36.7 26.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.8 tt -73.68 -34.78 65.03 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -70.16 -31.42 68.9 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.97 -19.82 60.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.587 ' HD1' ' HH ' ' A' ' 71' ' ' TYR . 58.6 t60 -73.11 -44.52 60.19 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.594 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' N ' ' A' ' 81' ' ' ILE . 2.8 mm -60.21 -52.04 65.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.48 0.657 . . . . 0.0 109.553 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -68.44 -18.32 64.4 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 109.647 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -86.21 -31.06 21.93 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.69 -1.204 . . . . 0.0 112.21 -178.4 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -129.6 -21.59 3.1 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.046 -1.034 . . . . 0.0 112.472 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.522 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 4.5 m-70 -102.28 -47.21 4.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.056 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.4 ttt 43.25 34.44 0.7 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.295 0.569 . . . . 0.0 109.768 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -147.01 116.07 6.9 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.311 -0.868 . . . . 0.0 109.464 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 87' ' ' ARG . . . 175.55 162.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.603 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -173.73 -88.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.415 -0.803 . . . . 0.0 109.465 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -158.39 129.22 6.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 110.243 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.665 ' HA ' HD11 ' A' ' 11' ' ' ILE . 52.0 t -67.97 146.35 53.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.395 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.3 -27.83 38.38 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -99.68 -44.97 5.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.599 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -84.7 -20.31 31.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.41 3.49 25.94 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.67 157.36 37.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.331 -1.1 . . . . 0.0 108.801 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.91 123.12 12.81 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.0 1.8 . . . . 0.0 111.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.665 HD11 ' HA ' ' A' ' 4' ' ' CYS . 75.3 mt -75.89 103.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.64 -0.662 . . . . 0.0 110.575 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -30.81 64.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -147.05 143.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -75.36 110.42 9.7 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.995 -1.066 . . . . 0.0 111.113 -178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -80.12 80.72 1.59 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.455 HH21 ' CG ' ' A' ' 21' ' ' LYS . 7.3 ttt-85 -66.55 131.15 45.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 122.112 -0.64 . . . . 0.0 110.239 -178.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.422 ' O ' ' N ' ' A' ' 21' ' ' LYS . 19.7 mtp -116.91 134.5 54.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.874 -0.516 . . . . 0.0 110.103 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -120.25 157.58 53.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.58 -2.19 47.13 Favored 'Cis proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.107 -1.205 . . . . 0.0 112.146 -0.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 7.1 t -52.8 -36.92 59.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.636 ' HE3' HD21 ' A' ' 72' ' ' LEU . 2.0 tttp 74.94 27.55 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.594 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 1.4 m80 -95.58 -178.24 4.34 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -145.71 153.5 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.868 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 34.9 m-85 -161.46 166.24 27.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -48.97 113.03 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.699 179.569 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -50.88 -18.02 0.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.347 -0.846 . . . . 0.0 109.883 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.427 ' O ' HD12 ' A' ' 31' ' ' LEU . 35.9 t70 -79.82 -33.04 40.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.519 ' O ' ' CG ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -85.34 -23.97 27.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.626 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.541 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -72.07 -35.66 69.35 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -85.44 -34.03 8.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.146 -0.971 . . . . 0.0 108.957 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.483 HD23 ' HD3' ' A' ' 34' ' ' LYS . 7.8 mt -72.69 -22.75 60.86 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.803 -1.159 . . . . 0.0 107.979 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 28' ' ' CYS . 35.6 m170 -83.79 -36.46 23.54 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.234 -0.916 . . . . 0.0 108.869 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -34.53 66.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 109.441 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HD3' HD23 ' A' ' 31' ' ' LEU . 12.9 ptmt -84.93 -28.76 25.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.228 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -68.52 -15.84 63.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.987 -1.071 . . . . 0.0 109.709 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.59 31.38 2.57 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.579 ' C ' ' H ' ' A' ' 39' ' ' MET . 6.4 t70 -131.47 57.79 1.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.61 34.91 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.725 0.774 . . . . 0.0 108.974 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.579 ' H ' ' C ' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -126.61 135.58 51.41 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -41.07 104.79 0.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.684 -0.635 . . . . 0.0 109.98 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -52.62 -16.23 5.25 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.444 1.429 . . . . 0.0 111.757 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.33 -44.24 2.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.541 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 2.8 m -106.99 -26.11 11.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.316 -1.108 . . . . 0.0 110.528 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.88 56.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.118 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.34 161.02 43.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.25 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.468 2.112 . . . . 0.0 112.073 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 39' ' ' MET . 88.8 t -58.0 105.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.235 -0.915 . . . . 0.0 109.07 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -68.67 -65.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -0.988 . . . . 0.0 108.774 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.467 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.39 125.49 9.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.01 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.541 HG21 ' HB1' ' A' ' 29' ' ' ALA . 4.2 mt -81.39 145.08 9.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 109.172 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.12 145.93 40.05 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.787 0.803 . . . . 0.0 110.095 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.97 143.72 26.66 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.333 0.587 . . . . 0.0 109.762 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 161.04 41.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 109.469 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.527 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -84.86 166.92 16.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.487 ' CG ' ' H ' ' A' ' 56' ' ' GLY . 8.4 ptp180 -58.81 -58.54 8.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.18 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.487 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -75.38 23.79 1.48 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.811 ' O ' HD23 ' A' ' 58' ' ' LEU . 16.5 m -86.1 -14.67 43.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.108 -1.23 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 57' ' ' SER . 1.1 mt -135.4 172.45 13.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.452 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 59' ' ' PHE . 18.9 m-85 -114.96 122.65 46.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 mmt -84.79 144.31 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.668 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.7 t -78.23 143.4 37.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.242 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 t -128.23 67.99 1.35 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.551 -0.718 . . . . 0.0 109.796 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.577 HG21 ' ND1' ' A' ' 85' ' ' HIS . 3.8 mm -126.81 -20.46 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -170.37 140.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.363 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -48.66 137.81 11.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.246 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.78 77.46 0.2 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.59 -171.48 3.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -1.108 . . . . 0.0 109.906 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.65 -59.82 4.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.417 -0.802 . . . . 0.0 109.672 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.467 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.3 OUTLIER -179.88 -168.95 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.742 -179.395 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.5 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -89.41 -173.48 4.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.407 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.612 ' C ' HD23 ' A' ' 72' ' ' LEU . 66.3 m-85 -154.89 171.31 19.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.224 -0.922 . . . . 0.0 108.671 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.14 -2.18 21.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.4 -0.812 . . . . 0.0 110.946 -178.162 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 74' ' ' GLN . 1.4 p -160.66 134.42 6.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.242 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -42.9 -29.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -65.35 -34.36 78.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.439 -0.788 . . . . 0.0 110.425 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -83.9 -35.41 24.11 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 108.288 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.617 HD23 ' C ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -75.94 -31.6 59.16 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.575 ' N ' HD23 ' A' ' 77' ' ' LEU . 5.9 tp-100 -73.77 -33.78 64.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.66 61.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.838 ' CE1' ' HE2' ' A' ' 85' ' ' HIS . 5.5 t60 -72.73 -51.53 18.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.196 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.588 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.6 mm -51.66 -53.05 18.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.666 -0.646 . . . . 0.0 109.657 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.07 -19.07 64.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.104 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -87.08 -28.15 22.72 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.723 -1.191 . . . . 0.0 112.031 -178.487 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -129.42 -23.42 2.93 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.454 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.838 ' HE2' ' CE1' ' A' ' 80' ' ' HIS . 4.8 m-70 -104.34 -47.27 4.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 0.0 109.27 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER 43.87 35.86 1.21 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.292 0.568 . . . . 0.0 109.866 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.2 ttp85 -174.55 154.88 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.53 140.99 50.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.543 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.965 0.412 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 4.4 m -46.0 145.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -82.36 -26.61 32.75 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 -33.31 12.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 110.567 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -104.33 -25.4 12.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -0.898 . . . . 0.0 110.83 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.26 -9.24 49.03 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.28 158.45 86.75 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.993 -1.298 . . . . 0.0 108.819 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -68.15 104.34 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.8 1.667 . . . . 0.0 112.883 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.611 HG23 ' HA ' ' A' ' 25' ' ' CYS . 78.4 mt -50.99 120.15 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.43 0.633 . . . . 0.0 110.236 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -88.31 -27.07 21.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.69 144.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -80.78 100.11 8.6 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.802 -1.186 . . . . 0.0 110.453 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 95.1 1.64 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.414 HH21 ' HG3' ' A' ' 21' ' ' LYS . 18.9 ttt-85 -80.89 137.28 36.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.037 -0.684 . . . . 0.0 110.168 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 9.7 mtp -121.74 134.18 54.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.122 0.486 . . . . 0.0 110.238 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.664 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -114.37 155.9 45.17 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.69 2.97 52.47 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.145 -1.19 . . . . 0.0 111.364 -0.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.3 t -56.74 -33.48 66.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.537 -0.727 . . . . 0.0 109.389 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 66.93 26.69 9.12 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 33.8 m170 -97.49 162.49 13.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.902 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -118.07 160.79 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.157 0.98 . . . . 0.0 111.019 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 93.5 m-85 -164.53 -165.23 0.91 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.611 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -85.06 113.12 21.24 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.715 ' O ' HG23 ' A' ' 30' ' ' ILE . 41.0 t80 -47.67 -16.38 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.973 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 25' ' ' CYS . 7.4 t70 -82.73 -50.68 8.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.027 -1.046 . . . . 0.0 109.488 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 3.0 m -78.86 -20.85 48.56 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.81 -1.182 . . . . 0.0 108.096 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.93 71.33 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.715 HG23 ' O ' ' A' ' 26' ' ' TYR . 40.7 pt -80.32 -33.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 121.001 -1.062 . . . . 0.0 108.793 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 28' ' ' CYS . 14.9 mt -64.0 -34.37 77.86 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.876 -1.13 . . . . 0.0 107.988 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.17 -42.52 72.36 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.94 95.82 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 mttp . . . . . 0 C--N 1.303 -1.431 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.218 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 39' ' ' MET . 10.8 ptm . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.556 0.693 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.451 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 1.2 t -62.12 139.8 96.03 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.77 . . . . 0.0 108.981 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.69 -36.97 20.08 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.875 1.716 . . . . 0.0 112.416 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.89 -36.94 0.79 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.601 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -83.6 -14.16 52.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.281 . . . . 0.0 110.277 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 t 47.65 36.02 5.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.077 -1.015 . . . . 0.0 109.464 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.33 161.11 38.15 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 108.786 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.73 73.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.153 1.902 . . . . 0.0 111.884 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 45' ' ' ASP . 59.0 t -47.16 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 0.0 109.501 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -66.72 -62.79 1.27 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.161 -0.962 . . . . 0.0 108.517 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -150.03 134.31 17.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.799 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -94.34 145.97 7.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.616 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.09 150.79 44.75 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.438 0.637 . . . . 0.0 109.781 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -94.91 150.12 20.51 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.566 -0.709 . . . . 0.0 109.75 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.87 168.26 25.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.267 -0.895 . . . . 0.0 109.69 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -80.64 157.43 25.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.308 -0.87 . . . . 0.0 108.828 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -75.5 26.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.052 . . . . 0.0 109.864 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -144.29 13.91 2.08 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.11 -19.05 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.777 -0.837 . . . . 0.0 110.365 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 mt -110.81 165.4 11.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.539 -0.726 . . . . 0.0 109.784 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 24.4 m-85 -119.19 113.88 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.0 mtp -80.61 144.41 32.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.726 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -74.15 176.35 6.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.72 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.698 ' C ' HD23 ' A' ' 72' ' ' LEU . 78.4 m-85 -159.05 -170.87 3.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.86 -11.43 14.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 110.278 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 74' ' ' GLN . 3.5 m -150.91 133.5 15.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.975 -1.078 . . . . 0.0 109.343 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 73' ' ' SER . 2.1 tp60 -44.12 -31.93 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -61.66 -31.98 72.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 110.496 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.02 -35.62 23.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 108.639 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.83 -34.35 62.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.744 HE22 HD22 ' A' ' 82' ' ' ASN . 0.9 OUTLIER -68.17 -39.01 82.67 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.543 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -66.02 -21.55 66.4 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.608 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 25.8 t60 -76.05 -36.91 58.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.919 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.6 mm -62.05 -53.28 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 110.038 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.744 HD22 HE22 ' A' ' 78' ' ' GLN . 3.8 p30 -72.18 -19.02 61.82 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.68 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 34.6 m170 -85.71 -25.9 26.21 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.525 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -129.97 -20.11 3.16 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.278 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.608 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 8.5 m-70 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.398 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.599 ' HA ' HD11 ' A' ' 11' ' ' ILE . 4.3 t -46.37 146.37 1.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 110.073 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -18.56 39.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.458 -0.776 . . . . 0.0 109.303 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.03 -51.23 3.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.55 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 10.3 m -84.14 -14.65 49.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.406 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.24 9.13 14.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.23 158.62 33.68 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.343 -1.092 . . . . 0.0 108.693 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.73 101.53 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.989 1.793 . . . . 0.0 112.267 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 4' ' ' CYS . 74.2 mt -50.27 120.74 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.514 0.673 . . . . 0.0 110.578 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.32 -31.66 20.06 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.06 141.89 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -81.74 102.03 10.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.544 -1.347 . . . . 0.0 110.688 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -75.54 85.74 0.84 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.604 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.5 ttt-85 -69.33 134.87 49.62 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 122.09 -0.653 . . . . 0.0 110.454 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 21' ' ' LYS . 9.4 mmm -118.4 132.42 56.26 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.652 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -116.24 156.46 47.07 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.72 -1.74 47.83 Favored 'Cis proline' 0 N--CA 1.49 1.285 0 C-N-CA 124.137 -1.193 . . . . 0.0 111.533 -0.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.581 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -51.04 -34.16 28.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.604 ' CG ' HH21 ' A' ' 16' ' ' ARG . 3.4 ttmt 67.68 25.86 8.04 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.581 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 21.3 m170 -94.16 179.77 5.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.2 m -144.54 153.27 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 110.788 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 73.9 m-85 -158.42 170.34 22.44 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -55.61 113.63 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.039 -1.465 . . . . 0.0 108.171 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 30' ' ' ILE . 35.5 t80 -49.43 -11.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.855 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -74.56 -44.5 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.021 -1.049 . . . . 0.0 108.831 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.583 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -80.49 -25.48 38.77 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.886 -1.133 . . . . 0.0 108.119 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.3 -36.69 83.58 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.486 -0.885 . . . . 0.0 108.702 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 26' ' ' TYR . 42.5 pt -78.86 -34.95 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.024 -1.047 . . . . 0.0 108.918 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.62 -21.9 66.62 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.267 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -80.09 -40.68 27.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.9 -29.82 62.27 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.465 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 mttp . . . . . 0 C--N 1.305 -1.365 0 O-C-N 121.102 -0.999 . . . . 0.0 108.424 179.698 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.445 ' O ' ' CG ' ' A' ' 39' ' ' MET . 15.4 ptm . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 121.261 0.553 . . . . 0.0 109.853 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.554 ' N ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.03 124.36 85.0 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.076 -1.015 . . . . 0.0 109.758 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -44.31 -22.86 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.127 1.885 . . . . 0.0 113.068 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.22 -64.65 0.87 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 62.9 m -69.69 -43.65 72.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.232 -1.158 . . . . 0.0 108.564 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.6 p 76.9 57.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.832 -0.543 . . . . 0.0 111.622 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.443 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 174.82 -48.19 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.386 -1.446 . . . . 0.0 112.117 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 45' ' ' ASP . 64.9 Cg_endo -86.47 51.44 2.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.57 2.18 . . . . 0.0 115.706 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 40' ' ' CYS . 1.8 t -95.35 117.28 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.263 -1.523 . . . . 0.0 109.211 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -98.27 -65.55 0.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.652 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -141.75 137.94 31.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.497 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.9 mt -92.45 145.9 7.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.737 -1.227 . . . . 0.0 109.696 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -137.28 149.0 46.79 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.755 0.788 . . . . 0.0 109.844 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 32.0 mt-30 -94.74 136.15 35.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.831 -0.543 . . . . 0.0 110.03 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.96 155.62 48.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.619 -0.675 . . . . 0.0 110.027 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.75 158.2 22.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.35 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 57' ' ' SER . 7.8 ttp180 -49.33 -69.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -0.98 . . . . 0.0 109.988 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.32 27.52 0.57 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 55' ' ' ARG . 17.0 t -85.05 -27.94 26.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.909 -1.347 . . . . 0.0 108.858 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -112.43 173.73 6.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 17.6 m-85 -113.27 120.54 41.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.852 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 mtp -81.65 144.66 31.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 109.916 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' NE2' ' A' ' 80' ' ' HIS . 50.3 t . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.362 -0.836 . . . . 0.0 109.479 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 70' ' ' THR . 12.0 mmt-85 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -48.19 173.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 109.424 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.761 ' C ' HD23 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -158.81 -173.75 4.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.761 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -116.65 -5.15 11.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.695 -0.628 . . . . 0.0 109.804 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -145.81 125.62 13.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.942 . . . . 0.0 109.061 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -45.38 -22.69 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.6 tmm_? -69.86 -36.32 75.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 110.129 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -82.57 -33.95 27.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.0 tp -70.1 -38.29 75.62 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -67.52 -30.43 70.08 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.48 -20.98 62.0 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.591 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -78.09 -41.58 34.82 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.355 -1.338 . . . . 0.0 108.429 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.8 mm -56.3 -54.98 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 109.281 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.497 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 5.8 p30 -69.35 -23.56 63.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.526 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.9 m170 -87.68 -11.73 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.189 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -115.37 -49.95 2.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.264 -0.897 . . . . 0.0 112.858 -177.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.214 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 4.9 t -45.95 146.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.818 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.8 -25.43 40.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -48.8 4.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.278 -0.889 . . . . 0.0 110.301 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 10.4 m -78.07 -15.61 58.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.83 13.06 12.03 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.66 158.75 31.2 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.546 -0.973 . . . . 0.0 108.48 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -65.85 103.45 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.088 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 4' ' ' CYS . 71.0 mt -49.47 116.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.336 0.589 . . . . 0.0 110.447 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 -31.72 33.94 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.57 145.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -73.99 102.07 4.04 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.491 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.13 85.72 1.11 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH2' ' OG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -71.28 141.44 50.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.904 -0.762 . . . . 0.0 110.519 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 21' ' ' LYS . 11.4 mtp -129.58 132.84 46.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.756 -0.59 . . . . 0.0 109.887 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.646 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -118.03 156.03 50.66 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.83 3.58 41.46 Favored 'Cis proline' 0 N--CA 1.492 1.385 0 C-N-CA 124.112 -1.203 . . . . 0.0 111.799 -0.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -55.39 -37.04 67.05 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.427 -0.795 . . . . 0.0 109.008 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HZ2' HD21 ' A' ' 72' ' ' LEU . 3.0 tttm 68.78 29.14 5.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 4.9 m80 -100.41 -174.75 2.73 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.759 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.572 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -141.66 155.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.396 -0.815 . . . . 0.0 110.998 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.8 m-85 -164.17 168.3 19.11 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -55.43 112.61 1.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.193 -1.403 . . . . 0.0 108.008 178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 30' ' ' ILE . 48.6 t80 -49.63 -31.3 10.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 0.0 109.883 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -39.99 84.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -81.38 -23.66 37.52 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.21 -35.89 74.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.517 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 26' ' ' TYR . 19.1 pt -86.7 -35.13 8.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.163 -0.961 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.71 -23.82 60.91 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.333 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.566 ' CE1' ' SG ' ' A' ' 28' ' ' CYS . 40.7 m170 -78.44 -55.45 5.21 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.24 -32.31 66.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.388 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 mttm . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.034 -1.041 . . . . 0.0 109.367 179.751 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.585 ' HA ' HG23 ' A' ' 47' ' ' VAL . 7.4 mtm . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -38.72 102.91 0.26 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.049 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.56 -19.48 5.0 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.796 1.664 . . . . 0.0 112.33 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.15 -37.21 2.95 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.71 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.0 m -104.84 -31.63 9.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -1.113 . . . . 0.0 110.319 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 75.59 63.02 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.079 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.432 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -130.8 160.31 67.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.88 90.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.553 2.169 . . . . 0.0 112.38 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 39' ' ' MET . 97.5 t -60.49 94.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 108.687 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ILE . 5.3 tt0 -61.75 -62.85 1.51 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.191 -0.943 . . . . 0.0 108.638 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.646 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.78 139.07 22.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.273 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.54 143.11 13.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.826 -1.171 . . . . 0.0 109.844 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -136.73 141.14 43.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.785 0.802 . . . . 0.0 110.025 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -85.52 149.2 25.54 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.329 0.585 . . . . 0.0 109.669 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.51 ' SG ' HD21 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -145.86 165.93 27.45 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.32 169.78 10.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.772 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -90.38 74.86 6.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.398 1.095 . . . . 0.0 108.649 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.82 4.42 0.1 Allowed Glycine 0 C--N 1.288 -2.113 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.442 ' C ' HD23 ' A' ' 58' ' ' LEU . 20.6 m -90.23 -34.0 15.96 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.089 -1.242 . . . . 0.0 109.536 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -100.23 173.88 6.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.701 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -134.66 128.5 33.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.673 -0.642 . . . . 0.0 109.521 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.08 144.73 29.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.537 -0.727 . . . . 0.0 110.577 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' CB ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 109.371 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.745 HH11 HH22 ' A' ' 84' ' ' ARG . 68.5 mtp180 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 121.254 0.549 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.527 ' OG1' ' NH2' ' A' ' 16' ' ' ARG . 1.2 p -56.18 170.01 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.686 ' C ' HD23 ' A' ' 72' ' ' LEU . 37.2 m-85 -158.0 170.01 23.27 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.728 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -108.03 -5.65 16.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.742 -0.598 . . . . 0.0 109.727 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.3 t -158.57 129.49 6.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 73' ' ' SER . 1.2 tp60 -42.27 -26.15 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.331 0.586 . . . . 0.0 109.439 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 tmt_? -64.17 -34.79 78.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -83.17 -36.52 24.65 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 108.41 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.34 -33.15 67.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.437 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 23.3 tp60 -69.99 -33.32 71.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.532 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.34 61.43 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.424 ' CD2' ' CB ' ' A' ' 61' ' ' CYS . 26.3 t60 -74.22 -44.12 54.44 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.471 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.495 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.8 mm -60.18 -53.53 47.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.549 -0.72 . . . . 0.0 109.196 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 14.8 m-20 -64.65 -22.51 66.99 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.22 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 18.1 m170 -87.41 -12.24 46.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.125 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.745 HH22 HH11 ' A' ' 69' ' ' ARG . 15.3 mmt-85 -120.9 -43.45 2.46 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.25 -0.906 . . . . 0.0 112.866 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.634 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.773 0 O-C-N 120.592 -1.317 . . . . 0.0 110.244 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.318 0.58 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.652 ' HA ' HD11 ' A' ' 11' ' ' ILE . 10.4 p -51.56 143.89 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.39 -0.819 . . . . 0.0 110.057 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.85 -4.48 57.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -85.46 -33.27 21.91 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.518 ' HG ' ' CB ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -135.68 -15.96 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.621 -0.674 . . . . 0.0 110.488 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.567 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.09 14.31 64.68 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.212 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.52 156.62 37.32 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.088 -1.243 . . . . 0.0 108.432 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.97 136.52 66.18 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.778 1.652 . . . . 0.0 111.788 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 4' ' ' CYS . 79.0 mt -88.17 93.79 4.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.61 0.719 . . . . 0.0 110.313 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -69.34 -36.35 76.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.23 142.72 36.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.603 ' CD2' HD12 ' A' ' 58' ' ' LEU . 19.3 m-85 -73.31 106.04 4.96 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.135 -0.978 . . . . 0.0 111.123 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.79 81.27 0.77 Allowed Glycine 0 C--N 1.297 -1.616 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 21' ' ' LYS . 19.8 ttm-85 -65.8 133.01 50.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.942 -0.74 . . . . 0.0 109.164 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.533 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 31.3 mtp -119.12 134.62 55.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 110.566 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -118.75 156.5 51.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.88 -1.32 43.76 Favored 'Cis proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.962 -1.266 . . . . 0.0 111.32 0.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.604 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.4 OUTLIER -49.87 -41.2 44.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.54 ' C ' HH12 ' A' ' 16' ' ' ARG . 5.4 ttmt 74.08 27.96 1.51 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.618 ' CE1' ' HG ' ' A' ' 43' ' ' CYS . 23.3 m80 -99.82 -175.99 3.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.486 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 2.9 m -145.3 153.55 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.171 -0.956 . . . . 0.0 111.376 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 66.3 m-85 -154.23 -149.94 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -90.54 107.81 19.4 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 30' ' ' ILE . 51.2 t80 -48.34 -13.48 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 109.832 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -83.05 -48.95 10.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 109.703 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 3.4 m -79.91 -23.15 42.0 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 108.361 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' ' CD1' ' A' ' 50' ' ' ILE . . . -68.31 -35.25 77.54 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' TYR . 38.4 pt -81.75 -34.34 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 O-C-N 120.948 -1.095 . . . . 0.0 109.241 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.62 -23.94 63.58 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.854 -1.139 . . . . 0.0 108.406 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.24 -40.4 27.11 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.185 -0.947 . . . . 0.0 108.833 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -31.24 63.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.1 mttt . . . . . 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 -179.427 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 42' ' ' GLY . 10.6 t -102.74 74.49 0.17 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.804 -0.56 . . . . 0.0 111.008 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -35.3 -21.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.517 2.145 . . . . 0.0 114.034 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -75.34 -35.48 47.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.618 ' HG ' ' CE1' ' A' ' 22' ' ' HIS . 1.9 m -125.81 -33.46 2.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 122.019 -0.695 . . . . 0.0 109.424 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' CYS . 2.8 p 83.99 78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.904 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.66 160.03 48.91 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.22 81.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.014 1.809 . . . . 0.0 111.612 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.4 t -48.49 101.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 108.728 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -61.53 1.74 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.459 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.3 122.97 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.292 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.472 ' CD1' ' O ' ' A' ' 29' ' ' ALA . 6.8 mt -79.89 147.41 6.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.876 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -139.03 162.54 34.69 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.605 0.717 . . . . 0.0 110.559 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.558 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 45.7 mt-30 -99.12 134.51 41.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.77 -0.581 . . . . 0.0 110.539 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.25 155.28 47.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.51 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.38 155.86 17.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.833 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 57' ' ' SER . 1.1 ptm180 -51.61 -55.44 19.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.815 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.56 7.69 0.94 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -103.61 -8.21 20.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.39 -1.065 . . . . 0.0 109.741 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.603 HD12 ' CD2' ' A' ' 14' ' ' TYR . 26.8 mt -130.99 169.09 16.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 110.098 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 44.8 m-85 -122.59 122.35 38.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.5 mtt -87.64 144.83 26.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 0.0 110.336 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 51.7 t . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.634 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 83.4 mtt-85 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.523 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.19 175.82 10.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.776 ' C ' HD23 ' A' ' 72' ' ' LEU . 88.6 m-85 -157.49 -164.63 1.61 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.378 -0.826 . . . . 0.0 108.941 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.776 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -116.31 -9.52 11.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.766 -0.584 . . . . 0.0 110.106 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 75' ' ' ARG . 62.7 m -147.22 128.45 14.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.653 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.24 -18.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.22 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' SER . 7.6 tmm_? -74.25 -33.91 63.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.695 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.94 -35.78 25.73 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.8 -33.95 64.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -71.03 -30.58 66.82 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.547 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.48 -21.15 61.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.428 ' HD1' ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -74.38 -39.83 62.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.174 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.41 HG23 ' HD2' ' A' ' 85' ' ' HIS . 28.0 mm -57.58 -59.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.871 0.843 . . . . 0.0 110.029 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.463 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.0 p30 -67.44 -20.11 65.46 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.555 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 37.5 m170 -86.94 -13.46 44.63 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.428 ' HG3' ' HD1' ' A' ' 80' ' ' HIS . 15.7 mmt-85 -124.79 -41.03 2.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.177 -0.952 . . . . 0.0 112.334 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.41 ' HD2' HG23 ' A' ' 81' ' ' ILE . 5.4 m-70 . . . . . 0 C--N 1.301 -1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.609 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 3.0 t80 . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 t -45.66 146.18 1.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.881 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -27.62 18.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.443 -0.786 . . . . 0.0 109.452 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.7 -38.78 10.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 1.9 m -96.09 -28.64 14.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.463 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.51 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.73 4.73 90.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.92 156.29 40.69 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.122 -1.222 . . . . 0.0 108.654 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.11 138.28 85.6 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.914 1.742 . . . . 0.0 112.089 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.594 HG23 ' HA ' ' A' ' 25' ' ' CYS . 40.5 mt -84.7 -67.4 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.642 -0.661 . . . . 0.0 111.002 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.0 -32.71 0.24 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.577 ' H ' ' C ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -145.17 120.06 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.409 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.4 m-85 -67.21 113.26 5.0 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.655 -0.653 . . . . 0.0 110.863 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.75 82.2 1.67 Allowed Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.404 HH21 ' HG3' ' A' ' 21' ' ' LYS . 4.0 ttt-85 -64.9 133.99 53.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 122.141 -0.623 . . . . 0.0 109.946 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.5 mtp -118.09 133.58 55.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.079 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.66 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.87 156.78 49.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.43 1.24 56.47 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.017 0.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.547 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 5.7 t -54.68 -38.04 66.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.407 -0.808 . . . . 0.0 109.13 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 5.4 tttm 76.56 29.33 0.68 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.599 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 2.6 m80 -101.58 -179.17 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -145.88 155.31 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.033 -1.042 . . . . 0.0 110.97 -179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 51.2 m-85 -159.71 167.12 29.1 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.594 ' HA ' HG23 ' A' ' 11' ' ' ILE . 20.4 p -51.68 110.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.212 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 30' ' ' ILE . 39.2 t80 -49.67 -10.92 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.622 -0.674 . . . . 0.0 110.356 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.1 m-20 -78.65 -44.31 24.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.725 -1.234 . . . . 0.0 109.51 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 3.6 p -80.51 -25.35 38.79 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 108.196 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -64.43 -37.71 88.46 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 26' ' ' TYR . 40.7 pt -82.57 -34.55 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.629 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.15 -19.48 59.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.151 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.18 -54.06 6.98 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.27 -0.894 . . . . 0.0 109.161 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -67.62 -30.97 70.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 mttp . . . . . 0 C--N 1.307 -1.27 0 O-C-N 121.024 -1.047 . . . . 0.0 109.071 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.55 ' HA ' HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -42.87 106.12 0.46 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.0 109.621 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.47 -21.92 8.17 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.568 1.512 . . . . 0.0 112.124 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.21 -42.12 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.747 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.599 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 4.8 m -100.88 -30.33 11.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -1.159 . . . . 0.0 110.608 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.19 57.04 0.09 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 109.06 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.3 OUTLIER -123.48 160.96 48.33 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.609 -0.682 . . . . 0.0 109.209 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.08 89.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.538 2.158 . . . . 0.0 112.048 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 39' ' ' MET . 98.5 t -57.45 101.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.187 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.55 -66.22 0.57 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.66 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -151.35 134.8 16.17 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.485 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.521 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.5 mt -88.26 145.81 7.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.666 -1.271 . . . . 0.0 109.107 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.53 146.82 44.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.75 142.16 27.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.774 -0.579 . . . . 0.0 109.605 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.38 159.07 44.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.355 -0.841 . . . . 0.0 110.204 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.38 162.82 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.05 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.524 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -66.32 -60.32 2.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 110.064 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.39 25.89 0.58 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.3 t -91.17 -23.6 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.4 173.45 6.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.734 -0.604 . . . . 0.0 109.71 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -117.08 119.91 36.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.4 mmt -75.9 144.52 41.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 110.341 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.035 179.493 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -82.71 174.79 10.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.954 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.726 ' C ' HD23 ' A' ' 72' ' ' LEU . 98.2 m-85 -158.31 -177.92 6.9 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.9 -2.7 13.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.587 -0.695 . . . . 0.0 110.549 -178.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ASP . 1.5 m -154.57 131.39 10.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.814 -1.179 . . . . 0.0 109.865 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.3 tp60 -43.39 -30.18 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -63.77 -35.05 79.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.509 -0.745 . . . . 0.0 110.131 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.1 m-20 -81.19 -37.82 28.07 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.995 0.903 . . . . 0.0 108.705 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 tt -74.43 -31.07 62.16 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLN . 22.6 tp60 -71.07 -33.73 70.52 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.31 -19.92 61.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -72.67 -47.52 46.75 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.601 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.516 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.5 mm -56.17 -51.05 67.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.688 -0.633 . . . . 0.0 109.61 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.05 -18.66 62.56 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.867 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.0 m170 -87.67 -27.32 22.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.075 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -23.82 2.96 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.485 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 5.4 m-70 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.163 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.615 ' HA ' HD11 ' A' ' 11' ' ' ILE . 48.8 t -46.93 146.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.874 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.43 -24.11 39.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.447 -0.783 . . . . 0.0 109.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -60.95 1.44 Allowed 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.375 -0.828 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 7.3 m -68.27 -14.93 63.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 110.291 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.49 11.33 5.12 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 152.49 37.83 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.988 . . . . 0.0 108.572 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.76 100.37 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.729 1.619 . . . . 0.0 112.259 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 4' ' ' CYS . 77.8 mt -47.37 117.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.681 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -83.14 -32.08 26.84 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.12 143.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -73.19 100.71 3.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 120.852 -1.155 . . . . 0.0 111.032 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -76.53 86.86 0.93 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.479 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.6 ttt-85 -77.79 141.43 39.22 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.761 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.553 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 11.2 mtp -128.72 132.45 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.968 -0.457 . . . . 0.0 109.949 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.664 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -114.6 156.22 45.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.73 4.08 46.07 Favored 'Cis proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.344 -0.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.2 t -55.81 -35.36 66.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.509 -0.745 . . . . 0.0 109.122 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 72' ' ' LEU . 4.5 tttt 66.62 27.77 9.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.605 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 27.0 m170 -93.54 -173.3 3.15 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.478 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.553 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -142.89 156.68 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 110.346 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 85.7 m-85 -165.66 166.26 18.14 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -57.68 114.75 2.41 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.553 ' O ' HG23 ' A' ' 30' ' ' ILE . 43.9 t80 -47.65 -21.27 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.016 -1.052 . . . . 0.0 109.808 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.36 -39.87 62.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.061 -1.024 . . . . 0.0 108.248 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.537 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.02 -22.29 33.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.53 -34.28 72.11 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 26' ' ' TYR . 45.4 pt -80.52 -35.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 121.104 -0.998 . . . . 0.0 108.67 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 28' ' ' CYS . 34.9 mt -62.57 -38.81 91.57 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.693 -1.203 . . . . 0.0 107.876 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.26 -34.88 73.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -35.78 76.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.835 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mttt . . . . . 0 C--N 1.302 -1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 108.704 179.623 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.7 ptp . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.881 0.848 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.491 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 1.5 t -71.0 136.65 84.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -45.81 -46.68 15.07 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.911 1.741 . . . . 0.0 113.074 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.08 4.26 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.214 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.605 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -94.07 -14.97 25.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.257 . . . . 0.0 110.586 -178.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 p 48.48 38.18 10.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -92.22 161.1 33.86 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.357 -0.84 . . . . 0.0 108.999 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLN . 19.6 Cg_endo -59.73 71.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.2 1.933 . . . . 0.0 112.068 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 45' ' ' ASP . 61.2 t -44.99 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.17 -0.956 . . . . 0.0 109.724 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' PRO . 3.7 tt0 -65.61 -61.74 1.92 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.069 -1.019 . . . . 0.0 108.344 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -148.76 137.53 21.39 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.769 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -94.78 147.31 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.641 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -140.53 154.48 46.56 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.29 0.567 . . . . 0.0 109.706 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.22 138.47 45.52 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.25 0.548 . . . . 0.0 109.692 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.69 165.97 25.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -82.88 157.89 22.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.853 . . . . 0.0 109.091 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -72.53 31.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -146.79 14.28 1.54 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.52 ' C ' HD23 ' A' ' 58' ' ' LEU . 62.9 m -97.21 -28.63 14.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.702 -0.881 . . . . 0.0 110.404 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -114.11 172.42 7.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.607 -0.683 . . . . 0.0 109.783 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 41.7 m-85 -116.89 124.1 48.64 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -86.44 144.55 27.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.91 . . . . 0.0 110.393 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.585 ' N ' ' SD ' ' A' ' 60' ' ' MET . 42.1 t . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.483 -0.761 . . . . 0.0 109.125 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.594 0.712 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.476 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -90.56 -173.84 3.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.701 ' C ' HD23 ' A' ' 72' ' ' LEU . 95.6 m-85 -152.39 178.29 9.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.991 . . . . 0.0 108.903 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.33 -10.04 14.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.715 -0.615 . . . . 0.0 109.743 -179.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 75' ' ' ARG . 48.2 t -153.18 132.29 12.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.002 . . . . 0.0 109.91 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.54 -22.08 0.43 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.103 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.8 ttt-85 -70.89 -32.51 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -83.52 -34.67 25.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 tt -75.68 -33.88 60.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.438 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 20.6 tp60 -70.3 -33.58 71.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.545 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.84 -19.32 60.77 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.629 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 24.3 t60 -74.81 -44.76 47.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.531 -1.267 . . . . 0.0 108.605 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.538 ' N ' HD13 ' A' ' 81' ' ' ILE . 1.9 mm -56.73 -53.3 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.722 0.772 . . . . 0.0 109.443 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 3.7 m-20 -69.38 -19.72 63.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.215 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 18.4 m170 -87.49 -25.92 23.46 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.781 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.64 -34.24 1.79 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.066 -1.021 . . . . 0.0 112.651 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.629 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 7.6 m-70 . . . . . 0 C--N 1.297 -1.679 0 O-C-N 120.917 -1.114 . . . . 0.0 109.001 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.624 ' HA ' HD11 ' A' ' 11' ' ' ILE . 13.2 t -45.76 146.39 1.16 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 109.991 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.64 -25.92 32.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.599 -0.688 . . . . 0.0 109.71 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.66 -42.63 7.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 48.1 m -90.55 -29.7 17.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.061 -1.024 . . . . 0.0 110.666 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 1.36 87.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.88 158.8 49.97 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 108.502 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -68.54 97.73 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.878 1.719 . . . . 0.0 112.5 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.624 HD11 ' HA ' ' A' ' 4' ' ' CYS . 97.0 mt -41.68 113.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -82.97 -32.71 26.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 11' ' ' ILE . 1.6 t -133.14 147.01 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.05 104.49 16.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.822 -1.174 . . . . 0.0 111.114 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.4 91.27 1.15 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.542 ' NH2' ' O ' ' A' ' 21' ' ' LYS . 2.5 tpt85 -74.63 135.84 41.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.082 -0.657 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.539 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 8.3 mtp -126.34 132.2 51.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.921 -0.487 . . . . 0.0 109.766 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.651 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.28 156.33 48.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.63 3.8 40.11 Favored 'Cis proline' 0 N--CA 1.49 1.321 0 C-N-CA 124.07 -1.221 . . . . 0.0 111.112 -0.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.6 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -55.07 -32.01 61.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' NH2' ' A' ' 16' ' ' ARG . 1.8 mttp 59.52 31.09 20.76 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.606 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 9.3 m170 -96.16 -173.15 2.72 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.591 -0.693 . . . . 0.0 109.374 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.488 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -147.36 149.0 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 110.58 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 37.1 m-85 -158.35 170.6 21.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -59.31 113.89 2.38 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 117.887 -1.525 . . . . 0.0 107.222 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -46.31 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 110.367 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.1 m-20 -78.93 -41.14 30.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.001 -1.062 . . . . 0.0 108.724 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -80.35 -22.08 41.76 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.0 -1.062 . . . . 0.0 108.57 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.632 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.84 -29.06 65.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 pt -89.14 -28.5 5.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.658 -1.276 . . . . 0.0 108.955 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 28' ' ' CYS . 24.4 mt -66.77 -35.89 81.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.09 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -76.27 -44.38 37.46 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.607 ' N ' ' CG ' ' A' ' 32' ' ' HIS . 1.2 pt-20 -52.31 -32.74 39.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 mttm . . . . . 0 C--N 1.304 -1.381 0 O-C-N 121.274 -0.891 . . . . 0.0 109.56 179.659 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 39' ' ' MET . 11.9 ptm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.607 0.717 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.408 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.8 OUTLIER -63.2 143.18 97.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 108.995 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.18 -38.11 95.49 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.125 1.217 . . . . 0.0 112.076 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.33 -45.38 1.35 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.61 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.606 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -89.48 -10.76 45.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.817 -1.402 . . . . 0.0 110.732 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t 48.37 37.48 8.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 108.842 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -89.56 161.1 40.34 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.406 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.2 76.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.488 2.125 . . . . 0.0 111.71 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' ASP . 17.3 t -48.97 109.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.283 -0.885 . . . . 0.0 109.983 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -72.03 -62.25 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 108.56 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.651 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.78 134.5 16.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.692 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.632 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -92.79 144.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.819 -1.176 . . . . 0.0 109.88 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -140.8 146.47 37.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.448 0.642 . . . . 0.0 109.44 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -91.27 150.88 21.13 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.584 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.87 167.84 26.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.466 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -90.49 165.27 13.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.362 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -59.5 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -0.969 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.66 18.9 22.88 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.741 ' O ' HD23 ' A' ' 58' ' ' LEU . 50.9 m -85.16 -21.23 29.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.052 -1.263 . . . . 0.0 108.999 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -132.06 173.1 11.56 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 6.3 m-85 -117.92 109.41 16.48 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.572 -0.705 . . . . 0.0 110.425 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -71.92 144.77 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 0.0 110.138 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.591 ' SG ' ' NE2' ' A' ' 80' ' ' HIS . 44.7 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.824 . . . . 0.0 109.555 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.863 0.363 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.492 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 7.8 p -94.22 158.56 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 110.867 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.597 ' C ' HD23 ' A' ' 72' ' ' LEU . 75.7 m-85 -152.1 173.35 15.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.756 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -100.92 -10.78 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.586 -178.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -162.12 138.99 8.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.807 -1.183 . . . . 0.0 110.519 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -42.99 -31.17 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.41 0.624 . . . . 0.0 109.752 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -66.27 -32.28 73.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.443 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.34 -33.56 22.03 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.2 OUTLIER -75.48 -35.18 60.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.65 ' N ' HD23 ' A' ' 77' ' ' LEU . 52.5 tp60 -72.63 -34.3 67.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.82 -19.64 62.65 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.591 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -77.76 -40.99 39.1 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.396 -1.322 . . . . 0.0 108.641 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.526 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.8 mm -55.71 -54.77 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 108.405 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.48 -26.28 66.29 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.772 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -89.97 -11.97 40.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.579 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -112.19 -54.6 2.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.226 -0.921 . . . . 0.0 112.945 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.429 ' H ' ' CD2' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.233 0.539 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.614 ' HA ' HD11 ' A' ' 11' ' ' ILE . 44.3 t -45.54 146.74 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.214 -0.928 . . . . 0.0 109.987 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -36.15 66.89 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -54.32 2.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 4.0 m -66.05 -13.87 60.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.094 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 4.72 0.47 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 7' ' ' CYS . 5.4 mp -88.96 157.87 47.97 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.249 . . . . 0.0 108.475 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.04 99.29 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.854 1.703 . . . . 0.0 112.539 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' A' ' 4' ' ' CYS . 88.1 mt -47.06 121.43 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -142.45 145.3 23.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -77.39 105.91 8.81 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.714 -1.241 . . . . 0.0 111.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.18 79.88 1.44 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 51' ' ' GLU . 11.5 ttt-85 -58.15 136.71 57.29 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.835 -0.803 . . . . 0.0 109.483 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.774 ' SD ' HG22 ' A' ' 47' ' ' VAL . 25.0 ttm -121.59 137.93 54.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.541 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -127.41 156.85 74.39 Favored Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 -0.34 38.15 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 C-N-CA 124.225 -1.156 . . . . 0.0 112.047 0.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 1.9 t -55.88 -36.82 68.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.1 OUTLIER 74.04 26.92 1.65 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.59 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 2.1 m170 -95.45 -169.25 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -146.44 153.89 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 109.979 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.2 m-85 -159.09 163.01 36.61 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -50.56 113.08 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.218 -1.393 . . . . 0.0 107.864 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -53.73 -19.18 3.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.453 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.41 -37.07 26.06 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.772 -1.205 . . . . 0.0 108.292 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.574 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.3 OUTLIER -83.2 -25.51 31.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -68.5 -32.26 72.12 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 pt -87.99 -33.87 6.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.189 -0.944 . . . . 0.0 109.211 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.39 -26.66 58.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.056 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 28' ' ' CYS . 18.2 m170 -76.74 -50.21 14.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.213 -0.929 . . . . 0.0 108.684 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.33 -27.97 68.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.3 mttt . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.665 -179.845 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 40' ' ' CYS . 2.7 mtt . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.32 0.581 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.53 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -37.1 102.1 0.23 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 122.017 -0.427 . . . . 0.0 111.088 -178.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.65 -14.55 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.667 1.578 . . . . 0.0 111.54 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.1 -38.61 4.02 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.192 -1.004 . . . . 0.0 110.835 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.4 m -120.54 -21.31 6.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.415 -1.05 . . . . 0.0 110.771 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 73.97 55.53 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.142 -179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.95 161.42 30.96 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' GLN . 13.1 Cg_endo -58.7 83.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.389 2.059 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' SD ' ' A' ' 17' ' ' MET . 89.6 t -51.69 97.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.205 -0.934 . . . . 0.0 109.07 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' PRO . 8.1 mt-30 -64.11 -64.0 1.0 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.274 -0.891 . . . . 0.0 108.984 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.46 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.27 126.66 7.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.554 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.426 HG21 ' HB1' ' A' ' 29' ' ' ALA . 1.9 mt -88.32 145.03 7.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 110.25 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' ARG . 24.5 mt-10 -137.31 151.5 48.71 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.766 0.793 . . . . 0.0 110.185 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -90.49 147.61 23.28 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.692 -0.63 . . . . 0.0 109.714 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -152.15 167.39 28.68 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.62 163.79 22.31 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.143 -0.973 . . . . 0.0 109.002 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' C ' ' H ' ' A' ' 57' ' ' SER . 4.6 mtm180 -66.74 -69.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 110.671 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.99 28.36 0.3 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.637 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 55' ' ' ARG . 32.5 m -93.25 -36.9 12.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.277 . . . . 0.0 109.798 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 58' ' ' LEU . 1.2 mt -99.14 173.34 6.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.731 . . . . 0.0 109.915 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.06 106.8 14.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 ttt -72.19 144.41 48.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 109.454 179.681 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.184 0.516 . . . . 0.0 109.634 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.521 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -62.23 177.99 0.43 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.7 ' C ' HD23 ' A' ' 72' ' ' LEU . 26.5 m-85 -162.51 179.44 7.77 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.7 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -109.49 -7.93 15.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 109.834 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' ARG . 40.5 t -157.52 130.03 7.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.022 -1.049 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -42.73 -27.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.648 -0.657 . . . . 0.0 109.308 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.4 tmt_? -64.01 -34.96 79.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 110.535 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' CG ' ' CD1' ' A' ' 71' ' ' TYR . 27.3 t0 -83.11 -35.61 25.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 108.626 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.39 -32.67 64.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -69.08 -35.25 76.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.561 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.89 -20.35 62.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -74.52 -44.09 52.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.004 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 81' ' ' ILE . 3.0 mm -58.02 -50.61 77.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.484 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.459 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.8 p30 -74.79 -18.56 60.45 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.796 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 35.1 m170 -86.19 -24.37 26.13 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.568 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.28 -26.59 2.55 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.108 -0.995 . . . . 0.0 112.115 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.486 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 6.2 m-70 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 109.064 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.111 0.482 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.474 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -44.69 146.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 110.249 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.65 -23.52 36.89 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' NZ ' ' SG ' ' A' ' 7' ' ' CYS . 2.4 ttpt -98.6 -50.68 4.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 110.518 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.423 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 2.0 m -87.32 -17.78 31.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 111.16 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.01 -1.81 9.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.73 158.63 70.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.144 -1.209 . . . . 0.0 108.749 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.01 102.92 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.941 1.761 . . . . 0.0 112.938 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.613 HG23 ' HA ' ' A' ' 25' ' ' CYS . 84.3 mt -49.73 125.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.513 0.673 . . . . 0.0 110.37 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -91.49 -29.41 17.02 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.83 143.75 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -79.8 103.93 10.03 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.05 81.84 1.02 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.839 -2.504 . . . . 0.0 106.839 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 21' ' ' LYS . 8.5 ttt-85 -64.76 131.55 47.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.31 0.576 . . . . 0.0 110.286 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.599 ' CE ' HG11 ' A' ' 47' ' ' VAL . 16.6 mtp -117.55 132.2 56.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.987 -0.445 . . . . 0.0 110.347 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.672 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.87 156.6 49.79 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.97 2.58 48.59 Favored 'Cis proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.154 -1.186 . . . . 0.0 111.289 -0.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.631 ' HG ' ' HD1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -56.27 -36.91 69.12 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.624 -0.673 . . . . 0.0 109.294 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.529 ' HZ3' ' HE1' ' A' ' 71' ' ' TYR . 5.0 ttmt 73.52 25.77 2.06 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.631 ' HD1' ' HG ' ' A' ' 20' ' ' CYS . 24.7 m80 -95.09 -179.06 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.195 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.478 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.3 m -146.33 151.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.083 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 31.6 m-85 -158.74 168.28 27.27 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.613 ' HA ' HG23 ' A' ' 11' ' ' ILE . 2.8 m -53.07 115.47 1.89 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.936 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.692 ' O ' HG23 ' A' ' 30' ' ' ILE . 38.3 t80 -50.9 -11.83 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' N ' ' C ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -76.72 -46.97 23.32 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.14 -0.975 . . . . 0.0 109.042 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.423 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 1.6 m -78.84 -22.96 45.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.998 -1.064 . . . . 0.0 108.412 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.697 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.692 HG23 ' O ' ' A' ' 26' ' ' TYR . 41.3 pt -80.02 -33.7 14.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.039 -1.038 . . . . 0.0 108.986 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.1 mt -67.11 -23.94 65.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.123 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -82.75 -34.77 27.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -27.07 44.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.518 -0.738 . . . . 0.0 109.06 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mttp . . . . . 0 N--CA 1.486 1.351 0 O-C-N 121.218 -0.927 . . . . 0.0 109.249 -179.796 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 ptm . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' SER . 51.9 t -71.34 114.57 28.96 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.863 . . . . 0.0 109.32 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -49.41 -15.56 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.426 1.417 . . . . 0.0 111.856 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.95 -63.92 0.84 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.0 m -90.4 -22.13 21.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.3 p 74.27 36.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' H ' ' HB3' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -103.18 157.18 34.3 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 85.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.442 2.095 . . . . 0.0 112.016 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.683 ' O ' HG23 ' A' ' 47' ' ' VAL . 5.2 m -55.08 104.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.1 tt0 -48.07 -54.94 11.45 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.041 -1.037 . . . . 0.0 108.353 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.672 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -159.04 135.51 9.25 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.796 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.697 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.0 mt -87.7 145.97 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.887 -1.133 . . . . 0.0 109.599 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -138.77 152.97 48.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.518 0.675 . . . . 0.0 109.731 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -96.38 139.14 32.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.74 -0.6 . . . . 0.0 109.877 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.19 161.05 39.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.4 157.92 26.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.279 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 57' ' ' SER . 68.1 mtp180 -53.51 -72.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.235 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.58 30.06 0.36 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 55' ' ' ARG . 19.6 t -86.86 -31.17 20.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.947 -1.325 . . . . 0.0 109.289 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -99.29 173.62 6.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 23.0 m-85 -118.59 117.31 28.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.8 mtt -79.55 144.59 33.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.335 -0.853 . . . . 0.0 110.751 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -80.22 176.02 10.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 110.012 -179.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.824 ' C ' HD23 ' A' ' 72' ' ' LEU . 87.4 m-85 -158.29 -168.39 2.45 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.824 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -119.89 -6.75 10.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.643 -179.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -146.2 127.98 15.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 108.847 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.4 ' HA ' HE21 ' A' ' 74' ' ' GLN . 1.5 tp60 -47.06 -26.0 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -66.35 -31.13 71.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.479 -0.763 . . . . 0.0 109.919 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.68 -34.39 24.98 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.1 -35.27 59.39 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.773 HE22 HD22 ' A' ' 82' ' ' ASN . 0.3 OUTLIER -67.09 -39.74 86.83 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.544 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -66.65 -20.75 66.06 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.13 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.477 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 61.7 t60 -74.8 -40.03 61.36 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.837 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 3.6 mm -60.15 -52.11 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.654 -0.654 . . . . 0.0 110.379 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.773 HD22 HE22 ' A' ' 78' ' ' GLN . 2.6 p30 -74.55 -18.09 60.64 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.036 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 35.1 m170 -85.85 -26.58 25.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.532 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -128.72 -26.11 2.75 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.856 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.477 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 6.7 m-70 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.037 -1.04 . . . . 0.0 109.026 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 8' ' ' GLY . 8.6 p -46.83 128.46 10.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 109.874 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.72 -13.1 60.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.24 -40.29 45.42 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.19 -0.944 . . . . 0.0 109.302 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.466 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -124.48 -21.11 4.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.762 -0.586 . . . . 0.0 110.708 -179.149 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.71 15.93 60.76 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.26 155.47 38.82 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.295 -1.121 . . . . 0.0 108.496 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.5 109.92 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.904 1.736 . . . . 0.0 112.154 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 4' ' ' CYS . 64.1 mt -58.12 112.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.559 0.695 . . . . 0.0 110.466 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -82.12 -33.55 29.61 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.85 137.5 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -76.35 104.81 7.05 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.95 -1.094 . . . . 0.0 110.652 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -78.35 86.44 1.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -70.49 133.43 46.8 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 122.146 -0.62 . . . . 0.0 111.023 -178.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' LYS . 2.7 mmm -118.91 135.25 54.68 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -119.2 153.32 53.21 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.95 -4.78 44.38 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 124.276 -1.135 . . . . 0.0 111.621 0.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t -48.18 -30.21 4.43 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 6.7 mtmm 60.29 28.93 18.57 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.592 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 28.3 m170 -93.86 173.05 7.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.545 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 13.7 m -136.67 151.22 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.707 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 83.4 m-85 -160.9 159.71 30.03 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -47.19 110.27 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.589 ' O ' HG23 ' A' ' 30' ' ' ILE . 32.6 t80 -47.06 -16.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.697 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -77.54 -44.82 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.069 . . . . 0.0 108.848 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.473 ' HA ' HD12 ' A' ' 31' ' ' LEU . 36.7 m -79.12 -21.0 47.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.899 -1.126 . . . . 0.0 108.0 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.3 78.2 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 26' ' ' TYR . 48.6 pt -76.11 -33.52 24.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 108.781 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 28' ' ' CYS . 30.6 mt -65.4 -39.7 92.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.618 -1.233 . . . . 0.0 107.681 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -71.97 -25.35 61.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.363 -0.836 . . . . 0.0 108.771 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.27 -36.89 39.07 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.087 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 C--N 1.303 -1.425 0 O-C-N 120.888 -1.133 . . . . 0.0 108.129 179.248 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.446 ' CG ' ' O ' ' A' ' 39' ' ' MET . 10.2 ptm . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.512 0.672 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -69.23 129.53 91.83 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.52 -29.35 2.1 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.22 1.946 . . . . 0.0 113.623 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.54 -63.68 1.02 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 44' ' ' SER . 70.8 m -67.55 -45.08 76.71 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.432 -1.04 . . . . 0.0 109.025 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 76.98 53.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.709 -0.62 . . . . 0.0 111.412 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.476 ' H ' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER 176.38 -48.59 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.489 -1.382 . . . . 0.0 112.205 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' H ' ' A' ' 45' ' ' ASP . 84.6 Cg_endo -83.48 46.28 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.637 2.225 . . . . 0.0 116.095 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 40' ' ' CYS . 2.0 t -92.95 118.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.272 -1.517 . . . . 0.0 109.397 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -101.74 -64.51 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.477 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.51 144.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.7 -1.25 . . . . 0.0 110.289 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -139.22 140.53 37.78 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.894 0.854 . . . . 0.0 109.943 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -85.27 147.06 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.7 162.01 38.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.442 -0.786 . . . . 0.0 109.882 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.84 162.03 19.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -50.96 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.44 27.32 0.46 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.5 t -81.77 -18.8 42.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.991 -1.3 . . . . 0.0 109.06 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mt -117.69 173.58 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 16.5 m-85 -118.22 117.0 27.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mmt -79.41 144.61 33.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.78 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.476 ' NH1' ' OH ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.25 0.548 . . . . 0.0 109.778 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.545 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -92.76 175.37 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.753 ' C ' HD23 ' A' ' 72' ' ' LEU . 98.4 m-85 -157.56 -174.73 5.01 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -115.63 -6.06 12.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.634 -0.666 . . . . 0.0 110.078 -178.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 76' ' ' ASP . 24.3 p -150.19 130.5 13.72 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.021 . . . . 0.0 109.606 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 78' ' ' GLN . 9.8 mm-40 -44.17 -31.01 0.86 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -62.24 -33.25 74.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 0.0 109.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.8 m-20 -82.98 -36.97 24.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 108.726 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 tt -75.13 -30.75 60.9 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 74' ' ' GLN . 23.9 tp60 -71.4 -34.52 70.44 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.18 -19.99 62.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.41 ' HD1' ' HH ' ' A' ' 71' ' ' TYR . 78.3 t60 -72.8 -47.51 45.9 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.671 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.5 mm -56.56 -51.08 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -70.46 -18.95 62.99 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.774 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.2 m170 -87.45 -27.87 22.45 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.828 -1.149 . . . . 0.0 112.151 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 -16.67 4.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.977 -1.077 . . . . 0.0 112.157 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.5 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.3 m-70 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 120.98 0.419 . . . . 0.0 111.012 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.657 ' HA ' HD11 ' A' ' 11' ' ' ILE . 41.8 t -46.62 146.17 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.57 -27.03 18.44 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 110.513 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.75 -38.96 11.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 110.069 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 11.5 m -93.19 -29.87 15.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.529 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.72 11.56 82.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.93 156.66 36.3 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.464 -1.021 . . . . 0.0 108.541 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.58 142.5 71.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.951 1.767 . . . . 0.0 111.668 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 4' ' ' CYS . 93.0 mt -95.39 73.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.521 -0.737 . . . . 0.0 110.77 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.42 -37.46 7.69 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.52 142.32 20.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -70.9 107.98 4.3 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.599 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -73.44 80.79 0.74 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 1.024 HH21 HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -61.07 141.96 57.01 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.027 -0.69 . . . . 0.0 109.932 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.576 ' CE ' HG11 ' A' ' 47' ' ' VAL . 6.9 mtp -130.7 126.31 36.19 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.655 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -115.06 158.06 41.87 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.25 -2.06 50.24 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.446 -0.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.594 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 9.7 t -57.4 -35.61 70.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 109.336 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' MET . 7.5 ttmt 75.92 29.57 0.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.594 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -94.04 164.44 13.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 58' ' ' LEU . 33.2 m -131.44 148.03 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.334 -0.854 . . . . 0.0 110.888 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 42.1 m-85 -154.92 168.78 25.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.517 ' HG ' ' HG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -51.17 109.15 0.3 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.42 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.471 ' CE2' ' CD ' ' A' ' 52' ' ' GLN . 38.2 t80 -47.13 -20.44 0.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.495 -0.753 . . . . 0.0 109.78 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -74.89 -35.48 62.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 12.3 p -82.46 -27.19 32.02 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -67.67 -37.04 81.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.902 . . . . 0.0 108.629 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 26' ' ' TYR . 25.5 pt -83.06 -34.61 11.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mt -73.72 -22.81 59.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.755 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -79.78 -42.93 23.44 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.183 -0.948 . . . . 0.0 108.778 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -75.05 -29.12 60.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.7 mttt . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.025 -1.047 . . . . 0.0 108.926 179.77 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' SER . 43.9 t -45.3 107.82 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.66 -17.14 2.76 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.262 1.308 . . . . 0.0 111.71 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.46 -50.77 1.51 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.431 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.577 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 69.8 m -92.48 -28.98 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.245 . . . . 0.0 109.942 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' CYS . 1.7 p 75.69 46.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.6 160.05 64.76 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.1 94.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.532 2.154 . . . . 0.0 112.181 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.674 ' O ' HG23 ' A' ' 47' ' ' VAL . 10.5 m -59.49 108.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' ILE . 2.5 tt0 -47.97 -56.23 8.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.655 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -160.66 132.41 5.87 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.903 0.859 . . . . 0.0 108.979 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.498 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.0 mt -84.25 145.23 8.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.815 -1.178 . . . . 0.0 109.508 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -138.59 156.67 47.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.842 0.829 . . . . 0.0 110.321 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.471 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 21.9 mt-30 -95.67 134.71 38.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.89 -0.506 . . . . 0.0 110.027 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.585 ' SG ' ' NH1' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -133.4 153.31 51.71 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.364 0.602 . . . . 0.0 109.987 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.59 158.64 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.795 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 57' ' ' SER . 15.5 ttp85 -48.62 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.442 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.21 28.65 0.26 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.869 -1.158 . . . . 0.0 110.329 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 55' ' ' ARG . 55.3 p -90.19 -19.11 24.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.337 . . . . 0.0 109.592 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.489 ' CD1' HG11 ' A' ' 23' ' ' VAL . 7.6 mt -119.49 173.61 6.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.774 -0.579 . . . . 0.0 109.989 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 26.4 m-85 -116.32 119.8 36.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mtt -85.43 144.49 27.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.494 -0.754 . . . . 0.0 109.358 179.614 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.495 ' O ' ' CE2' ' A' ' 71' ' ' TYR . 11.5 mpt_? . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -60.44 177.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.606 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.755 ' C ' HD23 ' A' ' 72' ' ' LEU . 57.6 m-85 -160.92 -167.4 1.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.419 -0.8 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.024 HD22 HH21 ' A' ' 16' ' ' ARG . 0.1 OUTLIER -114.63 -8.21 12.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.68 -0.638 . . . . 0.0 110.13 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' ARG . 72.6 m -147.45 127.97 14.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 109.626 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -45.9 -19.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 109.126 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.1 ttt-85 -71.37 -33.63 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.77 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.5 -37.68 24.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.66 -34.46 64.94 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 10.2 tp60 -70.54 -30.51 67.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.06 -21.19 61.56 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.62 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 16.4 t60 -76.66 -35.86 57.7 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.794 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.439 ' H ' HG12 ' A' ' 81' ' ' ILE . 5.8 mm -63.92 -51.29 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.445 -0.784 . . . . 0.0 109.695 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.472 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.2 p30 -74.23 -19.05 60.65 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.718 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 37.9 m170 -86.46 -23.04 26.15 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.781 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 -26.56 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.995 -1.066 . . . . 0.0 111.926 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.62 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 6.3 m-70 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 108.964 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 6.1 t -48.02 146.5 2.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.061 -1.024 . . . . 0.0 109.87 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.54 -24.06 45.86 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -64.88 1.01 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.426 -0.797 . . . . 0.0 109.441 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 12.5 m -61.14 -22.0 64.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.21 9.48 29.68 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -101.2 157.81 32.97 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.37 -1.077 . . . . 0.0 108.773 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.73 105.87 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.879 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 4' ' ' CYS . 60.9 mt -53.5 122.67 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.473 0.654 . . . . 0.0 110.594 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.403 ' CD ' ' H ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -86.0 -31.18 22.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.5 t -138.22 145.29 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.477 ' OH ' ' CE ' ' A' ' 60' ' ' MET . 3.2 m-30 -76.78 98.61 4.86 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.792 -1.193 . . . . 0.0 110.893 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 88.24 0.86 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -76.79 141.42 40.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.976 -0.72 . . . . 0.0 110.322 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.524 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 15.4 mtp -129.38 132.98 47.16 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.167 0.508 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.666 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -116.19 156.36 47.11 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.87 2.64 48.0 Favored 'Cis proline' 0 N--CA 1.491 1.324 0 C-N-CA 124.164 -1.182 . . . . 0.0 111.316 -0.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -53.09 -40.11 63.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 tttp 71.59 31.22 2.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.598 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 9.1 m170 -104.63 174.14 6.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.567 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -128.95 159.8 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.619 0.723 . . . . 0.0 110.349 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 74.6 m-85 -166.26 174.06 9.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -62.57 115.41 4.24 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.619 178.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.581 ' O ' HG23 ' A' ' 30' ' ' ILE . 45.0 t80 -49.44 -21.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 109.946 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.7 -41.23 60.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.03 -1.044 . . . . 0.0 108.568 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.502 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.13 -22.0 33.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.21 -33.52 71.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 26' ' ' TYR . 49.3 pt -80.22 -37.02 17.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 121.044 -1.035 . . . . 0.0 108.621 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.27 -36.01 78.86 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.004 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -70.02 -39.94 75.52 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mttt . . . . . 0 C--N 1.304 -1.395 0 O-C-N 121.196 -0.94 . . . . 0.0 108.859 179.779 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 39' ' ' MET . 10.2 ptm . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.675 0.75 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -62.22 143.3 95.45 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -52.93 -36.19 74.05 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.55 1.5 . . . . 0.0 112.044 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.56 -45.46 0.78 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.598 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 3.2 m -81.61 -15.91 53.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.993 -1.298 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t 49.37 36.75 10.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -90.61 161.18 37.18 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.016 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.99 75.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.297 1.998 . . . . 0.0 112.012 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ASP . 37.9 t -47.35 99.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.018 -1.051 . . . . 0.0 109.489 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.5 tt0 -67.31 -61.02 2.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 108.583 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.666 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -150.1 135.34 18.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.015 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.424 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.2 mt -93.83 146.68 6.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.953 -1.092 . . . . 0.0 109.845 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -141.38 141.38 33.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.98 142.82 27.75 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.645 -0.659 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 169.26 19.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.296 -0.877 . . . . 0.0 109.847 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -87.13 162.12 17.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.873 . . . . 0.0 109.583 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 55' ' ' ARG . 1.1 ttp180 -70.04 38.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.021 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -153.27 17.55 0.69 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.74 -27.33 12.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.875 . . . . 0.0 110.243 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 mt -113.0 172.32 7.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.57 -0.706 . . . . 0.0 110.017 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 19.5 m-85 -129.37 120.39 25.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.477 ' CE ' ' OH ' ' A' ' 14' ' ' TYR . 1.8 mpt? -81.77 144.76 30.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.245 -0.91 . . . . 0.0 110.628 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 54.1 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.456 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.52 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -91.94 179.32 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.497 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.725 ' C ' HD23 ' A' ' 72' ' ' LEU . 61.8 m-85 -158.37 -169.74 2.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.391 -0.818 . . . . 0.0 109.069 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -111.92 -9.71 14.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.673 -0.642 . . . . 0.0 110.191 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.6 t -152.9 133.84 14.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.969 -1.082 . . . . 0.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 73' ' ' SER . 5.1 mm-40 -44.96 -30.11 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.9 -34.9 79.0 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.014 0.911 . . . . 0.0 109.786 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.7 m-20 -83.39 -33.97 25.65 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.15 -0.969 . . . . 0.0 108.556 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -74.91 -34.17 62.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.479 ' N ' HD23 ' A' ' 77' ' ' LEU . 11.7 tp60 -70.25 -32.04 69.7 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.09 -20.84 61.59 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.3 OUTLIER -76.47 -38.77 54.85 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.013 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.539 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 5.3 mm -62.11 -54.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.46 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 4.8 p30 -69.21 -20.1 63.97 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.651 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 36.8 m170 -86.88 -13.37 45.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.515 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.41 ' HG3' ' HD1' ' A' ' 80' ' ' HIS . 13.1 mmt180 -122.21 -40.51 2.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.099 -1.001 . . . . 0.0 113.468 -177.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 120.856 -1.152 . . . . 0.0 110.143 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HA ' HD11 ' A' ' 11' ' ' ILE . 17.2 t -45.97 146.17 1.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.546 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.03 -27.44 24.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -91.64 -44.34 9.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 110.095 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 12.9 m -87.94 -27.03 22.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 110.334 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.71 11.4 83.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.14 158.19 32.24 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -1.044 . . . . 0.0 108.882 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.35 106.39 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.961 1.774 . . . . 0.0 112.128 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 4' ' ' CYS . 79.0 mt -54.23 105.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.875 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -71.78 -36.49 70.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.02 141.94 28.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -73.22 112.12 8.97 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.965 -1.084 . . . . 0.0 111.106 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -77.72 78.01 1.55 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.461 HH12 ' C ' ' A' ' 21' ' ' LYS . 4.0 tpt85 -58.23 140.53 52.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 122.155 -0.615 . . . . 0.0 110.235 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.534 ' CE ' HG11 ' A' ' 47' ' ' VAL . 5.5 mtp -130.04 129.01 43.1 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -120.89 156.22 56.76 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.69 0.53 52.94 Favored 'Cis proline' 0 N--CA 1.49 1.268 0 C-N-CA 124.191 -1.17 . . . . 0.0 112.084 0.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.569 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 35.4 t -54.9 -29.68 56.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 109.12 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' C ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER 68.83 25.98 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.575 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 0.2 OUTLIER -95.37 175.52 6.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.675 -0.641 . . . . 0.0 109.37 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -144.98 153.42 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.817 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 26.5 m-85 -159.58 168.14 26.83 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -48.79 111.78 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.86 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 30' ' ' ILE . 35.8 t80 -49.12 -18.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.391 -0.818 . . . . 0.0 109.098 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 25' ' ' CYS . 29.3 t0 -77.23 -36.37 54.72 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -82.86 -25.78 32.24 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -69.25 -36.97 77.72 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 26' ' ' TYR . 32.1 pt -80.57 -35.01 14.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.986 -1.071 . . . . 0.0 109.323 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -67.83 -22.17 65.16 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.516 -1.273 . . . . 0.0 107.965 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -82.3 -35.24 28.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -74.39 -31.8 62.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.662 -0.649 . . . . 0.0 109.603 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 mttt . . . . . 0 N--CA 1.488 1.438 0 O-C-N 121.158 -0.964 . . . . 0.0 110.137 -179.312 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.9 mtp . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 44' ' ' SER . 42.6 t -43.92 106.89 0.54 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.4 -17.22 4.02 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.305 1.337 . . . . 0.0 111.754 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.85 -47.71 2.63 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.394 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.575 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 62.1 m -99.37 -30.0 12.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 78.35 52.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.706 -0.622 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.41 158.47 75.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 109.068 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.71 100.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.605 2.203 . . . . 0.0 112.586 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.68 ' O ' HG23 ' A' ' 47' ' ' VAL . 12.7 m -68.31 106.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -49.24 -54.81 14.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.774 -1.204 . . . . 0.0 108.28 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.482 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -159.6 125.34 4.24 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.475 178.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.49 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.2 mt -78.94 144.83 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.917 -1.114 . . . . 0.0 109.096 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -138.93 153.24 48.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.917 0.865 . . . . 0.0 110.0 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -96.36 138.55 33.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.88 -0.512 . . . . 0.0 109.776 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 158.91 43.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.902 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.77 158.3 24.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.55 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -50.87 -71.0 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 110.142 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.28 27.62 0.44 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 55' ' ' ARG . 9.4 t -86.9 -25.18 24.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.87 -1.37 . . . . 0.0 109.125 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.8 mt -115.35 173.72 6.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.48 116.24 30.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.781 -0.574 . . . . 0.0 109.727 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.7 tpt -79.46 144.48 33.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.823 . . . . 0.0 109.159 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.544 ' N ' ' NE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.63 171.5 5.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.079 -1.013 . . . . 0.0 109.563 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.783 ' C ' HD23 ' A' ' 72' ' ' LEU . 1.9 m-85 -154.36 -174.45 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.373 -0.83 . . . . 0.0 108.796 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.783 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -118.61 -4.79 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.617 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -147.45 123.41 10.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.229 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 73' ' ' SER . 0.5 OUTLIER -44.39 -21.55 0.05 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.4 ttt180 -68.81 -37.0 78.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.403 -0.81 . . . . 0.0 109.649 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.41 -35.66 34.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.47 -32.96 66.65 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.7 tp60 -69.28 -30.91 69.11 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -74.82 -19.93 59.98 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -71.8 -47.46 53.16 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.749 -1.18 . . . . 0.0 108.207 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.471 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.9 mm -56.85 -55.77 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.644 0.735 . . . . 0.0 109.586 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.401 HD21 ' HG3' ' A' ' 78' ' ' GLN . 4.0 m-20 -64.64 -18.24 64.76 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 10.9 m170 -85.47 -32.39 22.29 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.924 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -130.61 -25.02 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.175 -0.953 . . . . 0.0 112.685 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.512 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 3.8 m-70 . . . . . 0 C--N 1.302 -1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 109.023 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.638 ' HA ' HD11 ' A' ' 11' ' ' ILE . 48.0 t -46.36 146.53 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.631 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.28 -28.33 38.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.373 -0.829 . . . . 0.0 109.711 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 -59.4 1.75 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 13.1 m -60.06 -28.62 67.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.14 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.2 73.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.3 158.37 31.89 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.432 -1.04 . . . . 0.0 108.638 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.17 100.04 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.855 1.703 . . . . 0.0 112.233 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 4' ' ' CYS . 89.5 mt -45.67 115.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.94 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.7 -32.28 25.62 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.87 140.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -76.76 103.85 6.94 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.819 -1.175 . . . . 0.0 110.835 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 84.29 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.511 HH21 ' CG ' ' A' ' 21' ' ' LYS . 6.2 ttt-85 -66.73 130.98 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 122.223 -0.575 . . . . 0.0 110.166 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.643 ' CE ' HG11 ' A' ' 47' ' ' VAL . 16.7 mtp -117.0 132.62 56.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.879 -0.513 . . . . 0.0 110.279 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.679 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -115.81 156.75 46.06 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.55 -1.54 51.83 Favored 'Cis proline' 0 N--CA 1.492 1.405 0 C-N-CA 124.119 -1.201 . . . . 0.0 111.958 -0.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.447 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 3.5 t -54.19 -31.58 53.32 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.2 OUTLIER 68.79 24.85 6.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.453 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.72 179.96 5.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.2 m -146.32 150.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 34.6 m-85 -159.09 169.71 23.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -52.5 114.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.206 179.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 30' ' ' ILE . 34.1 t80 -52.22 -15.3 0.57 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.339 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -41.14 63.55 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.548 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 p -81.23 -27.63 35.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.7 -35.99 81.44 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 108.809 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.3 pt -79.91 -34.48 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.129 -1.029 . . . . 0.0 108.873 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.9 mt -64.0 -24.86 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.204 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -80.63 -40.71 25.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -23.34 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.395 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mttt . . . . . 0 N--CA 1.486 1.37 0 O-C-N 121.261 -0.899 . . . . 0.0 108.584 179.513 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.6 t -64.01 114.3 13.22 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 109.002 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -54.68 -12.3 4.33 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.199 1.266 . . . . 0.0 111.554 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.74 -59.76 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 44' ' ' SER . 3.8 m -92.34 -24.55 18.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.226 -1.161 . . . . 0.0 109.969 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER 74.86 40.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.3 157.11 43.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.69 97.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.5 2.133 . . . . 0.0 112.228 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.643 HG11 ' CE ' ' A' ' 17' ' ' MET . 4.5 m -68.99 112.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -55.36 -53.66 53.44 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 108.897 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.679 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -157.68 133.67 9.37 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.791 -1.163 . . . . 0.0 109.787 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.715 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.1 mt -87.17 145.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 120.981 -1.074 . . . . 0.0 109.353 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -138.34 153.84 48.97 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.706 0.765 . . . . 0.0 109.764 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.492 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 33.0 mt-30 -95.17 139.4 31.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.663 -0.648 . . . . 0.0 110.084 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 m -139.89 157.8 45.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.661 -0.649 . . . . 0.0 109.859 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 158.67 21.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.798 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.51 ' C ' ' H ' ' A' ' 57' ' ' SER . 36.9 ttp85 -49.92 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -0.873 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.82 29.08 0.39 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 55' ' ' ARG . 10.8 t -85.62 -27.69 25.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.95 -1.324 . . . . 0.0 108.914 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mt -107.59 173.54 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.472 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 24.8 m-85 -118.15 119.61 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -80.51 144.11 32.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.664 -0.648 . . . . 0.0 109.467 179.858 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.689 ' NH1' ' HE ' ' A' ' 84' ' ' ARG . 49.3 mtt180 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -77.33 175.71 9.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.567 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.798 ' C ' HD23 ' A' ' 72' ' ' LEU . 92.1 m-85 -157.84 -170.66 3.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -118.46 -5.75 10.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.671 -0.643 . . . . 0.0 109.676 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.3 m -149.41 129.88 13.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.982 . . . . 0.0 109.431 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.472 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 6.6 mm-40 -47.28 -24.46 0.75 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 109.046 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -68.16 -32.77 73.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 109.115 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 m-20 -81.62 -36.38 28.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -75.41 -33.41 60.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -68.41 -33.36 74.08 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.22 -21.17 62.17 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.44 ' CD2' ' HE2' ' A' ' 85' ' ' HIS . 45.9 t60 -74.85 -38.22 62.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.028 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 mm -62.42 -52.62 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.146 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.488 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.8 p30 -72.37 -18.84 61.71 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.753 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 38.9 m170 -86.65 -26.7 24.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.464 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.689 ' HE ' ' NH1' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -130.51 -14.3 3.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.154 -0.966 . . . . 0.0 112.053 -178.077 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.44 ' HE2' ' CD2' ' A' ' 80' ' ' HIS . 10.2 m-70 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.117 -0.989 . . . . 0.0 109.828 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.516 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 4.0 m -46.45 146.3 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 108.988 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -25.88 21.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.35 -31.27 13.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.417 -0.802 . . . . 0.0 110.369 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -24.43 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.838 . . . . 0.0 110.646 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . 78.93 -0.44 78.49 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.082 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.531 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 4.2 mp -79.55 163.96 56.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.075 -1.25 . . . . 0.0 108.258 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.08 133.32 24.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.146 1.231 . . . . 0.0 112.091 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.534 HG23 ' HA ' ' A' ' 25' ' ' CYS . 73.0 mt -81.05 118.09 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.739 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.484 ' CD ' ' H ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -84.53 -29.71 25.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.96 144.78 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.53 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.3 m-85 -82.31 99.41 9.33 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.634 -1.291 . . . . 0.0 110.231 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.27 87.59 0.59 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.47 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.4 ttt-85 -64.91 143.5 57.91 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 122.115 -0.638 . . . . 0.0 110.169 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 21' ' ' LYS . 6.8 mtp -125.6 134.33 51.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -122.54 154.18 62.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.72 6.63 37.34 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 124.174 -1.177 . . . . 0.0 111.26 -0.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.596 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -55.7 -38.19 69.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.638 -0.663 . . . . 0.0 109.421 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.7 tttp 71.12 24.22 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.596 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 37.6 m170 -100.33 175.55 5.67 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 14' ' ' TYR . 1.3 m -143.12 154.03 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.832 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 48.0 m-85 -151.92 -158.36 0.89 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.727 ' HG ' ' HG ' ' A' ' 28' ' ' CYS . 0.5 OUTLIER -81.36 108.92 15.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.732 ' O ' HG23 ' A' ' 30' ' ' ILE . 43.2 t80 -49.84 -11.55 0.06 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.051 -1.031 . . . . 0.0 109.722 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.6 t70 -82.35 -49.29 10.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 108.996 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.727 ' HG ' ' HG ' ' A' ' 25' ' ' CYS . 3.9 m -79.4 -22.15 44.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.826 -1.172 . . . . 0.0 108.051 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.87 78.04 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.732 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.4 pt -78.86 -34.01 16.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 121.119 -0.988 . . . . 0.0 108.767 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 28' ' ' CYS . 18.9 mt -65.42 -38.7 90.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.832 -1.147 . . . . 0.0 107.995 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -70.54 -31.32 68.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.83 -36.24 62.4 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mttm . . . . . 0 C--N 1.303 -1.45 0 O-C-N 121.039 -1.038 . . . . 0.0 108.262 179.236 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.432 ' C ' HG13 ' A' ' 47' ' ' VAL . 19.5 mtp . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 121.94 0.876 . . . . 0.0 112.163 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 44' ' ' SER . 24.9 t -91.47 112.06 52.3 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -45.95 -19.17 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.86 1.706 . . . . 0.0 112.772 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 -62.51 0.82 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.567 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.5 m -93.83 2.27 56.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -1.157 . . . . 0.0 110.529 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.6 p 48.45 36.03 6.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 109.566 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.444 ' H ' ' HB3' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -95.71 161.43 27.6 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.299 -0.876 . . . . 0.0 109.003 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' GLN . 20.2 Cg_endo -62.93 80.67 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.344 2.029 . . . . 0.0 111.976 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.696 ' O ' HG23 ' A' ' 47' ' ' VAL . 5.6 m -52.96 98.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -50.6 -51.12 51.43 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.519 -1.363 . . . . 0.0 108.202 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.475 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -158.55 123.19 4.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.668 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.1 mt -81.05 144.91 9.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 120.797 -1.19 . . . . 0.0 109.168 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 16' ' ' ARG . 28.0 mt-10 -138.97 151.17 46.64 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.702 0.763 . . . . 0.0 110.363 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 19.5 mt-30 -85.72 143.29 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.347 0.594 . . . . 0.0 110.071 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.44 159.32 42.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.478 -0.764 . . . . 0.0 109.471 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.81 166.41 20.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.333 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.525 ' C ' ' H ' ' A' ' 57' ' ' SER . 3.5 tmm_? -68.51 -74.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 110.561 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.15 24.71 0.26 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.365 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.635 ' O ' HD23 ' A' ' 58' ' ' LEU . 3.3 m -92.56 -6.31 49.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.972 -1.31 . . . . 0.0 109.82 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 57' ' ' SER . 6.3 mt -129.03 174.81 9.21 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.621 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -120.67 108.58 14.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.801 -0.562 . . . . 0.0 110.332 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.52 144.74 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.381 -0.825 . . . . 0.0 110.368 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.592 ' HG ' ' CE1' ' A' ' 80' ' ' HIS . 49.6 t . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.405 -0.81 . . . . 0.0 109.673 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.941 0.4 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.47 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 2.1 p -94.12 155.0 17.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.647 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.636 ' C ' HD23 ' A' ' 72' ' ' LEU . 72.6 m-85 -149.97 176.98 10.28 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.734 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -103.11 -11.11 18.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.537 -0.727 . . . . 0.0 110.472 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ASP . 58.7 m -160.63 138.05 9.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.801 -1.187 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.621 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 4.9 mm-40 -43.34 -31.64 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.612 -0.68 . . . . 0.0 109.68 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -65.88 -31.68 72.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.415 -0.803 . . . . 0.0 109.962 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 73.6 m-20 -86.22 -32.73 21.01 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -76.83 -35.03 57.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.637 ' N ' HD23 ' A' ' 77' ' ' LEU . 40.1 tp60 -72.38 -34.73 68.14 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.08 -20.09 62.4 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.592 ' CE1' ' HG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -77.39 -39.12 48.26 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.645 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.517 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.5 mm -58.14 -55.35 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.19 -25.2 66.01 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.604 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -88.78 -11.04 46.07 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.808 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -118.37 -48.62 2.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.152 -0.967 . . . . 0.0 113.355 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 110.002 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.362 0.601 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 6.6 t -46.26 145.8 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.037 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -21.44 30.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.057 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -39.68 12.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.038 -1.038 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -106.58 -16.98 14.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 111.384 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.43 4.12 68.42 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.429 -1.367 . . . . 0.0 109.979 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.27 157.65 56.06 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.057 -1.261 . . . . 0.0 109.035 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.7 112.16 2.11 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.129 1.886 . . . . 0.0 112.549 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.488 HD11 ' HA ' ' A' ' 4' ' ' CYS . 67.6 mt -61.82 124.86 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.05 -29.25 18.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 t -133.4 145.31 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD2' HG11 ' A' ' 23' ' ' VAL . 3.2 m-30 -82.75 98.73 9.25 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.658 -1.276 . . . . 0.0 110.814 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.69 95.34 1.35 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.611 HH12 ' CB ' ' A' ' 70' ' ' THR . 3.0 tpt180 -81.52 144.83 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.99 -0.712 . . . . 0.0 111.064 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.541 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 5.4 mtp -131.72 130.18 41.61 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.663 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -113.9 157.28 42.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.345 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.48 -1.06 51.67 Favored 'Cis proline' 0 N--CA 1.491 1.344 0 C-N-CA 124.178 -1.176 . . . . 0.0 111.786 -0.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.596 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 14.5 t -52.01 -35.36 46.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.2 OUTLIER 69.3 30.17 4.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.596 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 30.8 m170 -100.22 165.9 11.26 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.876 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -122.64 161.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.942 0.877 . . . . 0.0 110.462 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.541 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 97.3 m-85 -163.55 -164.41 0.92 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -83.9 113.66 21.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.754 ' O ' HG23 ' A' ' 30' ' ' ILE . 41.1 t80 -47.53 -14.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.051 -1.03 . . . . 0.0 109.364 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -79.77 -42.96 23.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.465 ' HA ' HD12 ' A' ' 31' ' ' LEU . 54.5 m -83.08 -23.2 33.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -69.54 -37.41 77.06 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 26' ' ' TYR . 46.4 pt -74.74 -37.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.468 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 28' ' ' CYS . 9.0 mt -53.5 -38.52 63.78 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -67.05 -42.03 85.48 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.564 -0.71 . . . . 0.0 109.211 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' A' ' 50' ' ' ILE . 1.1 pt-20 -61.46 -34.0 74.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 108.782 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mttm . . . . . 0 C--N 1.302 -1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.998 179.619 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.455 ' CG ' ' O ' ' A' ' 39' ' ' MET . 7.5 ptm . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.503 0.668 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.503 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -57.04 145.89 62.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.86 -38.91 68.85 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.768 1.645 . . . . 0.0 112.61 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.84 -21.8 2.84 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.624 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.586 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -94.49 -15.81 23.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.176 -1.191 . . . . 0.0 110.169 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.9 p 47.63 36.48 5.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.503 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.3 OUTLIER -90.93 160.73 37.35 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 108.775 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' GLN . 14.9 Cg_endo -58.27 74.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.131 1.887 . . . . 0.0 112.001 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' ASP . 47.2 t -47.42 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.051 -1.03 . . . . 0.0 109.683 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' PRO . 5.0 tt0 -64.62 -61.06 2.43 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.663 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -150.61 137.64 19.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.911 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.579 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -94.61 147.21 5.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.805 -1.184 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -140.68 147.02 38.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.443 0.64 . . . . 0.0 109.826 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -97.02 144.8 26.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.633 -0.667 . . . . 0.0 109.221 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 168.08 25.07 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.012 . . . . 0.0 110.323 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 154.36 22.28 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -57.52 -23.78 52.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 110.081 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.82 21.83 44.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.83 -25.99 14.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -1.135 . . . . 0.0 109.924 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -114.15 172.68 6.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.697 -0.627 . . . . 0.0 109.628 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.504 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 53.4 m-85 -122.19 123.18 40.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 mmt -88.88 145.28 25.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.274 -0.891 . . . . 0.0 110.949 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.58 ' SG ' ' NE2' ' A' ' 80' ' ' HIS . 46.9 t . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.011 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.688 HH12 HH21 ' A' ' 84' ' ' ARG . 19.3 mmm-85 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.611 ' CB ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -83.84 174.87 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.813 ' C ' HD23 ' A' ' 72' ' ' LEU . 89.8 m-85 -156.18 -166.33 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.366 -0.834 . . . . 0.0 108.819 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.813 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -118.11 -8.81 10.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.678 -0.639 . . . . 0.0 110.046 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 76' ' ' ASP . 17.9 p -145.35 130.0 18.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.514 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.504 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 6.3 mm-40 -47.81 -25.65 1.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 108.699 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -68.4 -32.89 73.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.528 0.68 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 73' ' ' SER . 36.5 m-20 -84.21 -34.52 23.9 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 tt -74.95 -34.05 62.0 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -71.58 -30.22 65.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.06 -20.55 60.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.58 ' NE2' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -75.83 -41.0 53.8 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.724 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.53 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 4.6 mm -61.53 -52.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -64.65 -23.02 67.12 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.482 -0.761 . . . . 0.0 109.023 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 28.7 m170 -88.12 -12.9 42.72 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.531 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.688 HH21 HH12 ' A' ' 69' ' ' ARG . 11.1 mmt180 -118.67 -46.21 2.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 113.067 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.481 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 110.031 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.466 ' O ' ' CD2' ' A' ' 3' ' ' PHE . 13.9 p90 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.619 ' HA ' HD11 ' A' ' 11' ' ' ILE . 43.3 t -45.95 146.29 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.72 -30.45 26.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 110.624 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.45 -40.16 10.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.018 -1.051 . . . . 0.0 110.293 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 12.6 m -88.55 -25.86 22.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.052 -1.03 . . . . 0.0 110.089 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.42 10.49 70.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 158.29 32.46 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.36 -1.082 . . . . 0.0 108.601 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.02 98.96 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.857 1.704 . . . . 0.0 112.083 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' HA ' ' A' ' 4' ' ' CYS . 91.5 mt -45.58 110.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.986 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -35.07 40.86 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.0 138.75 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -78.78 106.96 11.15 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.98 -1.075 . . . . 0.0 110.78 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.58 85.13 0.85 Allowed Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -65.66 130.84 44.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 122.0 -0.706 . . . . 0.0 109.789 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.631 ' CE ' HG11 ' A' ' 47' ' ' VAL . 14.5 mtp -116.27 124.61 50.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.863 -0.523 . . . . 0.0 110.139 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.817 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -112.76 156.72 42.11 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.95 2.57 48.47 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 124.153 -1.186 . . . . 0.0 111.462 -0.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.581 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 1.0 OUTLIER -56.92 -35.81 69.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.549 -0.719 . . . . 0.0 109.433 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 ttmt 74.51 21.97 2.19 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.586 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 3.3 m80 -90.5 178.72 6.03 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.879 -0.729 . . . . 0.0 109.149 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.456 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.3 m -146.57 149.06 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 21.5 m-85 -158.61 170.0 23.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.562 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -50.68 112.7 0.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.77 179.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 30' ' ' ILE . 40.6 t80 -51.16 -15.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.613 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -82.26 -32.7 29.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.546 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -85.68 -26.29 26.05 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 108.651 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.493 ' HB1' HD13 ' A' ' 50' ' ' ILE . . . -72.29 -35.09 68.6 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 26' ' ' TYR . 2.1 pp -84.46 -34.92 10.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.252 -0.905 . . . . 0.0 108.811 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.548 HD23 ' HD3' ' A' ' 34' ' ' LYS . 7.6 mt -68.18 -22.97 64.8 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.004 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.39 -40.57 21.1 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.26 -36.74 85.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.475 -0.765 . . . . 0.0 109.91 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HD3' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.971 -1.081 . . . . 0.0 109.756 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.0 ptt? . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.8 t -74.52 114.6 35.54 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.306 -0.871 . . . . 0.0 109.016 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.51 -17.11 6.2 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.427 1.418 . . . . 0.0 112.349 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.56 -58.63 1.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.586 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 3.5 m -93.29 -24.85 18.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -1.169 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.5 p 76.35 41.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.39 158.18 42.08 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.06 92.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.578 2.185 . . . . 0.0 112.141 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.0 m -62.1 111.14 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.037 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -47.17 -58.89 3.57 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.13 -0.981 . . . . 0.0 108.932 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' HD11 ' A' ' 18' ' ' ILE . 31.3 ptt180 -161.93 125.89 3.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.278 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.493 HD13 ' HB1' ' A' ' 29' ' ' ALA . 3.3 mt -74.08 144.71 12.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.817 -1.177 . . . . 0.0 109.745 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -138.94 143.22 38.53 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 109.656 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -83.46 144.87 29.28 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.438 0.637 . . . . 0.0 110.079 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.21 158.86 43.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.795 . . . . 0.0 109.532 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.43 162.35 24.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.226 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 57' ' ' SER . 3.9 ptp85 -66.4 -59.79 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.039 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.497 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -72.99 21.27 1.01 Allowed Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -90.29 -17.98 26.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.128 -1.219 . . . . 0.0 109.632 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.5 mt -118.86 173.29 6.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 24.6 m-85 -114.21 117.15 30.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 60' ' ' MET . 1.6 mpt? -82.59 144.47 30.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.344 -0.847 . . . . 0.0 110.346 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.593 ' NE ' ' ND1' ' A' ' 80' ' ' HIS . 17.1 mtm180 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.54 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -78.79 176.61 9.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.74 ' C ' HD23 ' A' ' 72' ' ' LEU . 93.9 m-85 -158.66 -171.94 3.63 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.74 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -114.68 -7.72 12.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.077 -178.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 76' ' ' ASP . 1.6 m -146.2 126.37 13.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.1 tp60 -43.34 -26.95 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 73' ' ' SER . 5.5 tmm_? -63.95 -35.55 81.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.963 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.2 m-20 -80.85 -38.73 27.68 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.216 -0.928 . . . . 0.0 108.64 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.76 -30.93 64.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.9 tp60 -69.64 -32.66 71.46 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -20.11 61.4 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.593 ' ND1' ' NE ' ' A' ' 69' ' ' ARG . 53.1 t60 -73.04 -44.89 60.18 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.683 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.492 ' N ' HD13 ' A' ' 81' ' ' ILE . 3.3 mm -59.36 -50.9 78.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.441 0.639 . . . . 0.0 109.699 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -70.4 -18.79 63.03 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.572 -0.705 . . . . 0.0 109.605 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 15.9 m170 -86.71 -28.45 23.09 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.101 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -128.66 -21.77 3.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.128 -0.983 . . . . 0.0 112.025 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.515 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.5 m-70 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.584 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 1.5 p90 . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.984 0.897 . . . . 0.0 109.969 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 37.1 t -46.78 143.03 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 108.463 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 -28.75 19.98 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.013 -1.054 . . . . 0.0 110.464 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -93.86 -38.96 10.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.078 -1.014 . . . . 0.0 110.75 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -100.03 -23.46 14.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.94 . . . . 0.0 110.822 -179.186 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 6.97 88.75 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.322 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.67 152.13 51.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.967 -1.314 . . . . 0.0 108.367 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.62 137.7 81.91 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.749 1.633 . . . . 0.0 112.696 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.633 HG23 ' HA ' ' A' ' 25' ' ' CYS . 71.9 mt -86.95 116.31 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.075 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -81.92 -28.27 32.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.55 146.74 18.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.474 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.1 m-85 -78.81 98.56 6.36 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.722 -1.236 . . . . 0.0 110.377 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.55 83.71 0.55 Allowed Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' GLU . 5.4 ttt-85 -61.52 145.89 50.46 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.305 0.574 . . . . 0.0 110.003 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.569 ' CE ' HG11 ' A' ' 47' ' ' VAL . 5.3 mtp -128.58 133.55 48.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.921 -0.487 . . . . 0.0 110.4 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -122.35 154.75 62.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.13 4.17 48.25 Favored 'Cis proline' 0 N--CA 1.49 1.315 0 C-N-CA 124.219 -1.159 . . . . 0.0 111.493 0.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.59 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -56.42 -37.83 70.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.606 -0.684 . . . . 0.0 109.459 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.0 ttmm 74.29 27.39 1.48 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.59 ' ND1' ' SG ' ' A' ' 20' ' ' CYS . 13.0 m170 -100.58 177.61 4.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.474 HG21 ' CD2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -145.26 153.3 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.433 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 62.8 m-85 -153.51 -166.85 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.633 ' HA ' HG23 ' A' ' 11' ' ' ILE . 1.6 p -72.6 112.12 8.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.79 ' O ' HG23 ' A' ' 30' ' ' ILE . 34.0 t80 -51.55 -11.0 0.11 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.326 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.2 t70 -77.29 -48.85 16.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.014 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 31.3 m -78.45 -25.24 45.86 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.78 -1.2 . . . . 0.0 108.222 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.7 -35.68 80.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 108.979 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 26' ' ' TYR . 36.9 pt -80.77 -33.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.87 -23.69 66.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -77.38 -53.22 7.94 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.564 -0.71 . . . . 0.0 109.237 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.59 -24.67 64.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 mttm . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 108.559 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.9 ptm . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' SER . 46.6 t -77.13 114.55 40.89 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 109.41 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.19 -15.58 1.44 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.691 1.594 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.86 -62.24 0.82 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -92.35 -20.5 21.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -1.122 . . . . 0.0 110.194 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.4 p 72.11 35.45 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.281 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.46 160.77 26.6 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.56 -0.713 . . . . 0.0 109.107 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.08 81.54 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.434 2.089 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.6 m -52.66 111.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -59.65 -52.21 66.5 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.875 -1.141 . . . . 0.0 108.75 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.58 124.49 6.69 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.795 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.571 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.9 mt -84.93 144.86 8.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.836 -1.165 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 16' ' ' ARG . 29.0 mt-10 -137.77 149.79 46.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.621 0.724 . . . . 0.0 109.658 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -95.09 141.71 28.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.703 -0.623 . . . . 0.0 110.016 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 160.53 40.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.423 -0.798 . . . . 0.0 109.766 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 158.6 31.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 57' ' ' SER . 26.4 ttp85 -56.27 -71.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 0.0 110.046 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.39 30.64 0.46 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 55' ' ' ARG . 4.2 t -89.56 -26.29 20.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.295 . . . . 0.0 109.509 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mt -101.81 173.66 6.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.648 -0.657 . . . . 0.0 109.866 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.617 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -121.31 109.47 14.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 mtt -74.45 144.5 44.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 110.507 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.749 . . . . 0.0 109.015 179.311 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.04 167.33 18.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.082 -1.011 . . . . 0.0 109.738 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.746 ' C ' HD23 ' A' ' 72' ' ' LEU . 31.6 m-85 -154.31 177.87 10.65 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.245 -0.909 . . . . 0.0 109.124 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.746 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -114.43 -5.25 12.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.819 -0.55 . . . . 0.0 109.54 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 67.1 m -153.39 126.56 8.5 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.748 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.617 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 5.9 mm-40 -43.51 -24.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.672 -0.642 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 ttt180 -66.5 -33.23 75.22 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.99 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 8.1 m-20 -86.09 -33.34 20.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.051 -1.031 . . . . 0.0 108.278 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.2 OUTLIER -76.48 -31.8 57.98 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.445 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.663 ' N ' HD23 ' A' ' 77' ' ' LEU . 22.1 tp60 -72.78 -33.86 66.57 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -19.8 61.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.402 ' CD2' ' HE2' ' A' ' 85' ' ' HIS . 66.1 t60 -73.41 -45.3 55.48 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.761 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.4 mm -58.72 -51.2 74.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.501 0.667 . . . . 0.0 109.703 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 4.6 m-20 -70.59 -18.47 62.89 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.784 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 14.7 m170 -87.19 -27.34 23.07 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.099 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.67 -25.96 2.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.064 -1.023 . . . . 0.0 112.488 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.506 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.5 m-70 . . . . . 0 C--N 1.301 -1.502 0 O-C-N 120.995 -1.066 . . . . 0.0 108.968 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.212 0.529 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.623 ' HA ' HD11 ' A' ' 11' ' ' ILE . 49.9 t -46.53 146.29 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.84 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.09 -27.2 28.41 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.442 -0.786 . . . . 0.0 109.874 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -53.25 3.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.766 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.556 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 6.5 m -74.65 -27.6 60.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.76 7.69 70.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.03 158.28 34.38 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.296 -1.12 . . . . 0.0 108.564 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.77 96.44 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.852 1.701 . . . . 0.0 112.484 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 4' ' ' CYS . 96.5 mt -41.26 104.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.395 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -76.37 -32.13 58.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.01 146.64 29.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -83.05 104.38 13.21 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.81 -1.181 . . . . 0.0 110.818 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.58 91.0 1.16 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.424 HH21 ' CG ' ' A' ' 21' ' ' LYS . 8.8 ttt-85 -77.65 134.56 38.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.828 -0.807 . . . . 0.0 110.114 -178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.568 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 6.0 mtp -123.61 130.66 53.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.867 -0.521 . . . . 0.0 109.761 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.663 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -113.14 156.85 42.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.77 2.1 42.08 Favored 'Cis proline' 0 N--CA 1.491 1.353 0 C-N-CA 124.087 -1.214 . . . . 0.0 111.328 -0.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.529 ' HG ' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -53.93 -36.31 62.65 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.2 OUTLIER 65.6 26.88 11.58 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.594 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 4.7 m170 -93.63 -172.15 2.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.534 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -144.71 151.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.93 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 41.6 m-85 -162.85 166.77 23.66 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.556 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -55.44 111.75 0.96 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.47 -1.292 . . . . 0.0 107.938 178.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.499 ' O ' HG23 ' A' ' 30' ' ' ILE . 46.3 t80 -46.3 -21.0 0.13 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 109.767 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.8 t70 -74.36 -37.64 63.42 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.542 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -83.69 -22.61 32.0 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 108.515 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.71 -34.23 71.71 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.8 pt -80.97 -36.09 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 121.141 -0.974 . . . . 0.0 108.919 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 31' ' ' LEU . 78.7 mt -64.56 -37.27 86.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.86 -33.81 72.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -34.88 70.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--N 1.303 -1.417 0 O-C-N 121.042 -1.036 . . . . 0.0 108.64 179.754 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.1 ptp . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 122.167 0.984 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.8 OUTLIER -65.73 142.46 98.19 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -54.6 -34.18 81.97 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.532 1.488 . . . . 0.0 112.411 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.12 -43.22 0.8 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.043 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 2.4 m -86.26 -12.98 48.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.371 . . . . 0.0 110.549 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t 48.16 37.47 8.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 0.0 109.029 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.92 161.1 39.33 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.384 -0.822 . . . . 0.0 109.342 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.32 74.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.377 2.051 . . . . 0.0 111.815 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 45' ' ' ASP . 21.7 t -45.25 100.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -0.832 . . . . 0.0 110.031 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 18' ' ' ILE . 4.9 tt0 -66.07 -61.33 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.663 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -151.6 136.78 17.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.94 179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.1 mt -94.3 146.68 6.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.822 -1.174 . . . . 0.0 109.724 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.05 153.67 45.61 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.427 0.632 . . . . 0.0 109.991 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.55 142.53 30.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 165.55 28.08 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 155.68 23.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 0.0 108.937 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 57' ' ' SER . 10.5 ttp85 -51.56 -62.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 23.66 0.78 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.0 t -86.92 -25.68 24.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.938 -1.331 . . . . 0.0 109.216 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.03 173.89 6.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 15.1 m-85 -119.31 119.39 33.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mtt -80.08 144.49 33.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.483 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.268 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.3 mmm-85 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.86 174.72 11.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.711 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.765 ' C ' HD23 ' A' ' 72' ' ' LEU . 97.5 m-85 -156.77 -176.29 5.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.765 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -116.99 -3.34 11.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.617 -0.677 . . . . 0.0 110.086 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 75' ' ' ARG . 8.1 t -149.32 128.12 12.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 109.716 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.415 HE21 HD22 ' A' ' 77' ' ' LEU . 1.9 tp60 -45.66 -23.23 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.4 ttt180 -70.27 -33.16 71.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.363 -0.836 . . . . 0.0 109.687 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.1 m-20 -82.24 -36.7 26.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 HE21 ' A' ' 74' ' ' GLN . 1.8 tt -73.68 -34.78 65.03 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -70.16 -31.42 68.9 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.97 -19.82 60.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.587 ' HD1' ' HH ' ' A' ' 71' ' ' TYR . 58.6 t60 -73.11 -44.52 60.19 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.594 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.8 mm -60.21 -52.04 65.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.48 0.657 . . . . 0.0 109.553 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.44 -18.32 64.4 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 109.647 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 11.7 m170 -86.21 -31.06 21.93 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.69 -1.204 . . . . 0.0 112.21 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -129.6 -21.59 3.1 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.046 -1.034 . . . . 0.0 112.472 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.522 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.5 m-70 . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.056 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.534 0.683 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.665 ' HA ' HD11 ' A' ' 11' ' ' ILE . 52.0 t -67.97 146.35 53.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.395 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.3 -27.83 38.38 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -99.68 -44.97 5.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.599 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 4.5 m -84.7 -20.31 31.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.41 3.49 25.94 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.67 157.36 37.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.331 -1.1 . . . . 0.0 108.801 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.91 123.12 12.81 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.0 1.8 . . . . 0.0 111.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.665 HD11 ' HA ' ' A' ' 4' ' ' CYS . 75.3 mt -75.89 103.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.64 -0.662 . . . . 0.0 110.575 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -30.81 64.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -147.05 143.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -75.36 110.42 9.7 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.995 -1.066 . . . . 0.0 111.113 -178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -80.12 80.72 1.59 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.455 HH21 ' CG ' ' A' ' 21' ' ' LYS . 7.3 ttt-85 -66.55 131.15 45.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 122.112 -0.64 . . . . 0.0 110.239 -178.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.422 ' O ' ' N ' ' A' ' 21' ' ' LYS . 19.7 mtp -116.91 134.5 54.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.874 -0.516 . . . . 0.0 110.103 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -120.25 157.58 53.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.58 -2.19 47.13 Favored 'Cis proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.107 -1.205 . . . . 0.0 112.146 -0.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.519 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 7.1 t -52.8 -36.92 59.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.636 ' HE3' HD21 ' A' ' 72' ' ' LEU . 2.0 tttp 74.94 27.55 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' ND1' ' SG ' ' A' ' 43' ' ' CYS . 1.4 m80 -95.58 -178.24 4.34 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -145.71 153.5 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.868 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 34.9 m-85 -161.46 166.24 27.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -48.97 113.03 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.699 179.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -50.88 -18.02 0.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.347 -0.846 . . . . 0.0 109.883 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.427 ' O ' HD12 ' A' ' 31' ' ' LEU . 35.9 t70 -79.82 -33.04 40.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.563 ' SG ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -85.34 -23.97 27.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.541 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -72.07 -35.66 69.35 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -85.44 -34.03 8.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.146 -0.971 . . . . 0.0 108.957 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.483 HD23 ' HD3' ' A' ' 34' ' ' LYS . 7.8 mt -72.69 -22.75 60.86 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.803 -1.159 . . . . 0.0 107.979 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 28' ' ' CYS . 35.6 m170 -83.79 -36.46 23.54 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.234 -0.916 . . . . 0.0 108.869 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -34.53 66.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 109.441 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HD3' HD23 ' A' ' 31' ' ' LEU . 12.9 ptmt . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.228 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.523 ' HA ' HG23 ' A' ' 47' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -41.07 104.79 0.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.684 -0.635 . . . . 0.0 109.98 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -52.62 -16.23 5.25 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.444 1.429 . . . . 0.0 111.757 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.33 -44.24 2.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.541 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.601 ' SG ' ' ND1' ' A' ' 22' ' ' HIS . 2.8 m -106.99 -26.11 11.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.316 -1.108 . . . . 0.0 110.528 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.88 56.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.118 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.34 161.02 43.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.25 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.468 2.112 . . . . 0.0 112.073 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 39' ' ' MET . 88.8 t -58.0 105.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.235 -0.915 . . . . 0.0 109.07 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -68.67 -65.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -0.988 . . . . 0.0 108.774 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.467 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.39 125.49 9.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.01 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.541 HG21 ' HB1' ' A' ' 29' ' ' ALA . 4.2 mt -81.39 145.08 9.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 109.172 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.12 145.93 40.05 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.787 0.803 . . . . 0.0 110.095 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.97 143.72 26.66 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.333 0.587 . . . . 0.0 109.762 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 161.04 41.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 109.469 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.527 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -84.86 166.92 16.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.487 ' CG ' ' H ' ' A' ' 56' ' ' GLY . 8.4 ptp180 -58.81 -58.54 8.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.18 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.487 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -75.38 23.79 1.48 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.811 ' O ' HD23 ' A' ' 58' ' ' LEU . 16.5 m -86.1 -14.67 43.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.108 -1.23 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 57' ' ' SER . 1.1 mt -135.4 172.45 13.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.452 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 18.9 m-85 -114.96 122.65 46.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 mmt -84.79 144.31 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.668 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.242 179.77 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.467 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.705 0.764 . . . . 0.0 110.742 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.5 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -89.41 -173.48 4.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.407 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.612 ' C ' HD23 ' A' ' 72' ' ' LEU . 66.3 m-85 -154.89 171.31 19.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.224 -0.922 . . . . 0.0 108.671 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.773 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.14 -2.18 21.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.4 -0.812 . . . . 0.0 110.946 -178.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 74' ' ' GLN . 1.4 p -160.66 134.42 6.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.242 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -42.9 -29.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -65.35 -34.36 78.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.439 -0.788 . . . . 0.0 110.425 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -83.9 -35.41 24.11 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 108.288 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.617 ' C ' HD23 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -75.94 -31.6 59.16 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.575 ' N ' HD23 ' A' ' 77' ' ' LEU . 22.3 tp60 -73.77 -33.78 64.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.66 61.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 5.5 t60 -72.73 -51.53 18.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.196 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.588 ' N ' HD13 ' A' ' 81' ' ' ILE . 1.6 mm -51.66 -53.05 18.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.666 -0.646 . . . . 0.0 109.657 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.07 -19.07 64.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.104 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 14.1 m170 -87.08 -28.15 22.72 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.723 -1.191 . . . . 0.0 112.031 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -129.42 -23.42 2.93 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.454 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.616 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 4.8 m-70 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 0.0 109.27 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.456 ' O ' ' N ' ' A' ' 11' ' ' ILE . 5.1 m-70 -96.9 -66.07 0.93 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 109.299 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -76.72 124.02 27.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 109.997 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 9' ' ' LEU . 4.4 m -46.0 145.98 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.521 ' OD2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -82.36 -26.61 32.75 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.989 -1.069 . . . . 0.0 109.307 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 -33.31 12.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.339 -0.851 . . . . 0.0 110.567 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -104.33 -25.4 12.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -0.898 . . . . 0.0 110.83 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.26 -9.24 49.03 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.259 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.516 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 5.7 mp -73.28 158.45 86.75 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.993 -1.298 . . . . 0.0 108.819 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -68.15 104.34 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.8 1.667 . . . . 0.0 112.883 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.611 HG23 ' HA ' ' A' ' 25' ' ' CYS . 78.4 mt -50.99 120.15 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 121.43 0.633 . . . . 0.0 110.236 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -88.31 -27.07 21.92 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.3 t -136.69 144.64 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -80.78 100.11 8.6 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.802 -1.186 . . . . 0.0 110.453 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.2 95.1 1.64 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.414 HH21 ' HG3' ' A' ' 21' ' ' LYS . 18.9 ttt-85 -80.89 137.28 36.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 122.037 -0.684 . . . . 0.0 110.168 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 9.7 mtp -121.74 134.18 54.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.122 0.486 . . . . 0.0 110.238 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.664 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -114.37 155.9 45.17 Favored Pre-proline 0 N--CA 1.489 1.479 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.69 2.97 52.47 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.145 -1.19 . . . . 0.0 111.364 -0.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.3 t -56.74 -33.48 66.6 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.537 -0.727 . . . . 0.0 109.389 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER 66.93 26.69 9.12 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.585 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 33.8 m170 -97.49 162.49 13.28 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.902 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -118.07 160.79 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 CA-C-O 122.157 0.98 . . . . 0.0 111.019 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.589 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 93.5 m-85 -164.53 -165.23 0.91 Allowed 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.611 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -85.06 113.12 21.24 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 177.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.715 ' O ' HG23 ' A' ' 30' ' ' ILE . 41.0 t80 -47.67 -16.38 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.973 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 25' ' ' CYS . 7.4 t70 -82.73 -50.68 8.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.027 -1.046 . . . . 0.0 109.488 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.417 ' HA ' HD12 ' A' ' 31' ' ' LEU . 3.0 m -78.86 -20.85 48.56 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.81 -1.182 . . . . 0.0 108.096 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.74 -33.93 71.33 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.715 HG23 ' O ' ' A' ' 26' ' ' TYR . 40.7 pt -80.32 -33.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 O-C-N 121.001 -1.062 . . . . 0.0 108.793 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 28' ' ' CYS . 14.9 mt -64.0 -34.37 77.86 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.876 -1.13 . . . . 0.0 107.988 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -70.17 -42.52 72.36 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.94 95.82 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -70.69 -19.74 62.75 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -81.43 -54.68 5.25 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.557 -0.714 . . . . 0.0 110.256 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -117.05 -30.45 1.94 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 1.3 t70 70.83 13.99 7.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.288 -1.125 . . . . 0.0 109.826 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.67 36.32 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.028 -1.045 . . . . 0.0 110.861 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.46 ' CG ' ' O ' ' A' ' 39' ' ' MET . 10.8 ptm -145.81 118.08 8.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.987 -1.071 . . . . 0.0 110.248 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.451 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 1.2 t -62.12 139.8 96.03 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.77 . . . . 0.0 108.981 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.69 -36.97 20.08 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.875 1.716 . . . . 0.0 112.416 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -119.89 -36.94 0.79 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 -14.16 52.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.281 . . . . 0.0 110.277 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 t 47.65 36.02 5.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.077 -1.015 . . . . 0.0 109.464 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -90.33 161.11 38.15 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.236 -0.915 . . . . 0.0 108.786 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.73 73.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.153 1.902 . . . . 0.0 111.884 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 45' ' ' ASP . 59.0 t -47.16 99.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.008 -1.057 . . . . 0.0 109.501 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -66.72 -62.79 1.27 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.161 -0.962 . . . . 0.0 108.517 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -150.03 134.31 17.24 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.799 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -94.34 145.97 7.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.616 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.09 150.79 44.75 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.438 0.637 . . . . 0.0 109.781 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -94.91 150.12 20.51 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.566 -0.709 . . . . 0.0 109.75 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -151.87 168.26 25.7 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.267 -0.895 . . . . 0.0 109.69 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -80.64 157.43 25.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.308 -0.87 . . . . 0.0 108.828 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -75.5 26.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.052 . . . . 0.0 109.864 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -144.29 13.91 2.08 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.11 -19.05 18.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.777 -0.837 . . . . 0.0 110.365 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.2 mt -110.81 165.4 11.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.539 -0.726 . . . . 0.0 109.784 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 24.4 m-85 -119.19 113.88 21.57 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.0 mtp -80.61 144.41 32.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.726 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.74 143.21 33.1 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.4 t -141.44 74.44 1.46 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.812 . . . . 0.0 109.567 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mm -101.14 -61.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.551 -0.718 . . . . 0.0 109.397 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.645 HG22 ' N ' ' A' ' 65' ' ' GLN . 8.4 p -158.61 169.22 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.47 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.645 ' N ' HG22 ' A' ' 64' ' ' VAL . 3.9 tt0 49.38 -159.96 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.15 60.03 1.37 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.68 95.14 8.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -1.179 . . . . 0.0 109.526 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -110.66 40.27 2.03 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -75.35 93.66 2.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.953 . . . . 0.0 109.438 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -74.15 176.35 6.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.72 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.698 ' C ' HD23 ' A' ' 72' ' ' LEU . 78.4 m-85 -159.05 -170.87 3.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.701 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.86 -11.43 14.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.627 -0.67 . . . . 0.0 110.278 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 74' ' ' GLN . 3.5 m -150.91 133.5 15.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.975 -1.078 . . . . 0.0 109.343 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 73' ' ' SER . 2.1 tp60 -44.12 -31.93 1.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -61.66 -31.98 72.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.417 -0.802 . . . . 0.0 110.496 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -84.02 -35.62 23.71 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 108.639 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.83 -34.35 62.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.744 HE22 HD22 ' A' ' 82' ' ' ASN . 0.9 OUTLIER -68.17 -39.01 82.67 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 178.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.543 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -66.02 -21.55 66.4 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -76.05 -36.91 58.86 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.334 -1.347 . . . . 0.0 108.919 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.6 mm -62.05 -53.28 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 110.038 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.744 HD22 HE22 ' A' ' 78' ' ' GLN . 3.8 p30 -72.18 -19.02 61.82 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.68 -178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 34.6 m170 -85.71 -25.9 26.21 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.525 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -129.97 -20.11 3.16 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.252 -0.979 . . . . 0.0 112.278 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.461 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 8.5 m-70 -106.78 -47.64 3.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.398 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.0 ttt 51.03 60.09 4.14 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.65 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 0.0 OUTLIER 63.9 29.18 14.59 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.615 0.722 . . . . 0.0 109.238 -179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.65 ' HB3' ' O ' ' A' ' 87' ' ' ARG . . . 73.97 -63.91 0.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.338 -0.851 . . . . 0.0 109.5 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.539 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.522 ' O ' ' CZ ' ' A' ' 14' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.501 0.667 . . . . 0.0 109.407 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.493 ' N ' ' CG2' ' A' ' 1' ' ' VAL . 0.0 OUTLIER -95.37 -56.23 2.78 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.539 -0.725 . . . . 0.0 109.196 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -76.54 109.32 10.18 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 109.271 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.599 ' HA ' HD11 ' A' ' 11' ' ' ILE . 4.3 t -46.37 146.37 1.44 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.137 -0.977 . . . . 0.0 110.073 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -18.56 39.56 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.458 -0.776 . . . . 0.0 109.303 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.03 -51.23 3.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.505 -0.747 . . . . 0.0 110.089 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.3 m -84.14 -14.65 49.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.0 110.406 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.24 9.13 14.32 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.4 mp -96.23 158.62 33.68 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.343 -1.092 . . . . 0.0 108.693 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.73 101.53 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.989 1.793 . . . . 0.0 112.267 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.599 HD11 ' HA ' ' A' ' 4' ' ' CYS . 74.2 mt -50.27 120.74 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.514 0.673 . . . . 0.0 110.578 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -87.32 -31.66 20.06 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -136.06 141.89 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 1' ' ' VAL . 3.4 m-85 -81.74 102.03 10.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 120.544 -1.347 . . . . 0.0 110.688 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -75.54 85.74 0.84 Allowed Glycine 0 N--CA 1.483 1.777 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.604 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.5 ttt-85 -69.33 134.87 49.62 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 122.09 -0.653 . . . . 0.0 110.454 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 21' ' ' LYS . 9.4 mmm -118.4 132.42 56.26 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.652 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -116.24 156.46 47.07 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.72 -1.74 47.83 Favored 'Cis proline' 0 N--CA 1.49 1.285 0 C-N-CA 124.137 -1.193 . . . . 0.0 111.533 -0.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.04 -34.16 28.52 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.604 ' CG ' HH21 ' A' ' 16' ' ' ARG . 3.4 ttmt 67.68 25.86 8.04 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -94.16 179.77 5.21 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.2 m -144.54 153.27 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 110.788 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 73.9 m-85 -158.42 170.34 22.44 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -55.61 113.63 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.039 -1.465 . . . . 0.0 108.171 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 30' ' ' ILE . 35.5 t80 -49.43 -11.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.855 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -74.56 -44.5 50.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.021 -1.049 . . . . 0.0 108.831 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -25.48 38.77 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.886 -1.133 . . . . 0.0 108.119 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.3 -36.69 83.58 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.486 -0.885 . . . . 0.0 108.702 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 26' ' ' TYR . 42.5 pt -78.86 -34.95 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.024 -1.047 . . . . 0.0 108.918 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.62 -21.9 66.62 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.8 -1.16 . . . . 0.0 108.267 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -80.09 -40.68 27.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.9 -29.82 62.27 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.528 -0.732 . . . . 0.0 109.465 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -76.46 -34.44 58.7 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.102 -0.999 . . . . 0.0 108.424 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -81.44 10.1 6.29 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.354 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 51.71 51.14 40.26 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.493 ' OD1' ' SD ' ' A' ' 39' ' ' MET . 0.6 OUTLIER -97.63 -39.78 8.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.498 -1.001 . . . . 0.0 109.827 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.5 mtmt 50.61 59.91 4.24 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.35 1.071 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.493 ' SD ' ' OD1' ' A' ' 37' ' ' ASP . 15.4 ptm -151.56 124.06 8.38 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.853 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.554 ' N ' HG23 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -64.03 124.36 85.0 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.076 -1.015 . . . . 0.0 109.758 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -44.31 -22.86 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.127 1.885 . . . . 0.0 113.068 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.22 -64.65 0.87 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.47 ' O ' ' CB ' ' A' ' 44' ' ' SER . 62.9 m -69.69 -43.65 72.03 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.232 -1.158 . . . . 0.0 108.564 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.6 p 76.9 57.45 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.832 -0.543 . . . . 0.0 111.622 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.443 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 174.82 -48.19 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.386 -1.446 . . . . 0.0 112.117 177.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 45' ' ' ASP . 64.9 Cg_endo -86.47 51.44 2.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.57 2.18 . . . . 0.0 115.706 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 40' ' ' CYS . 1.8 t -95.35 117.28 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.263 -1.523 . . . . 0.0 109.211 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -98.27 -65.55 0.96 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.652 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -141.75 137.94 31.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.497 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.9 mt -92.45 145.9 7.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 120.737 -1.227 . . . . 0.0 109.696 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -137.28 149.0 46.79 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.755 0.788 . . . . 0.0 109.844 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 32.0 mt-30 -94.74 136.15 35.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.831 -0.543 . . . . 0.0 110.03 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -137.96 155.62 48.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.619 -0.675 . . . . 0.0 110.027 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.75 158.2 22.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.35 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 57' ' ' SER . 7.8 ttp180 -49.33 -69.2 0.12 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -0.98 . . . . 0.0 109.988 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.32 27.52 0.57 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 55' ' ' ARG . 17.0 t -85.05 -27.94 26.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.909 -1.347 . . . . 0.0 108.858 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -112.43 173.73 6.23 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 17.6 m-85 -113.27 120.54 41.54 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.852 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.7 mtp -81.65 144.66 31.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 109.916 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.3 t -73.47 139.36 45.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.362 -0.836 . . . . 0.0 109.479 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.0 m -98.95 -25.96 14.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.48 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.786 HG22 HG23 ' A' ' 64' ' ' VAL . 70.1 mt -84.12 142.74 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.883 . . . . 0.0 109.583 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.786 HG23 HG22 ' A' ' 63' ' ' ILE . 52.7 t 50.72 92.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.577 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -53.94 -12.38 0.56 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.387 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.64 -53.6 8.27 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.06 144.04 56.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -1.15 . . . . 0.0 109.465 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' THR . 6.0 ptpt -154.41 34.36 0.42 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.335 -0.853 . . . . 0.0 109.127 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 70' ' ' THR . 12.0 mmt-85 -67.06 74.96 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -48.19 173.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 109.424 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.761 ' C ' HD23 ' A' ' 72' ' ' LEU . 0.6 OUTLIER -158.81 -173.75 4.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.761 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -116.65 -5.15 11.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.695 -0.628 . . . . 0.0 109.804 -179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -145.81 125.62 13.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.942 . . . . 0.0 109.061 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -45.38 -22.69 0.15 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.6 tmm_? -69.86 -36.32 75.43 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.596 -0.69 . . . . 0.0 110.129 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -82.57 -33.95 27.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' HG ' ' HD1' ' A' ' 80' ' ' HIS . 10.0 tp -70.1 -38.29 75.62 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.6 tp60 -67.52 -30.43 70.08 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.48 -20.98 62.0 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.54 ' C ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -78.09 -41.58 34.82 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.355 -1.338 . . . . 0.0 108.429 179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.51 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.8 mm -56.3 -54.98 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.335 -0.853 . . . . 0.0 109.281 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.497 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 5.8 p30 -69.35 -23.56 63.78 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.526 -178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.9 m170 -87.68 -11.73 47.49 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.598 -1.241 . . . . 0.0 111.189 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -115.37 -49.95 2.74 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.264 -0.897 . . . . 0.0 112.858 -177.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.492 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -139.15 -24.66 0.88 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.063 -1.023 . . . . 0.0 110.214 -178.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' ILE . 3.6 ttm 55.06 38.38 30.41 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 109.582 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.437 ' HB2' HG21 ' A' ' 63' ' ' ILE . 13.4 mtp85 -90.17 0.6 57.1 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.171 -0.956 . . . . 0.0 109.443 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' HG21 ' A' ' 81' ' ' ILE . . . -47.24 150.81 0.79 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 118.016 -1.436 . . . . 0.0 109.52 -179.959 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.597 HG12 ' SD ' ' A' ' 60' ' ' MET . 19.0 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.576 ' ND1' ' NH1' ' A' ' 55' ' ' ARG . 37.8 t60 65.07 -58.06 0.27 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.298 0.571 . . . . 0.0 109.975 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 1' ' ' VAL . 32.5 m-85 -74.14 107.99 6.67 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.33 -0.856 . . . . 0.0 109.318 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.55 ' HA ' HD11 ' A' ' 11' ' ' ILE . 4.9 t -45.95 146.5 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.818 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.8 -25.43 40.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.51 -0.744 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -48.8 4.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.278 -0.889 . . . . 0.0 110.301 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.4 m -78.07 -15.61 58.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.113 -0.992 . . . . 0.0 109.939 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.83 13.06 12.03 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.66 158.75 31.2 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.546 -0.973 . . . . 0.0 108.48 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -65.85 103.45 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.854 1.703 . . . . 0.0 112.088 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 4' ' ' CYS . 71.0 mt -49.47 116.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-O 121.336 0.589 . . . . 0.0 110.447 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.17 -31.72 33.94 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.57 145.32 24.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -73.99 102.07 4.04 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 120.961 -1.087 . . . . 0.0 111.491 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.13 85.72 1.11 Allowed Glycine 0 N--CA 1.482 1.762 0 N-CA-C 107.345 -2.302 . . . . 0.0 107.345 177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH2' ' OG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -71.28 141.44 50.52 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.904 -0.762 . . . . 0.0 110.519 -178.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.517 ' O ' ' N ' ' A' ' 21' ' ' LYS . 11.4 mtp -129.58 132.84 46.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.756 -0.59 . . . . 0.0 109.887 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.646 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -118.03 156.03 50.66 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.83 3.58 41.46 Favored 'Cis proline' 0 N--CA 1.492 1.385 0 C-N-CA 124.112 -1.203 . . . . 0.0 111.799 -0.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -55.39 -37.04 67.05 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.427 -0.795 . . . . 0.0 109.008 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.555 ' HZ2' HD21 ' A' ' 72' ' ' LEU . 3.0 tttm 68.78 29.14 5.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 4.9 m80 -100.41 -174.75 2.73 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.759 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.572 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -141.66 155.88 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.396 -0.815 . . . . 0.0 110.998 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.8 m-85 -164.17 168.3 19.11 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.417 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -55.43 112.61 1.15 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.193 -1.403 . . . . 0.0 108.008 178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' O ' HG23 ' A' ' 30' ' ' ILE . 48.6 t80 -49.63 -31.3 10.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 0.0 109.883 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.59 -39.99 84.82 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.566 ' SG ' ' CE1' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -81.38 -23.66 37.52 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.21 -35.89 74.19 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.272 -0.971 . . . . 0.0 108.517 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 26' ' ' TYR . 19.1 pt -86.7 -35.13 8.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 121.163 -0.961 . . . . 0.0 109.419 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.71 -23.82 60.91 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.333 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.566 ' CE1' ' SG ' ' A' ' 28' ' ' CYS . 40.7 m170 -78.44 -55.45 5.21 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -57.24 -32.31 66.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.388 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -80.74 -26.86 37.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.034 -1.041 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -79.35 -5.67 55.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.939 . . . . 0.0 110.334 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.6 32.57 3.35 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.567 ' C ' ' H ' ' A' ' 39' ' ' MET . 0.8 OUTLIER -132.04 56.68 1.81 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.72 33.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.723 0.773 . . . . 0.0 108.921 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.585 ' HA ' HG23 ' A' ' 47' ' ' VAL . 7.4 mtm -131.72 137.27 48.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.505 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -38.72 102.91 0.26 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.778 -0.576 . . . . 0.0 110.049 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.56 -19.48 5.0 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.796 1.664 . . . . 0.0 112.33 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.15 -37.21 2.95 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.185 -1.007 . . . . 0.0 110.71 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.0 m -104.84 -31.63 9.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -1.113 . . . . 0.0 110.319 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 75.59 63.02 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.406 -0.809 . . . . 0.0 109.079 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.432 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.4 OUTLIER -130.8 160.31 67.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.88 90.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.553 2.169 . . . . 0.0 112.38 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.585 HG23 ' HA ' ' A' ' 39' ' ' MET . 97.5 t -60.49 94.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 108.687 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 18' ' ' ILE . 5.3 tt0 -61.75 -62.85 1.51 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.191 -0.943 . . . . 0.0 108.638 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.646 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.78 139.07 22.41 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.273 179.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.1 mt -97.54 143.11 13.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.826 -1.171 . . . . 0.0 109.844 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -136.73 141.14 43.04 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-O 121.785 0.802 . . . . 0.0 110.025 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -85.52 149.2 25.54 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.329 0.585 . . . . 0.0 109.669 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.51 ' SG ' HD21 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -145.86 165.93 27.45 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.32 169.78 10.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.772 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.576 ' NH1' ' ND1' ' A' ' 2' ' ' HIS . 11.0 ttm-85 -90.38 74.86 6.9 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 122.398 1.095 . . . . 0.0 108.649 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.82 4.42 0.1 Allowed Glycine 0 C--N 1.288 -2.113 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.442 ' C ' HD23 ' A' ' 58' ' ' LEU . 20.6 m -90.23 -34.0 15.96 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.089 -1.242 . . . . 0.0 109.536 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -100.23 173.88 6.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.538 -0.726 . . . . 0.0 109.701 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -134.66 128.5 33.19 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.673 -0.642 . . . . 0.0 109.521 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.597 ' SD ' HG12 ' A' ' 1' ' ' VAL . 0.0 OUTLIER -101.08 144.73 29.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.537 -0.727 . . . . 0.0 110.577 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.418 ' CB ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -64.61 111.39 2.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.624 -0.673 . . . . 0.0 109.371 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 64' ' ' VAL . 0.4 OUTLIER -45.56 -65.77 0.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.398 -0.814 . . . . 0.0 109.993 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.421 ' CG2' ' CE1' ' A' ' 85' ' ' HIS . 3.4 mt -45.0 93.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.558 -0.714 . . . . 0.0 109.515 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.752 HG22 ' H ' ' A' ' 65' ' ' GLN . 9.0 p -63.53 -120.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.331 -0.856 . . . . 0.0 109.395 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.752 ' H ' HG22 ' A' ' 64' ' ' VAL . 8.5 tt0 58.58 60.19 2.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.141 -0.975 . . . . 0.0 109.277 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.38 51.02 18.75 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.408 ' CB ' ' HE2' ' A' ' 80' ' ' HIS . 37.6 m -146.6 -111.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -1.13 . . . . 0.0 109.522 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp 48.29 42.11 17.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.745 HH11 HH22 ' A' ' 84' ' ' ARG . 68.5 mtp180 -91.75 112.76 24.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.139 -0.976 . . . . 0.0 109.778 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.527 ' OG1' ' NH2' ' A' ' 16' ' ' ARG . 1.2 p -56.18 170.01 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.237 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.686 ' C ' HD23 ' A' ' 72' ' ' LEU . 37.2 m-85 -158.0 170.01 23.27 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.107 -0.996 . . . . 0.0 109.501 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.728 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -108.03 -5.65 16.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.742 -0.598 . . . . 0.0 109.727 -179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 75' ' ' ARG . 2.3 t -158.57 129.49 6.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.056 -1.027 . . . . 0.0 109.774 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 73' ' ' SER . 1.2 tp60 -42.27 -26.15 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.331 0.586 . . . . 0.0 109.439 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 tmt_? -64.17 -34.79 78.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.514 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -83.17 -36.52 24.65 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.899 -1.126 . . . . 0.0 108.41 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.34 -33.15 67.09 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.437 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 23.3 tp60 -69.99 -33.32 71.9 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.532 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.34 61.43 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.418 ' CD2' ' CB ' ' A' ' 61' ' ' CYS . 26.3 t60 -74.22 -44.12 54.44 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.471 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 86' ' ' MET . 2.8 mm -60.18 -53.53 47.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.549 -0.72 . . . . 0.0 109.196 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 14.8 m-20 -64.65 -22.51 66.99 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.336 -0.853 . . . . 0.0 109.22 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 18.1 m170 -87.41 -12.24 46.79 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.125 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.745 HH22 HH11 ' A' ' 69' ' ' ARG . 15.3 mmt-85 -120.9 -43.45 2.46 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.25 -0.906 . . . . 0.0 112.866 -177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.634 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -153.15 -25.17 0.15 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.592 -1.317 . . . . 0.0 110.244 -179.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.52 ' N ' ' O ' ' A' ' 81' ' ' ILE . 1.3 ttt 66.04 38.99 4.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 109.62 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -91.96 -166.79 1.63 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.42 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.03 96.9 1.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.492 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.936 -1.48 . . . . 0.0 109.594 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 11' ' ' ILE . 2.9 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.495 ' O ' ' CG ' ' A' ' 3' ' ' PHE . 83.1 t60 -173.93 -88.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.495 ' CG ' ' O ' ' A' ' 2' ' ' HIS . 36.7 m-85 -160.54 106.05 1.47 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.46 -0.775 . . . . 0.0 110.21 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.652 ' HA ' HD11 ' A' ' 11' ' ' ILE . 10.4 p -51.56 143.89 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.39 -0.819 . . . . 0.0 110.057 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.85 -4.48 57.56 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -85.46 -33.27 21.91 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.41 -0.806 . . . . 0.0 109.623 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.484 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -135.68 -15.96 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.621 -0.674 . . . . 0.0 110.488 -179.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.567 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.09 14.31 64.68 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.212 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.52 156.62 37.32 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.088 -1.243 . . . . 0.0 108.432 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.97 136.52 66.18 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.778 1.652 . . . . 0.0 111.788 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.652 HD11 ' HA ' ' A' ' 4' ' ' CYS . 79.0 mt -88.17 93.79 4.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.61 0.719 . . . . 0.0 110.313 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -69.34 -36.35 76.83 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.23 142.72 36.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.603 ' CD2' HD12 ' A' ' 58' ' ' LEU . 19.3 m-85 -73.31 106.04 4.96 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.135 -0.978 . . . . 0.0 111.123 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.79 81.27 0.77 Allowed Glycine 0 C--N 1.297 -1.616 0 N-CA-C 106.692 -2.563 . . . . 0.0 106.692 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.54 HH12 ' C ' ' A' ' 21' ' ' LYS . 19.8 ttm-85 -65.8 133.01 50.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.942 -0.74 . . . . 0.0 109.164 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.533 ' SD ' ' CE1' ' A' ' 24' ' ' PHE . 31.3 mtp -119.12 134.62 55.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.727 -0.608 . . . . 0.0 110.566 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -118.75 156.5 51.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.88 -1.32 43.76 Favored 'Cis proline' 0 N--CA 1.491 1.352 0 C-N-CA 123.962 -1.266 . . . . 0.0 111.32 0.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.45 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -49.87 -41.2 44.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.54 ' C ' HH12 ' A' ' 16' ' ' ARG . 5.4 ttmt 74.08 27.96 1.51 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.605 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 23.3 m80 -99.82 -175.99 3.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.486 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 2.9 m -145.3 153.55 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.171 -0.956 . . . . 0.0 111.376 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CE1' ' SD ' ' A' ' 17' ' ' MET . 66.3 m-85 -154.23 -149.94 0.3 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -90.54 107.81 19.4 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 178.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 30' ' ' ILE . 51.2 t80 -48.34 -13.48 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 109.832 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -83.05 -48.95 10.05 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.102 -0.999 . . . . 0.0 109.703 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.484 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 3.4 m -79.91 -23.15 42.0 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.809 -1.182 . . . . 0.0 108.361 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.472 ' O ' ' CD1' ' A' ' 50' ' ' ILE . . . -68.31 -35.25 77.54 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.689 HG23 ' O ' ' A' ' 26' ' ' TYR . 38.4 pt -81.75 -34.34 12.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 O-C-N 120.948 -1.095 . . . . 0.0 109.241 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.62 -23.94 63.58 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.854 -1.139 . . . . 0.0 108.406 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.419 ' CE1' ' OD2' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -80.24 -40.4 27.11 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.185 -0.947 . . . . 0.0 108.833 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.41 -31.24 63.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.643 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -82.83 -26.4 31.73 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 110.088 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -81.94 -79.23 0.18 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.973 -1.079 . . . . 0.0 110.242 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.1 40.9 0.17 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.571 ' C ' ' H ' ' A' ' 39' ' ' MET . 1.8 m-20 -133.9 57.3 1.81 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.636 0.731 . . . . 0.0 109.088 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.96 32.88 0.06 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.571 ' H ' ' C ' ' A' ' 37' ' ' ASP . 1.9 mtt -127.37 167.73 15.8 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.566 ' O ' ' N ' ' A' ' 42' ' ' GLY . 10.6 t -102.74 74.49 0.17 Allowed Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.804 -0.56 . . . . 0.0 111.008 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -35.3 -21.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.517 2.145 . . . . 0.0 114.034 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 40' ' ' CYS . . . -75.34 -35.48 47.85 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.605 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.9 m -125.81 -33.46 2.72 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 122.019 -0.695 . . . . 0.0 109.424 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' CYS . 2.8 p 83.99 78.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.084 0.945 . . . . 0.0 109.904 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.66 160.03 48.91 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.22 81.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 122.014 1.809 . . . . 0.0 111.612 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.4 t -48.49 101.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 108.728 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -61.53 1.74 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.303 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.459 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -148.3 122.97 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.292 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.472 ' CD1' ' O ' ' A' ' 29' ' ' ALA . 6.8 mt -79.89 147.41 6.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.876 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -139.03 162.54 34.69 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.605 0.717 . . . . 0.0 110.559 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.558 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 45.7 mt-30 -99.12 134.51 41.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.77 -0.581 . . . . 0.0 110.539 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -139.25 155.28 47.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.51 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.38 155.86 17.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.833 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 57' ' ' SER . 1.1 ptm180 -51.61 -55.44 19.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.229 -0.919 . . . . 0.0 109.815 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.56 7.69 0.94 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -103.61 -8.21 20.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.39 -1.065 . . . . 0.0 109.741 -179.373 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.603 HD12 ' CD2' ' A' ' 14' ' ' TYR . 26.8 mt -130.99 169.09 16.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.695 -0.628 . . . . 0.0 110.098 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 44.8 m-85 -122.59 122.35 38.65 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.5 mtt -87.64 144.83 26.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 0.0 110.336 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 51.7 t -89.79 143.27 26.94 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.634 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 32.4 m -95.91 -58.21 2.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 109.563 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 72.4 mt -45.69 133.95 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 109.747 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 64' ' ' VAL . 65.6 t 47.11 76.34 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.353 -0.842 . . . . 0.0 109.498 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -49.02 -13.28 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.883 . . . . 0.0 109.362 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . -59.81 -52.04 55.37 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 69' ' ' ARG . 8.0 p -53.6 -60.39 3.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -1.175 . . . . 0.0 109.438 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER 48.82 11.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 0.0 109.747 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 67' ' ' CYS . 83.4 mtt-85 -60.93 110.04 1.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.951 . . . . 0.0 109.324 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.523 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.19 175.82 10.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.191 -0.943 . . . . 0.0 109.651 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.776 ' C ' HD23 ' A' ' 72' ' ' LEU . 88.6 m-85 -157.49 -164.63 1.61 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.378 -0.826 . . . . 0.0 108.941 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.776 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -116.31 -9.52 11.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.766 -0.584 . . . . 0.0 110.106 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.496 ' O ' ' N ' ' A' ' 75' ' ' ARG . 62.7 m -147.22 128.45 14.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.983 -1.073 . . . . 0.0 109.653 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.24 -18.01 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.22 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 73' ' ' SER . 7.6 tmm_? -74.25 -33.91 63.47 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.406 -0.809 . . . . 0.0 109.695 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -82.94 -35.78 25.73 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.8 -33.95 64.43 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -71.03 -30.58 66.82 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.547 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.48 -21.15 61.26 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.428 ' HD1' ' HG3' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -74.38 -39.83 62.47 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.537 -1.265 . . . . 0.0 108.174 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.41 HG23 ' HD2' ' A' ' 85' ' ' HIS . 28.0 mm -57.58 -59.54 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 CA-C-O 121.871 0.843 . . . . 0.0 110.029 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.463 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.0 p30 -67.44 -20.11 65.46 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 109.555 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.547 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 37.5 m170 -86.94 -13.46 44.63 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.201 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.428 ' HG3' ' HD1' ' A' ' 80' ' ' HIS . 15.7 mmt-85 -124.79 -41.03 2.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.177 -0.952 . . . . 0.0 112.334 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 86' ' ' MET . 5.4 m-70 -97.25 -46.58 6.06 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.036 -1.04 . . . . 0.0 108.609 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.419 ' C ' ' O ' ' A' ' 85' ' ' HIS . 0.2 OUTLIER 40.29 30.53 0.08 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.31 0.576 . . . . 0.0 110.087 179.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 85' ' ' HIS . 12.0 ttp85 -101.37 18.03 21.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.655 -0.653 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.24 149.9 0.94 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.563 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 1.037 HG22 ' H ' ' A' ' 2' ' ' HIS . 9.9 p . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 1.037 ' H ' HG22 ' A' ' 1' ' ' VAL . 0.6 OUTLIER -144.28 51.68 1.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.711 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.51 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 3.0 t80 -158.46 102.55 1.74 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 t -45.66 146.18 1.17 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.0 109.881 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.72 -27.62 18.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.443 -0.786 . . . . 0.0 109.452 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.7 -38.78 10.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.895 . . . . 0.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.09 -28.64 14.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.277 -0.889 . . . . 0.0 110.463 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.51 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.73 4.73 90.26 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.92 156.29 40.69 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.122 -1.222 . . . . 0.0 108.654 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.11 138.28 85.6 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.914 1.742 . . . . 0.0 112.089 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.594 HG23 ' HA ' ' A' ' 25' ' ' CYS . 40.5 mt -84.7 -67.4 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.642 -0.661 . . . . 0.0 111.002 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 70.0 -32.71 0.24 Allowed 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.577 ' H ' ' C ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -145.17 120.06 3.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.409 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.4 m-85 -67.21 113.26 5.0 Favored 'General case' 0 C--N 1.284 -2.24 0 O-C-N 121.655 -0.653 . . . . 0.0 110.863 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.75 82.2 1.67 Allowed Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.404 HH21 ' HG3' ' A' ' 21' ' ' LYS . 4.0 ttt-85 -64.9 133.99 53.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 122.141 -0.623 . . . . 0.0 109.946 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 22.5 mtp -118.09 133.58 55.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.079 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.66 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.87 156.78 49.61 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -83.43 1.24 56.47 Favored 'Cis proline' 0 N--CA 1.49 1.265 0 C-N-CA 124.207 -1.164 . . . . 0.0 112.017 0.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 5.7 t -54.68 -38.04 66.49 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.407 -0.808 . . . . 0.0 109.13 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 20' ' ' CYS . 5.4 tttm 76.56 29.33 0.68 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.592 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 2.6 m80 -101.58 -179.17 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -145.88 155.31 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.033 -1.042 . . . . 0.0 110.97 -179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.517 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 51.2 m-85 -159.71 167.12 29.1 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.594 ' HA ' HG23 ' A' ' 11' ' ' ILE . 20.4 p -51.68 110.63 0.48 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.493 -1.283 . . . . 0.0 108.212 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 30' ' ' ILE . 39.2 t80 -49.67 -10.92 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.622 -0.674 . . . . 0.0 110.356 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.1 m-20 -78.65 -44.31 24.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.725 -1.234 . . . . 0.0 109.51 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.6 p -80.51 -25.35 38.79 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.863 -1.148 . . . . 0.0 108.196 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -64.43 -37.71 88.46 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 26' ' ' TYR . 40.7 pt -82.57 -34.55 11.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.19 -0.944 . . . . 0.0 109.629 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.15 -19.48 59.86 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.788 -1.165 . . . . 0.0 108.151 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -77.18 -54.06 6.98 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.27 -0.894 . . . . 0.0 109.161 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -67.62 -30.97 70.68 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.584 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -74.73 -29.76 61.27 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.024 -1.047 . . . . 0.0 109.071 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -82.25 -79.27 0.18 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.142 -0.974 . . . . 0.0 109.819 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.74 31.93 0.11 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.548 ' C ' ' H ' ' A' ' 39' ' ' MET . 1.4 m-20 -125.63 52.85 1.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.809 0.814 . . . . 0.0 108.874 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.12 31.86 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.55 ' HA ' HG23 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -128.4 139.02 52.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.849 -0.532 . . . . 0.0 109.567 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -42.87 106.12 0.46 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.54 -0.725 . . . . 0.0 109.621 -179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.47 -21.92 8.17 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.568 1.512 . . . . 0.0 112.124 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.21 -42.12 2.65 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.176 -1.011 . . . . 0.0 110.747 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.8 m -100.88 -30.33 11.73 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.231 -1.159 . . . . 0.0 110.608 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.19 57.04 0.09 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.289 -0.882 . . . . 0.0 109.06 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.3 OUTLIER -123.48 160.96 48.33 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.609 -0.682 . . . . 0.0 109.209 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.08 89.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.538 2.158 . . . . 0.0 112.048 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 39' ' ' MET . 98.5 t -57.45 101.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.187 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.55 -66.22 0.57 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.66 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -151.35 134.8 16.17 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.485 179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.521 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.5 mt -88.26 145.81 7.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.666 -1.271 . . . . 0.0 109.107 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -137.53 146.82 44.61 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.717 0.77 . . . . 0.0 110.131 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -89.75 142.16 27.95 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.774 -0.579 . . . . 0.0 109.605 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.38 159.07 44.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.355 -0.841 . . . . 0.0 110.204 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.38 162.82 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.05 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.524 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -66.32 -60.32 2.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.071 -1.018 . . . . 0.0 110.064 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.39 25.89 0.58 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.3 t -91.17 -23.6 20.2 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.167 -1.196 . . . . 0.0 109.753 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.4 173.45 6.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.734 -0.604 . . . . 0.0 109.71 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -117.08 119.91 36.71 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.4 mmt -75.9 144.52 41.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.919 . . . . 0.0 110.341 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 t -84.85 143.22 29.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.035 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.6 m -146.38 74.04 1.35 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 109.791 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.438 HD11 HD12 ' A' ' 81' ' ' ILE . 24.4 mm -105.55 -75.6 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.562 -0.712 . . . . 0.0 109.216 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 65' ' ' GLN . 0.7 OUTLIER -93.78 -99.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.469 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.481 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.4 tt0 -168.21 35.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.345 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -146.24 -34.64 0.06 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.593 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 40.9 t -64.44 170.93 3.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -1.158 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.593 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 11.1 pttt 179.3 29.67 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.363 -0.836 . . . . 0.0 109.185 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.81 117.19 20.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.101 -1.0 . . . . 0.0 109.439 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.543 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -82.71 174.79 10.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 0.0 109.954 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.726 ' C ' HD23 ' A' ' 72' ' ' LEU . 98.2 m-85 -158.31 -177.92 6.9 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.726 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -113.9 -2.7 13.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.587 -0.695 . . . . 0.0 110.549 -178.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 76' ' ' ASP . 1.5 m -154.57 131.39 10.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.814 -1.179 . . . . 0.0 109.865 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.3 tp60 -43.39 -30.18 0.51 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -63.77 -35.05 79.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.509 -0.745 . . . . 0.0 110.131 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 73' ' ' SER . 3.1 m-20 -81.19 -37.82 28.07 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.995 0.903 . . . . 0.0 108.705 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 tt -74.43 -31.07 62.16 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLN . 22.6 tp60 -71.07 -33.73 70.52 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.546 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.31 -19.92 61.58 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -72.67 -47.52 46.75 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.705 -1.198 . . . . 0.0 108.601 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.516 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.5 mm -56.17 -51.05 67.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 O-C-N 121.688 -0.633 . . . . 0.0 109.61 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.05 -18.66 62.56 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.867 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.546 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.0 m170 -87.67 -27.32 22.51 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.075 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.12 -23.82 2.96 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.065 -1.022 . . . . 0.0 112.135 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.485 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 5.4 m-70 -102.19 -47.36 4.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.163 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.2 ttt 41.28 33.8 0.29 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.426 0.632 . . . . 0.0 110.079 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.8 ttt-85 -86.04 0.51 53.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.379 -0.826 . . . . 0.0 109.41 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.33 139.74 6.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.87 . . . . 0.0 109.453 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.53 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 11' ' ' ILE . 4.4 m-70 -95.98 -56.95 2.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.392 -0.817 . . . . 0.0 109.658 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.43 109.13 8.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.895 . . . . 0.0 109.624 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.615 ' HA ' HD11 ' A' ' 11' ' ' ILE . 48.8 t -46.93 146.35 1.7 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.874 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.43 -24.11 39.83 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.447 -0.783 . . . . 0.0 109.457 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -60.95 1.44 Allowed 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.375 -0.828 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 7.3 m -68.27 -14.93 63.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 110.291 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.49 11.33 5.12 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 152.49 37.83 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.988 . . . . 0.0 108.572 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -60.76 100.37 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.729 1.619 . . . . 0.0 112.259 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.615 HD11 ' HA ' ' A' ' 4' ' ' CYS . 77.8 mt -47.37 117.46 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.681 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -83.14 -32.08 26.84 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.12 143.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -73.19 100.71 3.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 120.852 -1.155 . . . . 0.0 111.032 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -76.53 86.86 0.93 Allowed Glycine 0 N--CA 1.484 1.868 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.479 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.6 ttt-85 -77.79 141.43 39.22 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.761 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.553 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 11.2 mtp -128.72 132.45 47.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.968 -0.457 . . . . 0.0 109.949 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.664 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -114.6 156.22 45.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.73 4.08 46.07 Favored 'Cis proline' 0 N--CA 1.491 1.346 0 C-N-CA 124.142 -1.191 . . . . 0.0 111.344 -0.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 4.2 t -55.81 -35.36 66.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.509 -0.745 . . . . 0.0 109.122 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.617 ' HE2' HD21 ' A' ' 72' ' ' LEU . 4.5 tttt 66.62 27.77 9.41 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 27.0 m170 -93.54 -173.3 3.15 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.478 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.553 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -142.89 156.68 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 110.346 179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.553 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 85.7 m-85 -165.66 166.26 18.14 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.443 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -57.68 114.75 2.41 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 177.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.553 ' O ' HG23 ' A' ' 30' ' ' ILE . 43.9 t80 -47.65 -21.27 0.34 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.016 -1.052 . . . . 0.0 109.808 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.36 -39.87 62.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.061 -1.024 . . . . 0.0 108.248 178.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.537 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.02 -22.29 33.62 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.53 -34.28 72.11 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 26' ' ' TYR . 45.4 pt -80.52 -35.45 15.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 121.104 -0.998 . . . . 0.0 108.67 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 28' ' ' CYS . 34.9 mt -62.57 -38.81 91.57 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.693 -1.203 . . . . 0.0 107.876 178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -70.26 -34.88 73.34 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.13 -35.78 76.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 108.835 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.0 mttt -75.69 -21.59 57.45 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.127 -0.983 . . . . 0.0 108.704 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -81.96 -73.08 0.4 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.416 -0.802 . . . . 0.0 110.545 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -92.54 -36.78 6.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 1.9 t0 75.2 13.41 3.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.398 -1.06 . . . . 0.0 110.284 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.29 29.45 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.836 -1.165 . . . . 0.0 111.356 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.7 ptp -141.73 130.41 22.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.954 -1.091 . . . . 0.0 110.157 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.539 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 1.5 t -71.0 136.65 84.91 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -45.81 -46.68 15.07 Favored 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.911 1.741 . . . . 0.0 113.074 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.16 -28.08 4.26 Favored Glycine 0 N--CA 1.499 2.834 0 C-N-CA 120.04 -1.076 . . . . 0.0 111.214 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 -14.97 25.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.257 . . . . 0.0 110.586 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.6 p 48.48 38.18 10.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -92.22 161.1 33.86 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.357 -0.84 . . . . 0.0 108.999 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLN . 19.6 Cg_endo -59.73 71.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.2 1.933 . . . . 0.0 112.068 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 45' ' ' ASP . 61.2 t -44.99 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.17 -0.956 . . . . 0.0 109.724 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' PRO . 3.7 tt0 -65.61 -61.74 1.92 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.069 -1.019 . . . . 0.0 108.344 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.664 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -148.76 137.53 21.39 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.769 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.546 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -94.78 147.31 5.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.641 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -140.53 154.48 46.56 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 121.29 0.567 . . . . 0.0 109.706 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.22 138.47 45.52 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.25 0.548 . . . . 0.0 109.692 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.69 165.97 25.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.423 -0.798 . . . . 0.0 109.831 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -82.88 157.89 22.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.336 -0.853 . . . . 0.0 109.091 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -72.53 31.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.103 -0.998 . . . . 0.0 110.161 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -146.79 14.28 1.54 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.52 ' C ' HD23 ' A' ' 58' ' ' LEU . 62.9 m -97.21 -28.63 14.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.702 -0.881 . . . . 0.0 110.404 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -114.11 172.42 7.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.607 -0.683 . . . . 0.0 109.783 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 41.7 m-85 -116.89 124.1 48.64 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -86.44 144.55 27.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.243 -0.91 . . . . 0.0 110.393 -179.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.585 ' N ' ' SD ' ' A' ' 60' ' ' MET . 42.1 t -95.91 109.75 22.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.483 -0.761 . . . . 0.0 109.125 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 88.7 p -102.52 51.21 0.81 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.466 -0.771 . . . . 0.0 109.969 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.618 HG21 ' ND1' ' A' ' 85' ' ' HIS . 3.7 mm -95.63 -46.87 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 109.263 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.689 HG22 ' N ' ' A' ' 65' ' ' GLN . 14.6 p -157.98 175.88 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -0.91 . . . . 0.0 109.425 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.689 ' N ' HG22 ' A' ' 64' ' ' VAL . 36.5 mt-30 -75.36 -17.63 60.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.464 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.403 ' H ' HG13 ' A' ' 64' ' ' VAL . . . -88.91 5.71 84.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.7 m -46.37 160.16 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -1.115 . . . . 0.0 109.528 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.764 ' HZ1' HH21 ' A' ' 84' ' ' ARG . 11.6 mttp -77.36 -70.53 0.46 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.388 -0.82 . . . . 0.0 109.889 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -175.61 -150.03 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.098 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.476 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -90.56 -173.84 3.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.701 ' C ' HD23 ' A' ' 72' ' ' LEU . 95.6 m-85 -152.39 178.29 9.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.115 -0.991 . . . . 0.0 108.903 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.705 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.33 -10.04 14.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.715 -0.615 . . . . 0.0 109.743 -179.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 75' ' ' ARG . 48.2 t -153.18 132.29 12.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.098 -1.002 . . . . 0.0 109.91 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.54 -22.08 0.43 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.396 -0.815 . . . . 0.0 109.103 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.8 ttt-85 -70.89 -32.51 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -83.52 -34.67 25.24 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 tt -75.68 -33.88 60.41 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.438 ' O ' ' ND2' ' A' ' 82' ' ' ASN . 20.6 tp60 -70.3 -33.58 71.71 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.545 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.84 -19.32 60.77 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.519 ' CG ' ' OH ' ' A' ' 71' ' ' TYR . 24.3 t60 -74.81 -44.76 47.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 118.531 -1.267 . . . . 0.0 108.605 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.538 ' N ' HD13 ' A' ' 81' ' ' ILE . 1.9 mm -56.73 -53.3 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.722 0.772 . . . . 0.0 109.443 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 3.7 m-20 -69.38 -19.72 63.83 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.215 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 18.4 m170 -87.49 -25.92 23.46 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.781 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.764 HH21 ' HZ1' ' A' ' 68' ' ' LYS . 0.3 OUTLIER -129.64 -34.24 1.79 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.066 -1.021 . . . . 0.0 112.651 -177.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.618 ' ND1' HG21 ' A' ' 63' ' ' ILE . 7.6 m-70 -94.01 -51.54 4.81 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.917 -1.114 . . . . 0.0 109.001 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 86' ' ' MET . 0.0 OUTLIER 40.93 35.03 0.31 Allowed 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.466 0.65 . . . . 0.0 109.782 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -173.27 113.54 0.23 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.42 155.27 1.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.367 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 CA-C-O 118.023 -1.432 . . . . 0.0 109.525 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.652 ' O ' HG12 ' A' ' 1' ' ' VAL . 65.2 t . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.797 0.808 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.739 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -121.52 24.81 9.69 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -76.9 112.77 13.87 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.662 -1.274 . . . . 0.0 109.18 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.624 ' HA ' HD11 ' A' ' 11' ' ' ILE . 13.2 t -45.76 146.39 1.16 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.276 -0.89 . . . . 0.0 109.991 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.64 -25.92 32.67 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.599 -0.688 . . . . 0.0 109.71 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.66 -42.63 7.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.248 -0.907 . . . . 0.0 110.542 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 m -90.55 -29.7 17.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.061 -1.024 . . . . 0.0 110.666 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.07 1.36 87.64 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.88 158.8 49.97 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 108.502 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -68.54 97.73 0.54 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.878 1.719 . . . . 0.0 112.5 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.624 HD11 ' HA ' ' A' ' 4' ' ' CYS . 97.0 mt -41.68 113.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.237 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -82.97 -32.71 26.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 11' ' ' ILE . 1.6 t -133.14 147.01 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.05 104.49 16.37 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 120.822 -1.174 . . . . 0.0 111.114 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.4 91.27 1.15 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 107.215 -2.354 . . . . 0.0 107.215 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.542 ' NH2' ' O ' ' A' ' 21' ' ' LYS . 2.5 tpt85 -74.63 135.84 41.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 122.082 -0.657 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.539 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 8.3 mtp -126.34 132.2 51.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.921 -0.487 . . . . 0.0 109.766 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.651 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.28 156.33 48.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.63 3.8 40.11 Favored 'Cis proline' 0 N--CA 1.49 1.321 0 C-N-CA 124.07 -1.221 . . . . 0.0 111.112 -0.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -55.07 -32.01 61.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' NH2' ' A' ' 16' ' ' ARG . 1.8 mttp 59.52 31.09 20.76 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.592 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 9.3 m170 -96.16 -173.15 2.72 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.591 -0.693 . . . . 0.0 109.374 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.488 ' C ' ' CD1' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -147.36 149.0 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.281 -0.887 . . . . 0.0 110.58 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.539 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 37.1 m-85 -158.35 170.6 21.86 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -59.31 113.89 2.38 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 117.887 -1.525 . . . . 0.0 107.222 178.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -46.31 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.574 -0.704 . . . . 0.0 110.367 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.1 m-20 -78.93 -41.14 30.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.001 -1.062 . . . . 0.0 108.724 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HA ' HD12 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -80.35 -22.08 41.76 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.0 -1.062 . . . . 0.0 108.57 179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.632 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.84 -29.06 65.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 pt -89.14 -28.5 5.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 120.658 -1.276 . . . . 0.0 108.955 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 28' ' ' CYS . 24.4 mt -66.77 -35.89 81.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 118.643 -1.223 . . . . 0.0 108.09 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.607 ' CG ' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -76.27 -44.38 37.46 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.607 ' N ' ' CG ' ' A' ' 32' ' ' HIS . 1.2 pt-20 -52.31 -32.74 39.26 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -83.56 -29.92 27.45 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.274 -0.891 . . . . 0.0 109.56 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -75.75 0.31 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.936 . . . . 0.0 110.904 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -78.32 -41.98 15.89 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 2.5 t0 77.78 8.19 2.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.641 -0.917 . . . . 0.0 110.211 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -175.71 43.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.001 -1.062 . . . . 0.0 111.157 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.441 ' O ' ' CG ' ' A' ' 39' ' ' MET . 11.9 ptm -148.82 122.38 9.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.577 -1.327 . . . . 0.0 110.49 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.408 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.8 OUTLIER -63.2 143.18 97.73 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.476 -0.765 . . . . 0.0 108.995 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.18 -38.11 95.49 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.125 1.217 . . . . 0.0 112.076 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.33 -45.38 1.35 Allowed Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.196 -1.002 . . . . 0.0 111.61 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -89.48 -10.76 45.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.817 -1.402 . . . . 0.0 110.732 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t 48.37 37.48 8.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.075 -1.016 . . . . 0.0 108.842 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.4 OUTLIER -89.56 161.1 40.34 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.553 -0.717 . . . . 0.0 109.406 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.2 76.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.488 2.125 . . . . 0.0 111.71 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 45' ' ' ASP . 17.3 t -48.97 109.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.283 -0.885 . . . . 0.0 109.983 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -72.03 -62.25 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.162 -0.961 . . . . 0.0 108.56 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.651 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.78 134.5 16.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.265 -0.897 . . . . 0.0 109.692 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.632 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -92.79 144.82 8.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.819 -1.176 . . . . 0.0 109.88 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -140.8 146.47 37.67 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.448 0.642 . . . . 0.0 109.44 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -91.27 150.88 21.13 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.509 -0.744 . . . . 0.0 109.584 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -150.87 167.84 26.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.263 -0.898 . . . . 0.0 109.674 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.466 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.2 OUTLIER -90.49 165.27 13.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.208 -0.933 . . . . 0.0 109.362 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -59.5 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.149 -0.969 . . . . 0.0 109.645 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.66 18.9 22.88 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.741 ' O ' HD23 ' A' ' 58' ' ' LEU . 50.9 m -85.16 -21.23 29.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.052 -1.263 . . . . 0.0 108.999 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.741 HD23 ' O ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -132.06 173.1 11.56 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 6.3 m-85 -117.92 109.41 16.48 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.572 -0.705 . . . . 0.0 110.425 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.5 mmt -71.92 144.77 48.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 0.0 110.138 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.521 ' SG ' ' CE1' ' A' ' 80' ' ' HIS . 44.7 t -95.88 143.1 27.37 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.381 -0.824 . . . . 0.0 109.555 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.54 -17.9 37.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.299 -0.876 . . . . 0.0 108.958 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.412 ' CG2' ' CE1' ' A' ' 85' ' ' HIS . 53.5 mt -94.25 92.42 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.453 -0.78 . . . . 0.0 109.293 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 65' ' ' GLN . 12.4 m -69.99 -166.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.626 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.431 ' CB ' ' O ' ' A' ' 64' ' ' VAL . 1.8 tt0 71.09 105.82 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.608 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 49.71 63.2 4.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.474 ' C ' ' H ' ' A' ' 69' ' ' ARG . 11.6 t -148.02 118.98 7.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -1.127 . . . . 0.0 109.299 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 70' ' ' THR . 9.9 tttt -50.55 -11.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.321 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 67' ' ' CYS . 5.4 mtp180 63.91 -75.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.768 . . . . 0.0 111.018 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.492 ' C ' ' CD1' ' A' ' 71' ' ' TYR . 7.8 p -94.22 158.56 15.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 110.867 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.597 ' C ' HD23 ' A' ' 72' ' ' LEU . 75.7 m-85 -152.1 173.35 15.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.756 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -100.92 -10.78 20.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.366 -0.834 . . . . 0.0 110.586 -178.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -162.12 138.99 8.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.807 -1.183 . . . . 0.0 110.519 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -42.99 -31.17 0.48 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.41 0.624 . . . . 0.0 109.752 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -66.27 -32.28 73.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.272 -0.893 . . . . 0.0 110.443 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.34 -33.56 22.03 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.2 OUTLIER -75.48 -35.18 60.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.65 ' N ' HD23 ' A' ' 77' ' ' LEU . 52.5 tp60 -72.63 -34.3 67.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.52 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.82 -19.64 62.65 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.526 ' NE2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -77.76 -40.99 39.1 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 118.396 -1.322 . . . . 0.0 108.641 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.526 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.8 mm -55.71 -54.77 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 108.405 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -67.48 -26.28 66.29 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.772 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -89.97 -11.97 40.09 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.579 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -112.19 -54.6 2.6 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.226 -0.921 . . . . 0.0 112.945 -177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' H ' ' CD2' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -134.53 -26.89 1.38 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 109.583 -178.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.515 ' N ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER 56.89 50.95 11.42 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.595 -0.691 . . . . 0.0 109.474 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.1 -21.51 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 109.64 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' A' ' 86' ' ' MET . . . -48.16 120.87 3.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.492 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.74 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -100.7 24.05 9.63 Favored 'General case' 0 C--O 1.201 -1.474 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -74.64 114.9 13.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.707 -1.246 . . . . 0.0 110.009 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.614 ' HA ' HD11 ' A' ' 11' ' ' ILE . 44.3 t -45.54 146.74 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.214 -0.928 . . . . 0.0 109.987 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -36.15 66.89 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 -54.32 2.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.477 ' C ' ' H ' ' A' ' 9' ' ' LEU . 4.0 m -66.05 -13.87 60.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.142 -0.974 . . . . 0.0 110.094 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.94 4.72 0.47 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 7' ' ' CYS . 5.4 mp -88.96 157.87 47.97 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.077 -1.249 . . . . 0.0 108.475 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -67.04 99.29 0.46 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.854 1.703 . . . . 0.0 112.539 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' A' ' 4' ' ' CYS . 88.1 mt -47.06 121.43 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -85.07 -30.86 23.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -142.45 145.3 23.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -77.39 105.91 8.81 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.714 -1.241 . . . . 0.0 111.141 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -78.18 79.88 1.44 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 106.682 -2.567 . . . . 0.0 106.682 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 51' ' ' GLU . 11.5 ttt-85 -58.15 136.71 57.29 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.835 -0.803 . . . . 0.0 109.483 -178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.774 ' SD ' HG22 ' A' ' 47' ' ' VAL . 25.0 ttm -121.59 137.93 54.53 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.095 0.474 . . . . 0.0 110.541 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -127.41 156.85 74.39 Favored Pre-proline 0 N--CA 1.494 1.747 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 -0.34 38.15 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 C-N-CA 124.225 -1.156 . . . . 0.0 112.047 0.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 1.9 t -55.88 -36.82 68.04 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.296 -0.878 . . . . 0.0 108.878 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.1 OUTLIER 74.04 26.92 1.65 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.59 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 2.1 m170 -95.45 -169.25 1.93 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -146.44 153.89 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.16 -0.962 . . . . 0.0 109.979 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 62.2 m-85 -159.09 163.01 36.61 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -50.56 113.08 0.8 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 118.218 -1.393 . . . . 0.0 107.864 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -53.73 -19.18 3.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 110.453 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.41 -37.07 26.06 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.772 -1.205 . . . . 0.0 108.292 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.532 ' O ' ' CG ' ' A' ' 32' ' ' HIS . 0.3 OUTLIER -83.2 -25.51 31.69 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -68.5 -32.26 72.12 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.7 pt -87.99 -33.87 6.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.189 -0.944 . . . . 0.0 109.211 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.39 -26.66 58.63 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 118.908 -1.117 . . . . 0.0 108.056 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 28' ' ' CYS . 18.2 m170 -76.74 -50.21 14.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.213 -0.929 . . . . 0.0 108.684 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -65.33 -27.97 68.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.551 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.34 -28.34 38.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.665 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -79.78 5.22 14.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.071 -1.018 . . . . 0.0 110.05 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.23 35.76 5.15 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 39' ' ' MET . 0.5 OUTLIER -130.12 53.69 1.92 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.822 -0.811 . . . . 0.0 108.894 179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -72.4 28.92 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.606 -0.683 . . . . 0.0 109.201 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.56 ' H ' ' C ' ' A' ' 37' ' ' ASP . 2.7 mtt -123.2 123.82 41.64 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.32 0.581 . . . . 0.0 109.492 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.556 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -37.1 102.1 0.23 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 122.017 -0.427 . . . . 0.0 111.088 -178.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -52.65 -14.55 3.35 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 121.667 1.578 . . . . 0.0 111.54 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.1 -38.61 4.02 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 120.192 -1.004 . . . . 0.0 110.835 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.4 m -120.54 -21.31 6.83 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.415 -1.05 . . . . 0.0 110.771 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 73.97 55.53 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.142 -179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.95 161.42 30.96 Favored Pre-proline 0 N--CA 1.489 1.493 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' GLN . 13.1 Cg_endo -58.7 83.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.389 2.059 . . . . 0.0 111.664 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' SD ' ' A' ' 17' ' ' MET . 89.6 t -51.69 97.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.205 -0.934 . . . . 0.0 109.07 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 46' ' ' PRO . 8.1 mt-30 -64.11 -64.0 1.0 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.274 -0.891 . . . . 0.0 108.984 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.46 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.27 126.66 7.96 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.554 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.426 HG21 ' HB1' ' A' ' 29' ' ' ALA . 1.9 mt -88.32 145.03 7.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 120.813 -1.179 . . . . 0.0 110.25 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' ARG . 24.5 mt-10 -137.31 151.5 48.71 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.766 0.793 . . . . 0.0 110.185 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -90.49 147.61 23.28 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.692 -0.63 . . . . 0.0 109.714 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -152.15 167.39 28.68 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.35 -0.844 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.62 163.79 22.31 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.143 -0.973 . . . . 0.0 109.002 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' C ' ' H ' ' A' ' 57' ' ' SER . 4.6 mtm180 -66.74 -69.11 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.052 -1.03 . . . . 0.0 110.671 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.99 28.36 0.3 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.877 -1.154 . . . . 0.0 110.637 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 55' ' ' ARG . 32.5 m -93.25 -36.9 12.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.028 -1.277 . . . . 0.0 109.798 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 58' ' ' LEU . 1.2 mt -99.14 173.34 6.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.731 . . . . 0.0 109.915 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -115.06 106.8 14.54 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 ttt -72.19 144.41 48.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.365 -0.834 . . . . 0.0 110.368 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 t -73.45 143.35 46.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 109.454 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.8 m -142.93 64.49 1.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.274 -0.891 . . . . 0.0 109.615 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.427 HD11 HD12 ' A' ' 81' ' ' ILE . 20.4 mm -101.51 -75.51 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.49 -0.757 . . . . 0.0 109.496 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER -90.08 -96.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.392 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.428 ' H ' HG23 ' A' ' 64' ' ' VAL . 3.4 tt0 -168.63 31.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.318 -0.864 . . . . 0.0 109.344 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.89 -34.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.2 t -65.21 143.05 58.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -1.187 . . . . 0.0 109.591 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -154.79 38.67 0.42 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.33 -0.856 . . . . 0.0 108.91 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -76.13 97.73 4.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.634 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.521 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.4 OUTLIER -62.23 177.99 0.43 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.7 ' C ' HD23 ' A' ' 72' ' ' LEU . 26.5 m-85 -162.51 179.44 7.77 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -0.927 . . . . 0.0 109.487 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.7 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -109.49 -7.93 15.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.865 -0.522 . . . . 0.0 109.834 -179.406 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 75' ' ' ARG . 40.5 t -157.52 130.03 7.36 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.022 -1.049 . . . . 0.0 109.803 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -42.73 -27.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.648 -0.657 . . . . 0.0 109.308 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.4 tmt_? -64.01 -34.96 79.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.468 -0.77 . . . . 0.0 110.535 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' CG ' ' CD1' ' A' ' 71' ' ' TYR . 27.3 t0 -83.11 -35.61 25.5 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.085 -1.009 . . . . 0.0 108.626 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.39 -32.67 64.59 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -69.08 -35.25 76.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.561 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -70.89 -20.35 62.52 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -74.52 -44.09 52.82 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.621 -1.232 . . . . 0.0 109.004 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 81' ' ' ILE . 3.0 mm -58.02 -50.61 77.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.484 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.459 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.8 p30 -74.79 -18.56 60.45 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.694 -1.202 . . . . 0.0 109.796 -178.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.561 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 35.1 m170 -86.19 -24.37 26.13 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.639 -1.225 . . . . 0.0 111.568 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.28 -26.59 2.55 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.108 -0.995 . . . . 0.0 112.115 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.486 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 6.2 m-70 -100.05 -49.01 4.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 109.064 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.4 ttt 40.16 32.92 0.14 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.396 0.617 . . . . 0.0 110.108 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -91.68 -1.71 57.32 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.442 -0.786 . . . . 0.0 109.497 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.3 -58.54 4.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.558 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 2' ' ' HIS . 1.5 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.52 0.676 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.535 ' N ' HG22 ' A' ' 1' ' ' VAL . 0.6 OUTLIER -91.44 -58.38 2.46 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.43 -0.794 . . . . 0.0 109.102 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -81.24 120.63 25.14 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 109.973 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -44.69 146.8 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.344 -0.847 . . . . 0.0 110.249 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.65 -23.52 36.89 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' NZ ' ' SG ' ' A' ' 7' ' ' CYS . 2.4 ttpt -98.6 -50.68 4.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.0 110.518 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' SG ' ' NZ ' ' A' ' 6' ' ' LYS . 2.0 m -87.32 -17.78 31.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 111.16 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.01 -1.81 9.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.73 158.63 70.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.144 -1.209 . . . . 0.0 108.749 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.01 102.92 0.96 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.941 1.761 . . . . 0.0 112.938 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.613 HG23 ' HA ' ' A' ' 25' ' ' CYS . 84.3 mt -49.73 125.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.513 0.673 . . . . 0.0 110.37 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -91.49 -29.41 17.02 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.83 143.75 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -79.8 103.93 10.03 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 120.591 -1.318 . . . . 0.0 110.557 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.05 81.84 1.02 Allowed Glycine 0 N--CA 1.482 1.718 0 N-CA-C 106.839 -2.504 . . . . 0.0 106.839 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 21' ' ' LYS . 8.5 ttt-85 -64.76 131.55 47.13 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.31 0.576 . . . . 0.0 110.286 -177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.599 ' CE ' HG11 ' A' ' 47' ' ' VAL . 16.6 mtp -117.55 132.2 56.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.987 -0.445 . . . . 0.0 110.347 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.672 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -117.87 156.6 49.79 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.97 2.58 48.59 Favored 'Cis proline' 0 N--CA 1.49 1.305 0 C-N-CA 124.154 -1.186 . . . . 0.0 111.289 -0.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.476 ' CB ' ' HD1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -56.27 -36.91 69.12 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.624 -0.673 . . . . 0.0 109.294 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.529 ' HZ3' ' HE1' ' A' ' 71' ' ' TYR . 5.0 ttmt 73.52 25.77 2.06 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.476 ' HD1' ' CB ' ' A' ' 20' ' ' CYS . 24.7 m80 -95.09 -179.06 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.195 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.478 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.3 m -146.33 151.69 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.083 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 31.6 m-85 -158.74 168.28 27.27 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.613 ' HA ' HG23 ' A' ' 11' ' ' ILE . 2.8 m -53.07 115.47 1.89 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 117.765 -1.574 . . . . 0.0 107.936 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.692 ' O ' HG23 ' A' ' 30' ' ' ILE . 38.3 t80 -50.9 -11.83 0.1 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.325 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' N ' ' C ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -76.72 -46.97 23.32 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.14 -0.975 . . . . 0.0 109.042 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.6 m -78.84 -22.96 45.36 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.998 -1.064 . . . . 0.0 108.412 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.697 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.692 HG23 ' O ' ' A' ' 26' ' ' TYR . 41.3 pt -80.02 -33.7 14.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.039 -1.038 . . . . 0.0 108.986 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.428 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 24.1 mt -67.11 -23.94 65.88 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.123 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.457 ' ND1' ' OD2' ' A' ' 37' ' ' ASP . 1.2 m-70 -82.75 -34.77 27.04 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -27.07 44.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.518 -0.738 . . . . 0.0 109.06 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -83.3 -35.23 25.42 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.218 -0.927 . . . . 0.0 109.249 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.428 ' CG ' ' O ' ' A' ' 31' ' ' LEU . 17.5 mmtm -73.82 -9.57 58.78 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.379 -0.826 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.29 33.06 15.0 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.457 ' OD2' ' ND1' ' A' ' 32' ' ' HIS . 4.6 m-20 -79.92 -44.47 20.3 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.182 -1.187 . . . . 0.0 109.392 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt 46.7 46.03 14.74 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.185 0.993 . . . . 0.0 109.542 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 ptm -147.17 139.06 24.31 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.447 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 44' ' ' SER . 51.9 t -71.34 114.57 28.96 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.32 -0.863 . . . . 0.0 109.32 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -49.41 -15.56 0.9 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.426 1.417 . . . . 0.0 111.856 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.95 -63.92 0.84 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 44' ' ' SER . 4.0 m -90.4 -22.13 21.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 0.0 110.214 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.3 p 74.27 36.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.626 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' H ' ' HB3' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -103.18 157.18 34.3 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.56 85.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.442 2.095 . . . . 0.0 112.016 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.683 ' O ' HG23 ' A' ' 47' ' ' VAL . 5.2 m -55.08 104.37 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.1 tt0 -48.07 -54.94 11.45 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.041 -1.037 . . . . 0.0 108.353 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.672 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -159.04 135.51 9.25 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.796 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.697 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.0 mt -87.7 145.97 6.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.887 -1.133 . . . . 0.0 109.599 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -138.77 152.97 48.38 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.518 0.675 . . . . 0.0 109.731 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -96.38 139.14 32.94 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.74 -0.6 . . . . 0.0 109.877 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -143.19 161.05 39.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.4 157.92 26.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 0.0 109.279 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 57' ' ' SER . 68.1 mtp180 -53.51 -72.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.235 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.58 30.06 0.36 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 55' ' ' ARG . 19.6 t -86.86 -31.17 20.93 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.947 -1.325 . . . . 0.0 109.289 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.7 mt -99.29 173.62 6.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.578 -0.701 . . . . 0.0 109.735 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 23.0 m-85 -118.59 117.31 28.63 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 9.8 mtt -79.55 144.59 33.76 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.335 -0.853 . . . . 0.0 110.751 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.44 141.48 36.28 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.6 m -141.0 75.86 1.52 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.361 -0.837 . . . . 0.0 109.6 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.663 HG22 HG13 ' A' ' 64' ' ' VAL . 15.6 mm -94.41 -70.84 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.831 . . . . 0.0 109.5 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG13 HG22 ' A' ' 63' ' ' ILE . 2.3 m -143.89 179.79 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.361 -0.837 . . . . 0.0 109.507 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.463 ' CG ' ' N ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER 47.13 -111.97 0.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.332 -0.855 . . . . 0.0 109.508 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 65' ' ' GLN . . . -148.13 31.6 1.3 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 19.4 t -47.35 131.87 13.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -1.192 . . . . 0.0 109.365 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -137.62 40.74 2.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.522 -0.736 . . . . 0.0 109.373 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -80.12 102.8 9.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.974 . . . . 0.0 109.234 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -80.22 176.02 10.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 110.012 -179.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.824 ' C ' HD23 ' A' ' 72' ' ' LEU . 87.4 m-85 -158.29 -168.39 2.45 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.824 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -119.89 -6.75 10.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.643 -179.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 m -146.2 127.98 15.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 108.847 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.4 ' HA ' HE21 ' A' ' 74' ' ' GLN . 1.5 tp60 -47.06 -26.0 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -66.35 -31.13 71.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.479 -0.763 . . . . 0.0 109.919 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.68 -34.39 24.98 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tt -76.1 -35.27 59.39 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.773 HE22 HD22 ' A' ' 82' ' ' ASN . 0.3 OUTLIER -67.09 -39.74 86.83 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.544 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -66.65 -20.75 66.06 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.13 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -74.8 -40.03 61.36 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.427 -1.309 . . . . 0.0 108.837 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.501 HD12 HD11 ' A' ' 63' ' ' ILE . 3.6 mm -60.15 -52.11 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.654 -0.654 . . . . 0.0 110.379 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.773 HD22 HE22 ' A' ' 78' ' ' GLN . 2.6 p30 -74.55 -18.09 60.64 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.036 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.544 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 35.1 m170 -85.85 -26.58 25.59 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.532 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -128.72 -26.11 2.75 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.121 -1.031 . . . . 0.0 111.856 -177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.476 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 6.7 m-70 -98.77 -49.16 4.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.037 -1.04 . . . . 0.0 109.026 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.429 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.1 ttt 38.74 31.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.57 0.7 . . . . 0.0 110.158 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 89' ' ' GLY . 3.3 mtp85 -87.94 -1.45 57.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.385 -0.822 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.11 -12.6 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.175 -0.953 . . . . 0.0 109.49 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 87' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.316 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.6 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 3' ' ' PHE . 28.3 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.8 t60 65.26 -59.77 0.26 Allowed 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.318 0.58 . . . . 0.0 109.871 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.472 ' N ' ' O ' ' A' ' 1' ' ' VAL . 7.7 m-85 -73.22 107.77 5.73 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.425 -0.797 . . . . 0.0 109.698 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 8' ' ' GLY . 8.6 p -46.83 128.46 10.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 109.874 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.72 -13.1 60.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.24 -40.29 45.42 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.19 -0.944 . . . . 0.0 109.302 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.48 -21.11 4.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.762 -0.586 . . . . 0.0 110.708 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 4' ' ' CYS . . . 87.71 15.93 60.76 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.376 -1.392 . . . . 0.0 109.678 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.26 155.47 38.82 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.295 -1.121 . . . . 0.0 108.496 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.5 109.92 1.72 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.904 1.736 . . . . 0.0 112.154 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 4' ' ' CYS . 64.1 mt -58.12 112.15 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.559 0.695 . . . . 0.0 110.466 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -82.12 -33.55 29.61 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.85 137.5 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -76.35 104.81 7.05 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 120.95 -1.094 . . . . 0.0 110.652 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.491 ' O ' ' SD ' ' A' ' 17' ' ' MET . . . -78.35 86.44 1.12 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 107.362 -2.295 . . . . 0.0 107.362 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -70.49 133.43 46.8 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 122.146 -0.62 . . . . 0.0 111.023 -178.058 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' LYS . 2.7 mmm -118.91 135.25 54.68 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -119.2 153.32 53.21 Favored Pre-proline 0 N--CA 1.495 1.813 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -80.95 -4.78 44.38 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 124.276 -1.135 . . . . 0.0 111.621 0.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' A' ' 22' ' ' HIS . 6.4 t -48.18 -30.21 4.43 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 6.7 mtmm 60.29 28.93 18.57 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.406 ' CD2' ' SG ' ' A' ' 20' ' ' CYS . 28.3 m170 -93.86 173.05 7.87 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.545 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 13.7 m -136.67 151.22 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.707 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 83.4 m-85 -160.9 159.71 30.03 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -47.19 110.27 0.28 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.589 ' O ' HG23 ' A' ' 30' ' ' ILE . 32.6 t80 -47.06 -16.69 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.697 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -77.54 -44.82 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.989 -1.069 . . . . 0.0 108.848 179.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.473 ' HA ' HD12 ' A' ' 31' ' ' LEU . 36.7 m -79.12 -21.0 47.24 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.899 -1.126 . . . . 0.0 108.0 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.3 78.2 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 26' ' ' TYR . 48.6 pt -76.11 -33.52 24.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 108.781 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 28' ' ' CYS . 30.6 mt -65.4 -39.7 92.52 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.618 -1.233 . . . . 0.0 107.681 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -71.97 -25.35 61.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.363 -0.836 . . . . 0.0 108.771 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 37' ' ' ASP . 0.5 OUTLIER -79.27 -36.89 39.07 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.087 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -75.95 -18.58 59.28 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.888 -1.133 . . . . 0.0 108.129 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 tptp -80.55 -36.76 32.58 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.477 -0.764 . . . . 0.0 109.583 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.61 -34.55 0.22 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.4 OUTLIER 67.44 29.07 7.52 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.394 -1.062 . . . . 0.0 109.707 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -172.46 31.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.24 -0.912 . . . . 0.0 110.674 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.446 ' CG ' ' O ' ' A' ' 39' ' ' MET . 10.2 ptm -149.46 120.02 7.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.0 -1.062 . . . . 0.0 110.973 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.558 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -69.23 129.53 91.83 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.328 -0.857 . . . . 0.0 110.055 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.52 -29.35 2.1 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.22 1.946 . . . . 0.0 113.623 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.54 -63.68 1.02 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 44' ' ' SER . 70.8 m -67.55 -45.08 76.71 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.432 -1.04 . . . . 0.0 109.025 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.6 OUTLIER 76.98 53.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.709 -0.62 . . . . 0.0 111.412 178.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.476 ' H ' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER 176.38 -48.59 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.489 -1.382 . . . . 0.0 112.205 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD2' ' H ' ' A' ' 45' ' ' ASP . 84.6 Cg_endo -83.48 46.28 2.04 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.637 2.225 . . . . 0.0 116.095 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 40' ' ' CYS . 2.0 t -92.95 118.66 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.272 -1.517 . . . . 0.0 109.397 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -101.74 -64.51 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 178.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.477 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.94 124.88 15.17 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -84.51 144.65 9.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 120.7 -1.25 . . . . 0.0 110.289 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -139.22 140.53 37.78 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.894 0.854 . . . . 0.0 109.943 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -85.27 147.06 26.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.7 162.01 38.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.442 -0.786 . . . . 0.0 109.882 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.84 162.03 19.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.388 -0.82 . . . . 0.0 109.34 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.3 OUTLIER -50.96 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.44 27.32 0.46 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.5 t -81.77 -18.8 42.9 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.991 -1.3 . . . . 0.0 109.06 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mt -117.69 173.58 6.65 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 16.5 m-85 -118.22 117.0 27.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.6 mmt -79.41 144.61 33.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -0.867 . . . . 0.0 110.78 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.13 139.35 34.91 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.7 m -141.04 76.28 1.54 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -0.8 . . . . 0.0 109.549 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.421 HD11 HD12 ' A' ' 81' ' ' ILE . 15.4 mm -97.21 -68.75 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.391 -0.818 . . . . 0.0 109.479 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.0 t -88.53 -79.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 0.0 109.537 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -178.75 -25.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.268 -0.895 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -92.96 -39.32 5.22 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -48.04 157.55 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.168 -1.195 . . . . 0.0 109.565 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.73 28.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.367 -0.833 . . . . 0.0 108.927 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.476 ' NH1' ' OH ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -76.48 125.38 29.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.164 -0.96 . . . . 0.0 109.778 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.545 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -92.76 175.37 6.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.753 ' C ' HD23 ' A' ' 72' ' ' LEU . 98.4 m-85 -157.56 -174.73 5.01 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -115.63 -6.06 12.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.634 -0.666 . . . . 0.0 110.078 -178.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 76' ' ' ASP . 24.3 p -150.19 130.5 13.72 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.021 . . . . 0.0 109.606 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 78' ' ' GLN . 9.8 mm-40 -44.17 -31.01 0.86 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -62.24 -33.25 74.25 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.423 -0.798 . . . . 0.0 109.647 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.8 m-20 -82.98 -36.97 24.65 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.344 -0.848 . . . . 0.0 108.726 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.7 tt -75.13 -30.75 60.9 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 74' ' ' GLN . 23.9 tp60 -71.4 -34.52 70.44 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.549 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.18 -19.99 62.34 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -72.8 -47.51 45.9 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 118.713 -1.195 . . . . 0.0 108.671 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.5 mm -56.56 -51.08 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -70.46 -18.95 62.99 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.774 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.549 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 19.2 m170 -87.45 -27.87 22.45 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.828 -1.149 . . . . 0.0 112.151 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -129.1 -16.67 4.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.977 -1.077 . . . . 0.0 112.157 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.5 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.3 m-70 -111.35 -45.41 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.3 ttt 42.02 34.86 0.49 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.378 0.609 . . . . 0.0 109.952 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -172.11 117.17 0.37 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.846 . . . . 0.0 109.446 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.65 159.1 28.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.525 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.52 0.676 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.479 ' CG ' ' N ' ' A' ' 3' ' ' PHE . 13.6 t-160 -174.63 -94.38 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.682 -0.636 . . . . 0.0 109.318 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.529 ' CZ ' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -161.12 105.23 1.32 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.832 . . . . 0.0 111.012 -179.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.657 ' HA ' HD11 ' A' ' 11' ' ' ILE . 41.8 t -46.62 146.17 1.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.57 -27.03 18.44 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.198 -0.939 . . . . 0.0 110.513 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.75 -38.96 11.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 110.069 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.5 m -93.19 -29.87 15.5 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.258 -0.902 . . . . 0.0 109.917 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.529 ' O ' ' CZ ' ' A' ' 3' ' ' PHE . . . 81.72 11.56 82.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.93 156.66 36.3 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.464 -1.021 . . . . 0.0 108.541 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.58 142.5 71.52 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 121.951 1.767 . . . . 0.0 111.668 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 4' ' ' CYS . 93.0 mt -95.39 73.2 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.521 -0.737 . . . . 0.0 110.77 -178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -46.42 -37.46 7.69 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.52 142.32 20.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -70.9 107.98 4.3 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.16 -0.963 . . . . 0.0 110.599 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -73.44 80.79 0.74 Allowed Glycine 0 N--CA 1.482 1.719 0 N-CA-C 107.757 -2.137 . . . . 0.0 107.757 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 1.024 HH21 HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -61.07 141.96 57.01 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 122.027 -0.69 . . . . 0.0 109.932 -178.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.576 ' CE ' HG11 ' A' ' 47' ' ' VAL . 6.9 mtp -130.7 126.31 36.19 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.655 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -115.06 158.06 41.87 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.25 -2.06 50.24 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.446 -0.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 9.7 t -57.4 -35.61 70.25 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.197 -0.939 . . . . 0.0 109.336 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 17' ' ' MET . 7.5 ttmt 75.92 29.57 0.79 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.41 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 0.1 OUTLIER -94.04 164.44 13.08 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.489 HG11 ' CD1' ' A' ' 58' ' ' LEU . 33.2 m -131.44 148.03 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.334 -0.854 . . . . 0.0 110.888 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 42.1 m-85 -154.92 168.78 25.8 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER -51.17 109.15 0.3 Allowed 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.46 -1.296 . . . . 0.0 108.42 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.471 ' CE2' ' CD ' ' A' ' 52' ' ' GLN . 38.2 t80 -47.13 -20.44 0.17 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.495 -0.753 . . . . 0.0 109.78 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -74.89 -35.48 62.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 25' ' ' CYS . 12.3 p -82.46 -27.19 32.02 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -67.67 -37.04 81.8 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.258 -0.902 . . . . 0.0 108.629 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 26' ' ' TYR . 25.5 pt -83.06 -34.61 11.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mt -73.72 -22.81 59.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.873 -1.131 . . . . 0.0 108.755 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 37' ' ' ASP . 6.7 m-70 -79.78 -42.93 23.44 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.183 -0.948 . . . . 0.0 108.778 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -75.05 -29.12 60.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.517 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -78.94 -30.8 44.87 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.025 -1.047 . . . . 0.0 108.926 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -77.62 -5.92 51.99 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.351 -0.843 . . . . 0.0 109.754 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.57 34.16 4.52 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 39' ' ' MET . 4.0 t70 -137.69 56.49 1.76 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.638 -0.919 . . . . 0.0 109.221 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -68.0 15.75 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.384 -0.822 . . . . 0.0 109.884 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.517 ' H ' ' C ' ' A' ' 37' ' ' ASP . 1.2 mtt -92.19 133.4 35.83 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.073 -1.017 . . . . 0.0 109.452 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' SER . 43.9 t -45.3 107.82 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.342 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.66 -17.14 2.76 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.262 1.308 . . . . 0.0 111.71 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.46 -50.77 1.51 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.431 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 44' ' ' SER . 69.8 m -92.48 -28.98 16.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.084 -1.245 . . . . 0.0 109.942 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' CYS . 1.7 p 75.69 46.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.6 160.05 64.76 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.1 94.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.532 2.154 . . . . 0.0 112.181 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.674 ' O ' HG23 ' A' ' 47' ' ' VAL . 10.5 m -59.49 108.89 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 18' ' ' ILE . 2.5 tt0 -47.97 -56.23 8.12 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.655 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -160.66 132.41 5.87 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.903 0.859 . . . . 0.0 108.979 178.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.498 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.0 mt -84.25 145.23 8.45 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 O-C-N 120.815 -1.178 . . . . 0.0 109.508 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -138.59 156.67 47.27 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.842 0.829 . . . . 0.0 110.321 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.471 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 21.9 mt-30 -95.67 134.71 38.27 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.89 -0.506 . . . . 0.0 110.027 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.585 ' SG ' ' NH1' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -133.4 153.31 51.71 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.364 0.602 . . . . 0.0 109.987 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.59 158.64 21.85 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -0.867 . . . . 0.0 109.795 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 57' ' ' SER . 15.5 ttp85 -48.62 -73.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.287 -0.883 . . . . 0.0 110.442 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.21 28.65 0.26 Allowed Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.869 -1.158 . . . . 0.0 110.329 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 55' ' ' ARG . 55.3 p -90.19 -19.11 24.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.928 -1.337 . . . . 0.0 109.592 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.489 ' CD1' HG11 ' A' ' 23' ' ' VAL . 7.6 mt -119.49 173.61 6.88 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.774 -0.579 . . . . 0.0 109.989 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 26.4 m-85 -116.32 119.8 36.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.4 mtt -85.43 144.49 27.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.0 t -97.93 143.34 28.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.494 -0.754 . . . . 0.0 109.358 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.0 p -140.95 74.45 1.46 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 109.608 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.413 HG21 ' ND1' ' A' ' 85' ' ' HIS . 3.4 mm -105.49 -74.56 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.637 -0.664 . . . . 0.0 109.373 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.66 12.13 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.423 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.418 ' O ' ' NE2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER 58.35 43.28 20.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.523 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -147.17 -53.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.0 152.19 45.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -1.133 . . . . 0.0 109.452 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.562 ' H ' HH11 ' A' ' 69' ' ' ARG . 13.6 tttt -151.23 43.13 0.77 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.205 -0.934 . . . . 0.0 109.424 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.562 HH11 ' H ' ' A' ' 68' ' ' LYS . 11.5 mpt_? -80.49 86.02 5.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.237 -0.914 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -60.44 177.74 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.606 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.755 ' C ' HD23 ' A' ' 72' ' ' LEU . 57.6 m-85 -160.92 -167.4 1.82 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.419 -0.8 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.024 HD22 HH21 ' A' ' 16' ' ' ARG . 0.1 OUTLIER -114.63 -8.21 12.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.68 -0.638 . . . . 0.0 110.13 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 75' ' ' ARG . 72.6 m -147.45 127.97 14.11 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 109.626 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -45.9 -19.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.551 -0.718 . . . . 0.0 109.126 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.1 ttt-85 -71.37 -33.63 69.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.39 -0.819 . . . . 0.0 109.77 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.5 -37.68 24.93 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tt -73.66 -34.46 64.94 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 10.2 tp60 -70.54 -30.51 67.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.556 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.06 -21.19 61.56 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -76.66 -35.86 57.7 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.794 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.439 ' H ' HG12 ' A' ' 81' ' ' ILE . 5.8 mm -63.92 -51.29 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.445 -0.784 . . . . 0.0 109.695 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.472 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.2 p30 -74.23 -19.05 60.65 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.039 -1.064 . . . . 0.0 109.718 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.556 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 37.9 m170 -86.46 -23.04 26.15 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.781 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.08 -26.56 2.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.995 -1.066 . . . . 0.0 111.926 -178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.498 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 6.3 m-70 -100.41 -49.87 4.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.068 -1.02 . . . . 0.0 108.964 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.415 ' C ' ' O ' ' A' ' 85' ' ' HIS . 1.3 ttp 41.71 32.72 0.27 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.402 0.62 . . . . 0.0 109.868 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -157.33 18.27 0.28 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -47.56 140.98 5.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.49 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.553 179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.7 t60 64.38 -56.64 0.25 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.221 0.534 . . . . 0.0 109.986 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 1' ' ' VAL . 0.5 OUTLIER -74.37 112.23 10.33 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.425 -0.797 . . . . 0.0 109.158 179.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.543 ' HA ' HD11 ' A' ' 11' ' ' ILE . 6.1 t -48.02 146.5 2.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.061 -1.024 . . . . 0.0 109.87 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.54 -24.06 45.86 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.397 -0.814 . . . . 0.0 109.678 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -64.88 1.01 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.426 -0.797 . . . . 0.0 109.441 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 12.5 m -61.14 -22.0 64.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.21 9.48 29.68 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -101.2 157.81 32.97 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.37 -1.077 . . . . 0.0 108.773 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.73 105.87 0.47 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.901 1.734 . . . . 0.0 111.879 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.543 HD11 ' HA ' ' A' ' 4' ' ' CYS . 60.9 mt -53.5 122.67 3.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.473 0.654 . . . . 0.0 110.594 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' CD ' ' H ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -86.0 -31.18 22.17 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.475 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.5 t -138.22 145.29 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.477 ' OH ' ' CE ' ' A' ' 60' ' ' MET . 3.2 m-30 -76.78 98.61 4.86 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.792 -1.193 . . . . 0.0 110.893 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.9 88.24 0.86 Allowed Glycine 0 N--CA 1.484 1.884 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -76.79 141.42 40.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.976 -0.72 . . . . 0.0 110.322 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.524 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 15.4 mtp -129.38 132.98 47.16 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.167 0.508 . . . . 0.0 110.172 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.666 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -116.19 156.36 47.11 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.094 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.87 2.64 48.0 Favored 'Cis proline' 0 N--CA 1.491 1.324 0 C-N-CA 124.164 -1.182 . . . . 0.0 111.316 -0.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -53.09 -40.11 63.86 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 tttp 71.59 31.22 2.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.551 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 9.1 m170 -104.63 174.14 6.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.567 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.1 OUTLIER -128.95 159.8 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.619 0.723 . . . . 0.0 110.349 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 74.6 m-85 -166.26 174.06 9.52 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -62.57 115.41 4.24 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.619 178.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.581 ' O ' HG23 ' A' ' 30' ' ' ILE . 45.0 t80 -49.44 -21.37 0.9 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.069 -1.019 . . . . 0.0 109.946 -179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.7 -41.23 60.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.03 -1.044 . . . . 0.0 108.568 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.492 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -83.13 -22.0 33.46 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.21 -33.52 71.78 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 26' ' ' TYR . 49.3 pt -80.22 -37.02 17.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 O-C-N 121.044 -1.035 . . . . 0.0 108.621 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.27 -36.01 78.86 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 118.647 -1.221 . . . . 0.0 108.004 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -70.02 -39.94 75.52 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -38.33 90.7 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -74.68 -19.82 60.11 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.196 -0.94 . . . . 0.0 108.859 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -72.54 0.42 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.869 . . . . 0.0 110.311 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -96.95 -33.71 5.95 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.076 -1.209 . . . . 0.0 110.076 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 1.7 t70 75.34 13.12 3.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.366 -1.079 . . . . 0.0 109.851 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.31 35.24 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.01 -1.056 . . . . 0.0 111.031 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 39' ' ' MET . 10.2 ptm -145.26 117.92 8.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.929 -1.107 . . . . 0.0 110.508 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -62.22 143.3 95.45 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -52.93 -36.19 74.05 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.55 1.5 . . . . 0.0 112.044 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.56 -45.46 0.78 Allowed Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.551 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 3.2 m -81.61 -15.91 53.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.993 -1.298 . . . . 0.0 110.415 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.2 t 49.37 36.75 10.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.009 -1.057 . . . . 0.0 108.984 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.3 OUTLIER -90.61 161.18 37.18 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.016 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.99 75.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.297 1.998 . . . . 0.0 112.012 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 45' ' ' ASP . 37.9 t -47.35 99.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.018 -1.051 . . . . 0.0 109.489 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 18' ' ' ILE . 3.5 tt0 -67.31 -61.02 2.12 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 108.583 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.666 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -150.1 135.34 18.01 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.015 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.424 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.2 mt -93.83 146.68 6.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.953 -1.092 . . . . 0.0 109.845 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -141.38 141.38 33.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.488 0.661 . . . . 0.0 109.935 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -95.98 142.82 27.75 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.645 -0.659 . . . . 0.0 109.782 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.53 169.26 19.3 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.296 -0.877 . . . . 0.0 109.847 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -87.13 162.12 17.72 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.304 -0.873 . . . . 0.0 109.583 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.536 ' NE ' ' O ' ' A' ' 55' ' ' ARG . 1.1 ttp180 -70.04 38.2 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.864 . . . . 0.0 110.021 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 54' ' ' THR . . . -153.27 17.55 0.69 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.74 -27.33 12.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.875 . . . . 0.0 110.243 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 mt -113.0 172.32 7.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.57 -0.706 . . . . 0.0 110.017 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 19.5 m-85 -129.37 120.39 25.48 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.477 ' CE ' ' OH ' ' A' ' 14' ' ' TYR . 1.8 mpt? -81.77 144.76 30.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.245 -0.91 . . . . 0.0 110.628 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.539 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 54.1 t -71.83 142.95 49.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.522 -0.736 . . . . 0.0 109.456 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.5 m -86.97 11.19 14.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.129 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 64' ' ' VAL . 3.7 mm -96.3 168.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.414 -0.803 . . . . 0.0 109.007 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.572 ' N ' HG22 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -142.34 178.24 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 109.622 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 58.69 80.91 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.0 109.445 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.99 64.46 1.53 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 68' ' ' LYS . 35.2 t -169.55 -129.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -1.131 . . . . 0.0 109.422 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 67' ' ' CYS . 3.9 tttp 73.51 27.92 1.77 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.29 -0.881 . . . . 0.0 109.72 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.7 mtt85 -93.18 126.96 38.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.52 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -91.94 179.32 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.184 -0.947 . . . . 0.0 109.497 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.725 ' C ' HD23 ' A' ' 72' ' ' LEU . 61.8 m-85 -158.37 -169.74 2.87 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.391 -0.818 . . . . 0.0 109.069 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -111.92 -9.71 14.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.673 -0.642 . . . . 0.0 110.191 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.6 t -152.9 133.84 14.03 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.969 -1.082 . . . . 0.0 109.816 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 73' ' ' SER . 5.1 mm-40 -44.96 -30.11 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.9 -34.9 79.0 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.014 0.911 . . . . 0.0 109.786 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.7 m-20 -83.39 -33.97 25.65 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.15 -0.969 . . . . 0.0 108.556 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -74.91 -34.17 62.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.479 ' N ' HD23 ' A' ' 77' ' ' LEU . 11.7 tp60 -70.25 -32.04 69.7 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.09 -20.84 61.59 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.413 ' CD2' HD13 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -76.47 -38.77 54.85 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.013 179.758 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.539 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 5.3 mm -62.11 -54.01 40.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.453 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.46 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 4.8 p30 -69.21 -20.1 63.97 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.651 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.537 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 36.8 m170 -86.88 -13.37 45.05 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.557 -1.257 . . . . 0.0 111.515 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.41 ' HG3' ' HD1' ' A' ' 80' ' ' HIS . 13.1 mmt180 -122.21 -40.51 2.49 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.099 -1.001 . . . . 0.0 113.468 -177.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.49 ' CE1' HG21 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -145.03 -27.73 0.47 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.856 -1.152 . . . . 0.0 110.143 -178.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.527 ' N ' ' O ' ' A' ' 81' ' ' ILE . 0.5 OUTLIER 63.05 34.72 13.61 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.546 -0.721 . . . . 0.0 109.567 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.86 172.33 7.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.432 -0.792 . . . . 0.0 109.347 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.45 -66.6 0.83 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 3' ' ' PHE . 6.8 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.7 t60 65.77 -56.07 0.35 Allowed 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.288 0.566 . . . . 0.0 109.946 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.456 ' N ' ' O ' ' A' ' 1' ' ' VAL . 58.1 m-85 -74.96 108.1 7.47 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.116 -0.99 . . . . 0.0 109.001 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' HA ' HD11 ' A' ' 11' ' ' ILE . 17.2 t -45.97 146.17 1.32 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.546 -179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.03 -27.44 24.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.384 -0.823 . . . . 0.0 110.075 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -91.64 -44.34 9.09 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.11 -0.994 . . . . 0.0 110.095 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.9 m -87.94 -27.03 22.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 110.334 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.71 11.4 83.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 mp -102.14 158.19 32.24 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -1.044 . . . . 0.0 108.882 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.35 106.39 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.961 1.774 . . . . 0.0 112.128 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 4' ' ' CYS . 79.0 mt -54.23 105.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.875 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -71.78 -36.49 70.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.02 141.94 28.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -73.22 112.12 8.97 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.965 -1.084 . . . . 0.0 111.106 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -77.72 78.01 1.55 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.461 HH12 ' C ' ' A' ' 21' ' ' LYS . 4.0 tpt85 -58.23 140.53 52.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 122.155 -0.615 . . . . 0.0 110.235 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.534 ' CE ' HG11 ' A' ' 47' ' ' VAL . 5.5 mtp -130.04 129.01 43.1 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -120.89 156.22 56.76 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.69 0.53 52.94 Favored 'Cis proline' 0 N--CA 1.49 1.268 0 C-N-CA 124.191 -1.17 . . . . 0.0 112.084 0.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.4 t -54.9 -29.68 56.53 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.355 -0.841 . . . . 0.0 109.12 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' C ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER 68.83 25.98 6.07 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.684 ' HE2' ' NH2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -95.37 175.52 6.55 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.675 -0.641 . . . . 0.0 109.37 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.9 OUTLIER -144.98 153.42 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 0.0 110.817 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 26.5 m-85 -159.58 168.14 26.83 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -48.79 111.78 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.86 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 30' ' ' ILE . 35.8 t80 -49.12 -18.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.391 -0.818 . . . . 0.0 109.098 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 25' ' ' CYS . 29.3 t0 -77.23 -36.37 54.72 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -82.86 -25.78 32.24 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.253 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -69.25 -36.97 77.72 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 26' ' ' TYR . 32.1 pt -80.57 -35.01 14.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 O-C-N 120.986 -1.071 . . . . 0.0 109.323 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 mt -67.83 -22.17 65.16 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.516 -1.273 . . . . 0.0 107.965 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.412 ' O ' ' N ' ' A' ' 37' ' ' ASP . 1.3 m-70 -82.3 -35.24 28.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.411 ' O ' ' OE1' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -74.39 -31.8 62.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.662 -0.649 . . . . 0.0 109.603 179.403 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 mttt -85.2 -32.11 22.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.158 -0.964 . . . . 0.0 110.137 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.2 mttt -75.66 -7.21 53.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 0.0 110.025 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.27 34.39 6.14 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 39' ' ' MET . 3.5 m-20 -132.74 55.47 1.89 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.722 ' O ' HG22 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -65.88 15.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.46 -0.775 . . . . 0.0 110.132 -179.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.537 ' H ' ' C ' ' A' ' 37' ' ' ASP . 57.9 mtp -94.28 133.28 37.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.983 -1.073 . . . . 0.0 109.704 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.518 ' O ' ' N ' ' A' ' 44' ' ' SER . 42.6 t -43.92 106.89 0.54 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.529 -0.732 . . . . 0.0 109.65 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.4 -17.22 4.02 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.305 1.337 . . . . 0.0 111.754 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.85 -47.71 2.63 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.394 -179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.512 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 62.1 m -99.37 -30.0 12.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 78.35 52.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.706 -0.622 . . . . 0.0 109.386 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.41 158.47 75.56 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.515 -0.741 . . . . 0.0 109.068 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.71 100.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.605 2.203 . . . . 0.0 112.586 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 38' ' ' LYS . 12.7 m -68.31 106.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -49.24 -54.81 14.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.774 -1.204 . . . . 0.0 108.28 -179.25 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.482 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -159.6 125.34 4.24 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.475 178.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.49 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.2 mt -78.94 144.83 10.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.917 -1.114 . . . . 0.0 109.096 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -138.93 153.24 48.21 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.917 0.865 . . . . 0.0 110.0 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -96.36 138.55 33.79 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.88 -0.512 . . . . 0.0 109.776 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -139.71 158.91 43.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.665 -0.647 . . . . 0.0 109.902 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.77 158.3 24.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.55 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -50.87 -71.0 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 110.142 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.28 27.62 0.44 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 55' ' ' ARG . 9.4 t -86.9 -25.18 24.55 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.87 -1.37 . . . . 0.0 109.125 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.8 mt -115.35 173.72 6.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.48 116.24 30.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.781 -0.574 . . . . 0.0 109.727 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.7 tpt -79.46 144.48 33.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.217 -0.927 . . . . 0.0 110.272 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.544 ' SG ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -76.41 129.69 36.93 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.382 -0.823 . . . . 0.0 109.159 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 t -107.8 -16.03 14.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 63' ' ' ILE . 1.3 mp -47.54 -55.31 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.904 HG12 ' H ' ' A' ' 66' ' ' GLY . 75.0 t -146.31 124.51 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -50.52 -16.92 0.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.312 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.904 ' H ' HG12 ' A' ' 64' ' ' VAL . . . -62.74 -56.51 20.82 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.6 151.13 27.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -1.104 . . . . 0.0 109.511 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.659 ' H ' ' HE ' ' A' ' 69' ' ' ARG . 32.8 mttp -153.68 42.33 0.55 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.196 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.684 ' NH2' ' HE2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.35 93.92 4.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.189 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.63 171.5 5.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.079 -1.013 . . . . 0.0 109.563 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.783 ' C ' HD23 ' A' ' 72' ' ' LEU . 1.9 m-85 -154.36 -174.45 4.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.373 -0.83 . . . . 0.0 108.796 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.783 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -118.61 -4.79 10.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.747 -0.596 . . . . 0.0 109.617 -179.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -147.45 123.41 10.7 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.121 -0.987 . . . . 0.0 109.229 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 73' ' ' SER . 0.5 OUTLIER -44.39 -21.55 0.05 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 73' ' ' SER . 8.4 ttt180 -68.81 -37.0 78.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.403 -0.81 . . . . 0.0 109.649 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -80.41 -35.66 34.87 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.47 -32.96 66.65 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.7 tp60 -69.28 -30.91 69.11 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.533 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -74.82 -19.93 59.98 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -71.8 -47.46 53.16 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.749 -1.18 . . . . 0.0 108.207 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.471 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.9 mm -56.85 -55.77 18.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.644 0.735 . . . . 0.0 109.586 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.401 HD21 ' HG3' ' A' ' 78' ' ' GLN . 4.0 m-20 -64.64 -18.24 64.76 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 10.9 m170 -85.47 -32.39 22.29 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.924 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -130.61 -25.02 2.41 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.175 -0.953 . . . . 0.0 112.685 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.512 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 3.8 m-70 -98.96 -49.7 4.44 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.033 -1.042 . . . . 0.0 109.023 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.491 ' SD ' ' O ' ' A' ' 86' ' ' MET . 0.0 OUTLIER 41.54 35.0 0.42 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.368 0.604 . . . . 0.0 109.815 179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -178.96 119.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.442 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -170.98 50.79 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 CA-C-O 117.942 -1.477 . . . . 0.0 109.545 -179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.45 ' O ' ' CZ ' ' A' ' 14' ' ' TYR . 34.9 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -92.64 -45.24 8.17 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.228 -0.92 . . . . 0.0 109.308 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -77.1 111.47 12.72 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 109.48 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.638 ' HA ' HD11 ' A' ' 11' ' ' ILE . 48.0 t -46.36 146.53 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.631 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -80.28 -28.33 38.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.373 -0.829 . . . . 0.0 109.711 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 -59.4 1.75 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 110.245 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.464 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 13.1 m -60.06 -28.62 67.94 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.19 -0.944 . . . . 0.0 110.14 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 10.2 73.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.3 158.37 31.89 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.432 -1.04 . . . . 0.0 108.638 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.17 100.04 0.52 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.855 1.703 . . . . 0.0 112.233 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 4' ' ' CYS . 89.5 mt -45.67 115.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.94 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.7 -32.28 25.62 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -139.87 140.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.45 ' CZ ' ' O ' ' A' ' 1' ' ' VAL . 4.0 m-85 -76.76 103.85 6.94 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 120.819 -1.175 . . . . 0.0 110.835 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.72 84.29 0.89 Allowed Glycine 0 N--CA 1.482 1.746 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.511 HH21 ' CG ' ' A' ' 21' ' ' LYS . 6.2 ttt-85 -66.73 130.98 44.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 122.223 -0.575 . . . . 0.0 110.166 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.643 ' CE ' HG11 ' A' ' 47' ' ' VAL . 16.7 mtp -117.0 132.62 56.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.879 -0.513 . . . . 0.0 110.279 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.679 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -115.81 156.75 46.06 Favored Pre-proline 0 N--CA 1.494 1.756 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -82.55 -1.54 51.83 Favored 'Cis proline' 0 N--CA 1.492 1.405 0 C-N-CA 124.119 -1.201 . . . . 0.0 111.958 -0.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.5 t -54.19 -31.58 53.32 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.2 OUTLIER 68.79 24.85 6.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.453 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 0.5 OUTLIER -89.72 179.96 5.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.2 m -146.32 150.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 34.6 m-85 -159.09 169.71 23.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -52.5 114.28 1.33 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 118.24 -1.384 . . . . 0.0 108.206 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 30' ' ' ILE . 34.1 t80 -52.22 -15.3 0.57 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 0.0 109.339 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.46 -41.14 63.55 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.464 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 2.1 p -81.23 -27.63 35.17 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.7 -35.99 81.44 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 108.809 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.3 pt -79.91 -34.48 15.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.129 -1.029 . . . . 0.0 108.873 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.9 mt -64.0 -24.86 67.88 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.204 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -80.63 -40.71 25.14 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -23.34 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.312 -0.867 . . . . 0.0 109.395 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -80.72 -36.49 32.06 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.261 -0.899 . . . . 0.0 108.584 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -78.04 -10.95 59.85 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.503 -0.748 . . . . 0.0 109.317 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.61 31.53 13.01 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.499 ' OD1' ' SD ' ' A' ' 39' ' ' MET . 0.3 OUTLIER -88.76 -40.76 12.98 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.279 -1.13 . . . . 0.0 109.221 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 42.95 23.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.522 -0.736 . . . . 0.0 110.24 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.499 ' SD ' ' OD1' ' A' ' 37' ' ' ASP . 3.7 ptt? -112.05 135.43 52.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.772 -0.58 . . . . 0.0 109.605 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.6 t -64.01 114.3 13.22 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.341 -0.849 . . . . 0.0 109.002 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -54.68 -12.3 4.33 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.199 1.266 . . . . 0.0 111.554 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.74 -59.76 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 44' ' ' SER . 3.8 m -92.34 -24.55 18.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.226 -1.161 . . . . 0.0 109.969 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.4 OUTLIER 74.86 40.32 0.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.436 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.3 157.11 43.31 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.69 97.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.5 2.133 . . . . 0.0 112.228 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.643 HG11 ' CE ' ' A' ' 17' ' ' MET . 4.5 m -68.99 112.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -55.36 -53.66 53.44 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 108.897 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.679 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -157.68 133.67 9.37 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 118.791 -1.163 . . . . 0.0 109.787 179.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.715 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.1 mt -87.17 145.76 7.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 120.981 -1.074 . . . . 0.0 109.353 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -138.34 153.84 48.97 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.706 0.765 . . . . 0.0 109.764 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.492 ' CG ' ' CD2' ' A' ' 26' ' ' TYR . 33.0 mt-30 -95.17 139.4 31.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.663 -0.648 . . . . 0.0 110.084 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 m -139.89 157.8 45.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.661 -0.649 . . . . 0.0 109.859 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.45 158.67 21.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.798 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.51 ' C ' ' H ' ' A' ' 57' ' ' SER . 36.9 ttp85 -49.92 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.303 -0.873 . . . . 0.0 110.097 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.82 29.08 0.39 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 55' ' ' ARG . 10.8 t -85.62 -27.69 25.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.95 -1.324 . . . . 0.0 108.914 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mt -107.59 173.54 6.28 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.472 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 24.8 m-85 -118.15 119.61 35.22 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.9 mtp -80.51 144.11 32.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 0.0 110.047 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.6 t -103.71 101.44 11.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.664 -0.648 . . . . 0.0 109.467 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.7 t -86.7 -23.8 25.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 81' ' ' ILE . 64.7 mt -45.24 130.69 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.419 -0.801 . . . . 0.0 109.75 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 65' ' ' GLN . 61.2 t 52.66 95.6 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.421 -0.8 . . . . 0.0 109.376 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 64' ' ' VAL . 14.1 mm100 -49.34 175.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.382 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.88 -47.03 3.15 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.8 163.47 17.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -1.162 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -173.0 41.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 109.189 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.689 ' NH1' ' HE ' ' A' ' 84' ' ' ARG . 49.3 mtt180 -78.58 112.04 15.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.24 -0.913 . . . . 0.0 109.481 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -77.33 175.71 9.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.567 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.798 ' C ' HD23 ' A' ' 72' ' ' LEU . 92.1 m-85 -157.84 -170.66 3.25 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.798 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -118.46 -5.75 10.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.671 -0.643 . . . . 0.0 109.676 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 76' ' ' ASP . 3.3 m -149.41 129.88 13.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.128 -0.982 . . . . 0.0 109.431 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.472 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 6.6 mm-40 -47.28 -24.46 0.75 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.211 -0.931 . . . . 0.0 109.046 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -68.16 -32.77 73.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.519 -0.738 . . . . 0.0 109.115 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.6 m-20 -81.62 -36.38 28.98 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tt -75.41 -33.41 60.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -68.41 -33.36 74.08 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.563 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.22 -21.17 62.17 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -74.85 -38.22 62.03 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.371 -1.331 . . . . 0.0 109.028 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 63' ' ' ILE . 9.0 mm -62.42 -52.62 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.522 -0.736 . . . . 0.0 110.146 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.488 ' OD1' ' CD2' ' A' ' 83' ' ' HIS . 11.8 p30 -72.37 -18.84 61.71 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.753 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 38.9 m170 -86.65 -26.7 24.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.464 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.689 ' HE ' ' NH1' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -130.51 -14.3 3.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.154 -0.966 . . . . 0.0 112.053 -178.077 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.438 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 10.2 m-70 -112.27 -44.48 3.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.117 -0.989 . . . . 0.0 109.828 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.469 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 6.2 ttm 47.81 53.22 11.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.452 -0.78 . . . . 0.0 109.163 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 86' ' ' MET . 0.5 OUTLIER 76.35 106.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.656 -0.652 . . . . 0.0 109.343 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -46.45 -76.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.444 -0.785 . . . . 0.0 109.57 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.991 -1.449 . . . . 0.0 109.54 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.729 ' O ' HD12 ' A' ' 11' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.581 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 0.4 OUTLIER -97.78 53.63 1.12 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.614 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.516 ' CE2' ' O ' ' A' ' 8' ' ' GLY . 0.3 OUTLIER -158.31 105.69 1.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.506 -0.746 . . . . 0.0 109.257 -179.62 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 9' ' ' LEU . 4.0 m -46.45 146.3 1.5 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 108.988 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.1 -25.88 21.65 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.35 -31.27 13.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.417 -0.802 . . . . 0.0 110.369 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 -24.43 11.87 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.36 -0.838 . . . . 0.0 110.646 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 3' ' ' PHE . . . 78.93 -0.44 78.49 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.082 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.531 ' O ' ' SG ' ' A' ' 4' ' ' CYS . 4.2 mp -79.55 163.96 56.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.075 -1.25 . . . . 0.0 108.258 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.08 133.32 24.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.146 1.231 . . . . 0.0 112.091 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 1' ' ' VAL . 73.0 mt -81.05 118.09 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.531 -0.73 . . . . 0.0 110.739 -179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.484 ' CD ' ' H ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -84.53 -29.71 25.7 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.96 144.78 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.53 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.3 m-85 -82.31 99.41 9.33 Favored 'General case' 0 C--N 1.293 -1.849 0 O-C-N 120.634 -1.291 . . . . 0.0 110.231 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.27 87.59 0.59 Allowed Glycine 0 N--CA 1.483 1.83 0 N-CA-C 107.461 -2.255 . . . . 0.0 107.461 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.47 HH21 ' CG ' ' A' ' 21' ' ' LYS . 2.4 ttt-85 -64.91 143.5 57.91 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 122.115 -0.638 . . . . 0.0 110.169 -178.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.561 ' SD ' ' SG ' ' A' ' 40' ' ' CYS . 6.8 mtp -125.6 134.33 51.95 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -122.54 154.18 62.9 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -80.72 6.63 37.34 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 124.174 -1.177 . . . . 0.0 111.26 -0.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -55.7 -38.19 69.35 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.638 -0.663 . . . . 0.0 109.421 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.7 tttp 71.12 24.22 3.94 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.591 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 37.6 m170 -100.33 175.55 5.67 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.53 HG21 ' CD2' ' A' ' 14' ' ' TYR . 1.3 m -143.12 154.03 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.832 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.485 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 48.0 m-85 -151.92 -158.36 0.89 Allowed 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.534 ' HA ' HG23 ' A' ' 11' ' ' ILE . 0.5 OUTLIER -81.36 108.92 15.37 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.732 ' O ' HG23 ' A' ' 30' ' ' ILE . 43.2 t80 -49.84 -11.55 0.06 Allowed 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.051 -1.031 . . . . 0.0 109.722 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.5 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.6 t70 -82.35 -49.29 10.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 108.996 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.414 ' HA ' HD12 ' A' ' 31' ' ' LEU . 3.9 m -79.4 -22.15 44.68 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.826 -1.172 . . . . 0.0 108.051 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.54 -35.87 78.04 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.732 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.4 pt -78.86 -34.01 16.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 O-C-N 121.119 -0.988 . . . . 0.0 108.767 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 28' ' ' CYS . 18.9 mt -65.42 -38.7 90.7 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.832 -1.147 . . . . 0.0 107.995 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -70.54 -31.32 68.34 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' ASP . 0.1 OUTLIER -74.83 -36.24 62.4 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -73.07 -20.92 60.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.039 -1.038 . . . . 0.0 108.262 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -81.75 -36.96 27.96 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.464 -0.773 . . . . 0.0 110.025 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -135.02 -34.65 0.25 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER 72.64 20.95 3.65 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.498 -1.001 . . . . 0.0 110.26 179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -164.81 41.43 0.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.913 -1.117 . . . . 0.0 110.533 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.432 ' C ' HG13 ' A' ' 47' ' ' VAL . 19.5 mtp -148.52 136.37 20.8 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.901 -1.124 . . . . 0.0 112.163 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.561 ' SG ' ' SD ' ' A' ' 17' ' ' MET . 24.9 t -91.47 112.06 52.3 Favored Pre-proline 0 N--CA 1.491 1.624 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -45.95 -19.17 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.86 1.706 . . . . 0.0 112.772 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 -62.51 0.82 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.553 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.5 m -93.83 2.27 56.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -1.157 . . . . 0.0 110.529 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.519 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.6 p 48.45 36.03 6.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 109.566 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.444 ' H ' ' HB3' ' A' ' 40' ' ' CYS . 0.1 OUTLIER -95.71 161.43 27.6 Favored Pre-proline 0 N--CA 1.487 1.38 0 O-C-N 121.299 -0.876 . . . . 0.0 109.003 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' GLN . 20.2 Cg_endo -62.93 80.67 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.344 2.029 . . . . 0.0 111.976 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.696 ' O ' HG23 ' A' ' 47' ' ' VAL . 5.6 m -52.96 98.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -50.6 -51.12 51.43 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.519 -1.363 . . . . 0.0 108.202 -179.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.475 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -158.55 123.19 4.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.668 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.1 mt -81.05 144.91 9.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 120.797 -1.19 . . . . 0.0 109.168 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 16' ' ' ARG . 28.0 mt-10 -138.97 151.17 46.64 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 121.702 0.763 . . . . 0.0 110.363 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.463 ' CD ' ' CE2' ' A' ' 26' ' ' TYR . 19.5 mt-30 -85.72 143.29 28.44 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.347 0.594 . . . . 0.0 110.071 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.44 159.32 42.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.478 -0.764 . . . . 0.0 109.471 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.81 166.41 20.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 109.333 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.525 ' C ' ' H ' ' A' ' 57' ' ' SER . 3.5 tmm_? -68.51 -74.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 110.561 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.15 24.71 0.26 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.857 -1.163 . . . . 0.0 110.365 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.635 ' O ' HD23 ' A' ' 58' ' ' LEU . 3.3 m -92.56 -6.31 49.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.972 -1.31 . . . . 0.0 109.82 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 57' ' ' SER . 6.3 mt -129.03 174.81 9.21 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.621 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 0.7 OUTLIER -120.67 108.58 14.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.801 -0.562 . . . . 0.0 110.332 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.52 144.74 49.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.381 -0.825 . . . . 0.0 110.368 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.503 ' SG ' ' CE1' ' A' ' 80' ' ' HIS . 49.6 t -79.82 143.48 34.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.405 -0.81 . . . . 0.0 109.673 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.9 t -109.85 47.99 0.92 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.59 -0.694 . . . . 0.0 109.473 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.2 mt -137.33 -46.99 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.48 -0.763 . . . . 0.0 109.367 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.509 HG22 ' H ' ' A' ' 66' ' ' GLY . 2.7 p -164.16 150.81 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.067 -1.021 . . . . 0.0 109.606 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -81.86 27.79 0.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.654 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.509 ' H ' HG22 ' A' ' 64' ' ' VAL . . . -98.65 -61.38 0.87 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.523 ' O ' ' N ' ' A' ' 69' ' ' ARG . 13.9 p -47.32 167.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -1.102 . . . . 0.0 109.36 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 70' ' ' THR . 23.0 mttt -47.99 -12.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.038 -1.039 . . . . 0.0 109.815 -179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 67' ' ' CYS . 6.7 ttm180 64.24 -67.56 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 110.775 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 68' ' ' LYS . 2.1 p -94.12 155.0 17.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.142 -0.974 . . . . 0.0 110.647 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.636 ' C ' HD23 ' A' ' 72' ' ' LEU . 72.6 m-85 -149.97 176.98 10.28 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.734 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -103.11 -11.11 18.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.537 -0.727 . . . . 0.0 110.472 -178.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 76' ' ' ASP . 58.7 m -160.63 138.05 9.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.801 -1.187 . . . . 0.0 110.51 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.621 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 4.9 mm-40 -43.34 -31.64 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.612 -0.68 . . . . 0.0 109.68 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -65.88 -31.68 72.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.415 -0.803 . . . . 0.0 109.962 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 73' ' ' SER . 73.6 m-20 -86.22 -32.73 21.01 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.3 OUTLIER -76.83 -35.03 57.83 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.637 ' N ' HD23 ' A' ' 77' ' ' LEU . 40.1 tp60 -72.38 -34.73 68.14 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -71.08 -20.09 62.4 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.537 ' C ' ' CD2' ' A' ' 80' ' ' HIS . 0.0 OUTLIER -77.39 -39.12 48.26 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.262 -1.375 . . . . 0.0 108.645 179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.517 HD13 ' NE2' ' A' ' 80' ' ' HIS . 3.5 mm -58.14 -55.35 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.19 -25.2 66.01 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.604 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 39.2 m170 -88.78 -11.04 46.07 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.926 -1.109 . . . . 0.0 111.808 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -118.37 -48.62 2.51 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.152 -0.967 . . . . 0.0 113.355 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -138.72 -22.56 0.97 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.021 -1.049 . . . . 0.0 110.002 -178.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' A' ' 86' ' ' MET . 0.0 OUTLIER 54.67 24.2 5.35 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.853 0.835 . . . . 0.0 109.772 179.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.589 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 36.3 ttt-85 -94.14 143.82 26.04 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.274 -0.891 . . . . 0.0 109.399 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 87' ' ' ARG . . . 170.77 178.82 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.947 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.561 HG23 ' CD2' ' A' ' 2' ' ' HIS . 3.6 m . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.561 ' CD2' HG23 ' A' ' 1' ' ' VAL . 4.2 m-70 66.23 -52.85 0.41 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.752 -0.593 . . . . 0.0 109.962 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' A' ' 3' ' ' PHE . 0.2 OUTLIER -72.2 119.29 16.19 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.81 . . . . 0.0 110.35 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.488 ' HA ' HD11 ' A' ' 11' ' ' ILE . 6.6 t -46.26 145.8 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.343 -0.848 . . . . 0.0 109.037 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -21.44 30.89 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.202 -0.936 . . . . 0.0 110.057 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -39.68 12.04 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.038 -1.038 . . . . 0.0 110.484 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.1 m -106.58 -16.98 14.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 111.384 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.43 4.12 68.42 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.429 -1.367 . . . . 0.0 109.979 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.27 157.65 56.06 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.057 -1.261 . . . . 0.0 109.035 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.7 112.16 2.11 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.129 1.886 . . . . 0.0 112.549 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.488 HD11 ' HA ' ' A' ' 4' ' ' CYS . 67.6 mt -61.82 124.86 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -90.05 -29.25 18.51 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.3 t -133.4 145.31 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD2' HG11 ' A' ' 23' ' ' VAL . 3.2 m-30 -82.75 98.73 9.25 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.658 -1.276 . . . . 0.0 110.814 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.69 95.34 1.35 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.611 HH12 ' CB ' ' A' ' 70' ' ' THR . 3.0 tpt180 -81.52 144.83 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.99 -0.712 . . . . 0.0 111.064 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.541 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 5.4 mtp -131.72 130.18 41.61 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.663 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -113.9 157.28 42.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.345 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -82.48 -1.06 51.67 Favored 'Cis proline' 0 N--CA 1.491 1.344 0 C-N-CA 124.178 -1.176 . . . . 0.0 111.786 -0.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.583 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 14.5 t -52.01 -35.36 46.46 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' A' ' 16' ' ' ARG . 0.2 OUTLIER 69.3 30.17 4.31 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.583 ' CE1' ' SG ' ' A' ' 20' ' ' CYS . 30.8 m170 -100.22 165.9 11.26 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.876 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.538 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -122.64 161.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.942 0.877 . . . . 0.0 110.462 179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.541 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 97.3 m-85 -163.55 -164.41 0.92 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -83.9 113.66 21.12 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.754 ' O ' HG23 ' A' ' 30' ' ' ILE . 41.1 t80 -47.53 -14.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.051 -1.03 . . . . 0.0 109.364 -178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.4 m-20 -79.77 -42.96 23.4 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.465 ' HA ' HD12 ' A' ' 31' ' ' LEU . 54.5 m -83.08 -23.2 33.21 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -69.54 -37.41 77.06 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.754 HG23 ' O ' ' A' ' 26' ' ' TYR . 46.4 pt -74.74 -37.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.468 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 28' ' ' CYS . 9.0 mt -53.5 -38.52 63.78 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -67.05 -42.03 85.48 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.564 -0.71 . . . . 0.0 109.211 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HB3' HD12 ' A' ' 50' ' ' ILE . 1.1 pt-20 -61.46 -34.0 74.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.166 -0.959 . . . . 0.0 108.782 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -77.68 -20.68 53.27 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.393 -0.817 . . . . 0.0 108.998 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -81.71 -31.71 31.99 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 110.243 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.18 -25.88 0.08 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 62.64 50.92 3.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -1.112 . . . . 0.0 109.983 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -155.74 9.68 0.27 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.871 -1.143 . . . . 0.0 111.017 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.455 ' CG ' ' O ' ' A' ' 39' ' ' MET . 7.5 ptm -144.5 114.26 7.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.09 -1.007 . . . . 0.0 110.317 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.503 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -57.04 145.89 62.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.86 -38.91 68.85 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.768 1.645 . . . . 0.0 112.61 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.84 -21.8 2.84 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.624 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.448 ' H ' ' HB3' ' A' ' 40' ' ' CYS . 0.0 OUTLIER -94.49 -15.81 23.88 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.176 -1.191 . . . . 0.0 110.169 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.9 p 47.63 36.48 5.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.399 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.503 ' H ' ' HB2' ' A' ' 40' ' ' CYS . 0.3 OUTLIER -90.93 160.73 37.35 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 121.327 -0.858 . . . . 0.0 108.775 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' GLN . 14.9 Cg_endo -58.27 74.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 C-N-CA 122.131 1.887 . . . . 0.0 112.001 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 45' ' ' ASP . 47.2 t -47.42 94.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.051 -1.03 . . . . 0.0 109.683 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' PRO . 5.0 tt0 -64.62 -61.06 2.43 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.663 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -150.61 137.64 19.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.911 179.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.579 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.7 mt -94.61 147.21 5.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 O-C-N 120.805 -1.184 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -140.68 147.02 38.61 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.443 0.64 . . . . 0.0 109.826 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -97.02 144.8 26.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.633 -0.667 . . . . 0.0 109.221 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.24 168.08 25.07 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.082 -1.012 . . . . 0.0 110.323 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.9 154.36 22.28 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.408 -0.807 . . . . 0.0 108.844 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -57.52 -23.78 52.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 110.081 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -97.82 21.83 44.05 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.83 -25.99 14.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -1.135 . . . . 0.0 109.924 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -114.15 172.68 6.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.697 -0.627 . . . . 0.0 109.628 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.504 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 53.4 m-85 -122.19 123.18 40.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 4.8 mmt -88.88 145.28 25.65 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.274 -0.891 . . . . 0.0 110.949 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.53 ' SG ' ' CD1' ' A' ' 81' ' ' ILE . 46.9 t -90.34 143.05 27.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.497 -0.752 . . . . 0.0 109.011 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -62.2 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.052 -1.03 . . . . 0.0 109.561 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.5 HG21 ' ND1' ' A' ' 85' ' ' HIS . 6.3 mt -44.91 120.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.545 -0.722 . . . . 0.0 109.719 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.939 HG22 ' H ' ' A' ' 65' ' ' GLN . 9.8 p -92.19 -144.16 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.863 . . . . 0.0 109.447 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.939 ' H ' HG22 ' A' ' 64' ' ' VAL . 23.4 tt0 60.8 98.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.044 -1.035 . . . . 0.0 109.487 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 46.9 57.66 6.72 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.598 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 43.8 t -150.38 -115.49 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.345 -1.091 . . . . 0.0 109.538 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 12.4 mttp 47.83 31.49 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.543 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.688 HH12 HH21 ' A' ' 84' ' ' ARG . 19.3 mmm-85 -91.45 117.04 29.35 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.23 -0.919 . . . . 0.0 109.431 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.611 ' CB ' HH12 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -83.84 174.87 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 0.0 109.719 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.813 ' C ' HD23 ' A' ' 72' ' ' LEU . 89.8 m-85 -156.18 -166.33 2.14 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.366 -0.834 . . . . 0.0 108.819 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.813 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -118.11 -8.81 10.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.678 -0.639 . . . . 0.0 110.046 -179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 76' ' ' ASP . 17.9 p -145.35 130.0 18.03 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.12 -0.987 . . . . 0.0 109.514 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.504 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 6.3 mm-40 -47.81 -25.65 1.35 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.334 -0.854 . . . . 0.0 108.699 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -68.4 -32.89 73.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.528 0.68 . . . . 0.0 109.237 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 73' ' ' SER . 36.5 m-20 -84.21 -34.52 23.9 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.1 tt -74.95 -34.05 62.0 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -71.58 -30.22 65.59 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.06 -20.55 60.95 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.529 ' CD2' HD13 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -75.83 -41.0 53.8 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.724 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.53 ' CD1' ' SG ' ' A' ' 61' ' ' CYS . 4.6 mm -61.53 -52.77 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -64.65 -23.02 67.12 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.482 -0.761 . . . . 0.0 109.023 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 28.7 m170 -88.12 -12.9 42.72 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.531 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.688 HH21 HH12 ' A' ' 69' ' ' ARG . 11.1 mmt180 -118.67 -46.21 2.57 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.095 -1.003 . . . . 0.0 113.067 -177.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.5 ' ND1' HG21 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -142.21 -25.97 0.65 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.007 -1.058 . . . . 0.0 110.031 -179.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.51 ' N ' ' O ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER 60.2 35.55 21.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.492 -0.755 . . . . 0.0 109.708 179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.468 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.9 ttm-85 -95.3 56.67 1.9 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.394 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 87' ' ' ARG . . . 61.89 149.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.571 -179.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.452 ' O ' ' CZ ' ' A' ' 14' ' ' TYR . 9.9 m . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.274 0.559 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -90.29 -47.15 7.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.377 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.466 ' O ' ' CD2' ' A' ' 3' ' ' PHE . 13.9 p90 -77.98 106.8 10.08 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.076 -1.015 . . . . 0.0 109.329 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.619 ' HA ' HD11 ' A' ' 11' ' ' ILE . 43.3 t -45.95 146.29 1.27 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.476 ' CG ' ' NZ ' ' A' ' 68' ' ' LYS . 1.0 OUTLIER -83.72 -30.45 26.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.0 110.624 -179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.45 -40.16 10.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.018 -1.051 . . . . 0.0 110.293 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.546 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 12.6 m -88.55 -25.86 22.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.052 -1.03 . . . . 0.0 110.089 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.42 10.49 70.44 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 158.29 32.46 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.36 -1.082 . . . . 0.0 108.601 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -68.02 98.96 0.54 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.857 1.704 . . . . 0.0 112.083 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.619 HD11 ' HA ' ' A' ' 4' ' ' CYS . 91.5 mt -45.58 110.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.986 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -35.07 40.86 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.0 138.75 45.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' CZ ' ' O ' ' A' ' 1' ' ' VAL . 3.7 m-85 -78.78 106.96 11.15 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 120.98 -1.075 . . . . 0.0 110.78 -178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.58 85.13 0.85 Allowed Glycine 0 N--CA 1.481 1.639 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -65.66 130.84 44.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 122.0 -0.706 . . . . 0.0 109.789 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.631 ' CE ' HG11 ' A' ' 47' ' ' VAL . 14.5 mtp -116.27 124.61 50.62 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.863 -0.523 . . . . 0.0 110.139 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.817 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -112.76 156.72 42.11 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -179.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.95 2.57 48.47 Favored 'Cis proline' 0 C--N 1.316 -1.184 0 C-N-CA 124.153 -1.186 . . . . 0.0 111.462 -0.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 1.0 OUTLIER -56.92 -35.81 69.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.549 -0.719 . . . . 0.0 109.433 -179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 ttmt 74.51 21.97 2.19 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.573 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 3.3 m80 -90.5 178.72 6.03 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.879 -0.729 . . . . 0.0 109.149 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.456 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 1.3 m -146.57 149.06 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.456 ' CD1' ' O ' ' A' ' 23' ' ' VAL . 21.5 m-85 -158.61 170.0 23.16 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.68 112.7 0.74 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.77 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.493 ' O ' HG23 ' A' ' 30' ' ' ILE . 40.6 t80 -51.16 -15.3 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 109.613 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -82.26 -32.7 29.5 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.546 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -85.68 -26.29 26.05 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 108.651 178.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.493 ' HB1' HD13 ' A' ' 50' ' ' ILE . . . -72.29 -35.09 68.6 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 26' ' ' TYR . 2.1 pp -84.46 -34.92 10.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.252 -0.905 . . . . 0.0 108.811 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.548 HD23 ' HD3' ' A' ' 34' ' ' LYS . 7.6 mt -68.18 -22.97 64.8 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.004 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -82.39 -40.57 21.1 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.26 -36.74 85.05 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.475 -0.765 . . . . 0.0 109.91 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HD3' HD23 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -83.01 -27.43 30.37 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.971 -1.081 . . . . 0.0 109.756 -179.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.1 mttm -78.38 22.76 0.32 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.938 -1.101 . . . . 0.0 109.67 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 34' ' ' LYS . . . 69.97 39.79 74.17 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.595 ' C ' ' H ' ' A' ' 39' ' ' MET . 0.5 OUTLIER -138.16 57.67 1.7 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.553 -0.969 . . . . 0.0 108.91 179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.514 ' O ' HG22 ' A' ' 47' ' ' VAL . 4.6 pttt -66.07 20.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.395 -0.816 . . . . 0.0 109.905 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.595 ' H ' ' C ' ' A' ' 37' ' ' ASP . 8.0 ptt? -97.58 159.18 15.08 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.153 -0.967 . . . . 0.0 109.236 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.557 ' O ' ' N ' ' A' ' 44' ' ' SER . 15.8 t -74.52 114.6 35.54 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.306 -0.871 . . . . 0.0 109.016 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.51 -17.11 6.2 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 121.427 1.418 . . . . 0.0 112.349 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.56 -58.63 1.26 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 3.5 m -93.29 -24.85 18.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.213 -1.169 . . . . 0.0 110.444 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.5 p 76.35 41.17 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.39 158.18 42.08 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.06 92.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.578 2.185 . . . . 0.0 112.141 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.633 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.0 m -62.1 111.14 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.037 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -47.17 -58.89 3.57 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.13 -0.981 . . . . 0.0 108.932 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' HD11 ' A' ' 18' ' ' ILE . 31.3 ptt180 -161.93 125.89 3.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.278 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.493 HD13 ' HB1' ' A' ' 29' ' ' ALA . 3.3 mt -74.08 144.71 12.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 O-C-N 120.817 -1.177 . . . . 0.0 109.745 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -138.94 143.22 38.53 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.761 0.791 . . . . 0.0 109.656 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -83.46 144.87 29.28 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.438 0.637 . . . . 0.0 110.079 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.21 158.86 43.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.429 -0.795 . . . . 0.0 109.532 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.43 162.35 24.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.226 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 57' ' ' SER . 3.9 ptp85 -66.4 -59.79 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.194 -0.941 . . . . 0.0 110.039 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.497 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -72.99 21.27 1.01 Allowed Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -90.29 -17.98 26.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.128 -1.219 . . . . 0.0 109.632 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.5 mt -118.86 173.29 6.96 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 24.6 m-85 -114.21 117.15 30.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.588 ' N ' ' SD ' ' A' ' 60' ' ' MET . 1.6 mpt? -82.59 144.47 30.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.344 -0.847 . . . . 0.0 110.346 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -99.5 102.38 13.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.59 -32.32 32.12 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.966 . . . . 0.0 110.014 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 81' ' ' ILE . 3.3 mt -43.5 126.62 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.464 -0.772 . . . . 0.0 110.182 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 63' ' ' ILE . 25.3 t 53.54 105.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.603 -0.686 . . . . 0.0 109.858 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.429 ' O ' ' O ' ' A' ' 64' ' ' VAL . 1.1 mt-30 -56.61 -165.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.96 -62.63 2.48 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -72.22 164.69 25.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -1.139 . . . . 0.0 109.347 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.476 ' NZ ' ' CG ' ' A' ' 5' ' ' ASP . 14.8 pttt -177.81 38.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.922 . . . . 0.0 109.351 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.593 ' NE ' ' ND1' ' A' ' 80' ' ' HIS . 17.1 mtm180 -75.49 111.43 10.78 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.186 -0.946 . . . . 0.0 109.382 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.54 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -78.79 176.61 9.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.656 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.74 ' C ' HD23 ' A' ' 72' ' ' LEU . 93.9 m-85 -158.66 -171.94 3.63 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.74 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -114.68 -7.72 12.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.606 -0.684 . . . . 0.0 110.077 -178.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 76' ' ' ASP . 1.6 m -146.2 126.37 13.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 78' ' ' GLN . 1.1 tp60 -43.34 -26.95 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 73' ' ' SER . 5.5 tmm_? -63.95 -35.55 81.04 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.411 -0.806 . . . . 0.0 109.963 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 73' ' ' SER . 4.2 m-20 -80.85 -38.73 27.68 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.216 -0.928 . . . . 0.0 108.64 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.76 -30.93 64.54 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 74' ' ' GLN . 19.9 tp60 -69.64 -32.66 71.46 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -20.11 61.4 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.593 ' ND1' ' NE ' ' A' ' 69' ' ' ARG . 53.1 t60 -73.04 -44.89 60.18 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.683 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.502 HD12 HD13 ' A' ' 63' ' ' ILE . 3.3 mm -59.36 -50.9 78.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-O 121.441 0.639 . . . . 0.0 109.699 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -70.4 -18.79 63.03 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.572 -0.705 . . . . 0.0 109.605 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 15.9 m170 -86.71 -28.45 23.09 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.716 -1.193 . . . . 0.0 112.101 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -128.66 -21.77 3.38 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.128 -0.983 . . . . 0.0 112.025 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.515 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.5 m-70 -104.9 -46.38 4.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.584 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' HIS . 0.2 OUTLIER 40.72 33.03 0.17 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.437 0.637 . . . . 0.0 110.028 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.653 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 13.4 ttp180 -73.47 -69.38 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.448 -0.782 . . . . 0.0 109.561 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 87' ' ' ARG . . . 72.59 174.63 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.475 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.745 ' O ' HD12 ' A' ' 11' ' ' ILE . 1.5 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.4 0.619 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.578 ' H ' HG12 ' A' ' 1' ' ' VAL . 0.4 OUTLIER -91.3 54.35 2.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.442 -0.786 . . . . 0.0 109.873 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 1.5 p90 -152.45 108.74 3.4 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.984 0.897 . . . . 0.0 109.969 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.1 t -46.78 143.03 3.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.1 -1.0 . . . . 0.0 108.463 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.01 -28.75 19.98 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.013 -1.054 . . . . 0.0 110.464 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -93.86 -38.96 10.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.078 -1.014 . . . . 0.0 110.75 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 -23.46 14.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.195 -0.94 . . . . 0.0 110.822 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 81.55 6.97 88.75 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.322 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.67 152.13 51.24 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.967 -1.314 . . . . 0.0 108.367 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.62 137.7 81.91 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.749 1.633 . . . . 0.0 112.696 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.745 HD12 ' O ' ' A' ' 1' ' ' VAL . 71.9 mt -86.95 116.31 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.68 -0.637 . . . . 0.0 110.075 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.0 ptpt -81.92 -28.27 32.91 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.55 146.74 18.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.474 ' CD2' HG21 ' A' ' 23' ' ' VAL . 3.1 m-85 -78.81 98.56 6.36 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.722 -1.236 . . . . 0.0 110.377 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.55 83.71 0.55 Allowed Glycine 0 N--CA 1.481 1.681 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 51' ' ' GLU . 5.4 ttt-85 -61.52 145.89 50.46 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.305 0.574 . . . . 0.0 110.003 -178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.569 ' CE ' HG11 ' A' ' 47' ' ' VAL . 5.3 mtp -128.58 133.55 48.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.921 -0.487 . . . . 0.0 110.4 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.473 ' CG1' ' O ' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -122.35 154.75 62.5 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -82.13 4.17 48.25 Favored 'Cis proline' 0 N--CA 1.49 1.315 0 C-N-CA 124.219 -1.159 . . . . 0.0 111.493 0.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -56.42 -37.83 70.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.606 -0.684 . . . . 0.0 109.459 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.0 ttmm 74.29 27.39 1.48 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.478 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 13.0 m170 -100.58 177.61 4.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.474 HG21 ' CD2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER -145.26 153.3 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 110.433 179.538 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.445 ' CD1' ' C ' ' A' ' 23' ' ' VAL . 62.8 m-85 -153.51 -166.85 2.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.633 ' HA ' HG23 ' A' ' 11' ' ' ILE . 1.6 p -72.6 112.12 8.37 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.79 ' O ' HG23 ' A' ' 30' ' ' ILE . 34.0 t80 -51.55 -11.0 0.11 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.326 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 25' ' ' CYS . 3.2 t70 -77.29 -48.85 16.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.014 . . . . 0.0 109.407 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.3 m -78.45 -25.24 45.86 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.78 -1.2 . . . . 0.0 108.222 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -66.7 -35.68 80.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 108.979 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 26' ' ' TYR . 36.9 pt -80.77 -33.55 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.87 -23.69 66.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -77.38 -53.22 7.94 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.564 -0.71 . . . . 0.0 109.237 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.59 -24.67 64.62 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 109.733 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -78.53 -35.37 46.3 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 108.559 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -81.54 -2.2 49.03 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.424 -0.797 . . . . 0.0 109.408 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.07 25.76 51.06 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.494 ' OD1' ' SD ' ' A' ' 39' ' ' MET . 0.5 OUTLIER -81.75 -34.61 30.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.377 -1.072 . . . . 0.0 109.495 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' A' ' 37' ' ' ASP . 9.4 ptmt 33.09 45.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.584 0.706 . . . . 0.0 110.31 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.494 ' SD ' ' OD1' ' A' ' 37' ' ' ASP . 3.9 ptm -130.86 144.3 51.36 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' SER . 46.6 t -77.13 114.55 40.89 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.35 -0.844 . . . . 0.0 109.41 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.19 -15.58 1.44 Allowed 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.691 1.594 . . . . 0.0 112.171 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.86 -62.24 0.82 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 1.6 m -92.35 -20.5 21.02 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.293 -1.122 . . . . 0.0 110.194 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 40' ' ' CYS . 1.4 p 72.11 35.45 1.27 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.281 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.46 160.77 26.6 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.56 -0.713 . . . . 0.0 109.107 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -63.08 81.54 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.434 2.089 . . . . 0.0 111.966 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.6 m -52.66 111.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -59.65 -52.21 66.5 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.875 -1.141 . . . . 0.0 108.75 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.473 ' O ' ' CG1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -154.58 124.49 6.69 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 118.905 -1.118 . . . . 0.0 109.795 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.571 HG21 ' HB1' ' A' ' 29' ' ' ALA . 2.9 mt -84.93 144.86 8.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 O-C-N 120.836 -1.165 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 16' ' ' ARG . 29.0 mt-10 -137.77 149.79 46.71 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.621 0.724 . . . . 0.0 109.658 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -95.09 141.71 28.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.703 -0.623 . . . . 0.0 110.016 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -143.92 160.53 40.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.423 -0.798 . . . . 0.0 109.766 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 158.6 31.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.222 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 57' ' ' SER . 26.4 ttp85 -56.27 -71.82 0.08 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 0.0 110.046 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.39 30.64 0.46 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 55' ' ' ARG . 4.2 t -89.56 -26.29 20.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.998 -1.295 . . . . 0.0 109.509 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 mt -101.81 173.66 6.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.648 -0.657 . . . . 0.0 109.866 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.617 ' CD2' ' NE2' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -121.31 109.47 14.95 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.8 -0.562 . . . . 0.0 109.664 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 mtt -74.45 144.5 44.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.383 -0.823 . . . . 0.0 110.507 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 t -84.83 143.08 29.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.749 . . . . 0.0 109.015 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.6 t -139.74 75.26 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.365 -0.834 . . . . 0.0 109.985 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.615 HG21 ' HD1' ' A' ' 85' ' ' HIS . 3.4 mm -117.82 -84.8 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.602 HG23 ' H ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -95.28 -90.24 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.371 -0.83 . . . . 0.0 109.426 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.602 ' H ' HG23 ' A' ' 64' ' ' VAL . 2.3 pt20 -174.09 158.44 3.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.4 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.49 -50.72 4.45 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 1.5 t -47.3 -88.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -1.155 . . . . 0.0 109.449 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 16.0 mttt 53.77 38.35 28.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.72 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -80.01 124.53 28.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.081 -1.012 . . . . 0.0 109.217 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.04 167.33 18.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.082 -1.011 . . . . 0.0 109.738 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.746 ' C ' HD23 ' A' ' 72' ' ' LEU . 31.6 m-85 -154.31 177.87 10.65 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.245 -0.909 . . . . 0.0 109.124 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.746 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -114.43 -5.25 12.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.819 -0.55 . . . . 0.0 109.54 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 75' ' ' ARG . 67.1 m -153.39 126.56 8.5 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.249 -0.98 . . . . 0.0 109.748 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.617 ' NE2' ' CD2' ' A' ' 59' ' ' PHE . 5.9 mm-40 -43.51 -24.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.672 -0.642 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 73' ' ' SER . 6.7 ttt180 -66.5 -33.23 75.22 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.251 -0.906 . . . . 0.0 109.99 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 8.1 m-20 -86.09 -33.34 20.96 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.051 -1.031 . . . . 0.0 108.278 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 78' ' ' GLN . 0.2 OUTLIER -76.48 -31.8 57.98 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.445 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.663 ' N ' HD23 ' A' ' 77' ' ' LEU . 22.1 tp60 -72.78 -33.86 66.57 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.52 -19.8 61.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -73.41 -45.3 55.48 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.761 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.4 mm -58.72 -51.2 74.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-O 121.501 0.667 . . . . 0.0 109.703 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 78' ' ' GLN . 4.6 m-20 -70.59 -18.47 62.89 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.784 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 14.7 m170 -87.19 -27.34 23.07 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.099 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.67 -25.96 2.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.064 -1.023 . . . . 0.0 112.488 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.615 ' HD1' HG21 ' A' ' 63' ' ' ILE . 4.5 m-70 -100.19 -49.2 4.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.995 -1.066 . . . . 0.0 108.968 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 ttt 42.87 33.85 0.54 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.374 0.607 . . . . 0.0 109.762 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.642 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 13.2 ttp180 -81.54 -22.23 38.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.872 . . . . 0.0 109.622 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 87' ' ' ARG . . . 72.7 10.24 5.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.43 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.561 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.3 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.714 ' H ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -96.36 22.78 7.4 Favored 'General case' 0 C--O 1.203 -1.371 0 O-C-N 121.362 -0.836 . . . . 0.0 109.199 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -78.74 110.07 13.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.76 -1.212 . . . . 0.0 109.585 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.623 ' HA ' HD11 ' A' ' 11' ' ' ILE . 49.9 t -46.53 146.29 1.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.84 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.09 -27.2 28.41 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.442 -0.786 . . . . 0.0 109.874 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 -53.25 3.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.303 -0.873 . . . . 0.0 109.766 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.542 ' SG ' ' CB ' ' A' ' 28' ' ' CYS . 6.5 m -74.65 -27.6 60.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.831 . . . . 0.0 110.26 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.76 7.69 70.45 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.03 158.28 34.38 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.296 -1.12 . . . . 0.0 108.564 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.77 96.44 0.44 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.852 1.701 . . . . 0.0 112.484 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 4' ' ' CYS . 96.5 mt -41.26 104.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.395 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -76.37 -32.13 58.43 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -136.01 146.64 29.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -83.05 104.38 13.21 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.81 -1.181 . . . . 0.0 110.818 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.58 91.0 1.16 Allowed Glycine 0 N--CA 1.483 1.813 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.424 HH21 ' CG ' ' A' ' 21' ' ' LYS . 8.8 ttt-85 -77.65 134.56 38.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.828 -0.807 . . . . 0.0 110.114 -178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.568 ' SD ' ' CD1' ' A' ' 24' ' ' PHE . 6.0 mtp -123.61 130.66 53.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.867 -0.521 . . . . 0.0 109.761 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.663 HD11 ' HG2' ' A' ' 49' ' ' ARG . 0.7 OUTLIER -113.14 156.85 42.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.77 2.1 42.08 Favored 'Cis proline' 0 N--CA 1.491 1.353 0 C-N-CA 124.087 -1.214 . . . . 0.0 111.328 -0.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -36.31 62.65 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.2 OUTLIER 65.6 26.88 11.58 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.579 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 4.7 m170 -93.63 -172.15 2.81 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.534 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.522 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -144.71 151.79 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.93 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.568 ' CD1' ' SD ' ' A' ' 17' ' ' MET . 41.6 m-85 -162.85 166.77 23.66 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -55.44 111.75 0.96 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.47 -1.292 . . . . 0.0 107.938 178.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.499 ' O ' HG23 ' A' ' 30' ' ' ILE . 46.3 t80 -46.3 -21.0 0.13 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 109.767 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 25' ' ' CYS . 1.8 t70 -74.36 -37.64 63.42 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.542 ' CB ' ' SG ' ' A' ' 7' ' ' CYS . 0.4 OUTLIER -83.69 -22.61 32.0 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.217 -0.927 . . . . 0.0 108.515 178.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -70.71 -34.23 71.71 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 26' ' ' TYR . 39.8 pt -80.97 -36.09 14.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 121.141 -0.974 . . . . 0.0 108.919 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 31' ' ' LEU . 78.7 mt -64.56 -37.27 86.97 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -69.86 -33.81 72.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -34.88 70.53 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.364 -0.835 . . . . 0.0 108.987 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -73.65 -24.98 60.07 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.042 -1.036 . . . . 0.0 108.64 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -81.99 -74.75 0.33 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.413 -0.805 . . . . 0.0 110.565 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' ' 37' ' ' ASP . . . -87.15 -38.88 7.63 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 36' ' ' GLY . 2.3 t0 74.04 13.79 4.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -1.113 . . . . 0.0 110.014 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 ptmm? -173.58 35.62 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.928 -1.108 . . . . 0.0 111.277 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.1 ptp -148.21 126.53 12.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.676 -1.265 . . . . 0.0 110.455 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HB2' ' H ' ' A' ' 45' ' ' ASP . 0.8 OUTLIER -65.73 142.46 98.19 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -54.6 -34.18 81.97 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.532 1.488 . . . . 0.0 112.411 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -114.12 -43.22 0.8 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 120.24 -0.981 . . . . 0.0 111.043 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.579 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 2.4 m -86.26 -12.98 48.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.371 . . . . 0.0 110.549 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t 48.16 37.47 8.17 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.023 . . . . 0.0 109.029 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -89.92 161.1 39.33 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.384 -0.822 . . . . 0.0 109.342 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.32 74.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.377 2.051 . . . . 0.0 111.815 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 45' ' ' ASP . 21.7 t -45.25 100.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.369 -0.832 . . . . 0.0 110.031 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 18' ' ' ILE . 4.9 tt0 -66.07 -61.33 2.1 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.663 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -151.6 136.78 17.48 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.94 179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.61 HG21 ' HB1' ' A' ' 29' ' ' ALA . 3.1 mt -94.3 146.68 6.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.822 -1.174 . . . . 0.0 109.724 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -141.05 153.67 45.61 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.427 0.632 . . . . 0.0 109.991 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -99.55 142.53 30.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -145.28 165.55 28.08 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.08 155.68 23.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.426 -0.796 . . . . 0.0 108.937 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 57' ' ' SER . 10.5 ttp85 -51.56 -62.77 1.42 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 110.162 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 23.66 0.78 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 55' ' ' ARG . 8.0 t -86.92 -25.68 24.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.938 -1.331 . . . . 0.0 109.216 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.03 173.89 6.4 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 15.1 m-85 -119.31 119.39 33.86 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 7.0 mtt -80.08 144.49 33.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.337 -0.852 . . . . 0.0 110.325 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER -99.23 94.86 6.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.566 -0.709 . . . . 0.0 109.268 179.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.8 m -79.9 -22.73 42.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.928 . . . . 0.0 109.435 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.1 mt -44.46 143.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.557 -0.714 . . . . 0.0 109.84 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 66' ' ' GLY . 47.6 t 51.86 94.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.39 -0.819 . . . . 0.0 109.457 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -56.86 90.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.892 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 64' ' ' VAL . . . -179.87 -51.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.595 ' SG ' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -91.96 166.39 12.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -1.1 . . . . 0.0 109.519 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.595 ' N ' ' SG ' ' A' ' 67' ' ' CYS . 0.5 OUTLIER -162.87 46.39 0.14 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.264 -0.897 . . . . 0.0 109.447 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.3 mmm-85 -81.08 121.98 26.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.934 . . . . 0.0 109.297 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -81.86 174.72 11.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -0.942 . . . . 0.0 109.711 -179.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.765 ' C ' HD23 ' A' ' 72' ' ' LEU . 97.5 m-85 -156.77 -176.29 5.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.765 HD23 ' C ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -116.99 -3.34 11.6 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.617 -0.677 . . . . 0.0 110.086 -179.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 75' ' ' ARG . 8.1 t -149.32 128.12 12.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 109.716 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.415 HE21 HD22 ' A' ' 77' ' ' LEU . 1.9 tp60 -45.66 -23.23 0.23 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' N ' ' C ' ' A' ' 73' ' ' SER . 6.4 ttt180 -70.27 -33.16 71.27 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.363 -0.836 . . . . 0.0 109.687 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 73' ' ' SER . 2.1 m-20 -82.24 -36.7 26.91 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD22 HE21 ' A' ' 74' ' ' GLN . 1.8 tt -73.68 -34.78 65.03 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -70.16 -31.42 68.9 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.54 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -73.97 -19.82 60.54 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.587 ' HD1' ' HH ' ' A' ' 71' ' ' TYR . 58.6 t60 -73.11 -44.52 60.19 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.594 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 81' ' ' ILE . 2.8 mm -60.21 -52.04 65.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.48 0.657 . . . . 0.0 109.553 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.44 -18.32 64.4 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.573 -0.704 . . . . 0.0 109.647 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 11.7 m170 -86.21 -31.06 21.93 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.69 -1.204 . . . . 0.0 112.21 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -129.6 -21.59 3.1 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.046 -1.034 . . . . 0.0 112.472 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.522 ' N ' ' CD2' ' A' ' 85' ' ' HIS . 4.5 m-70 -102.28 -47.21 4.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.124 -0.985 . . . . 0.0 109.056 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 85' ' ' HIS . 2.4 ttt 43.25 34.44 0.7 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.295 0.569 . . . . 0.0 109.768 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -147.01 116.07 6.9 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.311 -0.868 . . . . 0.0 109.464 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 87' ' ' ARG . . . 175.55 162.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.916 . . . . 0.0 109.473 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 CA-C-O 118.022 -1.432 . . . . 0.0 109.603 179.988 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -173.73 -88.79 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.415 -0.803 . . . . 0.0 109.465 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -158.39 129.22 6.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 110.243 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.665 ' HA ' HD11 ' A' ' 11' ' ' ILE . 52.0 t -67.97 146.35 53.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.577 -0.702 . . . . 0.0 109.395 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.3 -27.83 38.38 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -99.68 -44.97 5.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 0.0 110.599 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -84.7 -20.31 31.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 110.204 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.41 3.49 25.94 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.67 157.36 37.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.331 -1.1 . . . . 0.0 108.801 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.91 123.12 12.81 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.0 1.8 . . . . 0.0 111.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.665 HD11 ' HA ' ' A' ' 4' ' ' CYS . 75.3 mt -75.89 103.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.64 -0.662 . . . . 0.0 110.575 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -30.81 64.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 1.5 t -147.05 143.37 20.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -75.36 110.42 9.7 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.995 -1.066 . . . . 0.0 111.113 -178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 24' ' ' PHE . . . -80.12 80.72 1.59 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 106.955 -2.458 . . . . 0.0 106.955 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.455 HH21 ' CG ' ' A' ' 21' ' ' LYS . 7.3 ttt-85 -66.55 131.15 45.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 122.112 -0.64 . . . . 0.0 110.239 -178.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.422 ' O ' ' N ' ' A' ' 21' ' ' LYS . 19.7 mtp -116.91 134.5 54.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.874 -0.516 . . . . 0.0 110.103 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 49' ' ' ARG . 0.6 OUTLIER -120.25 157.58 53.04 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.58 -2.19 47.13 Favored 'Cis proline' 0 N--CA 1.491 1.33 0 C-N-CA 124.107 -1.205 . . . . 0.0 112.146 -0.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 21' ' ' LYS . 7.1 t -52.8 -36.92 59.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.636 ' HE3' HD21 ' A' ' 72' ' ' LEU . 2.0 tttp 74.94 27.55 1.17 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.594 ' CE1' ' SG ' ' A' ' 43' ' ' CYS . 1.4 m80 -95.58 -178.24 4.34 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -145.71 153.5 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.868 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' A' ' 23' ' ' VAL . 34.9 m-85 -161.46 166.24 27.5 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -48.97 113.03 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.851 -1.14 . . . . 0.0 108.699 179.569 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -50.88 -18.02 0.68 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.347 -0.846 . . . . 0.0 109.883 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.427 ' O ' HD12 ' A' ' 31' ' ' LEU . 35.9 t70 -79.82 -33.04 40.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.519 ' O ' ' CG ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -85.34 -23.97 27.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.541 ' HB1' HG21 ' A' ' 50' ' ' ILE . . . -72.07 -35.66 69.35 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 pp -85.44 -34.03 8.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.146 -0.971 . . . . 0.0 108.957 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.483 HD23 ' HD3' ' A' ' 34' ' ' LYS . 7.8 mt -72.69 -22.75 60.86 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.803 -1.159 . . . . 0.0 107.979 178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 28' ' ' CYS . 35.6 m170 -83.79 -36.46 23.54 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.234 -0.916 . . . . 0.0 108.869 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -34.53 66.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 109.441 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HD3' HD23 ' A' ' 31' ' ' LEU . 12.9 ptmt -84.93 -28.76 25.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.048 -1.033 . . . . 0.0 110.228 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -68.52 -15.84 63.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.987 -1.071 . . . . 0.0 109.709 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 112.59 31.38 2.57 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.579 ' C ' ' H ' ' A' ' 39' ' ' MET . 6.4 t70 -131.47 57.79 1.75 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.61 34.91 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.725 0.774 . . . . 0.0 108.974 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.579 ' H ' ' C ' ' A' ' 37' ' ' ASP . 0.3 OUTLIER -126.61 135.58 51.41 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -41.07 104.79 0.36 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.684 -0.635 . . . . 0.0 109.98 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -52.62 -16.23 5.25 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 121.444 1.429 . . . . 0.0 111.757 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.33 -44.24 2.59 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.147 -1.025 . . . . 0.0 110.541 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.594 ' SG ' ' CE1' ' A' ' 22' ' ' HIS . 2.8 m -106.99 -26.11 11.32 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.316 -1.108 . . . . 0.0 110.528 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 40' ' ' CYS . 0.5 OUTLIER 74.88 56.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.118 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.34 161.02 43.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.25 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.468 2.112 . . . . 0.0 112.073 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 39' ' ' MET . 88.8 t -58.0 105.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.235 -0.915 . . . . 0.0 109.07 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -68.67 -65.49 0.69 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -0.988 . . . . 0.0 108.774 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.467 ' H ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -150.39 125.49 9.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.01 179.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.541 HG21 ' HB1' ' A' ' 29' ' ' ALA . 4.2 mt -81.39 145.08 9.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 109.172 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -139.12 145.93 40.05 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 121.787 0.803 . . . . 0.0 110.095 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -88.97 143.72 26.66 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.333 0.587 . . . . 0.0 109.762 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.67 161.04 41.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.326 -0.859 . . . . 0.0 109.469 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.527 ' N ' ' OG ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -84.86 166.92 16.47 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.149 -0.97 . . . . 0.0 109.455 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.487 ' CG ' ' H ' ' A' ' 56' ' ' GLY . 8.4 ptp180 -58.81 -58.54 8.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.18 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.487 ' H ' ' CG ' ' A' ' 55' ' ' ARG . . . -75.38 23.79 1.48 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.811 ' O ' HD23 ' A' ' 58' ' ' LEU . 16.5 m -86.1 -14.67 43.54 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.108 -1.23 . . . . 0.0 109.388 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 57' ' ' SER . 1.1 mt -135.4 172.45 13.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.71 -0.619 . . . . 0.0 109.452 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 59' ' ' PHE . 18.9 m-85 -114.96 122.65 46.91 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.5 mmt -84.79 144.31 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.668 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.7 t -78.23 143.4 37.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 109.242 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.4 t -128.23 67.99 1.35 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.551 -0.718 . . . . 0.0 109.796 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.577 HG21 ' ND1' ' A' ' 85' ' ' HIS . 3.8 mm -126.81 -20.46 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -170.37 140.16 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.0 109.363 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -48.66 137.81 11.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.246 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.78 77.46 0.2 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -89.59 -171.48 3.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -1.108 . . . . 0.0 109.906 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.65 -59.82 4.38 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.417 -0.802 . . . . 0.0 109.672 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.467 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.3 OUTLIER -179.88 -168.95 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.278 -0.889 . . . . 0.0 110.742 -179.395 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.5 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -89.41 -173.48 4.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.407 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.612 ' C ' HD23 ' A' ' 72' ' ' LEU . 66.3 m-85 -154.89 171.31 19.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.224 -0.922 . . . . 0.0 108.671 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.773 ' N ' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -107.14 -2.18 21.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.4 -0.812 . . . . 0.0 110.946 -178.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 74' ' ' GLN . 1.4 p -160.66 134.42 6.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.242 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.418 ' O ' ' N ' ' A' ' 78' ' ' GLN . 0.7 OUTLIER -42.9 -29.72 0.35 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -65.35 -34.36 78.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.439 -0.788 . . . . 0.0 110.425 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -83.9 -35.41 24.11 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.082 -1.011 . . . . 0.0 108.288 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.617 ' C ' HD23 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -75.94 -31.6 59.16 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.575 ' N ' HD23 ' A' ' 77' ' ' LEU . 22.3 tp60 -73.77 -33.78 64.4 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' CG ' ' A' ' 83' ' ' HIS . . . -72.69 -19.66 61.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.838 ' CE1' ' HE2' ' A' ' 85' ' ' HIS . 5.5 t60 -72.73 -51.53 18.87 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.196 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.588 ' N ' HD13 ' A' ' 81' ' ' ILE . 1.6 mm -51.66 -53.05 18.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.666 -0.646 . . . . 0.0 109.657 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -69.07 -19.07 64.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.104 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 79' ' ' ALA . 14.1 m170 -87.08 -28.15 22.72 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.723 -1.191 . . . . 0.0 112.031 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -129.42 -23.42 2.93 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.454 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.838 ' HE2' ' CE1' ' A' ' 80' ' ' HIS . 4.8 m-70 -104.34 -47.27 4.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 0.0 109.27 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.401 ' C ' ' O ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER 43.87 35.86 1.21 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.292 0.568 . . . . 0.0 109.866 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.2 ttp85 -174.55 154.88 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.53 140.99 50.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 CA-C-O 118.021 -1.433 . . . . 0.0 109.543 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_